<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1">
<title>Lifenome — Precision Health API Platform</title>
<link href="https://fonts.googleapis.com/css2?family=Sora:wght@300;400;500;600;700;800&family=DM+Mono:wght@300;400;500&family=DM+Sans:ital,wght@0,300;0,400;0,500;0,600;1,300&display=swap" rel="stylesheet">
<style>


















*{margin:0;padding:0;box-sizing:border-box}
:root{
  --ink:#0a0e1a;--ink2:#2c3550;--ink3:#5a6a8a;--ink4:#9aaccc;
  --paper:#fff;--sheet:#f3f6fb;--border:#dde6f0;--border2:#c4d4e8;
  --blue:#1452d4;--blue-lt:#e8effe;
  --s1:0 1px 4px rgba(10,14,26,.06);
  --s2:0 2px 12px rgba(10,14,26,.09),0 8px 32px rgba(10,14,26,.07);
  --r:10px;
}
html,body{height:100%;font-family:'DM Sans',sans-serif;background:var(--sheet);color:var(--ink);font-size:14px;line-height:1.5}

/* ─── ONBOARDING ─────────────────────────────────────────────────────── */
.ob-page{display:flex;flex-direction:column;align-items:center;justify-content:center;
  min-height:100vh;padding:40px 20px;
  background:linear-gradient(145deg,#f0f4ff 0%,#fff8fc 50%,#f0fff8 100%)}
.ob-card{background:#fff;border-radius:18px;box-shadow:var(--s2);
  padding:48px 52px;width:100%;max-width:700px}
.ob-logo{height:52px;display:block;margin:0 auto 24px;object-fit:contain}
.ob-title{font-family:'Sora',sans-serif;font-size:22px;font-weight:800;color:var(--ink);
  text-align:center;margin-bottom:6px}
.ob-sub{font-size:13px;color:var(--ink3);text-align:center;margin-bottom:36px;line-height:1.65}
.ob-row{display:grid;grid-template-columns:1fr 1fr;gap:14px}
.ob-fieldset{margin-bottom:20px}
.ob-label{font-size:12px;font-weight:600;color:var(--ink2);display:block;margin-bottom:6px}
.ob-input{width:100%;padding:11px 14px;border:1.5px solid var(--border);border-radius:8px;
  font-family:'DM Sans',sans-serif;font-size:14px;color:var(--ink);background:#fff;
  transition:border-color .15s,box-shadow .15s;outline:none}
.ob-input:focus{border-color:var(--blue);box-shadow:0 0 0 3px rgba(20,82,212,.12)}
.ob-input::placeholder{color:var(--ink4)}
.ob-types-label{font-size:12px;font-weight:600;color:var(--ink2);margin-bottom:12px;display:block}
/* 4-column grid of thumbnail tiles */
.ob-types-grid{display:grid;grid-template-columns:repeat(4,1fr);gap:10px;margin-bottom:28px}
.ob-type{display:flex;flex-direction:column;align-items:center;gap:0;
  border:2px solid var(--border);border-radius:12px;cursor:pointer;
  transition:all .15s;text-align:center;background:#fff;user-select:none;overflow:hidden}
.ob-type:hover{border-color:var(--blue);transform:translateY(-2px);box-shadow:var(--s1)}
.ob-type.sel{border-color:var(--blue);box-shadow:0 0 0 3px rgba(20,82,212,.15)}
.ob-type-img{width:100%;height:56px;object-fit:cover;display:block;transition:opacity .15s}
.ob-type.sel .ob-type-img{opacity:.85}
.ob-type-lbl{font-size:10.5px;font-weight:600;color:var(--ink2);line-height:1.3;
  padding:7px 6px;display:block}
.ob-type.sel .ob-type-lbl{color:var(--blue)}
.ob-type-check{width:16px;height:16px;border-radius:50%;background:var(--blue);
  color:#fff;font-size:9px;display:none;align-items:center;justify-content:center;
  position:absolute;top:4px;right:4px}
.ob-type{position:relative}
.ob-type.sel .ob-type-check{display:flex}
.ob-btn{width:100%;padding:14px;border-radius:10px;background:var(--blue);color:#fff;
  border:none;cursor:pointer;font-family:'Sora',sans-serif;font-size:14px;font-weight:700;
  transition:all .15s;display:flex;align-items:center;justify-content:center;gap:8px}
.ob-btn:hover{background:#1045b8;box-shadow:0 4px 16px rgba(20,82,212,.3)}
.ob-btn:disabled{opacity:.4;cursor:not-allowed}
.ob-err{font-size:11.5px;color:#c03030;margin-top:8px;display:none}
.ob-err.show{display:block}
.ob-pass-err{font-size:11.5px;color:#c03030;margin-top:6px;display:none}
.ob-pass-err.show{display:block}
.ob-sel-count{font-size:11px;color:var(--blue);font-weight:600;margin-bottom:10px;
  display:block;min-height:16px}

/* ─── MAIN APP ────────────────────────────────────────────────────────── */
.hdr{background:#fff;border-bottom:1px solid var(--border);height:64px;
  display:flex;align-items:center;justify-content:space-between;padding:0 24px;
  box-shadow:var(--s1);position:sticky;top:0;z-index:300}
.hdr-left{display:flex;align-items:center;gap:14px}
.hdr-logo{height:44px;object-fit:contain;cursor:pointer}
.hdr-sep{width:1px;height:26px;background:var(--border2)}
.hdr-title{font-family:'Sora',sans-serif;font-size:12.5px;font-weight:700;color:var(--ink);display:block;line-height:1.2}
.hdr-sub{font-size:11px;color:var(--ink3);display:block;margin-top:1px}
.hdr-org{font-family:'DM Mono',monospace;font-size:10.5px;padding:3px 10px;border-radius:20px;
  background:var(--blue-lt);border:1px solid rgba(20,82,212,.2);color:var(--blue);font-weight:500;max-width:180px;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}
.hdr-right{display:flex;align-items:center;gap:8px}
.hdr-pill{font-family:'DM Mono',monospace;font-size:11px;padding:3px 10px;border-radius:20px;
  background:var(--sheet);border:1px solid var(--border);color:var(--ink3)}
.cart-btn{display:flex;align-items:center;gap:7px;padding:7px 14px;border-radius:8px;
  background:var(--ink);color:#fff;border:none;cursor:pointer;
  font-family:'Sora',sans-serif;font-size:12px;font-weight:700;transition:all .15s}
.cart-btn:hover{background:#1a2a4a}
.cart-count{background:rgba(255,255,255,.2);color:#fff;font-family:'DM Mono',monospace;
  font-size:10px;padding:1px 7px;border-radius:10px;min-width:20px;text-align:center}
.cart-btn.has-items{background:#c03030}
.layout{display:grid;grid-template-columns:268px 1fr;min-height:calc(100vh - 64px)}
.sidebar{background:#fff;border-right:1px solid var(--border);padding:10px 6px;
  overflow-y:auto;position:sticky;top:64px;max-height:calc(100vh - 64px)}
.sb-lbl{font-family:'DM Mono',monospace;font-size:9px;font-weight:600;letter-spacing:.14em;
  text-transform:uppercase;color:var(--ink4);padding:0 8px;margin:12px 0 5px;display:block}
.all-btn{display:flex;align-items:center;gap:9px;width:100%;padding:8px 9px;
  border-radius:8px;border:2px solid transparent;background:transparent;
  cursor:pointer;text-align:left;transition:all .13s;margin-bottom:5px}
.all-btn:hover{background:#f0f4ff;border-color:rgba(20,82,212,.2)}
.all-btn.active{background:var(--blue-lt);border-color:var(--blue)}
.all-thumb{width:40px;height:40px;border-radius:7px;overflow:hidden;flex-shrink:0;
  background:linear-gradient(135deg,#1452d4,#7a40d4)}
.all-thumb img{width:100%;height:100%;object-fit:cover}
.all-name{font-family:'Sora',sans-serif;font-size:12.5px;font-weight:700;color:var(--ink);display:block}
.all-sub{font-size:10.5px;color:var(--ink3);display:block;margin-top:1px}
.cat-btn{display:flex;align-items:center;gap:9px;width:100%;padding:6px 9px;
  border-radius:7px;border:1.5px solid transparent;background:transparent;
  cursor:pointer;text-align:left;transition:all .13s;margin-bottom:2px}
.cat-btn:hover{background:rgba(255,255,255,.9);border-color:var(--border)}
.cat-btn.active{background:#fff;border-color:var(--cc,var(--blue));
  box-shadow:0 0 0 3px color-mix(in srgb,var(--cc,var(--blue)) 10%,transparent)}
.cat-thumb{width:34px;height:34px;border-radius:6px;overflow:hidden;flex-shrink:0;border:1px solid var(--border)}
.cat-thumb img{width:100%;height:100%;object-fit:cover;display:block}
.cat-name{font-size:11.5px;font-weight:600;color:var(--ink);display:block;
  white-space:nowrap;overflow:hidden;text-overflow:ellipsis}
.cat-sub-text{font-size:10px;color:var(--ink3);display:block;margin-top:1px;
  white-space:nowrap;overflow:hidden;text-overflow:ellipsis}
.sb-more-toggle{width:calc(100% - 16px);margin:4px 8px;padding:7px 10px;
  border-radius:7px;border:1px dashed var(--border2);background:transparent;
  cursor:pointer;font-size:11px;font-weight:600;color:var(--ink3);
  display:flex;align-items:center;gap:6px;transition:all .13s}
.sb-more-toggle:hover{background:var(--sheet);color:var(--ink)}
.sb-more-arrow{transition:transform .2s;font-size:10px;margin-left:auto}
.sb-more-toggle.open .sb-more-arrow{transform:rotate(180deg)}
.sb-more-section{overflow:hidden;max-height:0;transition:max-height .35s ease}
.sb-more-section.open{max-height:800px}
.main{padding:20px 24px;overflow-y:auto}
.prog-hdr{display:flex;gap:18px;align-items:flex-start;margin-bottom:18px;
  padding-bottom:16px;border-bottom:2px solid var(--border)}
.prog-hdr-thumb{width:72px;height:72px;border-radius:10px;overflow:hidden;
  flex-shrink:0;border:1px solid var(--border);box-shadow:var(--s1)}
.prog-hdr-thumb img{width:100%;height:100%;object-fit:cover}
.prog-crumb{font-family:'DM Mono',monospace;font-size:8.5px;font-weight:600;
  letter-spacing:.12em;text-transform:uppercase;color:var(--ink4);margin-bottom:3px;display:block}
.prog-title{font-family:'Sora',sans-serif;font-size:22px;font-weight:800;color:var(--ink);
  letter-spacing:-.3px;margin-bottom:4px}
.prog-title em{font-style:normal;color:var(--ac,var(--blue))}
.prog-desc{font-size:12px;color:var(--ink2);line-height:1.6;margin-bottom:7px;max-width:580px}
.prog-tags{display:flex;flex-wrap:wrap;gap:4px;margin-bottom:8px}
.prog-tag{font-size:10px;font-weight:500;padding:2px 8px;border-radius:20px;
  background:color-mix(in srgb,var(--ac,var(--blue)) 8%,white);
  color:var(--ac,var(--blue));border:1px solid color-mix(in srgb,var(--ac,var(--blue)) 16%,transparent)}
.prog-stats{display:flex;gap:6px;flex-wrap:wrap}
.prog-stat{display:flex;align-items:center;gap:6px;padding:6px 11px;border-radius:8px;
  border:1px solid var(--border);background:var(--sheet)}
.ps-num{font-family:'Sora',sans-serif;font-size:17px;font-weight:800;color:var(--ac,var(--blue));line-height:1}
.ps-lbl{font-size:10px;color:var(--ink3);font-weight:500;line-height:1.2}

/* competitor badge */
.comp-badge{font-size:9px;font-weight:700;padding:2px 6px;border-radius:4px;
  display:inline-flex;align-items:center;gap:3px;margin-left:4px;
  background:#fff3e0;border:1px solid #f0a030;color:#b06010}

.body-grid{display:grid;grid-template-columns:1fr 330px;gap:16px;align-items:start}
.ds-panel{background:#fff;border:1px solid var(--border);border-radius:var(--r);
  padding:14px;position:sticky;top:calc(64px + 14px);box-shadow:var(--s1)}
.ds-panel-title{font-family:'Sora',sans-serif;font-size:12px;font-weight:700;color:var(--ink);margin-bottom:2px}
.ds-panel-sub{font-size:10.5px;color:var(--ink3);margin-bottom:10px;line-height:1.5}
.ds-item{border:1px solid var(--border);border-radius:7px;background:var(--sheet);
  margin-bottom:3px;overflow:hidden;cursor:pointer;transition:all .12s;user-select:none}
.ds-item:hover{border-color:var(--border2);background:#fff}
.ds-item.on{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 4%,white)}
.ds-row{display:flex;align-items:center;gap:7px;padding:7px 9px}
.ds-num{font-family:'DM Mono',monospace;font-size:8.5px;font-weight:600;width:14px;color:var(--ink4);flex-shrink:0}
.ds-ico{font-size:13px;flex-shrink:0;width:16px;text-align:center}
.ds-info{flex:1;min-width:0}
.ds-name{font-size:11.5px;font-weight:600;color:var(--ink);display:block}
.ds-hint{font-size:10px;color:var(--ink3);display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis}
.ds-chk{width:14px;height:14px;border-radius:3px;border:1.5px solid var(--border2);
  display:flex;align-items:center;justify-content:center;font-size:8px;flex-shrink:0;
  transition:all .12s;background:transparent;color:transparent}
.ds-item.on .ds-chk{background:var(--ac,var(--blue));border-color:var(--ac,var(--blue));color:#fff}
.ds-badge{font-family:'DM Mono',monospace;font-size:9px;font-weight:600;padding:1px 5px;
  border-radius:10px;background:var(--ac,var(--blue));color:#fff;display:none;flex-shrink:0}
.ds-item.on .ds-badge{display:inline}
.blood-sub{border-top:1px solid var(--border);background:#fff;padding:7px 9px;display:none}
.ds-item.on .blood-sub{display:block}
.blood-sub-lbl{font-size:9.5px;font-weight:700;color:var(--ink3);margin-bottom:5px;
  text-transform:uppercase;letter-spacing:.07em}
.bt{display:flex;align-items:flex-start;gap:6px;padding:4px 7px;border-radius:4px;
  border:1px solid transparent;cursor:pointer;transition:all .1s;background:var(--sheet);margin-bottom:2px}
.bt:hover{border-color:var(--border2)}
.bt.sel{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 5%,white)}
.bt-radio{width:11px;height:11px;border-radius:50%;border:1.5px solid var(--border2);
  flex-shrink:0;margin-top:2px;transition:all .1s;display:flex;align-items:center;justify-content:center}
.bt.sel .bt-radio{border-color:var(--ac,var(--blue))}
.bt-dot{width:5px;height:5px;border-radius:50%;background:var(--ac,var(--blue));display:none}
.bt.sel .bt-dot{display:block}
.bt-name{font-size:11px;font-weight:600;color:var(--ink);display:block}
.bt-items{font-size:9.5px;color:var(--ink3);display:block;margin-top:1px;line-height:1.4}
.no-src{text-align:center;padding:40px 16px;color:var(--ink4)}
.no-src-icon{font-size:26px;margin-bottom:8px}
.no-src-p{font-size:12px;line-height:1.6}
.total-bar{display:flex;align-items:center;gap:12px;flex-wrap:wrap;padding:10px 14px;
  border-radius:8px;margin-bottom:14px;
  background:linear-gradient(135deg,color-mix(in srgb,var(--ac,var(--blue)) 7%,white),white);
  border:1px solid color-mix(in srgb,var(--ac,var(--blue)) 12%,transparent)}
.t-num{font-family:'Sora',sans-serif;font-size:19px;font-weight:800;color:var(--ac,var(--blue));line-height:1}
.t-lbl{font-size:10px;color:var(--ink3);font-weight:500;margin-top:2px}
.t-sep{width:1px;height:22px;background:var(--border);margin:0 2px;flex-shrink:0}
.src-block{margin-bottom:14px;animation:fu .2s ease both}
@keyframes fu{from{opacity:0;transform:translateY(4px)}to{opacity:1;transform:translateY(0)}}
.src-hdr{display:flex;align-items:center;gap:8px;padding:8px 12px;border-radius:7px 7px 0 0;color:#fff}
.src-hdr-ico{font-size:14px}
.src-hdr-name{font-family:'Sora',sans-serif;font-size:12px;font-weight:700;flex:1}
.src-hdr-count{font-family:'DM Mono',monospace;font-size:10px;background:rgba(255,255,255,.15);padding:2px 7px;border-radius:9px}
.ins-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(230px,1fr));gap:5px;
  padding:6px;background:var(--sheet);border:1px solid var(--border);border-top:none;border-radius:0 0 7px 7px}
.ins-card{background:#fff;border:1px solid var(--border);border-radius:6px;padding:10px 12px;
  transition:all .12s;position:relative}
.ins-card:hover{box-shadow:var(--s2);border-color:var(--border2)}
.ins-card.carted{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 3%,white)}
.ic-cart{position:absolute;top:8px;right:8px;width:17px;height:17px;border-radius:4px;
  border:1.5px solid var(--border2);display:flex;align-items:center;justify-content:center;
  font-size:9px;cursor:pointer;transition:all .12s;background:#fff;color:transparent}
.ic-cart:hover{border-color:var(--ac,var(--blue));background:color-mix(in srgb,var(--ac,var(--blue)) 8%,white)}
.ins-card.carted .ic-cart{background:var(--ac,var(--blue));border-color:var(--ac,var(--blue));color:#fff}
.ic-src{font-family:'DM Mono',monospace;font-size:8px;font-weight:500;letter-spacing:.08em;
  text-transform:uppercase;padding:2px 5px;border-radius:3px;margin-bottom:4px;display:inline-block}
.ic-cat{font-size:9px;font-weight:600;padding:1px 7px;border-radius:20px;
  display:inline-block;margin-bottom:3px;margin-right:20px}
.ic-name{font-size:11.5px;font-weight:700;color:var(--ink);margin-bottom:2px;
  line-height:1.3;padding-right:20px}
.ic-desc{font-size:10px;color:var(--ink3);line-height:1.5;margin-bottom:4px}
.ic-unit{font-family:'DM Mono',monospace;font-size:9px;color:var(--ink2);background:var(--sheet);
  padding:2px 5px;border-radius:3px;border:1px solid var(--border);display:inline-block;margin-bottom:2px}
.ic-range{font-size:9px;color:#0a7c6e;font-style:italic;line-height:1.4;display:block;margin-bottom:3px}
.ic-markers{display:flex;flex-wrap:wrap;gap:2px}
.ic-m{font-family:'DM Mono',monospace;font-size:8.5px;padding:1px 5px;border-radius:3px;
  background:var(--sheet);border:1px solid var(--border);color:var(--ink3)}
.api-block{margin-top:14px;background:var(--ink);border-radius:8px;padding:14px 16px}
.api-title{font-family:'Sora',sans-serif;font-size:11.5px;font-weight:700;color:#fff;margin-bottom:7px}
.api-eps{display:flex;flex-direction:column;gap:3px}
.api-ep{display:flex;align-items:center;gap:8px;background:rgba(255,255,255,.04);
  border:1px solid rgba(255,255,255,.08);border-radius:4px;padding:5px 9px}
.api-method{font-family:'DM Mono',monospace;font-size:9px;font-weight:600;padding:2px 5px;border-radius:3px;flex-shrink:0}
.api-method.get{background:rgba(20,200,150,.18);color:#0dd9a0}
.api-method.post{background:rgba(80,120,250,.18);color:#7095fd}
.api-path{font-family:'DM Mono',monospace;font-size:9.5px;color:rgba(255,255,255,.5);flex:1}
.api-note{margin-top:7px;font-size:9.5px;color:rgba(255,255,255,.25);font-family:'DM Mono',monospace}

/* competitor insight callout box */
.comp-callout{background:linear-gradient(135deg,#fff8e8,#fffaf2);
  border:1px solid #e8c060;border-radius:6px;padding:8px 11px;margin:8px 0 6px;
  font-size:10px;color:#7a5010;line-height:1.5}
.comp-callout strong{color:#5a3800}

/* ─── CART OVERLAY ────────────────────────────────────────────────────── */
.cart-overlay{display:none;position:fixed;inset:0;z-index:500;
  background:rgba(10,14,26,.5);backdrop-filter:blur(4px)}
.cart-overlay.open{display:flex;justify-content:flex-end}
.cart-panel{background:#fff;width:min(760px,100vw);height:100%;
  display:flex;flex-direction:column;box-shadow:-8px 0 40px rgba(10,14,26,.15);
  animation:slideIn .25s ease both}
@keyframes slideIn{from{transform:translateX(40px);opacity:0}to{transform:translateX(0);opacity:1}}
.cart-hdr{display:flex;align-items:center;justify-content:space-between;
  padding:18px 22px;border-bottom:1px solid var(--border);background:var(--ink)}
.cart-hdr-title{font-family:'Sora',sans-serif;font-size:15px;font-weight:800;color:#fff}
.cart-hdr-sub{font-size:10.5px;color:rgba(255,255,255,.5);margin-top:2px}
.cart-close{width:30px;height:30px;border-radius:6px;background:rgba(255,255,255,.1);
  border:none;cursor:pointer;color:#fff;font-size:16px;
  display:flex;align-items:center;justify-content:center;transition:all .12s}
.cart-close:hover{background:rgba(255,255,255,.2)}
.cart-body{flex:1;overflow-y:auto;padding:18px 22px}
.cart-empty{text-align:center;padding:48px 20px;color:var(--ink4)}
.cart-sec-title{font-family:'Sora',sans-serif;font-size:10.5px;font-weight:700;
  letter-spacing:.06em;text-transform:uppercase;color:var(--ink3);margin-bottom:10px;
  display:flex;align-items:center;gap:8px}
.cart-sec-title::after{content:'';flex:1;height:1px;background:var(--border)}
.modality-block{border:1px solid var(--border);border-radius:9px;overflow:hidden;margin-bottom:8px}
.modality-hdr{display:flex;align-items:center;gap:10px;padding:11px 14px;color:#fff}
.mod-ico{font-size:16px;flex-shrink:0}
.mod-hdr-name{font-family:'Sora',sans-serif;font-size:13px;font-weight:700;flex:1}
.mod-hdr-count{font-family:'DM Mono',monospace;font-size:10px;background:rgba(255,255,255,.15);padding:2px 8px;border-radius:9px}
.modality-biomarkers{padding:10px 14px;background:var(--sheet)}
.mod-bm-lbl{font-size:10px;font-weight:700;color:var(--ink3);text-transform:uppercase;
  letter-spacing:.07em;margin-bottom:7px}
.mod-bm-list{display:flex;flex-wrap:wrap;gap:4px}
.mod-bm{font-family:'DM Mono',monospace;font-size:9.5px;padding:2px 7px;border-radius:4px;
  background:#fff;border:1px solid var(--border);color:var(--ink2)}
.cart-ins-prog{margin-bottom:10px}
.cart-prog-hdr{font-family:'Sora',sans-serif;font-size:11px;font-weight:700;
  display:flex;align-items:center;gap:6px;margin-bottom:5px}
.cart-dot{width:8px;height:8px;border-radius:50%;flex-shrink:0;margin-top:1px}
.cart-item{display:flex;align-items:flex-start;gap:9px;padding:8px 11px;
  border:1px solid var(--border);border-radius:6px;background:var(--sheet);margin-bottom:4px}
.cart-item-info{flex:1;min-width:0}
.cart-item-name{font-size:11.5px;font-weight:600;color:var(--ink);display:block;line-height:1.3}
.cart-item-meta{font-size:10px;color:var(--ink3);margin-top:2px;display:block}
.cart-item-range{font-size:9px;color:#0a7c6e;margin-top:2px;display:block;font-style:italic}
.cart-rm{background:none;border:none;cursor:pointer;color:var(--ink4);font-size:13px;
  padding:2px 4px;border-radius:4px;transition:all .1s;flex-shrink:0}
.cart-rm:hover{background:#fee;color:#c33}
.cart-footer{padding:14px 22px;border-top:1px solid var(--border);background:#fff;
  display:flex;flex-direction:column;gap:8px}
.send-btn{width:100%;padding:13px;border-radius:9px;
  background:linear-gradient(135deg,#1452d4,#7a30c8);color:#fff;
  border:none;cursor:pointer;font-family:'Sora',sans-serif;font-size:13px;font-weight:700;
  transition:all .15s;display:flex;align-items:center;justify-content:center;gap:8px}
.send-btn:hover{filter:brightness(1.1);box-shadow:0 4px 16px rgba(20,82,212,.35)}
.export-btn{width:100%;padding:10px;border-radius:9px;
  background:var(--sheet);color:var(--ink);
  border:1.5px solid var(--border);cursor:pointer;font-family:'DM Sans',sans-serif;
  font-size:12px;font-weight:600;transition:all .15s;display:flex;align-items:center;
  justify-content:center;gap:7px}
.export-btn:hover{border-color:var(--border2);background:#fff}


/* Subcategory group headers in insight grid */
.subcat-hdr{
  grid-column:1/-1;
  display:flex;align-items:center;gap:8px;
  margin:10px 0 4px;
  padding:6px 10px;
  background:linear-gradient(90deg,color-mix(in srgb,var(--ac,#1452d4) 8%,white),transparent);
  border-left:3px solid var(--ac,#1452d4);
  border-radius:0 6px 6px 0;
}
.subcat-hdr-ico{font-size:14px}
.subcat-hdr-name{
  font-family:'Sora',sans-serif;font-size:11.5px;font-weight:800;
  color:var(--ac,#1452d4);letter-spacing:.01em;
}
.subcat-hdr-count{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:1px 6px;border-radius:9px;
  background:color-mix(in srgb,var(--ac,#1452d4) 10%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 18%,transparent);
  color:var(--ac,#1452d4);margin-left:auto;
}
/* Subcategory badge on insight card */
.ic-subcat{
  font-size:8.5px;font-weight:700;padding:1px 5px;border-radius:3px;
  display:inline-block;margin-bottom:3px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  color:var(--ac,#1452d4);border:1px solid color-mix(in srgb,var(--ac,#1452d4) 12%,transparent);
  text-transform:uppercase;letter-spacing:.05em;
}


/* ─── INSIGHT TYPE FILTER ────────────────────────────────────────── */
.filter-bar{
  display:flex;align-items:center;gap:8px;flex-wrap:wrap;
  padding:10px 14px;background:#fff;border:1px solid var(--border);
  border-radius:9px;margin-bottom:14px;
  box-shadow:var(--s1);
}
.filter-bar-lbl{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  letter-spacing:.12em;text-transform:uppercase;color:var(--ink4);
  margin-right:4px;flex-shrink:0;
}
.filter-chip{
  display:flex;align-items:center;gap:5px;padding:5px 11px;
  border-radius:20px;border:1.5px solid var(--border2);
  background:#fff;cursor:pointer;user-select:none;
  transition:all .13s;font-size:11.5px;font-weight:600;color:var(--ink3);
}
.filter-chip:hover{border-color:var(--chip-color,var(--blue));color:var(--chip-color,var(--blue))}
.filter-chip.active{
  background:color-mix(in srgb,var(--chip-color,var(--blue)) 10%,white);
  border-color:var(--chip-color,var(--blue));
  color:var(--chip-color,var(--blue));
}
.filter-chip-ico{font-size:12px;line-height:1}
.filter-chip-cnt{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:1px 5px;border-radius:8px;
  background:color-mix(in srgb,var(--chip-color,var(--blue)) 12%,white);
  color:var(--chip-color,var(--blue));
  display:none;
}
.filter-chip.active .filter-chip-cnt{display:inline}
.filter-sep{width:1px;height:18px;background:var(--border2);margin:0 2px;flex-shrink:0}

/* ─── SUBCATEGORY HEADERS (enhanced) ─────────────────────────────── */
.subcat-hdr{
  grid-column:1/-1;
  display:flex;align-items:center;gap:8px;
  margin:10px 0 4px;
  padding:6px 10px;
  background:linear-gradient(90deg,color-mix(in srgb,var(--ac,#1452d4) 8%,white),transparent);
  border-left:3px solid var(--ac,#1452d4);
  border-radius:0 6px 6px 0;
}
.subcat-hdr-ico{font-size:14px}
.subcat-hdr-name{
  font-family:'Sora',sans-serif;font-size:11.5px;font-weight:800;
  color:var(--ac,#1452d4);letter-spacing:.01em;
}
.subcat-hdr-count{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:1px 6px;border-radius:9px;
  background:color-mix(in srgb,var(--ac,#1452d4) 10%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 18%,transparent);
  color:var(--ac,#1452d4);margin-left:auto;
}

/* ─── RECOMMENDATION CARD STYLING ────────────────────────────────── */
.ins-card[data-itype="recommendation"]{
  border-color:color-mix(in srgb,#16a34a 25%,var(--border));
  background:linear-gradient(135deg,#f0fdf4,#fff);
}
.ins-card[data-itype="recommendation"].carted{
  border-color:#16a34a;
  background:linear-gradient(135deg,color-mix(in srgb,#16a34a 6%,white),white);
}
.ins-card[data-itype="recommendation"] .ic-cart:hover{
  border-color:#16a34a;
  background:color-mix(in srgb,#16a34a 10%,white);
}
.ins-card[data-itype="recommendation"].carted .ic-cart{
  background:#16a34a;border-color:#16a34a;
}
.rec-badge{
  display:inline-flex;align-items:center;gap:3px;
  font-size:8.5px;font-weight:700;padding:2px 6px;border-radius:3px;
  background:linear-gradient(135deg,#dcfce7,#bbf7d0);
  border:1px solid #86efac;color:#15803d;
  text-transform:uppercase;letter-spacing:.05em;margin-bottom:3px;
}
.rec-type-badge{
  display:inline-flex;align-items:center;gap:3px;
  font-size:8px;font-weight:600;padding:1px 5px;border-radius:3px;
  margin-left:4px;
}
.rec-type-badge.program{background:#dbeafe;border:1px solid #93c5fd;color:#1d4ed8}
.rec-type-badge.product{background:#fef9c3;border:1px solid #fcd34d;color:#92400e}

/* ─── ASSESSMENT CARD SUBTLE INDICATOR ──────────────────────────── */
.ins-card[data-itype="biomarker_assessment"]{
  border-left:2px solid color-mix(in srgb,var(--ac,#1452d4) 30%,var(--border));
}
.assess-badge{
  display:inline-flex;align-items:center;gap:3px;
  font-size:8.5px;font-weight:700;padding:2px 6px;border-radius:3px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 15%,transparent);
  color:var(--ac,#1452d4);text-transform:uppercase;
  letter-spacing:.05em;margin-bottom:3px;
}

/* ─── EMPTY STATE FOR FILTERS ────────────────────────────────────── */
.filter-empty{
  grid-column:1/-1;text-align:center;padding:32px 20px;color:var(--ink4);
}
.filter-empty-ico{font-size:24px;margin-bottom:6px}
.filter-empty-p{font-size:12px;line-height:1.6}

/* Subcat badge */
.ic-subcat{
  font-size:8.5px;font-weight:700;padding:1px 5px;border-radius:3px;
  display:inline-block;margin-bottom:3px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  color:var(--ac,#1452d4);border:1px solid color-mix(in srgb,var(--ac,#1452d4) 12%,transparent);
  text-transform:uppercase;letter-spacing:.05em;
}
.comp-badge{font-size:9px;font-weight:700;padding:2px 6px;border-radius:4px;
  display:inline-flex;align-items:center;gap:3px;margin-left:4px;
  background:#fff3e0;border:1px solid #f0a030;color:#b06010}
.comp-callout{background:linear-gradient(135deg,#fff8e8,#fffaf2);
  border:1px solid #e8c060;border-radius:6px;padding:8px 11px;margin:8px 0 6px;
  font-size:10px;color:#7a5010;line-height:1.5}


/* ─── COVER FORM: chip selectors ─────────────────────────────────── */
.ob-chip-group{display:flex;flex-wrap:wrap;gap:7px;margin-top:4px}
.ob-chip-group--2{gap:10px}
.ob-chip{
  padding:6px 13px;border-radius:20px;border:1.5px solid var(--border2);
  background:#fff;cursor:pointer;user-select:none;
  font-size:11.5px;font-weight:600;color:var(--ink3);
  transition:all .13s;line-height:1.3;white-space:nowrap;
}
.ob-chip:hover{border-color:var(--blue);color:var(--blue);background:var(--blue-lt)}
.ob-chip.sel{
  background:var(--blue);border-color:var(--blue);color:#fff;
  box-shadow:0 2px 8px rgba(20,82,212,.25);
}
.ob-chip--lg{padding:7px 22px;font-size:13px;border-radius:8px}

/* ─── COVER FORM: range slider ────────────────────────────────────── */
.ob-slider-wrap{margin-top:4px}
.ob-slider{
  -webkit-appearance:none;appearance:none;
  width:100%;height:5px;border-radius:3px;
  background:linear-gradient(to right,var(--blue) 0%,var(--blue) 10%,var(--border2) 10%,var(--border2) 100%);
  outline:none;cursor:pointer;
}
.ob-slider::-webkit-slider-thumb{
  -webkit-appearance:none;appearance:none;
  width:18px;height:18px;border-radius:50%;
  background:var(--blue);border:2px solid #fff;
  box-shadow:0 1px 6px rgba(20,82,212,.35);cursor:pointer;
}
.ob-slider::-moz-range-thumb{
  width:18px;height:18px;border-radius:50%;
  background:var(--blue);border:2px solid #fff;
  box-shadow:0 1px 6px rgba(20,82,212,.35);cursor:pointer;border:none;
}
.ob-slider-ticks{
  display:flex;justify-content:space-between;
  font-size:10px;color:var(--ink4);margin-top:5px;font-family:'DM Mono',monospace;
}

/* ─── COVER FORM: select dropdown ────────────────────────────────── */
.ob-select{
  -webkit-appearance:none;appearance:none;
  background-image:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='12' height='8' viewBox='0 0 12 8'%3E%3Cpath d='M1 1l5 5 5-5' stroke='%236b7280' stroke-width='1.5' fill='none' stroke-linecap='round'/%3E%3C/svg%3E");
  background-repeat:no-repeat;background-position:right 12px center;
  padding-right:32px;cursor:pointer;
}

/* ─── COVER CARD wider for new fields ────────────────────────────── */
.ob-card{max-width:760px}


/* ─── SEARCH BOX ─────────────────────────────────────────────────── */
.search-wrap{
  display:flex;align-items:center;gap:0;
  background:#fff;border:1.5px solid var(--border2);
  border-radius:9px;overflow:hidden;margin-bottom:12px;
  box-shadow:var(--s1);transition:border-color .15s,box-shadow .15s;
}
.search-wrap:focus-within{
  border-color:var(--blue);
  box-shadow:0 0 0 3px rgba(20,82,212,.1);
}
.search-ico{padding:0 12px;font-size:15px;color:var(--ink4);flex-shrink:0}
.search-input{
  flex:1;border:none;outline:none;padding:10px 0;
  font-family:'DM Sans',sans-serif;font-size:13px;color:var(--ink);
  background:transparent;
}
.search-input::placeholder{color:var(--ink4)}
.search-clear{
  padding:0 12px;font-size:16px;color:var(--ink4);cursor:pointer;
  display:none;line-height:1;flex-shrink:0;
}
.search-clear.visible{display:block}
.search-match{background:linear-gradient(120deg,#fef08a,#fde047);border-radius:2px;padding:0 1px}
.search-info{
  grid-column:1/-1;font-size:11.5px;color:var(--ink3);
  padding:4px 2px;font-family:'DM Mono',monospace;
}

/* ─── COLLAPSIBLE INSIGHT CARDS ──────────────────────────────────── */
.ins-card .ic-body{
  overflow:hidden;
  max-height:500px;
  transition:max-height .25s ease, opacity .2s ease;
  opacity:1;
}
.ins-card.collapsed .ic-body{
  max-height:0;
  opacity:0;
}
.ic-toggle{
  position:absolute;top:10px;right:36px;
  width:18px;height:18px;border-radius:50%;
  border:1.5px solid var(--border2);
  background:#fff;cursor:pointer;
  display:flex;align-items:center;justify-content:center;
  font-size:9px;color:var(--ink3);transition:all .15s;
  z-index:2;
}
.ic-toggle:hover{border-color:var(--ac,#1452d4);color:var(--ac,#1452d4)}
.ins-card.collapsed .ic-toggle{transform:rotate(180deg)}
.ic-name-row{
  display:flex;align-items:flex-start;gap:6px;
  cursor:pointer;padding-right:20px;
}
.ic-name-row:hover .ic-name{text-decoration:underline;text-decoration-color:var(--ac,#1452d4);text-underline-offset:2px}

/* ─── GENOMIC SCOPE BADGE ─────────────────────────────────────────── */
.ic-genomic{
  display:flex;flex-wrap:wrap;gap:5px;
  margin:5px 0 4px;
}
.ic-genomic-pill{
  display:inline-flex;align-items:center;gap:4px;
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  padding:2px 7px;border-radius:10px;
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  border:1px solid color-mix(in srgb,var(--ac,#1452d4) 14%,transparent);
  color:var(--ac,#1452d4);letter-spacing:.02em;
}
.ic-genomic-pill .gp-lbl{font-weight:400;color:var(--ink4);font-size:8px;margin-right:1px}

/* ─── DNA TIERS (like blood tiers) ───────────────────────────────── */
.dna-sub,.micro-sub,.ehr-sub{
  background:linear-gradient(135deg,#f8faff,#f0f4ff);
  border-top:1px solid var(--border);
  padding:10px 12px;
  display:none;
}
.ds-item.on .dna-sub,
.ds-item.on .micro-sub,
.ds-item.on .ehr-sub{display:block}
.dna-sub-lbl,.micro-sub-lbl,.ehr-sub-lbl{
  font-family:'DM Mono',monospace;font-size:9px;font-weight:600;
  text-transform:uppercase;letter-spacing:.1em;color:var(--ink4);
  margin-bottom:6px;display:block;
}
.dt, .mt, .et{
  display:flex;align-items:flex-start;gap:8px;padding:6px 8px;
  border-radius:7px;cursor:pointer;transition:background .12s;margin-bottom:3px;
}
.dt:hover,.mt:hover,.et:hover{background:rgba(20,82,212,.05)}
.dt.sel,.mt.sel,.et.sel{
  background:color-mix(in srgb,var(--ac,#1452d4) 8%,white);
}
.dt-radio,.mt-radio,.et-radio{
  width:14px;height:14px;border-radius:50%;border:2px solid var(--border2);
  flex-shrink:0;margin-top:2px;display:flex;align-items:center;justify-content:center;
  transition:border-color .12s;
}
.dt.sel .dt-radio,.mt.sel .mt-radio,.et.sel .et-radio{
  border-color:var(--ac,#1452d4);
}
.dt-dot,.mt-dot,.et-dot{
  width:6px;height:6px;border-radius:50%;
  background:var(--ac,#1452d4);
  display:none;
}
.dt.sel .dt-dot,.mt.sel .mt-dot,.et.sel .et-dot{display:block}
.dt-name,.mt-name,.et-name{
  font-size:11.5px;font-weight:700;color:var(--ink);display:block;line-height:1.2;
}
.dt-stats,.mt-stats{
  display:flex;flex-wrap:wrap;gap:4px;margin-top:3px;
}
.dt-stat,.mt-stat{
  font-family:'DM Mono',monospace;font-size:8.5px;
  padding:1px 5px;border-radius:4px;
  background:rgba(20,82,212,.07);color:var(--blue);
  font-weight:600;
}
.dt-items,.et-items{
  font-size:10px;color:var(--ink3);display:block;margin-top:2px;line-height:1.4;
}
.micro-sub-section{margin-bottom:8px}
.micro-sub-section-lbl{
  font-family:'DM Mono',monospace;font-size:8px;font-weight:700;
  text-transform:uppercase;letter-spacing:.1em;
  color:var(--ink4);padding:0 4px;margin-bottom:3px;display:block;
}


/* ─── CARD COLLAPSIBLE ───────────────────────────────────── */
.ic-collapsible{overflow:hidden;max-height:400px;transition:max-height .22s ease,opacity .18s ease;opacity:1}
.ins-card.collapsed .ic-collapsible{max-height:0;opacity:0}
.ic-name-click{
  display:flex;align-items:flex-start;justify-content:space-between;gap:6px;
  cursor:pointer;margin-bottom:2px;
}
.ic-name-click:hover .ic-name{color:var(--ac,#1452d4)}
.ic-tog{
  flex-shrink:0;width:18px;height:18px;border-radius:50%;
  border:1.5px solid var(--border2);background:#fff;
  display:flex;align-items:center;justify-content:center;
  font-size:8px;color:var(--ink4);transition:all .15s;margin-top:2px;
}
.ic-tog:hover{border-color:var(--ac,#1452d4);color:var(--ac,#1452d4)}
.ins-card.collapsed .ic-tog{transform:rotate(180deg)}
.ic-mkr-lbl{font-size:9px;font-weight:600;color:var(--ink3);margin:4px 0 2px;text-transform:uppercase;letter-spacing:.06em}



/* ── DNA PAGINATION ────────────────────────────────────────────── */
.dna-page-bar{grid-column:1/-1;display:flex;align-items:center;justify-content:space-between;padding:6px 10px;background:var(--sheet);border-radius:7px;margin-bottom:8px;font-size:11px;font-family:'DM Mono',monospace;color:var(--ink3);}
.dna-page-bar strong{color:var(--ink2)}
.dna-page-btn{padding:3px 10px;border-radius:5px;border:1.5px solid var(--border2);background:#fff;font-size:11px;cursor:pointer;font-weight:600;color:var(--ink2);transition:all .12s;}
.dna-page-btn:hover{border-color:var(--ac,#1452d4);color:var(--ac,#1452d4)}
.dna-page-btn:disabled{opacity:.35;cursor:default}
.subcat-cards{display:contents}



/* ── STATS BAR (collapsible biomarker pill row) ──────────────────── */
.stats-bar-wrap{margin-bottom:10px}
.stats-bar-toggle{
  display:flex;align-items:center;gap:6px;padding:6px 10px;
  background:#fff;border:1.5px solid var(--border2);border-radius:8px;
  cursor:pointer;font-size:11px;font-family:'DM Mono',monospace;
  font-weight:600;color:var(--ink3);transition:all .15s;
  user-select:none;
}
.stats-bar-toggle:hover{border-color:var(--ac,#1452d4);color:var(--ac,#1452d4)}
.stats-bar-toggle-arrow{margin-left:auto;font-size:9px;transition:transform .15s}
.stats-bar-toggle.open .stats-bar-toggle-arrow{transform:rotate(180deg)}
.stats-bar{
  display:flex;flex-wrap:wrap;gap:6px;padding:8px 4px 4px;
  overflow:hidden;max-height:0;opacity:0;
  transition:max-height .22s ease, opacity .18s ease;
}
.stats-bar.open{max-height:200px;opacity:1}
.stats-pill{
  display:flex;flex-direction:column;align-items:center;
  padding:5px 10px;border-radius:8px;min-width:72px;
  background:color-mix(in srgb,var(--pc,#1452d4) 7%,white);
  border:1.5px solid color-mix(in srgb,var(--pc,#1452d4) 16%,transparent);
}
.sp-val{
  font-family:'DM Mono',monospace;font-size:14px;font-weight:700;
  color:var(--pc,#1452d4);line-height:1.1;
}
.sp-lbl{
  font-family:'DM Mono',monospace;font-size:8px;font-weight:600;
  text-transform:uppercase;letter-spacing:.07em;
  color:var(--ink4);margin-top:2px;
}

/* ── SELECT-ALL DATASOURCE ───────────────────────────────────────── */
.ds-select-all{
  display:flex;align-items:center;gap:8px;padding:7px 10px;
  border-radius:7px;cursor:pointer;margin-bottom:6px;
  background:var(--sheet);border:1.5px solid var(--border2);
  transition:all .12s;
}
.ds-select-all:hover{border-color:var(--ac,#1452d4)}
.ds-select-all.on{
  background:color-mix(in srgb,var(--ac,#1452d4) 6%,white);
  border-color:var(--ac,#1452d4);
}
.ds-sa-chk{
  width:14px;height:14px;border-radius:3px;flex-shrink:0;
  border:1.5px solid var(--border2);background:#fff;
  display:flex;align-items:center;justify-content:center;
  font-size:9px;color:var(--ac,#1452d4);transition:all .12s;
}
.ds-select-all.on .ds-sa-chk{
  background:var(--ac,#1452d4);border-color:var(--ac,#1452d4);
  color:#fff;
}
.ds-sa-lbl{font-size:11.5px;font-weight:600;color:var(--ink2)}
.ds-select-all:not(.on) .ds-sa-chk::after{content:''}
.ds-select-all.on .ds-sa-chk::after{content:'✓';font-size:9px}



/* ─── ACCORDION SECTIONS ──────────────────────────────────────────── */
.ins-accordion{display:flex;flex-direction:column;gap:10px}
.acc-section{border-radius:10px;overflow:hidden;border:1.5px solid var(--border);background:#fff}
.acc-section.collapsed .acc-body{display:none}
.acc-hdr{
  display:flex;align-items:center;gap:8px;padding:12px 14px;
  cursor:pointer;user-select:none;
  background:color-mix(in srgb,var(--acc-color,#1452d4) 5%,white);
  border-bottom:1.5px solid color-mix(in srgb,var(--acc-color,#1452d4) 12%,transparent);
  transition:background .15s;
}
.acc-hdr:hover{background:color-mix(in srgb,var(--acc-color,#1452d4) 10%,white)}
.acc-ico{font-size:16px;line-height:1}
.acc-lbl{font-family:'Sora',sans-serif;font-size:13px;font-weight:700;color:var(--ink1);flex:1}
.acc-cnt{
  font-family:'DM Mono',monospace;font-size:10px;font-weight:600;
  padding:2px 9px;border-radius:12px;
  background:color-mix(in srgb,var(--acc-color,#1452d4) 12%,white);
  color:var(--acc-color,#1452d4);
  border:1px solid color-mix(in srgb,var(--acc-color,#1452d4) 20%,transparent);
}
.acc-arrow{
  font-size:9px;color:var(--acc-color,#1452d4);
  transition:transform .2s;margin-left:4px;
}
.acc-section.collapsed .acc-arrow{transform:rotate(180deg)}
.acc-body{padding:10px}

/* ─── INSIGHT CARD GRID ────────────────────────────────────────────── */
.ins-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(270px,1fr));gap:10px}

/* ─── SUBCAT HEADER ────────────────────────────────────────────────── */
.subcat-hdr{
  display:flex;align-items:center;gap:6px;
  padding:6px 4px;margin:8px 0 4px;
  font-family:'Sora',sans-serif;font-size:11px;font-weight:700;
  color:var(--ink3);border-bottom:1.5px solid var(--border2);
}
.subcat-hdr-ico{font-size:12px}
.subcat-hdr-name{flex:1}
.subcat-hdr-count{
  font-family:'DM Mono',monospace;font-size:9.5px;
  padding:1px 7px;border-radius:10px;
  background:var(--sheet);color:var(--ink4);
}

/* ─── INSTRUCTIONS PANEL ──────────────────────────────────────────── */
.instr-btn{
  display:inline-flex;align-items:center;gap:6px;
  padding:5px 12px;border-radius:20px;border:1.5px solid var(--border2);
  background:#fff;font-size:11.5px;font-weight:600;color:var(--ink3);
  cursor:pointer;transition:all .15s;margin-left:10px;
}
.instr-btn:hover{border-color:#1452d4;color:#1452d4;background:rgba(20,82,212,.05)}
.instr-overlay{
  position:fixed;inset:0;background:rgba(10,15,30,.45);z-index:1000;
  display:none;align-items:flex-start;justify-content:center;padding:40px 20px;
  backdrop-filter:blur(3px);
}
.instr-overlay.open{display:flex}
.instr-modal{
  background:#fff;border-radius:16px;max-width:740px;width:100%;
  max-height:82vh;overflow:hidden;display:flex;flex-direction:column;
  box-shadow:0 20px 60px rgba(0,0,0,.18);
}
.instr-modal-hdr{
  display:flex;align-items:center;padding:18px 22px 14px;
  border-bottom:1.5px solid var(--border);
}
.instr-modal-title{
  font-family:'Sora',sans-serif;font-size:17px;font-weight:700;
  color:var(--ink1);flex:1;
}
.instr-modal-close{
  width:28px;height:28px;border-radius:50%;border:1.5px solid var(--border2);
  background:#fff;cursor:pointer;display:flex;align-items:center;
  justify-content:center;font-size:14px;color:var(--ink3);
  transition:all .12s;
}
.instr-modal-close:hover{background:var(--sheet);color:var(--ink1)}
.instr-modal-body{overflow-y:auto;padding:20px 22px 28px;flex:1}
.instr-step{display:flex;gap:14px;margin-bottom:22px}
.instr-step:last-child{margin-bottom:0}
.instr-step-num{
  flex-shrink:0;width:32px;height:32px;border-radius:50%;
  background:linear-gradient(135deg,#1452d4,#4f78e8);
  color:#fff;font-family:'Sora',sans-serif;font-size:13px;font-weight:800;
  display:flex;align-items:center;justify-content:center;margin-top:1px;
}
.instr-step-body{}
.instr-step-title{font-family:'Sora',sans-serif;font-size:13px;font-weight:700;color:var(--ink1);margin-bottom:4px}
.instr-step-desc{font-size:12.5px;line-height:1.6;color:var(--ink3)}
.instr-step-desc strong{color:var(--ink2);font-weight:600}
.instr-tip{
  background:linear-gradient(135deg,rgba(20,82,212,.04),rgba(79,120,232,.08));
  border:1.5px solid rgba(20,82,212,.12);border-radius:10px;
  padding:12px 14px;margin-top:20px;
  font-size:12px;color:var(--ink2);line-height:1.6;
}
.instr-tip strong{color:#1452d4}
.instr-section-lbl{
  font-family:'DM Mono',monospace;font-size:9.5px;font-weight:700;
  text-transform:uppercase;letter-spacing:.1em;color:var(--ink4);
  margin:18px 0 10px;padding-bottom:4px;border-bottom:1px solid var(--border2);
}



/* ─── HEADER SCOPE PILLS ──────────────────────────────────────────── */
.t-scope-wrap{display:flex;flex-direction:column;gap:3px;min-width:0}
.t-scope-lbl{font-family:'DM Mono',monospace;font-size:8.5px;font-weight:700;
  text-transform:uppercase;letter-spacing:.08em;color:var(--ink4)}
.t-scope-pills{display:flex;flex-wrap:wrap;gap:4px;align-items:center}
.t-scope-pill{
  display:inline-flex;align-items:center;gap:3px;
  padding:2px 7px;border-radius:10px;
  background:color-mix(in srgb,var(--sc,#1452d4) 8%,white);
  border:1px solid color-mix(in srgb,var(--sc,#1452d4) 18%,transparent);
}
.tsp-v{
  font-family:'DM Mono',monospace;font-size:11px;font-weight:700;
  color:var(--sc,#1452d4);line-height:1;
}
.tsp-l{
  font-family:'DM Mono',monospace;font-size:8.5px;font-weight:500;
  color:var(--ink4);text-transform:uppercase;letter-spacing:.06em;
}
.total-bar{flex-wrap:wrap;gap:8px 0;row-gap:6px}




</style>
</head>
<body>
<div class="ob-page" id="ob-page">
  <div class="ob-card">
    <img class="ob-logo" src="data:image/jpeg;base64,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" alt="Lifenome">

    <div style="display:flex;align-items:center;justify-content:center;gap:10px;margin-bottom:4px">
      <div class="ob-title" style="margin-bottom:0">Precision Health API Platform</div>
      <button class="instr-btn" onclick="openInstructions()" style="margin-left:0;flex-shrink:0">&#128218; How to Use</button>
    </div>
    <div class="ob-sub">Interactive Product Catalog and Solution Design Tool — Tell us about your organization to get a curated, relevant view of available health verticals and biomarker insights.</div>

    <!-- Row 1: Org Name + Email -->
    <div class="ob-row">
      <div class="ob-fieldset">
        <label class="ob-label" for="ob-name">Organization Name *</label>
        <input class="ob-input" id="ob-name" type="text" placeholder="Your organization name" oninput="updateObBtn()">
      </div>
      <div class="ob-fieldset">
        <label class="ob-label" for="ob-email">Work Email *</label>
        <input class="ob-input" id="ob-email" type="email" placeholder="you@organization.com" oninput="updateObBtn()">
      </div>
    </div>

    <!-- Website -->
    <div class="ob-fieldset">
      <label class="ob-label" for="ob-url">Organization Website</label>
      <input class="ob-input" id="ob-url" type="url" placeholder="https://yourorganization.com">
    </div>

    <!-- Partner Password -->
    <div class="ob-fieldset">
      <label class="ob-label" for="ob-pass">Partner Access Password *</label>
      <input class="ob-input" id="ob-pass" type="password" placeholder="Enter partner password" oninput="updateObBtn()">
      <div class="ob-err ob-pass-err" id="ob-pass-err">Wrong Password. Please contact your Lifenome Point of Contact for Password.</div>
    </div>

    <!-- Organization Type -->
    <div class="ob-fieldset">
      <div class="ob-types-label">Organization Type * <span class="ob-sel-count" id="ob-sel-count"></span></div>
      <div class="ob-types-grid" id="ob-types-grid"></div>
      <div class="ob-err" id="ob-err"></div>
    </div>

    <!-- Row 2: Revenue + Stage -->
    <div class="ob-row">
      <div class="ob-fieldset">
        <label class="ob-label">Annual Revenue</label>
        <div class="ob-chip-group" id="ob-rev">
          <div class="ob-chip" onclick="selectChip(this,'ob-rev')">&lt;$1M</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-rev')">$1M–$10M</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-rev')">$10M–$50M</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-rev')">$50M+</div>
        </div>
      </div>
      <div class="ob-fieldset">
        <label class="ob-label">Company Stage</label>
        <div class="ob-chip-group" id="ob-stage">
          <div class="ob-chip" onclick="selectChip(this,'ob-stage')">Pre-seed</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-stage')">Seed</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-stage')">Series A+</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-stage')">Growth / Public</div>
        </div>
      </div>
    </div>

    <!-- Row 3: Volume + Dev Team -->
    <div class="ob-row">
      <div class="ob-fieldset">
        <label class="ob-label">Expected Monthly Data Volume</label>
        <div class="ob-chip-group" id="ob-vol">
          <div class="ob-chip" onclick="selectChip(this,'ob-vol')">&lt;1K users</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-vol')">1K–10K</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-vol')">10K–100K</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-vol')">100K+</div>
        </div>
      </div>
      <div class="ob-fieldset">
        <label class="ob-label">Development Team Size</label>
        <div class="ob-chip-group" id="ob-dev">
          <div class="ob-chip" onclick="selectChip(this,'ob-dev')">Solo / No dev</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-dev')">1–5 devs</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-dev')">6–20 devs</div>
          <div class="ob-chip" onclick="selectChip(this,'ob-dev')">20+ devs</div>
        </div>
      </div>
    </div>

    <!-- Primary Product Interest -->
    <div class="ob-fieldset">
      <label class="ob-label">Primary Product Interest</label>
      <div class="ob-chip-group" id="ob-prod" style="flex-wrap:wrap">
        <div class="ob-chip ob-chip--lg" onclick="selectChip(this,'ob-prod')">White-label Reports</div>
        <div class="ob-chip ob-chip--lg" onclick="selectChip(this,'ob-prod')">API Integration</div>
        <div class="ob-chip ob-chip--lg" onclick="selectChip(this,'ob-prod')">Recommendation Engine</div>
        <div class="ob-chip ob-chip--lg" onclick="selectChip(this,'ob-prod')">Full Platform License</div>
      </div>
    </div>

    <!-- Years in Business slider -->
    <div class="ob-fieldset">
      <label class="ob-label">Years in Business: <span id="ob-yib-val">3</span></label>
      <div class="ob-slider-wrap">
        <input class="ob-slider" id="ob-yib" type="range" min="1" max="10" value="3">
        <div class="ob-slider-ticks">
          <span>1</span><span>2</span><span>3</span><span>4</span><span>5</span>
          <span>6</span><span>7</span><span>8</span><span>9</span><span>10+</span>
        </div>
      </div>
    </div>

    <button class="ob-btn" id="ob-submit" onclick="submitOnboarding()" disabled>
      &#x27A1;&nbsp; Explore Your Precision Health Verticals
    </button>
  </div>
</div>

<!-- INSTRUCTIONS OVERLAY -->
<div class="instr-overlay" id="instr-overlay" onclick="closeInstructions(event)">
  <div class="instr-modal" onclick="event.stopPropagation()">
    <div class="instr-modal-hdr">
      <span class="instr-modal-title">&#128218; How to Use This Tool</span>
      <div class="instr-modal-close" onclick="closeInstructions()">&#215;</div>
    </div>
    <div class="instr-modal-body">

      <div class="instr-section-lbl">Step 1 — Fill Out the Cover Page</div>

      <div class="instr-step">
        <div class="instr-step-num">1</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Enter Your Organization Details</div>
          <div class="instr-step-desc">Type your <strong>organization name</strong> and <strong>work email address</strong> in the required fields. These personalize the catalog view and generate your solution summary. The website field is optional.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">2</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Enter Your Partner Access Password</div>
          <div class="instr-step-desc">Enter the <strong>partner access password</strong> provided by your Lifenome point of contact. This is required to access the product catalog. If you don&#x27;t have a password, reach out to your Lifenome representative.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">3</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Select Your Organization Type(s)</div>
          <div class="instr-step-desc">Choose the organization type(s) that best describe your company — e.g. <strong>Longevity Clinic</strong>, <strong>Health App</strong>, <strong>Meal Delivery</strong>, <strong>Food &amp; Beverage Brand</strong>. Select multiple if relevant. This tailors which health verticals are shown as primary recommendations.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">4</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Fill In the Optional Profile Fields</div>
          <div class="instr-step-desc">Select your <strong>annual revenue range</strong>, <strong>company stage</strong>, <strong>expected data volume</strong>, <strong>dev team size</strong>, and <strong>primary product interest</strong>. These help our team tailor a proposal. Then click <strong>Explore Your Precision Health Verticals</strong>.</div>
        </div>
      </div>

      <div class="instr-section-lbl">Step 2 — Select Verticals &amp; Data Sources</div>

      <div class="instr-step">
        <div class="instr-step-num">5</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Select a Health Vertical</div>
          <div class="instr-step-desc">Use the <strong>left sidebar</strong> to browse health verticals (Longevity, Fertility, Menopause, Precision Medicine, Meal Delivery, etc.). Your organization type pre-selects the most relevant ones. Click a vertical to focus, or click <strong>All Categories</strong> to see the full 14-vertical catalog.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">6</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Choose Your Data Sources</div>
          <div class="instr-step-desc">Use the <strong>right panel</strong> to select which data inputs your platform supports: <strong>Blood Biomarkers</strong> (Standard / Advanced / Elite tiers), <strong>DNA</strong> (Genotyping / Exome / WGS), <strong>Microbiome</strong> (16S or Shotgun by body site), <strong>Wearable</strong>, <strong>EHR</strong>, <strong>Epigenetics</strong>, and more. Select multiple simultaneously.</div>
        </div>
      </div>

      <div class="instr-section-lbl">Step 3 — Explore Insights</div>

      <div class="instr-step">
        <div class="instr-step-num">7</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Browse Insights by Type</div>
          <div class="instr-step-desc">Insights are organized into three sections: <strong>&#128161; Recommendations</strong> (personalized program &amp; product plans), <strong>&#128202; Health Indices</strong> (composite scores and dashboards), and <strong>&#128300; Biomarker Assessments</strong> (individual readings with risk levels). Click each section header to expand or collapse it.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">8</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Expand Individual Insight Cards</div>
          <div class="instr-step-desc">Each card shows only the <strong>source badge</strong> and <strong>insight name</strong> by default. Click the card name or the <strong>&#9660; arrow</strong> to expand the full description, output unit, assessment range, and the personalization biomarkers used.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">9</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Search &amp; Filter</div>
          <div class="instr-step-desc">Use the <strong>search bar</strong> to find insights by name, keyword, or biomarker. Use the <strong>filter chips</strong> (Recommendations / Health Indices / Biomarker Assessments) to show or hide types. The <strong>Analytical Scope</strong> bar shows total genomic and clinical coverage of your selected sources in real time.</div>
        </div>
      </div>

      <div class="instr-section-lbl">Step 4 — Build Your Solution</div>

      <div class="instr-step">
        <div class="instr-step-num">10</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Add Insights to Your Solutions Cart</div>
          <div class="instr-step-desc">Click the <strong>&#10003; checkbox</strong> in the top-right of any insight card to add it to your <strong>Solutions Cart</strong>. The cart collects selected insights and generates the corresponding <strong>API endpoint configuration</strong> for your technical team.</div>
        </div>
      </div>

      <div class="instr-step">
        <div class="instr-step-num">11</div>
        <div class="instr-step-body">
          <div class="instr-step-title">Review API Endpoints</div>
          <div class="instr-step-desc">At the bottom of the insights panel, the <strong>Solutions Cart — API Endpoints</strong> block shows the Lifenome API calls corresponding to your selected data sources. Use the <strong>Send Summary</strong> button to email a full configuration to your team, or <strong>Export Cart</strong> to download a JSON spec.</div>
        </div>
      </div>

      <div class="instr-tip">
        <strong>&#128161; Pro tip:</strong> Start by selecting your organization type on the cover page — this pre-configures the most relevant verticals. Then add data sources one at a time to see how the insight catalog expands. The <strong>Analytical Scope</strong> bar at the top shows your total coverage in real time.
      </div>

    </div>
  </div>
</div>

<!-- ═══════ MAIN APP ═══════ -->
<div class="app-page" id="app-page" style="display:none">
  <header class="hdr">
    <div class="hdr-left">
      <img class="hdr-logo" src="data:image/jpeg;base64,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" alt="Lifenome"
        onclick="document.getElementById('ob-page').style.display='flex';document.getElementById('app-page').style.display='none';"
        title="Back to start">
      <div class="hdr-sep"></div>
      <div>
        <span class="hdr-title">Precision Health Intelligence</span>
        <span class="hdr-sub">Partner API and Testing Selector</span>
      </div>
      <span class="hdr-org" id="hdr-org-name"></span>
    </div>
    <div class="hdr-right">
      <span class="hdr-pill">v6.0</span>
      <span class="hdr-pill" style="background:#e5f4f2;border-color:rgba(10,124,110,.2);color:#0a7c6e">&#11044; API Live</span>
      <button class="instr-btn" onclick="openInstructions()">&#128218; How to Use</button>
      <button class="cart-btn" id="hdr-cart-btn" onclick="openCart()">
        &#128722; Solutions Cart <span class="cart-count" id="hdr-cart-count">0</span>
      </button>
    </div>
  </header>
  <div class="layout">
    <nav class="sidebar" id="sidebar">
      <div style="padding:20px;text-align:center;color:var(--ink4);font-size:12px">Loading...</div>
    </nav>
    <main class="main" id="main">
      <div style="display:flex;flex-direction:column;align-items:center;justify-content:center;min-height:60vh;text-align:center">
        <div style="font-family:Sora,sans-serif;font-size:18px;font-weight:800;color:var(--ink2);margin-bottom:8px">Welcome to Your Precision Health Platform</div>
        <div style="font-size:13px;color:var(--ink3);max-width:420px;line-height:1.65">Select a vertical from the left sidebar, then toggle data sources to explore available insights. New: Mental Health & Brain Wellness vertical + Function Health and InsideTracker-inspired indices.</div>
      </div>
    </main>
  </div>
</div>

<!-- CART OVERLAY -->
<div class="cart-overlay" id="cart-overlay" onclick="if(event.target===this)closeCart()">
  <div class="cart-panel">
    <div class="cart-hdr">
      <div>
        <div class="cart-hdr-title">&#128722; Solutions Cart</div>
        <div class="cart-hdr-sub">Selected insights, required testing modalities &amp; biomarkers</div>
      </div>
      <button class="cart-close" onclick="closeCart()">&#10005;</button>
    </div>
    <div class="cart-body" id="cart-body"></div>
    <div class="cart-footer" id="cart-footer"></div>
  </div>
</div>
<script>










const CLIENT_TYPES = [
  {
    "id": "longevity_clinic",
    "label": "Longevity Clinic / Brand",
    "thumb": "https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=120&q=70",
    "primary": [
      "longevity",
      "prevention",
      "supplements"
    ],
    "secondary": [
      "precision_medicine",
      "weightloss",
      "glp1",
      "athlete",
      "mental_health"
    ]
  },
  {
    "id": "womens_health",
    "label": "Women's Health Brand",
    "thumb": "https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=120&q=70",
    "primary": [
      "fertility",
      "menopause",
      "weightloss"
    ],
    "secondary": [
      "supplements",
      "skincare",
      "hairloss",
      "prevention",
      "mental_health",
      "precision_medicine"
    ]
  },
  {
    "id": "supplement_brand",
    "label": "Supplementation Brand",
    "thumb": "data:image/jpeg;base64,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",
    "primary": [
      "supplements",
      "longevity"
    ],
    "secondary": [
      "prevention",
      "weightloss",
      "athlete",
      "mental_health"
    ]
  },
  {
    "id": "hospitality",
    "label": "Hospitality Brand",
    "thumb": "https://images.unsplash.com/photo-1566073771259-6a8506099945?w=120&q=70",
    "primary": [
      "longevity",
      "skincare",
      "weightloss"
    ],
    "secondary": [
      "menopause",
      "supplements",
      "prevention",
      "mental_health"
    ]
  },
  {
    "id": "medspa",
    "label": "MedSpa",
    "thumb": "https://images.unsplash.com/photo-1540555700478-4be289fbecef?w=120&q=70",
    "primary": [
      "skincare",
      "hairloss",
      "longevity"
    ],
    "secondary": [
      "menopause",
      "weightloss",
      "glp1",
      "mental_health"
    ]
  },
  {
    "id": "gym_fitness",
    "label": "Gym / Fitness Organization",
    "thumb": "https://images.unsplash.com/photo-1534438327276-14e5300c3a48?w=120&q=70",
    "primary": [
      "athlete",
      "weightloss",
      "longevity"
    ],
    "secondary": [
      "supplements",
      "prevention",
      "glp1"
    ]
  },
  {
    "id": "skin_hair",
    "label": "Skin & Hair Care Brand",
    "thumb": "https://images.unsplash.com/photo-1522335789203-aabd1fc54bc9?w=120&q=70",
    "primary": [
      "skincare",
      "hairloss"
    ],
    "secondary": [
      "supplements",
      "menopause",
      "longevity"
    ]
  },
  {
    "id": "glp1_brand",
    "label": "GLP-1",
    "thumb": "https://images.unsplash.com/photo-1576765607924-3f7b8410a787?w=120&q=70",
    "primary": [
      "glp1",
      "weightloss"
    ],
    "secondary": [
      "prevention",
      "longevity",
      "supplements",
      "mental_health"
    ]
  },
  {
    "id": "health_app",
    "label": "Health & Fitness App",
    "thumb": "https://images.unsplash.com/photo-1605296867304-46d5465a13f1?w=120&q=70",
    "primary": [
      "longevity",
      "prevention",
      "weightloss"
    ],
    "secondary": [
      "athlete",
      "supplements",
      "skincare",
      "mental_health",
      "precision_medicine"
    ]
  },
  {
    "id": "healthcare_system",
    "label": "Healthcare System",
    "thumb": "https://images.unsplash.com/photo-1551601651-2a8555f1a136?w=120&q=70",
    "primary": [
      "precision_medicine",
      "prevention",
      "longevity",
      "fertility",
      "menopause",
      "mental_health"
    ],
    "secondary": [
      "glp1",
      "weightloss",
      "supplements"
    ]
  },
  {
    "id": "mental_health_org",
    "label": "Mental Health Organization",
    "thumb": "https://images.unsplash.com/photo-1499209974431-9dddcece7f88?w=120&q=70",
    "primary": [
      "mental_health",
      "longevity",
      "prevention"
    ],
    "secondary": [
      "supplements",
      "weightloss",
      "menopause",
      "precision_medicine"
    ]
  },
  {
    "id": "meal_delivery",
    "label": "Meal Delivery Service",
    "thumb": "https://images.unsplash.com/photo-1512621776951-a57141f2eefd?w=120&q=70",
    "primary": [
      "meal_delivery",
      "supplements",
      "weightloss"
    ],
    "secondary": [
      "longevity",
      "mental_health",
      "prevention",
      "glp1"
    ]
  },
  {
    "id": "food_beverage",
    "label": "Food & Beverage Brand",
    "thumb": "https://images.unsplash.com/photo-1542838132-92c53300491e?w=120&q=70",
    "primary": [
      "food_beverage",
      "supplements",
      "prevention"
    ],
    "secondary": [
      "longevity",
      "weightloss",
      "skincare"
    ]
  },
  {
    "id": "other",
    "label": "Other (Show All Categories)",
    "thumb": "https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?w=120&q=70",
    "primary": [
      "longevity",
      "fertility",
      "menopause",
      "athlete",
      "prevention",
      "weightloss",
      "glp1",
      "supplements",
      "skincare",
      "hairloss",
      "mental_health",
      "precision_medicine"
    ],
    "secondary": []
  }
];

const DATA_SOURCES = [
  { id:'lifestyle',     ico:'📋', name:'Lifestyle Assessment',      hint:'SAQ / health history / psychometrics',   ep:'/api/v1/stateless/lifestyle',               method:'POST' },
  { id:'wearable',      ico:'⌚', name:'Wearable Data',              hint:'Activity, sleep, HRV, HR, SpO2',         ep:'/api/v1/stateless/wearable',                method:'POST' },
  { id:'functional',    ico:'🏋️', name:'Functional Biomarkers',     hint:'VO₂max, body comp, grip, FMS, RMR',      ep:'/api/v1/stateless/functional',              method:'POST' },
  { id:'physiological', ico:'🔬', name:'Imaging',                   hint:'Medical imaging / smartphone camera',    ep:'/api/v1/stateless/physiological',           method:'POST' },
  { id:'ehr',           ico:'🏥', name:'EHR / Medical Records',     hint:'Select data depth below',                ep:'/api/v1/stateless/ehr',                     method:'POST', hasEHR:true },
  { id:'blood',         ico:'🩸', name:'Blood Biomarkers',          hint:'Select panel tier below',                ep:'/api/v1/stateless/biomarkers',              method:'POST', hasBlood:true },
  { id:'dna_array',     ico:'🧬', name:'DNA',                       hint:'Select sequencing tier below',           ep:'/api/v1/samples/{id}/traits',               method:'GET',  hasDNA:true },
  { id:'dna_exome',     ico:'🔬', name:'DNA — Exome (WES)',         hint:'Whole exome sequencing VCF',             ep:'/api/v1/exome/report',                      method:'POST' },
  { id:'dna_wgs',       ico:'🧪', name:'DNA — WGS',                 hint:'Whole genome sequencing VCF',            ep:'/api/v1/samples/{id}/traits?mode=wgs',      method:'GET'  },
  { id:'micro_16s',     ico:'🦠', name:'Microbiome',                hint:'Select sequencing type below',           ep:'/api/v1/stateless/microbiome',              method:'POST', hasMicro:true },
  { id:'micro_wgs',     ico:'🔭', name:'Gut Microbiome Shotgun',    hint:'Functional metagenomics (gut)',          ep:'/api/v1/stateless/microbiome-wgs',          method:'POST' },
  { id:'epigenetics',   ico:'⚗️', name:'Epigenetics / Methylation',hint:'850K CpG sites / DNAm clocks',           ep:'/api/v1/stateless/epigenetics',             method:'POST' },
  { id:'recommendation',ico:'💡', name:'Recommendation Engine',    hint:'Programs, products & protocols',         ep:'/api/v1/recommendations/{userId}',          method:'POST' }
];

const DNA_TIERS = {
  dna_array: { name:'Genotyping Array', hint:'700K SNPs — 23andMe / Ancestry / Clinical Array', snps:'700,000 SNPs', indels:'100,000 InDels', genes:'20,000 genes', ep:'/api/v1/samples/{id}/traits' },
  dna_exome: { name:'Exome (WES)',      hint:'4M SNPs — Whole Exome Sequencing VCF',            snps:'4,000,000 SNPs', indels:'800,000 InDels', genes:'20,500 genes', ep:'/api/v1/exome/report' },
  dna_wgs:   { name:'WGS (Whole Genome)',hint:'4.5M SNPs — 30× WGS CRAM/VCF',                  snps:'4,500,000 SNPs', indels:'900,000 InDels', genes:'20,500 genes', ep:'/api/v1/samples/{id}/traits?mode=wgs' }
};

const MICRO_TIERS = {
  '16s_gut':       { name:'16S — Gut',        hint:'V3–V4 amplicon, ~2,000 bacterial taxa', bacteria:'2,000+ taxa', ep:'/api/v1/stateless/microbiome-16s-gut' },
  '16s_oral':      { name:'16S — Oral',       hint:'V1–V3 amplicon, ~700 bacterial taxa',  bacteria:'700+ taxa',   ep:'/api/v1/stateless/microbiome-16s-oral' },
  '16s_skin':      { name:'16S — Skin',       hint:'V1–V3 amplicon, ~500 bacterial taxa',  bacteria:'500+ taxa',   ep:'/api/v1/stateless/microbiome-16s-skin' },
  'shotgun_gut':   { name:'Shotgun — Gut',    hint:'Metagenomic WGS, 10,000+ taxa, 5M+ genes', bacteria:'10,000+ taxa', microgenes:'5M+ genes', ep:'/api/v1/stateless/microbiome-wgs-gut' },
  'shotgun_oral':  { name:'Shotgun — Oral',   hint:'Metagenomic WGS, 1,500+ taxa',         bacteria:'1,500+ taxa', ep:'/api/v1/stateless/microbiome-wgs-oral' },
  'shotgun_skin':  { name:'Shotgun — Skin',   hint:'Metagenomic WGS, 1,000+ taxa',         bacteria:'1,000+ taxa', ep:'/api/v1/stateless/microbiome-wgs-skin' }
};

const EHR_TIERS = {
  basic:         { name:'Basic EHR',            items:['Demographics','ICD-10 Diagnoses','Active Medications','Allergies','Vital Signs'] },
  standard:      { name:'Standard EHR',         items:['All Basic +','Lab Results History','CPT Procedures','Immunizations','Family History'] },
  advanced:      { name:'Advanced EHR',         items:['All Standard +','Imaging Reports','Pathology','Specialist Notes','Hospitalizations'] },
  comprehensive: { name:'Full EHR Integration', items:['All Advanced +','Genomic Test Results','SDOH Factors','Behavioral Health','Patient-Reported Outcomes (PRO)'] }
};

var dnaTier='dna_array', microTier='16s_gut', ehrTier='standard';

const BLOOD_TIERS = {
  basic:         { name:'Basic Panel',     items:['CBC','CMP','Fasting Glucose','HbA1c','Lipid Panel (TC/LDL/HDL/TG)','TSH'] },
  standard:      { name:'Standard Panel',  items:['All Basic +','hs-CRP','Homocysteine','Ferritin','Vitamin B12','Folate','25-OH Vitamin D','Fasting Insulin','ALT/AST/GGT','Free T3/T4'] },
  advanced:      { name:'Advanced Panel',  items:['All Standard +','ApoB','Lp(a)','oxidized LDL','IGF-1','DHEA-S','Cortisol AM','SHBG','Total/Free Testosterone','Estradiol','Magnesium RBC','Zinc','Selenium','CoQ10','NAD+','IL-6','TNF-α','Cystatin-C','Omega-3 Index'] },
  comprehensive: { name:'Comprehensive',   items:['All Advanced +','p-tau217','GFAP','NfL','Aβ42/40 ratio','Amino acid panel (tryptophan, tyrosine, branched-chain)','8-OHdG','Total antioxidant capacity','Heavy metals (Pb, Hg, As, Cd)','ANA screen','anti-dsDNA','TPO Ab','TgAb','LPS/Endotoxin','Zonulin','ACTH','Aldosterone','Full autoimmune panel','Adiponectin','NT-proBNP'] }
};

var activeSources=new Set(), bloodTier='standard', cart=[];
var orgTypes=[], orgName='', orgEmail='', orgUrl='';

function hesc(s){ return String(s||"").replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;").replace(/"/g,"&quot;"); }
function srcBg(id){ var m={"lifestyle":"#4f46e5","wearable":"#0891b2","functional":"#d97706","physiological":"#7c3aed","blood":"#dc2626","dna_array":"#065f46","dna_exome":"#065f46","dna_wgs":"#065f46","micro_16s":"#059669","micro_wgs":"#059669","epigenetics":"#0284c7","ehr":"#475569"}; return m[id]||"#374151"; }
function tierIdx(t){return{basic:0,standard:1,advanced:2,comprehensive:3}[t]||0;}
function insActive(ins){
  if(ins.src==='blood'&&ins.tier) return tierIdx(ins.tier)<=tierIdx(bloodTier);
  if(ins.src==='dna_array'||ins.src==='dna_exome'||ins.src==='dna_wgs'){
    return activeSources.has(ins.src)||activeSources.has('dna_array');
  }
  return true;
}
function cartKey(progId,insName){ return progId+"~~"+insName; }
function ds(id){ for(var i=0;i<DATA_SOURCES.length;i++) if(DATA_SOURCES[i].id===id) return DATA_SOURCES[i]; return null; }
var COMPETITOR_INSIGHTS = {
  'InnerAge Biological Age Score': 'InsideTracker InnerAge 2.0',
  'Endurance Healthspan Category Score': 'InsideTracker',
  'Recovery & Muscle Damage Index': 'InsideTracker',
  'Metabolism Healthspan Score': 'InsideTracker',
  'Gut-Brain Axis Health Score': 'InsideTracker',
  'Advanced Cardiovascular Risk Score': 'Function Health + InsideTracker',
  'Insulin Resistance & Pre-Diabetes Index': 'InsideTracker metabolism',
  'Organ Function Surveillance Panel': 'Function Health',
  'Heavy Metal & Toxin Burden Index': 'Function Health',
  'Autoimmune Surveillance Index': 'Function Health',
  'Brain Aging & Alzheimer\'s Risk Score': 'Function Health',
  'Omega-3 Index & Essential Fatty Acid Profile': 'Function Health',
  'Electrolyte & Mineral Optimization Panel': 'InsideTracker Ultimate',
  'Mood-Nutrient Deficiency Panel': 'Function Health',
  'Thyroid-Mood Connection Score': 'Function Health',
  'Neuroinflammation Index': 'Function Health + InsideTracker'
};



function countIns(srcId){
  var progs=program?[program]:PROGRAMS,n=0;
  if(srcId==='recommendation'){ for(var pi=0;pi<progs.length;pi++) for(var ii=0;ii<progs[pi].insights.length;ii++) if(progs[pi].insights[ii].src==='recommendation') n++; return n; }
  // hasDNA parent counts all dna sub-sources
  var dnaDs=null; for(var di=0;di<DATA_SOURCES.length;di++) if(DATA_SOURCES[di].id===srcId&&DATA_SOURCES[di].hasDNA){dnaDs=DATA_SOURCES[di];break;}
  var dnaIds=dnaDs?['dna_array','dna_exome','dna_wgs']:null;
  for(var pi=0;pi<progs.length;pi++) for(var ii=0;ii<progs[pi].insights.length;ii++){
    var ins=progs[pi].insights[ii];
    var match=dnaIds?(dnaIds.indexOf(ins.src)>=0):(ins.src===srcId);
    if(match&&insActive(ins)) n++;
  }
  return n;
}

/* ── ONBOARDING ──────────────────────────────────────────────────── */
function initOnboarding(){
  setTimeout(initSlider, 100);
  var grid=document.getElementById('ob-types-grid');
  var h='';
  for(var i=0;i<CLIENT_TYPES.length;i++){
    var ct=CLIENT_TYPES[i];
    h+='<div class="ob-type" data-id="'+ct.id+'" onclick="toggleType(this,\''+ct.id+'\')">';
    h+='<div class="ob-type-check">&#10003;</div>';
    h+='<img class="ob-type-img" src="'+hesc(ct.thumb)+'" alt="" loading="lazy">';
    h+='<span class="ob-type-lbl">'+hesc(ct.label)+'</span>';
    h+='</div>';
  }
  grid.innerHTML=h;
}
function toggleType(el,id){
  el.classList.toggle('sel');
  var idx=orgTypes.indexOf(id);
  if(idx>=0) orgTypes.splice(idx,1); else orgTypes.push(id);
  updateObBtn();
  var cnt=document.getElementById('ob-sel-count');
  if(cnt) cnt.textContent=orgTypes.length>0?orgTypes.length+' type'+(orgTypes.length!==1?'s':'')+' selected':'';
}
function updateObBtn(){
  var btn=document.getElementById('ob-submit');
  var n=document.getElementById('ob-name').value.trim();
  var e=document.getElementById('ob-email').value.trim();
  var pw=(document.getElementById('ob-pass')||{value:''}).value.trim();
  btn.disabled=(!n||!e||!pw||orgTypes.length===0);
}
function submitOnboarding(){
  var n=document.getElementById('ob-name').value.trim();
  var e=document.getElementById('ob-email').value.trim();
  var u=document.getElementById('ob-url').value.trim();
  var pw=(document.getElementById('ob-pass')||{value:''}).value.trim();
  var err=document.getElementById('ob-err');
  var perr=document.getElementById('ob-pass-err');
  if(perr) perr.classList.remove('show');
  if(!n||!e||orgTypes.length===0){err.textContent='Please fill in name, email, and select at least one organization type.';err.classList.add('show');return;}
  if(!/^[^\s@]+@[^\s@]+\.[^\s@]+$/.test(e)){err.textContent='Please enter a valid email address.';err.classList.add('show');return;}
  if(pw.toLowerCase()!=='ln2026partner'){
    if(perr) perr.classList.add('show');
    else{err.textContent='Wrong Password. Please contact your Lifenome Point of Contact for Password.';err.classList.add('show');}
    return;
  }
  err.classList.remove('show');
  orgName=n;orgEmail=e;orgUrl=u;
  document.getElementById('ob-page').style.display='none';
  document.getElementById('app-page').style.display='block';
  document.getElementById('hdr-org-name').textContent=n;
  buildSidebar();
}

/* ── CHIP SELECTORS & SLIDER ─────────────────────────────────────────── */
function selectChip(el, groupId) {
  var group = document.getElementById(groupId);
  if (!group) return;
  var chips = group.querySelectorAll('.ob-chip');
  chips.forEach(function(c) { c.classList.remove('sel'); });
  el.classList.add('sel');
  updateObBtn();
}
function chipVal(groupId) {
  var group = document.getElementById(groupId);
  if (!group) return '';
  var sel = group.querySelector('.ob-chip.sel');
  return sel ? sel.textContent.trim() : '';
}
function initSlider() {
  var slider = document.getElementById('ob-yib');
  var valEl  = document.getElementById('ob-yib-val');
  if (!slider || !valEl) return;
  slider.oninput = function() {
    valEl.textContent = this.value >= 10 ? '10+' : this.value;
    // update gradient fill
    var pct = (this.value / this.max) * 100;
    this.style.background = 'linear-gradient(to right,var(--blue) 0%,var(--blue) '+pct+'%,#e2e8f0 '+pct+'%,#e2e8f0 100%)';
  };
  // set initial fill
  var pct = (slider.value / slider.max) * 100;
  slider.style.background = 'linear-gradient(to right,var(--blue) 0%,var(--blue) '+pct+'%,#e2e8f0 '+pct+'%,#e2e8f0 100%)';
}


/* ── INSTRUCTIONS ──────────────────────────────────────────────── */
function openInstructions(){
  document.getElementById('instr-overlay').classList.add('open');
  document.body.style.overflow='hidden';
}
function closeInstructions(e){
  if(e&&e.target!==document.getElementById('instr-overlay')) return;
  document.getElementById('instr-overlay').classList.remove('open');
  document.body.style.overflow='';
}

/* ── SIDEBAR ─────────────────────────────────────────────────────────── */
function getPrimaryProgIds(){
  var primary=new Set(), secondary=new Set();
  for(var i=0;i<orgTypes.length;i++){
    for(var j=0;j<CLIENT_TYPES.length;j++){
      if(CLIENT_TYPES[j].id===orgTypes[i]){
        CLIENT_TYPES[j].primary.forEach(function(id){primary.add(id);});
        CLIENT_TYPES[j].secondary.forEach(function(id){if(!primary.has(id))secondary.add(id);});
      }
    }
  }
  return{primary:[...primary],secondary:[...secondary].filter(function(id){return !primary.has(id);})};
}
function buildSidebar(){
  var sb=document.getElementById('sidebar'); if(!sb) return;
  var ids=getPrimaryProgIds();
  var h='<span class="sb-lbl">Overview</span>';
  h+='<button class="all-btn active" id="btn-all" onclick="selAll()">';
  h+='<div class="all-thumb"><img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=80&q=70" alt="" loading="lazy"></div>';
  h+='<div style="flex:1;min-width:0"><span class="all-name">All Categories</span><span class="all-sub">Browse all '+PROGRAMS.length+' verticals</span></div>';
  h+='</button>';
  h+='<span class="sb-lbl">Recommended for You</span>';
  for(var i=0;i<PROGRAMS.length;i++){
    var p=PROGRAMS[i];
    if(ids.primary.indexOf(p.id)<0) continue;
    h+=makeCatBtn(p);
  }
  if(ids.secondary.length>0){
    h+='<button class="sb-more-toggle" id="sb-more-btn" onclick="toggleSbMore()">';
    h+='<span>Additional Categories</span><span class="sb-more-arrow">&#x25BC;</span></button>';
    h+='<div class="sb-more-section" id="sb-more-sec">';
    for(var i=0;i<PROGRAMS.length;i++){
      var p=PROGRAMS[i];
      if(ids.secondary.indexOf(p.id)<0) continue;
      h+=makeCatBtn(p);
    }
    h+='</div>';
  }
  sb.innerHTML=h;
}
function makeCatBtn(p){
  return '<button class="cat-btn" id="btn-'+p.id+'" style="--cc:'+p.color+'" onclick="selProg(\''+p.id+'\')">'+
    '<div class="cat-thumb"><img src="'+hesc(p.img)+'" alt="" loading="lazy"></div>'+
    '<div style="flex:1;min-width:0"><span class="cat-name">'+hesc(p.name)+'</span>'+
    '<span class="cat-sub-text">'+hesc(p.sub)+'</span></div>'+
    '</button>';
}
function toggleSbMore(){
  var btn=document.getElementById('sb-more-btn'), sec=document.getElementById('sb-more-sec');
  if(!btn||!sec) return;
  var open=sec.classList.contains('open');
  sec.classList.toggle('open',!open); btn.classList.toggle('open',!open);
}
function setActiveSidebarBtn(id){
  var all=document.querySelectorAll('.cat-btn,.all-btn');
  for(var i=0;i<all.length;i++) all[i].classList.remove('active');
  var btn=document.getElementById('btn-'+id); if(btn) btn.classList.add('active');
}
function selAll(){ program=null; activeSources=new Set(); bloodTier='standard'; setActiveSidebarBtn('all'); render(); }
function selProg(id){
  for(var i=0;i<PROGRAMS.length;i++) if(PROGRAMS[i].id===id){program=PROGRAMS[i];break;}
  activeSources=new Set(); bloodTier='standard'; setActiveSidebarBtn(id); render();
}

/* ── RENDER ──────────────────────────────────────────────────────────── */
function render(){
  var main=document.getElementById('main'); if(!main) return;
  var ac=program?program.color:'#1452d4';
  main.style.setProperty('--ac',ac);
  var hdr='';
  if(!program){
    var totalIns=0, totalMkrs=new Set();
    for(var i=0;i<PROGRAMS.length;i++){
      totalIns+=PROGRAMS[i].insights.length;
      for(var j=0;j<PROGRAMS[i].insights.length;j++)
        (PROGRAMS[i].insights[j].markers||[]).forEach(function(m){totalMkrs.add(m);});
    }
    hdr='<div class="prog-hdr"><div class="prog-hdr-thumb"><img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=160&q=75" alt="" loading="lazy"></div>';
    hdr+='<div style="flex:1"><span class="prog-crumb">All Categories</span>';
    hdr+='<div class="prog-title">All <em>Health Verticals</em></div>';
    hdr+='<div class="prog-desc">Select data sources to explore insights across all '+PROGRAMS.length+' verticals. Includes indices inspired by Function Health and InsideTracker healthspan categories.</div>';
    hdr+='<div class="prog-stats"><div class="prog-stat"><div><div class="ps-num">'+PROGRAMS.length+'</div><div class="ps-lbl">Verticals</div></div></div>';
    hdr+='<div class="prog-stat"><div><div class="ps-num">'+totalIns+'</div><div class="ps-lbl">Total Insights</div></div></div>';
    hdr+='<div class="prog-stat"><div><div class="ps-num">'+totalMkrs.size+'</div><div class="ps-lbl">Unique Biomarkers</div></div></div>';
    hdr+='</div></div></div>';
  } else {
    var p=program;
    var tags=''; for(var t=0;t<p.tags.length;t++) tags+='<span class="prog-tag">'+hesc(p.tags[t])+'</span>';
    var mkrSet=new Set();
    for(var i=0;i<p.insights.length;i++) (p.insights[i].markers||[]).forEach(function(m){mkrSet.add(m);});
    hdr='<div class="prog-hdr"><div class="prog-hdr-thumb"><img src="'+hesc(p.img)+'" alt="" loading="lazy"></div>';
    hdr+='<div style="flex:1"><span class="prog-crumb">Health Vertical &middot; '+hesc(p.sub)+'</span>';
    hdr+='<div class="prog-title"><em>'+hesc(p.name)+'</em></div>';
    hdr+='<div class="prog-desc">'+hesc(p.desc)+'</div>';
    hdr+='<div class="prog-tags">'+tags+'</div>';
    hdr+='<div class="prog-stats">';
    hdr+='<div class="prog-stat"><div><div class="ps-num" style="color:'+p.color+'">'+p.insights.length+'</div><div class="ps-lbl">Health Insights</div></div></div>';
    hdr+='<div class="prog-stat"><div><div class="ps-num" style="color:'+p.color+'">'+mkrSet.size+'</div><div class="ps-lbl">Max Biomarkers</div></div></div>';
    hdr+='</div></div></div>';
  }
  main.innerHTML=hdr+'<div class="body-grid"><div id="ins-col">'+renderInsights()+'</div><div id="ds-col" style="--ac:'+ac+'">'+renderDsPanel(ac)+'</div></div>';
  bindDS();
}

/* ── DATA SOURCES PANEL ─────────────────────────────────────────── */
function renderDsPanel(ac){
  var h='<div class="ds-panel" style="--ac:'+ac+'">';
  h+='<div class="ds-panel-title">&#9889; Data Sources</div>';
  h+='<div class="ds-panel-sub">Toggle to unlock insights. Check cards to add to Solutions Cart.</div>';
  // SELECT ALL toggle
  var allSrcIds = DATA_SOURCES.filter(function(d){
    return d.id!=='dna_exome'&&d.id!=='dna_wgs'&&d.id!=='micro_wgs'&&d.id!=='recommendation';
  }).map(function(d){return d.id;});
  var allOn = allSrcIds.every(function(id){return activeSources.has(id);});
  h+='<div class="ds-select-all'+(allOn?' on':'')+'\" onclick="toggleAllSources()">';
  h+='<div class="ds-sa-chk">'+(allOn?'&#10003;':'')+'</div>';
  h+='<span class="ds-sa-lbl">'+(allOn?'Deselect All Sources':'Select All Sources')+'</span>';
  h+='</div>';
  for(var i=0;i<DATA_SOURCES.length;i++){
    var d=DATA_SOURCES[i],on=activeSources.has(d.id),cnt=countIns(d.id);
    if(d.id==='dna_exome'||d.id==='dna_wgs'||d.id==='micro_wgs'||d.id==='recommendation') continue;
    var num=(i<9?'0':'')+(i+1);
    h+='<div class="ds-item'+(on?' on':'')+(d.id==='recommendation'?' ds-rec':'')+'\" data-src="'+d.id+'">';
    h+='<div class="ds-row"><span class="ds-num">'+num+'</span><span class="ds-ico">'+d.ico+'</span>';
    var hintStr=d.hint;
    if(on&&d.hasBlood)  hintStr=BLOOD_TIERS[bloodTier].name;
    if(on&&d.hasDNA)    hintStr=DNA_TIERS[dnaTier].hint;
    if(on&&d.hasMicro)  hintStr=MICRO_TIERS[microTier].hint;
    if(on&&d.hasEHR)    hintStr=EHR_TIERS[ehrTier].name;
    h+='<div class="ds-info"><span class="ds-name">'+hesc(d.name)+'</span>';
    h+='<span class="ds-hint">'+hesc(hintStr)+'</span></div>';
    h+='<span class="ds-badge">'+cnt+'</span>';
    h+='<div class="ds-chk">&#10003;</div></div>';
    if(d.hasBlood){
      h+='<div class="blood-sub"><div class="blood-sub-lbl">Panel Comprehensiveness</div>';
      var tkeys=['basic','standard','advanced','comprehensive'];
      for(var ti=0;ti<tkeys.length;ti++){
        var tk=tkeys[ti],td=BLOOD_TIERS[tk],sel=bloodTier===tk;
        h+='<div class="bt'+(sel?' sel':'')+'\" data-tier="'+tk+'">';
        h+='<div class="bt-radio"><div class="bt-dot"></div></div>';
        h+='<div><span class="bt-name">'+hesc(td.name)+'</span>';
        h+='<span class="bt-items">'+hesc(td.items.slice(0,3).join(', '))+'...</span></div></div>';
      }
      h+='</div>';
    }
    if(d.hasDNA){
      h+='<div class="dna-sub"><div class="dna-sub-lbl">Sequencing Depth</div>';
      var dtkeys=['dna_array','dna_exome','dna_wgs'];
      for(var di=0;di<dtkeys.length;di++){
        var dk=dtkeys[di],dd=DNA_TIERS[dk],dsel=dnaTier===dk;
        h+='<div class="dt'+(dsel?' sel':'')+'\" data-dna="'+dk+'">';
        h+='<div class="dt-radio"><div class="dt-dot"></div></div>';
        h+='<div style="flex:1"><span class="dt-name">'+hesc(dd.name)+'</span>';
        h+='<div class="dt-stats"><span class="dt-stat">'+hesc(dd.snps)+'</span><span class="dt-stat">'+hesc(dd.indels)+'</span><span class="dt-stat">'+hesc(dd.genes)+'</span></div>';
        h+='</div></div>';
      }
      h+='</div>';
    }
    if(d.hasMicro){
      h+='<div class="micro-sub"><div class="micro-sub-lbl">Sequencing Type & Site</div>';
      var mGroups=[{lbl:'16S rRNA Amplicon',keys:['16s_gut','16s_oral','16s_skin']},{lbl:'Shotgun Metagenomics',keys:['shotgun_gut','shotgun_oral','shotgun_skin']}];
      for(var mg=0;mg<mGroups.length;mg++){
        h+='<div class="micro-sub-section"><span class="micro-sub-section-lbl">'+hesc(mGroups[mg].lbl)+'</span>';
        for(var mi=0;mi<mGroups[mg].keys.length;mi++){
          var mk=mGroups[mg].keys[mi],md=MICRO_TIERS[mk],msel=microTier===mk;
          h+='<div class="mt'+(msel?' sel':'')+'\" data-micro="'+mk+'">';
          h+='<div class="mt-radio"><div class="mt-dot"></div></div>';
          h+='<div style="flex:1"><span class="mt-name">'+hesc(md.name)+'</span>';
          h+='<div class="mt-stats"><span class="mt-stat">'+hesc(md.bacteria)+'</span>';
          if(md.microgenes) h+='<span class="mt-stat">'+hesc(md.microgenes)+'</span>';
          h+='</div></div></div>';
        }
        h+='</div>';
      }
      h+='</div>';
    }
    if(d.hasEHR){
      h+='<div class="ehr-sub"><div class="ehr-sub-lbl">Data Depth</div>';
      var ekeys=['basic','standard','advanced','comprehensive'];
      for(var ei=0;ei<ekeys.length;ei++){
        var ek=ekeys[ei],ed=EHR_TIERS[ek],esel=ehrTier===ek;
        h+='<div class="et'+(esel?' sel':'')+'\" data-ehr="'+ek+'">';
        h+='<div class="et-radio"><div class="et-dot"></div></div>';
        h+='<div><span class="et-name">'+hesc(ed.name)+'</span>';
        h+='<span class="et-items">'+hesc(ed.items.slice(0,3).join(', '))+'...</span></div></div>';
      }
      h+='</div>';
    }
    h+='</div>';
  }
  h+='</div>'; return h;
}
function toggleAllSources(){
  var allSrcIds = DATA_SOURCES.filter(function(d){
    return d.id!=='dna_exome'&&d.id!=='dna_wgs'&&d.id!=='micro_wgs'&&d.id!=='recommendation';
  }).map(function(d){return d.id;});
  var allOn = allSrcIds.every(function(id){return activeSources.has(id);});
  if(allOn){ activeSources.clear(); }
  else { allSrcIds.forEach(function(id){ activeSources.add(id); }); }
  refresh();
}


/* ── BIOMARKER STATS ─────────────────────────────────────────────── */

/* ── BIOMARKER STATS ─────────────────────────────────────────────────── */
function calcBiomarkerStats(progs, srcArrFull) {
  var stats = {
    total_insights: 0,
    snps: 0, indels: 0, genes: 0, cpg: 0,
    blood: 0, wearable: 0, functional: 0, lifestyle: 0,
    bacteria: 0, epigenetic: 0, imaging: 0, ehr: 0
  };
  var dnaScope = DNA_TIERS[dnaTier] || DNA_TIERS['dna_array'];
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (!srcArrFull || srcArrFull.indexOf(ins.src) < 0) continue;
      if (ins.src !== 'recommendation' && !insActive(ins)) continue;
      stats.total_insights++;
      var m = (ins.markers || []).length;
      switch (ins.src) {
        case 'blood':        stats.blood       += m; break;
        case 'wearable':     stats.wearable    += m; break;
        case 'functional':   stats.functional  += m; break;
        case 'lifestyle':    stats.lifestyle   += m; break;
        case 'epigenetics':  stats.epigenetic  += m; break;
        case 'physiological':stats.imaging     += m; break;
        case 'ehr':          stats.ehr         += m; break;
        case 'micro_16s':
        case 'micro_wgs':    stats.bacteria    += m; break;
        case 'dna_array':
        case 'dna_exome':
        case 'dna_wgs':
          // use scope maximums
          break;
      }
    }
  }
  // DNA scope stats are maximum of selected tier
  var hasDNA = srcArrFull && (srcArrFull.indexOf('dna_array') >= 0 || srcArrFull.indexOf('dna_exome') >= 0 || srcArrFull.indexOf('dna_wgs') >= 0);
  if (hasDNA) {
    var snpNum  = parseInt((dnaScope.snps  || '0').replace(/[^0-9]/g,''));
    var indelNum= parseInt((dnaScope.indels|| '0').replace(/[^0-9]/g,''));
    var geneNum = parseInt((dnaScope.genes || '0').replace(/[^0-9]/g,''));
    stats.snps   = snpNum;
    stats.indels = indelNum;
    stats.genes  = geneNum;
  }
  var hasEpi = srcArrFull && srcArrFull.indexOf('epigenetics') >= 0;
  if (hasEpi) stats.cpg = 850000;
  return stats;
}

function fmtNum(n) {
  if (!n) return '0';
  if (n >= 1000000) return (n/1000000).toFixed(1).replace(/\.0$/,'') + 'M';
  if (n >= 1000) return (n/1000).toFixed(0) + 'K';
  return String(n);
}

var _statsOpen = false;
function toggleStatsBar(){
  _statsOpen = !_statsOpen;
  var bar = document.getElementById('stats-bar-inner');
  var tog = document.getElementById('stats-bar-tog');
  if(bar){ bar.classList.toggle('open', _statsOpen); }
  if(tog){ tog.classList.toggle('open', _statsOpen); }
}
function renderStatsBar(stats, ac) {
  var pills = [];
  if (stats.snps)       pills.push(['SNPs',         fmtNum(stats.snps),         '#7c3aed']);
  if (stats.indels)     pills.push(['InDels',        fmtNum(stats.indels),       '#6d28d9']);
  if (stats.genes)      pills.push(['Genes',         fmtNum(stats.genes),        '#4f46e5']);
  if (stats.cpg)        pills.push(['CpG Sites',     fmtNum(stats.cpg),          '#0891b2']);
  if (stats.blood)      pills.push(['Blood Mkrs',    String(stats.blood),        '#dc2626']);
  if (stats.wearable)   pills.push(['Wearable Mkrs', String(stats.wearable),     '#16a34a']);
  if (stats.functional) pills.push(['Func Mkrs',     String(stats.functional),   '#d97706']);
  if (stats.bacteria)   pills.push(['Bacteria',      fmtNum(stats.bacteria),     '#059669']);
  if (stats.epigenetic) pills.push(['Epigenetic',    String(stats.epigenetic),   '#0284c7']);
  if (stats.imaging)    pills.push(['Imaging Mkrs',  String(stats.imaging),      '#7c3aed']);
  if (stats.ehr)        pills.push(['EHR Mkrs',      String(stats.ehr),          '#475569']);
  if (stats.lifestyle)  pills.push(['Lifestyle Mkrs',String(stats.lifestyle),    '#64748b']);
  if (!pills.length) return '';
  var summary = pills.length + ' biomarker categories';
  var h = '<div class="stats-bar-wrap">';
  h += '<div class="stats-bar-toggle'+(_statsOpen?' open':'')+'" id="stats-bar-tog" onclick="toggleStatsBar()">';
  h += '&#128202; Biomarker Coverage — <strong>'+pills.length+' categories</strong>';
  h += '<span class="stats-bar-toggle-arrow">&#9660;</span>';
  h += '</div>';
  h += '<div class="stats-bar'+(_statsOpen?' open':'')+'" id="stats-bar-inner">';
  for (var i = 0; i < pills.length; i++) {
    h += '<div class="stats-pill" style="--pc:'+pills[i][2]+'">';
    h += '<span class="sp-val">'+pills[i][1]+'</span>';
    h += '<span class="sp-lbl">'+pills[i][0]+'</span>';
    h += '</div>';
  }
  h += '</div></div>';
  return h;
}


/* ── FILTER BAR ──────────────────────────────────────────────────── */
function renderFilterBar(ac) {
  var progs = program ? [program] : PROGRAMS;
  var counts = {biomarker_assessment:0, health_dashboard:0, recommendation:0};
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (ins.src !== 'recommendation' && !activeSources.has(ins.src)) continue;
      if (ins.src !== 'blood' || !ins.tier || tierIdx(ins.tier) <= tierIdx(bloodTier)) {
        var t = ins.insight_type || 'health_dashboard';
        if (counts[t] !== undefined) counts[t]++;
      }
    }
  }
  var allActive = activeFilters.size === 3;
  var h = '<div class="filter-bar">';
  h += '<span class="filter-bar-lbl">Show</span>';
  h += '<div class="filter-chip'+(allActive?' active':'')+'" data-filter="all" style="--chip-color:'+ac+'" onclick="toggleAllFilters()">';
  h += '<span class="filter-chip-ico">⚡</span> All Insights';
  h += '</div>';
  h += '<div class="filter-sep"></div>';
  h += '<div class="filter-chip'+(activeFilters.has('biomarker_assessment')?' active':'')+'" data-filter="biomarker_assessment" style="--chip-color:#0077cc" onclick="toggleFilter(\'biomarker_assessment\')">';
  h += '<span class="filter-chip-ico">🔬</span> Biomarker Assessments';
  h += '<span class="filter-chip-cnt">'+counts.biomarker_assessment+'</span></div>';
  h += '<div class="filter-chip'+(activeFilters.has('health_dashboard')?' active':'')+'" data-filter="health_dashboard" style="--chip-color:'+ac+'" onclick="toggleFilter(\'health_dashboard\')">';
  h += '<span class="filter-chip-ico">📊</span> Health Indices';
  h += '<span class="filter-chip-cnt">'+counts.health_dashboard+'</span></div>';
  h += '<div class="filter-chip'+(activeFilters.has('recommendation')?' active':'')+'" data-filter="recommendation" style="--chip-color:#16a34a" onclick="toggleFilter(\'recommendation\')">';
  h += '<span class="filter-chip-ico">💡</span> Recommendations';
  h += '<span class="filter-chip-cnt">'+counts.recommendation+'</span></div>';
  h += '</div>';
  return h;
}
function toggleFilter(type) {
  if (activeFilters.has(type)) {
    // don't allow all off
    if (activeFilters.size > 1) activeFilters.delete(type);
  } else {
    activeFilters.add(type);
  }
  updateFilterUI();
  refresh();
}
function toggleAllFilters() {
  if (activeFilters.size === 3) {
    // all on → keep all on (don't allow turning all off this way)
    return;
  }
  activeFilters = new Set(['biomarker_assessment','health_dashboard','recommendation']);
  updateFilterUI();
  refresh();
}
function updateFilterUI() {
  var chips = document.querySelectorAll('.filter-chip');
  for (var i = 0; i < chips.length; i++) {
    var chip = chips[i];
    var ft = chip.getAttribute('data-filter');
    if (ft === 'all') {
      chip.classList.toggle('active', activeFilters.size === 3);
    } else {
      chip.classList.toggle('active', activeFilters.has(ft));
    }
  }
  // Update counts
  updateFilterCounts();
}
function updateFilterCounts() {
  var progs = program ? [program] : PROGRAMS;
  var counts = {biomarker_assessment:0, health_dashboard:0, recommendation:0};
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (!activeSources.has(ins.src) && ins.src !== 'recommendation') continue;
      if (ins.src === 'recommendation' && !activeFilters.has('recommendation')) continue;
      var t = ins.insight_type || 'health_dashboard';
      if (counts[t] !== undefined) counts[t]++;
    }
  }
  ['biomarker_assessment','health_dashboard','recommendation'].forEach(function(ft) {
    var chip = document.querySelector('.filter-chip[data-filter="'+ft+'"]');
    if (chip) {
      var cnt = chip.querySelector('.filter-chip-cnt');
      if (cnt) cnt.textContent = counts[ft];
    }
  });
}

/* ── ACCORDION ───────────────────────────────────────────────────── */
var _openAccordion = null;

/* ── RENDER INSIGHTS ─────────────────────────────────────────────── */
function renderInsights(){
  if(activeSources.size===0)
    return '<div class="no-src"><div class="no-src-icon">&#9655;</div><div class="no-src-p">Select a data source from the right panel<br>and a vertical from the left to explore insights.</div></div>';
  var progs=program?[program]:PROGRAMS, ac=program?program.color:'#1452d4';
  var srcArr=[];
  var _dnaAdded=false;
  activeSources.forEach(function(s){
    if(s==='dna_array'||s==='dna_exome'||s==='dna_wgs'){
      if(!_dnaAdded){ srcArr.push(s); _dnaAdded=true; }
    } else { srcArr.push(s); }
  });
  var srcArrFull=srcArr.slice();
  if(activeFilters.has('recommendation')) srcArrFull.push('recommendation');

  // Collect ALL items across all sources, grouped by insight_type
  var byType = { recommendation:[], health_dashboard:[], biomarker_assessment:[] };
  for(var si=0;si<srcArrFull.length;si++){
    var srcId=srcArrFull[si];
    var _isDNA2=(srcId==='dna_array'||srcId==='dna_exome'||srcId==='dna_wgs');
    var _dnaIds2=['dna_array','dna_exome','dna_wgs'];
    for(var pi=0;pi<progs.length;pi++) for(var ii=0;ii<progs[pi].insights.length;ii++){
      var ins=progs[pi].insights[ii];
      var _sm=_isDNA2?(_dnaIds2.indexOf(ins.src)>=0):(ins.src===srcId);
      if(!_sm) continue;
      if(srcId!=='recommendation'&&!insActive(ins)) continue;
      var itype=ins.insight_type||'health_dashboard';
      if(!activeFilters.has(itype)) continue;
      if(byType[itype]) byType[itype].push({ins:ins,prog:progs[pi],srcId:srcId});
    }
  }

  var total = byType.recommendation.length + byType.health_dashboard.length + byType.biomarker_assessment.length;

  // Stats bar
  var stats = calcBiomarkerStats(progs, srcArrFull);
  var statsBarHtml = renderStatsBar(stats, ac);

  // Filter bar
  var filterBarHtml = renderFilterBar(ac);

  // Summary bar
  // Build scope summary for header bar
  var scopeParts = [];
  if(stats.snps)     scopeParts.push({v:fmtNum(stats.snps),     l:'SNPs',          c:'#7c3aed'});
  if(stats.indels)   scopeParts.push({v:fmtNum(stats.indels),   l:'InDels',        c:'#6d28d9'});
  if(stats.genes)    scopeParts.push({v:fmtNum(stats.genes),    l:'Genes',         c:'#4f46e5'});
  if(stats.cpg)      scopeParts.push({v:fmtNum(stats.cpg),      l:'CpG Sites',     c:'#0891b2'});
  if(stats.bacteria) scopeParts.push({v:fmtNum(stats.bacteria), l:'Bacterial Taxa', c:'#059669'});
  if(stats.blood)    scopeParts.push({v:String(stats.blood),    l:'Blood Mkrs',    c:'#dc2626'});
  if(stats.wearable) scopeParts.push({v:String(stats.wearable), l:'Wearable Mkrs', c:'#16a34a'});
  if(stats.epigenetic) scopeParts.push({v:String(stats.epigenetic), l:'Epigenetic', c:'#0284c7'});
  if(stats.lifestyle) scopeParts.push({v:String(stats.lifestyle), l:'Lifestyle Mkrs', c:'#64748b'});
  if(stats.imaging)  scopeParts.push({v:String(stats.imaging),  l:'Imaging Mkrs',  c:'#7c3aed'});

  var bar='<div class="total-bar">';
  bar+='<div><div class="t-num">'+total+'</div><div class="t-lbl">Matching Insights</div></div>';
  bar+='<div class="t-sep"></div><div><div class="t-num">'+activeSources.size+'</div><div class="t-lbl">Data Sources</div></div>';
  if(cart.length>0) bar+='<div class="t-sep"></div><div><div class="t-num" style="color:#c03030">'+cart.length+'</div><div class="t-lbl">In Cart</div></div>';
  if(scopeParts.length>0){
    bar+='<div class="t-sep"></div>';
    bar+='<div class="t-scope-wrap">';
    bar+='<div class="t-scope-lbl">Analytical Scope</div>';
    bar+='<div class="t-scope-pills">';
    for(var si=0;si<scopeParts.length;si++){
      bar+='<span class="t-scope-pill" style="--sc:'+scopeParts[si].c+'">';
      bar+='<span class="tsp-v">'+scopeParts[si].v+'</span>';
      bar+='<span class="tsp-l">'+scopeParts[si].l+'</span>';
      bar+='</span>';
    }
    bar+='</div></div>';
  }
  bar+='</div>';

  // Render three accordion sections in order: Recommendations, Health Indices, Biomarker Assessments
  var sections = [
    { key:'recommendation',      label:'Recommendations',       ico:'💡', color:'#16a34a' },
    { key:'health_dashboard',    label:'Health Indices',        ico:'📊', color:ac        },
    { key:'biomarker_assessment',label:'Biomarker Assessments', ico:'🔬', color:'#0077cc' }
  ];

  var accordion = '<div class="ins-accordion">';
  for(var si=0;si<sections.length;si++){
    var sec = sections[si];
    var items = byType[sec.key];
    if(items.length===0) continue;
    // Sort items by subcategory then name
    items.sort(function(a,b){
      // 1. By category (program name)
      var pa = a.prog.name||'', pb = b.prog.name||'';
      var pc = pa.localeCompare(pb);
      if(pc!==0) return pc;
      // 2. By subcategory
      var sa = a.ins.subcategory||'', sb = b.ins.subcategory||'';
      var sc = sa.localeCompare(sb);
      if(sc!==0) return sc;
      // 3. By data source order
      var SRC_ORDER=['lifestyle','wearable','physiological','ehr','blood','dna_array','dna_exome','dna_wgs','micro_16s','micro_wgs','epigenetics','recommendation'];
      var si = SRC_ORDER.indexOf(a.ins.src), sj = SRC_ORDER.indexOf(b.ins.src);
      si = si<0?99:si; sj = sj<0?99:sj;
      if(si!==sj) return si-sj;
      // 4. Alphabetically by name
      return a.ins.name.localeCompare(b.ins.name);
    });
    var sectionId = 'acc-'+sec.key;
    // Cards grouped by subcategory
    var cards = renderInsightList(items, ac, !program);
    accordion += '<div class="acc-section" id="'+sectionId+'">';
    accordion += '<div class="acc-hdr" onclick="toggleAccordion(\''+sectionId+'\')" style="--acc-color:'+sec.color+'">';
    accordion += '<span class="acc-ico">'+sec.ico+'</span>';
    accordion += '<span class="acc-lbl">'+sec.label+'</span>';
    accordion += '<span class="acc-cnt">'+items.length+' insight'+(items.length!==1?'s':'')+'</span>';
    accordion += '<span class="acc-arrow">&#9650;</span>';
    accordion += '</div>';
    accordion += '<div class="acc-body">'+cards+'</div>';
    accordion += '</div>';
  }
  accordion += '</div>';

  // API endpoints
  var epH=''; srcArrFull.forEach(function(srcId){
    if(srcId==='recommendation'){
      epH+='<div class="api-ep"><span class="api-method post">POST</span><span class="api-path">/api/v1/recommendations/{userId}</span></div>';
      return;
    }
    var d3=ds(srcId); if(!d3) return;
    epH+='<div class="api-ep"><span class="api-method '+d3.method.toLowerCase()+'">'+d3.method+'</span><span class="api-path">'+hesc(d3.ep)+'</span></div>';
  });
  var api='<div class="api-block"><div class="api-title">&#128299; Solutions Cart — API Endpoints</div><div class="api-eps">'+epH+'</div><div class="api-note">Full OpenAPI spec: developers.lifenome.com &bull; Auth: Bearer Token (RFC6750)</div></div>';

  var srchBar='<div class="srch-wrap"><span class="srch-ico">&#128269;</span>'+
    '<input class="srch-inp" id="srch-inp" placeholder="Search insights by name, keyword or biomarker..." oninput="doSearch(this.value)" autocomplete="off">'+
    '<span class="srch-x" id="srch-x" onclick="clearSearch()">&#215;</span></div>';

  return srchBar+filterBarHtml+statsBarHtml+bar+accordion+api;
}

function toggleAccordion(sectionId){
  var sec=document.getElementById(sectionId);
  if(!sec) return;
  var wasOpen=!sec.classList.contains('collapsed');
  // collapse all
  document.querySelectorAll('.acc-section').forEach(function(s){ s.classList.add('collapsed'); });
  // if was open leave all closed; if was closed open this one
  if(!wasOpen) sec.classList.remove('collapsed');
  // re-run search if active
  if(_sq) applySearch();
}

function renderInsightList(items, ac, showProgChip) {
  // Group by subcategory
  var groups={}, order=[];
  for(var i=0;i<items.length;i++){
    var sc=items[i].ins.subcategory||'';
    if(!groups[sc]){groups[sc]=[];order.push(sc);}
    groups[sc].push(items[i]);
  }
  var html='';
  for(var gi=0;gi<order.length;gi++){
    var sc=order[gi], sc_items=groups[sc];
    if(sc){
      var ico=SUBCAT_ICONS[sc]||'▸';
      html+='<div class="subcat-hdr"><span class="subcat-hdr-ico">'+ico+'</span>';
      html+='<span class="subcat-hdr-name">'+hesc(sc)+'</span>';
      html+='<span class="subcat-hdr-count">'+sc_items.length+' insight'+(sc_items.length!==1?'s':'')+'</span></div>';
    }
    for(var ci=0;ci<sc_items.length;ci++){
      html+=renderInsCard(sc_items[ci], ac, showProgChip);
    }
  }
  return html;
}



function renderInsCard(item, ac, showProgChip) {
  var ins = item.ins, p = item.prog;
  var key = cartKey(p.id, ins.name);
  var inCart = false;
  for (var ki = 0; ki < cart.length; ki++) if (cart[ki].key === key) { inCart = true; break; }
  var itype = ins.insight_type || 'health_dashboard';
  var srcColor = itype === 'recommendation' ? '#16a34a' : ac;
  var tierLbl = (ins.src === 'blood' && ins.tier) ? ' &middot; ' + BLOOD_TIERS[ins.tier].name : '';
  var catChip = showProgChip ? ('<span class="ic-cat" style="background:color-mix(in srgb,'+p.color+' 10%,white);color:'+p.color+';border:1px solid color-mix(in srgb,'+p.color+' 18%,transparent)">'+hesc(p.name)+'</span>') : '';
  var compSource = COMPETITOR_INSIGHTS[ins.name];
  var compBadge = compSource ? '<span class="comp-badge">&#128270; '+hesc(compSource)+'</span>' : '';
  var typeBadge = '';
  if (itype === 'recommendation') {
    var rtLabel = ins.rec_type === 'product' ? '&#128717; Product Recs' : '&#128203; Program Recs';
    typeBadge = '<div class="rec-badge">&#128161; Recommendation <span class="rec-type-badge '+(ins.rec_type||'program')+'">'+rtLabel+'</span></div>';
  } else if (itype === 'biomarker_assessment') {
    typeBadge = '<div class="assess-badge">&#128300; Biomarker Assessment</div>';
  }
  var srcName = ins.src;
  for (var di = 0; di < DATA_SOURCES.length; di++) if (DATA_SOURCES[di].id === ins.src) { srcName = DATA_SOURCES[di].name; break; }
  if (ins.src === 'recommendation') srcName = 'Recommendation Engine';
  var mArr = ins.markers || [], mkrs = '';
  var mkrLabel = itype === 'recommendation' ? '<div class="ic-mkr-lbl">Personalized by:</div>' : '';
  for (var mi = 0; mi < Math.min(mArr.length, 6); mi++) mkrs += '<span class="ic-m">'+hesc(mArr[mi])+'</span>';
  if (mArr.length > 6) mkrs += '<span class="ic-m">+'+(mArr.length-6)+' more</span>';
  var gpills = genomicPills(ins, ac);
  return (
    '<div class="ins-card collapsed'+(inCart?' carted':'')+'" data-key="'+hesc(key)+'" data-prog="'+hesc(p.id)+
    '" data-name="'+hesc(ins.name)+'" data-src="'+hesc(ins.src)+'" data-unit="'+hesc(ins.unit||'')+
    '" data-range="'+hesc(ins.range||'')+'" data-itype="'+hesc(itype)+'" style="--ac:'+ac+'">'+
    '<div class="ic-cart" title="Add to Solutions Cart">&#10003;</div>'+
    (catChip?'<div class="ic-cat-row">'+catChip+'</div>':'')+
    typeBadge +
    '<div class="ic-src" style="background:color-mix(in srgb,'+srcColor+' 9%,white);color:'+srcColor+';border:1px solid color-mix(in srgb,'+srcColor+' 14%,transparent)">'+hesc(srcName)+tierLbl+'</div>'+
    '<div class="ic-name-click"><div class="ic-name">'+hesc(ins.name)+compBadge+'</div><div class="ic-tog" title="Expand details">&#9660;</div></div>'+
    '<div class="ic-collapsible">'+
    (ins.desc?'<div class="ic-desc">'+hesc(ins.desc)+'</div>':'')+
    (ins.unit?'<div><span class="ic-unit">'+hesc(ins.unit)+'</span></div>':'')+
    (ins.range?'<div class="ic-range">'+hesc(ins.range)+'</div>':'')+
    mkrLabel+
    '<div class="ic-markers">'+mkrs+'</div>'+
    '</div>'+
    '</div>'
  );
}

/* ── EVENT BINDING ───────────────────────────────────────────────── */
function bindDS(){
  var rows=document.querySelectorAll('.ds-row');
  for(var i=0;i<rows.length;i++)(function(row){
    row.onclick=function(){
      var item=row.parentElement,src=item.getAttribute('data-src');
      if(activeSources.has(src)) activeSources.delete(src); else activeSources.add(src);
      refresh();
    };
  })(rows[i]);
  var tiers=document.querySelectorAll('.bt');
  for(var i=0;i<tiers.length;i++)(function(tier){
    tier.onclick=function(e){
      e.stopPropagation(); bloodTier=tier.getAttribute('data-tier');
      if(!activeSources.has('blood')) activeSources.add('blood'); refresh();
    };
  })(tiers[i]);
  var dts=document.querySelectorAll('.dt');
  for(var i=0;i<dts.length;i++)(function(dt){
    dt.onclick=function(e){
      e.stopPropagation();
      dnaTier=dt.getAttribute('data-dna');
      activeSources.delete('dna_array'); activeSources.delete('dna_exome'); activeSources.delete('dna_wgs');
      activeSources.add(dnaTier); refresh();
    };
  })(dts[i]);
  var mts=document.querySelectorAll('.mt');
  for(var i=0;i<mts.length;i++)(function(mt){
    mt.onclick=function(e){
      e.stopPropagation(); microTier=mt.getAttribute('data-micro');
      activeSources.delete('micro_16s'); activeSources.delete('micro_wgs');
      activeSources.add(microTier.startsWith('shotgun')?'micro_wgs':'micro_16s'); refresh();
    };
  })(mts[i]);
  var ets=document.querySelectorAll('.et');
  for(var i=0;i<ets.length;i++)(function(et){
    et.onclick=function(e){
      e.stopPropagation(); ehrTier=et.getAttribute('data-ehr');
      if(!activeSources.has('ehr')) activeSources.add('ehr'); refresh();
    };
  })(ets[i]);
  var cards=document.querySelectorAll('.ins-card');
  for(var i=0;i<cards.length;i++)(function(card){
    var chk=card.querySelector('.ic-cart');
    if(chk) chk.onclick=function(e){
      e.stopPropagation();
      cartToggle(card.getAttribute('data-key'),card.getAttribute('data-prog'),
        card.getAttribute('data-name'),card.getAttribute('data-src'),
        card.getAttribute('data-unit')||'',card.getAttribute('data-range')||'');
    };
    var nameClick=card.querySelector('.ic-name-click');
    if(nameClick) nameClick.onclick=function(e){
      e.stopPropagation();
      card.classList.toggle('collapsed');
    };
  })(cards[i]);
}

function refresh(){
  var insCol=document.getElementById('ins-col'),dsCol=document.getElementById('ds-col');
  var ac=program?program.color:'#1452d4';
  if(insCol) insCol.innerHTML=renderInsights();
  if(dsCol){dsCol.innerHTML=renderDsPanel(ac);dsCol.style.setProperty('--ac',ac);}
  bindDS(); updateCartBtn(); updateFilterUI();
}

/* ── CART ─────────────────────────────────────────────────────────────── */
function cartToggle(key,progId,insName,srcId,unit,range){
  var found=-1; for(var i=0;i<cart.length;i++) if(cart[i].key===key){found=i;break;}
  if(found>=0){ cart.splice(found,1); }
  else{
    var prog=null; for(var i=0;i<PROGRAMS.length;i++) if(PROGRAMS[i].id===progId){prog=PROGRAMS[i];break;}
    var markers=[]; if(prog) for(var i=0;i<prog.insights.length;i++) if(prog.insights[i].name===insName){markers=prog.insights[i].markers||[];break;}
    cart.push({key:key,progId:progId,progName:prog?prog.name:progId,progColor:prog?prog.color:'#1452d4',insName:insName,srcId:srcId,unit:unit,range:range,markers:markers});
  }
  var safeKey=key.replace(/'/g,"\\'");
  var card=document.querySelector('[data-key="'+safeKey+'"]');
  if(card) card.classList.toggle('carted',found<0);
  updateCartBtn(); refreshBar();
  if(document.getElementById('cart-overlay').classList.contains('open')) renderCartPanel();
}
function refreshBar(){
  var bar=document.querySelector('.total-bar'); if(!bar) return;
  var progs=program?[program]:PROGRAMS,total=0;
  activeSources.forEach(function(srcId){
    for(var pi=0;pi<progs.length;pi++) for(var ii=0;ii<progs[pi].insights.length;ii++){
      var ins=progs[pi].insights[ii]; if(ins.src===srcId&&insActive(ins)) total++;
    }
  });
  bar.innerHTML='<div><div class="t-num">'+total+'</div><div class="t-lbl">Insights Available</div></div>'+
    '<div class="t-sep"></div><div><div class="t-num">'+activeSources.size+'</div><div class="t-lbl">Data Sources</div></div>'+
    (cart.length>0?'<div class="t-sep"></div><div><div class="t-num" style="color:#c03030">'+cart.length+'</div><div class="t-lbl">In Cart</div></div>':'');
}
function updateCartBtn(){
  var btn=document.getElementById('hdr-cart-btn'),cnt=document.getElementById('hdr-cart-count');
  if(cnt) cnt.textContent=cart.length;
  if(btn){if(cart.length>0) btn.classList.add('has-items'); else btn.classList.remove('has-items');}
}
function openCart(){ document.getElementById('cart-overlay').classList.add('open'); renderCartPanel(); }
function closeCart(){ document.getElementById('cart-overlay').classList.remove('open'); }

/* ── CART PANEL ───────────────────────────────────────────────────────── */
function renderCartPanel(){
  var body=document.getElementById('cart-body'),footer=document.getElementById('cart-footer');
  if(cart.length===0){
    body.innerHTML='<div class="cart-empty"><div style="font-size:32px;margin-bottom:12px">&#128722;</div><p style="font-size:13px;color:var(--ink3)">Your Solutions Cart is empty.<br>Check insights to add them here.</p></div>';
    footer.innerHTML=''; return;
  }
  var srcMarkers={};
  for(var ci=0;ci<cart.length;ci++){
    var c=cart[ci];
    if(!srcMarkers[c.srcId]) srcMarkers[c.srcId]=new Set();
    (c.markers||[]).forEach(function(m){srcMarkers[c.srcId].add(m);});
  }
  var usedSrcs=[]; for(var ci=0;ci<cart.length;ci++) if(usedSrcs.indexOf(cart[ci].srcId)<0) usedSrcs.push(cart[ci].srcId);
  var modH='<div style="margin-bottom:18px"><div class="cart-sec-title">Required Testing Modalities & Biomarkers</div>';
  for(var di=0;di<DATA_SOURCES.length;di++){
    var d2=DATA_SOURCES[di]; if(usedSrcs.indexOf(d2.id)<0) continue;
    var cnt2=0; for(var ci=0;ci<cart.length;ci++) if(cart[ci].srcId===d2.id) cnt2++;
    var bms=srcMarkers[d2.id]?[...srcMarkers[d2.id]]:[];
    if(d2.hasBlood) BLOOD_TIERS[bloodTier].items.forEach(function(bm){bms.indexOf(bm)<0&&bms.push(bm);});
    var bmHtml=''; for(var bi=0;bi<bms.length;bi++) bmHtml+='<span class="mod-bm">'+hesc(bms[bi])+'</span>';
    modH+='<div class="modality-block"><div class="modality-hdr" style="background:'+srcBg(d2.id)+'">';
    modH+='<span class="mod-ico">'+d2.ico+'</span>';
    modH+='<span class="mod-hdr-name">'+hesc(d2.name)+(d2.hasBlood?' — '+BLOOD_TIERS[bloodTier].name:'')+'</span>';
    modH+='<span class="mod-hdr-count">'+cnt2+' insight'+(cnt2!==1?'s':'')+'</span></div>';
    modH+='<div class="modality-biomarkers"><div class="mod-bm-lbl">Biomarkers &amp; Inputs Required</div>';
    modH+='<div class="mod-bm-list">'+bmHtml+'</div></div></div>';
  }
  modH+='</div>';
  var byProg={};
  for(var ci=0;ci<cart.length;ci++){var c2=cart[ci]; if(!byProg[c2.progId]) byProg[c2.progId]=[]; byProg[c2.progId].push(c2);}
  var insH='<div><div class="cart-sec-title">Selected Insights ('+cart.length+')</div>';
  var progIds=Object.keys(byProg);
  for(var pi2=0;pi2<progIds.length;pi2++){
    var pid=progIds[pi2],items=byProg[pid],pc=items[0].progColor;
    insH+='<div class="cart-ins-prog"><div class="cart-prog-hdr" style="color:'+pc+'"><span class="cart-dot" style="background:'+pc+'"></span>'+hesc(items[0].progName)+'</div>';
    for(var ii2=0;ii2<items.length;ii2++){
      var item2=items[ii2],dsName=item2.srcId;
      for(var di2=0;di2<DATA_SOURCES.length;di2++) if(DATA_SOURCES[di2].id===item2.srcId){dsName=DATA_SOURCES[di2].name;break;}
      insH+='<div class="cart-item" data-key="'+hesc(item2.key)+'">';
      insH+='<div class="cart-dot" style="background:'+pc+';margin-top:4px"></div>';
      insH+='<div class="cart-item-info"><span class="cart-item-name">'+hesc(item2.insName)+'</span>';
      insH+='<span class="cart-item-meta">'+hesc(dsName)+(item2.unit?' &bull; '+hesc(item2.unit):'')+'</span>';
      if(item2.range) insH+='<span class="cart-item-range">'+hesc(item2.range)+'</span>';
      insH+='</div>';
      insH+='<button class="cart-rm" data-key="'+hesc(item2.key)+'" data-prog="'+hesc(item2.progId)+'" data-name="'+hesc(item2.insName)+'" data-src="'+hesc(item2.srcId)+'" data-unit="'+hesc(item2.unit||'')+'" data-range="'+hesc(item2.range||'')+'">&#10005;</button>';
      insH+='</div>';
    }
    insH+='</div>';
  }
  insH+='</div>';
  var epH='<div class="api-block"><div class="api-title">&#128299; Your Solution API Endpoints</div><div class="api-eps">';
  for(var si=0;si<usedSrcs.length;si++){
    var d3=ds(usedSrcs[si]); if(!d3) continue;
    epH+='<div class="api-ep"><span class="api-method '+d3.method.toLowerCase()+'">'+d3.method+'</span><span class="api-path">'+hesc(d3.ep)+'</span></div>';
  }
  epH+='</div><div class="api-note">Contact partnerships@lifenome.com for API key and pricing proposal.</div></div>';
  body.innerHTML=modH+insH+epH;
  var rmBtns=body.querySelectorAll('.cart-rm');
  for(var ri=0;ri<rmBtns.length;ri++)(function(btn){
    btn.onclick=function(){
      cartToggle(btn.getAttribute('data-key'),btn.getAttribute('data-prog'),btn.getAttribute('data-name'),
        btn.getAttribute('data-src'),btn.getAttribute('data-unit')||'',btn.getAttribute('data-range')||'');
    };
  })(rmBtns[ri]);
  footer.innerHTML=
    '<button class="send-btn" onclick="sendEmail()">&#9993;&nbsp; Send API Selection to Lifenome Partnership Team</button>'+
    '<button class="export-btn" onclick="exportCart()">&#128229; Download Solution Spec <span style="font-family:DM Mono,monospace;font-size:10px;background:rgba(0,0,0,.07);padding:1px 7px;border-radius:4px">'+cart.length+' insights</span></button>';
}

/* ── EMAIL & EXPORT ─────────────────────────────────────────────────── */
function buildEmailBody(){
  var lines=[];
  lines.push('Organization: '+orgName);
  lines.push('Email: '+orgEmail);
  if(orgUrl) lines.push('Website: '+orgUrl);
  lines.push('');
  var typeLabels=[];
  for(var i=0;i<orgTypes.length;i++) for(var j=0;j<CLIENT_TYPES.length;j++) if(CLIENT_TYPES[j].id===orgTypes[i]) typeLabels.push(CLIENT_TYPES[j].label);
  lines.push('Organization Type(s): '+typeLabels.join(', '));
  lines.push('');
  lines.push('\u2500'.repeat(50));
  lines.push('API CART SELECTION ('+cart.length+' insights)');
  lines.push('\u2500'.repeat(50));
  lines.push('');
  var usedSrcs=[]; for(var ci=0;ci<cart.length;ci++) if(usedSrcs.indexOf(cart[ci].srcId)<0) usedSrcs.push(cart[ci].srcId);
  lines.push('REQUIRED TESTING MODALITIES:');
  lines.push('');
  var srcMarkers2={};
  for(var ci=0;ci<cart.length;ci++){
    var c=cart[ci]; if(!srcMarkers2[c.srcId]) srcMarkers2[c.srcId]=new Set();
    (c.markers||[]).forEach(function(m){srcMarkers2[c.srcId].add(m);});
  }
  for(var si=0;si<usedSrcs.length;si++){
    var d4=ds(usedSrcs[si]);
    var cnt3=0; for(var ci=0;ci<cart.length;ci++) if(cart[ci].srcId===usedSrcs[si]) cnt3++;
    lines.push((d4?d4.name:usedSrcs[si])+(d4&&d4.hasBlood?' ['+BLOOD_TIERS[bloodTier].name+']':'')+'  ('+cnt3+' insights)');
    lines.push('  API Endpoint: '+(d4?d4.ep:''));
    var bms=srcMarkers2[usedSrcs[si]]?[...srcMarkers2[usedSrcs[si]]]:[];
    if(d4&&d4.hasBlood) BLOOD_TIERS[bloodTier].items.forEach(function(bm){bms.indexOf(bm)<0&&bms.push(bm);});
    if(bms.length>0) lines.push('  Biomarkers / Inputs: '+bms.join(' | '));
    lines.push('');
  }
  lines.push('\u2500'.repeat(50));
  lines.push('SELECTED INSIGHTS BY PROGRAM:');
  lines.push('');
  var byProg2={};
  for(var ci=0;ci<cart.length;ci++){var c3=cart[ci]; if(!byProg2[c3.progId]) byProg2[c3.progId]=[]; byProg2[c3.progId].push(c3);}
  Object.keys(byProg2).forEach(function(pid){
    var items=byProg2[pid];
    lines.push('[ '+items[0].progName+' ]');
    items.forEach(function(c4){
      lines.push('  * '+c4.insName);
      if(c4.unit) lines.push('    Unit: '+c4.unit);
      if(c4.range) lines.push('    Reference: '+c4.range);
    });
    lines.push('');
  });
  return lines.join('\n');
}
function sendEmail(){
  var subject=encodeURIComponent('API and Testing Selection \u2014 '+orgName);
  var body=encodeURIComponent(buildEmailBody());
  window.location.href='mailto:ali@lifenome.com?subject='+subject+'&body='+body;
}
function exportCart(){
  var blob=new Blob([buildEmailBody()],{type:'text/plain'});
  var a=document.createElement('a');a.href=URL.createObjectURL(blob);
  a.download='lifenome-api-selection-'+(orgName||'org').replace(/\s+/g,'-').toLowerCase()+'.txt';
  a.click();
}

const SUBCAT_ICONS = {"Chronic Disease Management & Prevention": "\ud83c\udfe5", "Cancer Genetics & Risk": "\ud83c\udf97\ufe0f", "Pharmacogenomics": "\ud83d\udc8a", "Neurological & Psychiatric Disease Risk": "\ud83e\udde0", "Women's Health Genomics": "\ud83c\udf38", "Digestive & Gastrointestinal Genomics": "\ud83e\udda0", "Immune, Autoimmune & Allergy Genomics": "\ud83d\udee1\ufe0f", "Respiratory & Pulmonary Genomics": "\ud83e\udec1", "Cardiogenomics & Structural Heart Disease": "\u2764\ufe0f", "Metabolic & Endocrine Rare Disease": "\u2697\ufe0f", "Renal, Ophthalmology & ENT Genomics": "\ud83d\udc41\ufe0f", "Nutrition Genomics & Precision Supplementation": "\ud83e\udd57", "Addiction & Behavioral Genomics": "\ud83e\uddec", "Dermatology & Skin Disease Genomics": "\ud83d\udd2c", "Hematology & Blood Disorders": "\ud83e\ude78", "Developmental & Congenital Disorders": "\ud83e\udde9", "Oral Health Genomics": "\ud83e\uddb7", "Epigenetic Disease Risk": "\ud83d\udd2d"};

function renderSubcatGrouped(items, ac, showProgChip) {
  // Group by subcategory
  var groups={}, order=[];
  for(var i=0;i<items.length;i++){
    var k=items[i].ins.subcategory||'General';
    if(!groups[k]){groups[k]=[];order.push(k);}
    groups[k].push(items[i]);
  }
  // Apply insight type filter
  var filtered={}, filteredOrder=[];
  for(var oi=0;oi<order.length;oi++){
    var k=order[oi];
    var arr=groups[k].filter(function(it){
      var itype=it.ins.insight_type||'health_dashboard';
      return activeFilters.has(itype);
    });
    if(arr.length>0){filtered[k]=arr;filteredOrder.push(k);}
  }
  if(filteredOrder.length===0) return '<div class="filter-empty">No insights match the active filters.</div>';
  var h='';
  for(var oi=0;oi<filteredOrder.length;oi++){
    var k=filteredOrder[oi], arr=filtered[k];
    h+='<div class="subcat-hdr" style="--ac:'+ac+'"><span class="subcat-ico">◈</span>'+hesc(k)+'<span class="subcat-cnt">'+arr.length+'</span></div>';
    // Paginate if large (>30 items)
    var PAGE=30;
    if(arr.length>PAGE){
      var pageId='pg_'+Math.random().toString(36).slice(2,8);
      h+='<div id="'+pageId+'" class="subcat-cards">';
      h+='<div class="dna-page-bar"><span>Showing <strong id="'+pageId+'_s">1</strong>–<strong id="'+pageId+'_e">'+Math.min(PAGE,arr.length)+'</strong> of <strong>'+arr.length+'</strong> traits</span>';
      h+='<span style="display:flex;gap:6px">';
      h+='<button class="dna-page-btn" id="'+pageId+'_prev" onclick="changePage(\''+pageId+'\',\'prev\')" disabled>&#8592; Prev</button>';
      h+='<button class="dna-page-btn" id="'+pageId+'_next" onclick="changePage(\''+pageId+'\',\'next\')">Next &#8594;</button>';
      h+='</span></div>';
      // Render first page
      for(var ci=0;ci<Math.min(PAGE,arr.length);ci++) h+=renderInsCard(arr[ci],ac,showProgChip);
      h+='</div>';
      // Store all items for pagination
      if(!window._pgData) window._pgData={};
      window._pgData[pageId]={items:arr,page:0,pageSize:PAGE,ac:ac,showProgChip:showProgChip};
    } else {
      h+='<div class="subcat-cards">';
      for(var ci=0;ci<arr.length;ci++) h+=renderInsCard(arr[ci],ac,showProgChip);
      h+='</div>';
    }
  }
  return h;
}

function genomicPills(ins, ac) {
  var gs = ins.genomic_scope; if (!gs) return '';
  var pills = '';
  var lbl = function(l,v){ return '<span class="ic-gp"><span class="gp-l">'+l+'</span>'+hesc(v)+'</span>'; };
  if (gs.snps)     pills += lbl('SNPs', gs.snps);
  if (gs.indels)   pills += lbl('InDels', gs.indels);
  if (gs.genes)    pills += lbl('Genes', gs.genes);
  if (gs.cpg)      pills += lbl('CpG sites', gs.cpg);
  if (gs.bacteria) pills += lbl('Bacterial taxa', gs.bacteria);
  return pills ? '<div class="ic-genomic">'+pills+'</div>' : '';
}



var COMPETITOR_INSIGHTS = {"InnerAge Biological Age Score": "InsideTracker InnerAge 2.0", "Blood-Based Biological Age": "InsideTracker InnerAge 2.0", "Endurance Healthspan Category Score": "InsideTracker", "Recovery & Muscle Damage Index": "InsideTracker", "Metabolism Healthspan Score": "InsideTracker", "Gut-Brain Axis Health Score": "InsideTracker", "Advanced Cardiovascular Risk Score": "Function Health + InsideTracker", "Insulin Resistance & Pre-Diabetes Index": "InsideTracker metabolism", "Organ Function Surveillance Panel": "Function Health", "Heavy Metal & Toxin Burden Index": "Function Health", "Autoimmune Surveillance Index": "Function Health", "Brain Aging & Alzheimer's Risk Score": "Function Health", "Omega-3 Index & Essential Fatty Acid Profile": "Function Health", "Electrolyte & Mineral Optimization Panel": "InsideTracker Ultimate", "Mood-Nutrient Deficiency Panel": "Function Health", "Thyroid-Mood Connection Score": "Function Health", "Neuroinflammation Index": "Function Health + InsideTracker"};

// ─── INSIGHT TYPE FILTER STATE ──────────────────────────────────────
var activeFilters = new Set(['biomarker_assessment','health_dashboard','recommendation']);

function toggleFilter(type) {
  if (activeFilters.has(type)) {
    // don't allow all off
    if (activeFilters.size > 1) activeFilters.delete(type);
  } else {
    activeFilters.add(type);
  }
  updateFilterUI();
  refresh();
}

function updateFilterUI() {
  var chips = document.querySelectorAll('.filter-chip');
  for (var i = 0; i < chips.length; i++) {
    var chip = chips[i];
    var ft = chip.getAttribute('data-filter');
    if (ft === 'all') {
      chip.classList.toggle('active', activeFilters.size === 3);
    } else {
      chip.classList.toggle('active', activeFilters.has(ft));
    }
  }
  // Update counts
  updateFilterCounts();
}

function toggleAllFilters() {
  if (activeFilters.size === 3) {
    // all on → keep all on (don't allow turning all off this way)
    return;
  }
  activeFilters = new Set(['biomarker_assessment','health_dashboard','recommendation']);
  updateFilterUI();
  refresh();
}

function updateFilterCounts() {
  var progs = program ? [program] : PROGRAMS;
  var counts = {biomarker_assessment:0, health_dashboard:0, recommendation:0};
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (!activeSources.has(ins.src) && ins.src !== 'recommendation') continue;
      if (ins.src === 'recommendation' && !activeFilters.has('recommendation')) continue;
      var t = ins.insight_type || 'health_dashboard';
      if (counts[t] !== undefined) counts[t]++;
    }
  }
  ['biomarker_assessment','health_dashboard','recommendation'].forEach(function(ft) {
    var chip = document.querySelector('.filter-chip[data-filter="'+ft+'"]');
    if (chip) {
      var cnt = chip.querySelector('.filter-chip-cnt');
      if (cnt) cnt.textContent = counts[ft];
    }
  });
}

// Filter bar HTML
function renderFilterBar(ac) {
  var progs = program ? [program] : PROGRAMS;
  var counts = {biomarker_assessment:0, health_dashboard:0, recommendation:0};
  for (var pi = 0; pi < progs.length; pi++) {
    for (var ii = 0; ii < progs[pi].insights.length; ii++) {
      var ins = progs[pi].insights[ii];
      if (ins.src !== 'recommendation' && !activeSources.has(ins.src)) continue;
      if (ins.src !== 'blood' || !ins.tier || tierIdx(ins.tier) <= tierIdx(bloodTier)) {
        var t = ins.insight_type || 'health_dashboard';
        if (counts[t] !== undefined) counts[t]++;
      }
    }
  }
  var allActive = activeFilters.size === 3;
  var h = '<div class="filter-bar">';
  h += '<span class="filter-bar-lbl">Show</span>';
  h += '<div class="filter-chip'+(allActive?' active':'')+'" data-filter="all" style="--chip-color:'+ac+'" onclick="toggleAllFilters()">';
  h += '<span class="filter-chip-ico">⚡</span> All Insights';
  h += '</div>';
  h += '<div class="filter-sep"></div>';
  h += '<div class="filter-chip'+(activeFilters.has('biomarker_assessment')?' active':'')+'" data-filter="biomarker_assessment" style="--chip-color:#0077cc" onclick="toggleFilter(\'biomarker_assessment\')">';
  h += '<span class="filter-chip-ico">🔬</span> Biomarker Assessments';
  h += '<span class="filter-chip-cnt">'+counts.biomarker_assessment+'</span></div>';
  h += '<div class="filter-chip'+(activeFilters.has('health_dashboard')?' active':'')+'" data-filter="health_dashboard" style="--chip-color:'+ac+'" onclick="toggleFilter(\'health_dashboard\')">';
  h += '<span class="filter-chip-ico">📊</span> Health Indices';
  h += '<span class="filter-chip-cnt">'+counts.health_dashboard+'</span></div>';
  h += '<div class="filter-chip'+(activeFilters.has('recommendation')?' active':'')+'" data-filter="recommendation" style="--chip-color:#16a34a" onclick="toggleFilter(\'recommendation\')">';
  h += '<span class="filter-chip-ico">💡</span> Recommendations';
  h += '<span class="filter-chip-cnt">'+counts.recommendation+'</span></div>';
  h += '</div>';
  return h;
}

function renderSubcatGrouped(items, ac, showProgChip) {
  var groups = {}, order = [];
  for (var i = 0; i < items.length; i++) {
    var sc = items[i].ins.subcategory || '';
    if (!groups[sc]) { groups[sc] = []; order.push(sc); }
    groups[sc].push(items[i]);
  }
  var html = '';
  for (var gi = 0; gi < order.length; gi++) {
    var sc = order[gi], sc_items = groups[sc];
    if (sc) {
      var ico = SUBCAT_ICONS[sc] || '▸';
      html += '<div class="subcat-hdr"><span class="subcat-hdr-ico">'+ico+'</span>';
      html += '<span class="subcat-hdr-name">'+hesc(sc)+'</span>';
      html += '<span class="subcat-hdr-count">'+sc_items.length+' insight'+(sc_items.length!==1?'s':'')+'</span></div>';
    }
    for (var ci = 0; ci < sc_items.length; ci++) {
      html += renderInsCard(sc_items[ci], ac, showProgChip);
    }
  }
  if (html === '') {
    html = '<div class="filter-empty"><div class="filter-empty-ico">🔍</div><div class="filter-empty-p">No insights match this filter.<br>Try selecting a different insight type above.</div></div>';
  }
  return html;
}




/* ── SEARCH ─────────────────────────────────────────────────────────── */
var _sq = '';
function doSearch(v){
  _sq = (v||'').trim().toLowerCase();
  var x = document.getElementById('srch-x');
  if(x) x.classList.toggle('vis', _sq.length > 0);
  applySearch();
}
function clearSearch(){
  _sq='';
  var inp=document.getElementById('srch-inp'); if(inp) inp.value='';
  var x=document.getElementById('srch-x'); if(x) x.classList.remove('vis');
  applySearch();
}
function applySearch(){
  var cards=document.querySelectorAll('.ins-card'), matched=0;
  cards.forEach(function(card){
    if(!_sq){ card.style.display=''; return; }
    var name=(card.getAttribute('data-name')||'').toLowerCase();
    var unit=(card.getAttribute('data-unit')||'').toLowerCase();
    var desc=card.querySelector('.ic-desc'); var dt=desc?(desc.textContent||'').toLowerCase():'';
    var mkrs=''; card.querySelectorAll('.ic-m').forEach(function(m){mkrs+=' '+m.textContent.toLowerCase();});
    var hit=name.includes(_sq)||dt.includes(_sq)||mkrs.includes(_sq)||unit.includes(_sq);
    card.style.display=hit?'':'none';
    if(hit){ matched++; card.classList.remove('collapsed'); hlName(card,_sq); }
  });
  document.querySelectorAll('.src-block').forEach(function(b){
    var vis=b.querySelectorAll('.ins-card:not([style*="display: none"])').length>0;
    b.style.display=vis?'':'none';
  });
  document.querySelectorAll('.subcat-hdr').forEach(function(h){
    var sib=h.nextElementSibling,any=false;
    while(sib&&!sib.classList.contains('subcat-hdr')){
      if(sib.classList.contains('ins-card')&&sib.style.display!=='none') any=true;
      sib=sib.nextElementSibling;
    }
    h.style.display=any?'':'none';
  });
  var st=document.getElementById('srch-status');
  if(_sq){
    if(!st){ st=document.createElement('div'); st.id='srch-status'; st.className='srch-status';
      var col=document.getElementById('ins-col'); if(col) col.insertBefore(st,col.firstChild); }
    st.className='srch-status'+(_sq&&matched===0?' none':'');
    st.textContent=matched>0?matched+' insight'+(matched!==1?'s':'')+' match "'+_sq+'"':'No insights match "'+_sq+'"';
    st.style.display='block';
  } else if(st){ st.style.display='none'; }
}
function hlName(card, q){
  var el=card.querySelector('.ic-name'); if(!el) return;
  var txt=el.textContent||'', lo=txt.toLowerCase(), idx=lo.indexOf(q);
  if(idx>=0) el.innerHTML=hesc(txt.slice(0,idx))+'<mark class="sh">'+hesc(txt.slice(idx,idx+q.length))+'</mark>'+hesc(txt.slice(idx+q.length));
}


/* ── DNA PAGINATION ────────────────────────────────────────────── */
function changePage(pageId, dir){
  if(!window._pgData||!window._pgData[pageId]) return;
  var d=window._pgData[pageId];
  var maxPage=Math.ceil(d.items.length/d.pageSize)-1;
  if(dir==='next'&&d.page<maxPage) d.page++;
  else if(dir==='prev'&&d.page>0) d.page--;
  var start=d.page*d.pageSize, end=Math.min(start+d.pageSize,d.items.length);
  // Update counter
  var sEl=document.getElementById(pageId+'_s'), eEl=document.getElementById(pageId+'_e');
  if(sEl) sEl.textContent=start+1;
  if(eEl) eEl.textContent=end;
  // Update buttons
  var prevBtn=document.getElementById(pageId+'_prev'), nextBtn=document.getElementById(pageId+'_next');
  if(prevBtn) prevBtn.disabled=(d.page===0);
  if(nextBtn) nextBtn.disabled=(d.page===maxPage);
  // Re-render cards
  var container=document.getElementById(pageId);
  if(!container) return;
  // Remove old cards (keep page bar = first child)
  var children=Array.from(container.children);
  for(var i=1;i<children.length;i++) container.removeChild(children[i]);
  // Add new cards
  var frag=document.createDocumentFragment();
  for(var ci=start;ci<end;ci++){
    var tmp=document.createElement('div');
    tmp.innerHTML=renderInsCard(d.items[ci],d.ac,d.showProgChip);
    frag.appendChild(tmp.firstChild);
  }
  container.appendChild(frag);
  bindDS(); // re-bind events
}

const PROGRAMS = [
  {
    "id": "longevity",
    "name": "Longevity",
    "sub": "Lifespan Optimization",
    "color": "#1452d4",
    "lt": "#e8effe",
    "img": "https://images.unsplash.com/photo-1571019613454-1cb2f99b2d8b?w=320&q=75",
    "desc": "Multi-omic lifespan optimization combining biological age, inflammaging, metabolic vitality, and epigenetic clocks into actionable longevity protocols.",
    "tags": [
      "biological age",
      "lifespan",
      "inflammaging",
      "epigenetic clock",
      "PGS"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Lifestyle Longevity Risk Score",
        "desc": "Composite modifiable risk index from smoking, sleep duration, exercise frequency, stress load, and alcohol patterns.",
        "markers": [
          "sleep hrs",
          "exercise freq",
          "smoking status",
          "alcohol units/wk",
          "stress score"
        ],
        "unit": "Score 0\u2013100",
        "range": "Low risk: >70 | High risk: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Healthspan Trajectory Projection",
        "desc": "Lifestyle-adjusted projection of remaining healthy life years, calibrated to population norms.",
        "markers": [
          "diet quality",
          "activity level",
          "social connection",
          "BMI",
          "sleep regularity"
        ],
        "unit": "Projected healthy years",
        "range": "Reference: chronological age \u2212 10 yr",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "HRV Aging Biomarker",
        "desc": "30-day RMSSD trend as real-time autonomic aging marker. Declining HRV correlates with accelerated biological aging.",
        "markers": [
          "HRV RMSSD ms",
          "resting HR bpm",
          "recovery score %"
        ],
        "unit": "RMSSD in ms",
        "range": "Optimal: >55 ms | Concern: <30 ms",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "VO2 Max Biological Age Proxy",
        "desc": "Cardiorespiratory fitness-based biological age estimation. VO2 max is one of the strongest predictors of longevity.",
        "markers": [
          "VO2 max mL/kg/min",
          "zone 2 weekly hrs",
          "training load AU"
        ],
        "unit": "mL/kg/min",
        "range": "Excellent 40s M: >46 | Poor: <35",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Sleep Architecture Score",
        "desc": "Deep/REM ratio and circadian alignment score reflecting cellular repair quality and immune regulation.",
        "markers": [
          "deep sleep %",
          "REM %",
          "sleep efficiency %",
          "circadian alignment hr"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: deep >20%, REM >20%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Resting Heart Rate Trend",
        "desc": "Long-term resting HR trajectory as cardiometabolic aging signal. Upward drift indicates declining fitness age.",
        "markers": [
          "resting HR bpm 30-day",
          "7-day HR variability",
          "nocturnal HR"
        ],
        "unit": "bpm",
        "range": "Optimal: 50\u201365 bpm | Concern: >75 bpm",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Facial Biological Age",
        "desc": "Lifenome patented smartphone camera-based facial biological age estimate informed by methylation clock correlates.",
        "markers": [
          "periorbital aging score",
          "skin texture index",
          "facial symmetry",
          "wrinkle depth proxy"
        ],
        "unit": "Estimated biological age (yr)",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Age Index",
        "desc": "Smartphone-derived body fat %, visceral fat proxy, and muscle mass index combined into a morphological age score.",
        "markers": [
          "body fat %",
          "visceral fat proxy",
          "muscle mass index",
          "waist-hip ratio"
        ],
        "unit": "Morphological age score",
        "range": "Optimal: body fat M<20%, F<28%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Grip Strength Proxy",
        "desc": "Camera-based hand posture analysis as proxy for grip strength \u2014 a validated all-cause mortality predictor.",
        "markers": [
          "hand posture analysis",
          "forearm volume proxy"
        ],
        "unit": "Estimated kg force",
        "range": "Optimal M: >40 kg | F: >25 kg",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Metabolic Vitality Score",
        "desc": "Fasting glucose, HbA1c, and lipid panel combined into a foundational metabolic age signal.",
        "markers": [
          "fasting glucose mg/dL",
          "HbA1c %",
          "LDL mg/dL",
          "HDL mg/dL",
          "TG mg/dL",
          "TSH mIU/L"
        ],
        "unit": "Composite score 0\u2013100",
        "range": "Optimal glucose: 70\u2013100 | HbA1c: <5.7%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Inflammaging Index",
        "desc": "Chronic low-grade inflammation composite: hs-CRP, homocysteine, ferritin as the biological age accelerator panel.",
        "markers": [
          "hs-CRP mg/L",
          "homocysteine \u00b5mol/L",
          "ferritin ng/mL",
          "vitamin D ng/mL"
        ],
        "unit": "Composite risk score",
        "range": "hs-CRP optimal: <1.0 mg/L | Hcy: <10 \u00b5mol/L",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Hormonal Vitality Score",
        "desc": "IGF-1, DHEA-S, testosterone, and cortisol AM balance as validated longevity endocrine markers.",
        "markers": [
          "IGF-1 ng/mL",
          "DHEA-S \u00b5g/dL",
          "cortisol AM \u00b5g/dL",
          "testosterone ng/dL",
          "SHBG nmol/L"
        ],
        "unit": "Composite hormonal age",
        "range": "IGF-1 optimal 40\u201360s: 100\u2013200 ng/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "ApoB / Lp(a) Cardiovascular Age",
        "desc": "Most predictive lipid markers for arterial aging \u2014 ApoB and Lp(a) supersede standard LDL for longevity risk.",
        "markers": [
          "ApoB mg/dL",
          "Lp(a) nmol/L",
          "oxidized LDL U/L",
          "LDL-P nmol/L"
        ],
        "unit": "ApoB mg/dL + Lp(a) nmol/L",
        "range": "ApoB optimal: <80 mg/dL | Lp(a): <75 nmol/L",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Kidney Biological Age (eGFR)",
        "desc": "eGFR and cystatin-C based kidney age \u2014 renal function declines predictably with biological aging.",
        "markers": [
          "eGFR mL/min/1.73m2",
          "cystatin-C mg/L",
          "creatinine mg/dL",
          "BUN mg/dL"
        ],
        "unit": "eGFR mL/min/1.73m\u00b2",
        "range": "Optimal: >90 | Mild decline: 60\u201389",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "NAD+ / Mitochondrial Panel",
        "desc": "NAD+, CoQ10, and glutathione as direct cellular energy and antioxidant capacity longevity biomarkers.",
        "markers": [
          "NAD+ \u00b5mol/L",
          "CoQ10 \u00b5g/mL",
          "GSH \u00b5mol/L",
          "IL-6 pg/mL",
          "TNF-\u03b1 pg/mL"
        ],
        "unit": "NAD+ \u00b5mol/L",
        "range": "Optimal NAD+: >40 \u00b5mol/L | Decline: <25",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Telomere-Associated Blood Panel",
        "desc": "IL-6, TNF-\u03b1, and lymphocyte/neutrophil ratio as blood-based correlates of telomere length.",
        "markers": [
          "IL-6 pg/mL",
          "TNF-\u03b1 pg/mL",
          "neutrophil:lymphocyte ratio",
          "WBC x10\u00b3/\u00b5L"
        ],
        "unit": "NLR ratio",
        "range": "NLR optimal: 1.0\u20132.5 | Concern: >3.5",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Polygenic Longevity Score",
        "desc": "Lifenome 184-trait wellbeing PGS spanning fitness, nutrition, personality, and biological resilience genetics.",
        "markers": [
          "APOE status",
          "MTHFR C677T/A1298C",
          "telomere-length SNPs",
          "184 wellbeing PGS"
        ],
        "unit": "Percentile vs population",
        "range": "Top quartile: >75th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Medical Disease PGS Panel",
        "desc": "213-condition medical PGS covering all major disease categories as all-cause mortality and morbidity modifiers.",
        "markers": [
          "circulatory PGS",
          "metabolic PGS",
          "cancer PGS",
          "neurological PGS",
          "213 medical traits"
        ],
        "unit": "Per-disease risk percentile",
        "range": "Elevated: >75th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Pharmacogenomics Longevity Panel",
        "desc": "193-trait PGx covering supplement absorption, drug metabolism, and statin response for longevity protocols.",
        "markers": [
          "CYP2D6/2C19/3A4 status",
          "SLCO1B1 statin",
          "VDR vitamin D",
          "193 PGx traits"
        ],
        "unit": "Metabolizer phenotype",
        "range": "Normal / Poor / Rapid / Ultrarapid",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Circadian Rhythm Chronotype PGS",
        "desc": "Genetic chronotype (morning/evening) and sleep architecture predisposition \u2014 affects biological aging rate.",
        "markers": [
          "CLOCK gene",
          "PER3 SNPs",
          "BMAL1 variants",
          "chronotype PGS"
        ],
        "unit": "Chronotype score",
        "range": "Intermediate optimal; extreme owl/lark = risk",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Rare Variant Longevity Risk",
        "desc": "Pathogenic and likely-pathogenic variants in longevity-associated genes across 230 Exome+ clinical panels.",
        "markers": [
          "PCSK9 gain-of-function",
          "LMNA variants",
          "TP53 germline",
          "MEN1",
          "TERT",
          "16,600+ panel traits"
        ],
        "unit": "Pathogenicity classification",
        "range": "ACMG P/LP = actionable",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_exome",
        "name": "Mitochondrial DNA Variants",
        "desc": "mtDNA variants affecting oxidative phosphorylation efficiency \u2014 haplogroup and pathogenic variant analysis.",
        "markers": [
          "mtDNA copy number",
          "OXPHOS variants",
          "mitochondrial haplogroup"
        ],
        "unit": "mtDNA copy number",
        "range": "Optimal: >100 copies/cell",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_wgs",
        "name": "Full Genome Longevity Scan",
        "desc": "WGS improves PRS accuracy by 25\u201335% and discovers ultra-rare structural variants missed by arrays and exome.",
        "markers": [
          "All array PGS enhanced",
          "structural variants",
          "copy number variants",
          "rare INDELs"
        ],
        "unit": "Enhanced PRS score",
        "range": "WGS PRS \u00b11.5 SD from mean",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Microbiome Diversity Longevity Index",
        "desc": "Alpha and beta diversity as independent aging predictors \u2014 centenarians show distinct microbiome signatures.",
        "markers": [
          "Shannon diversity index",
          "Firmicutes:Bacteroidetes ratio",
          "Akkermansia % abundance",
          "Bifidobacterium %"
        ],
        "unit": "Shannon index (H)",
        "range": "Optimal H: >3.0 | Concern: <2.0",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_16s",
        "name": "Leaky Gut & Systemic Inflammation",
        "desc": "Intestinal permeability markers measured via microbiome composition correlates affecting inflammaging.",
        "markers": [
          "zonulin-correlated species",
          "LPS-producing bacteria %",
          "mucosal barrier species"
        ],
        "unit": "Dysbiosis score 0\u201310",
        "range": "Optimal: <3 | High risk: >7",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Functional Longevity Metabolomics",
        "desc": "Butyrate producers, SCFA synthesis capacity, and tryptophan metabolism from shotgun functional analysis.",
        "markers": [
          "butyrate pathway gene count",
          "SCFA producers %",
          "tryptophan metabolism genes",
          "serotonin pathway capacity"
        ],
        "unit": "Functional gene abundance (RPKM)",
        "range": "Butyrate genes: optimal >1.5 RPKM",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Epigenetic Biological Age (DNAmAge)",
        "desc": "Horvath, GrimAge, DunedinPACE, and PhenoAge clocks \u2014 gold-standard multi-algorithm biological age battery.",
        "markers": [
          "Horvath age (yr)",
          "GrimAge (yr)",
          "DunedinPACE (yr/yr)",
          "PhenoAge (yr)"
        ],
        "unit": "Biological age in years",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "epigenetics",
        "name": "Epigenetic Age Acceleration",
        "desc": "Age gap vs. chronological age \u2014 the most actionable longevity intervention target available.",
        "markers": [
          "AgeAccelGrim (yr)",
          "AgeAccelHorvath (yr)",
          "DunedinPACE pace value",
          "methylation clock consensus"
        ],
        "unit": "Age acceleration in years",
        "range": "Optimal: \u22640 yr | High: >5 yr acceleration",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "epigenetics",
        "name": "Methylation-Based Disease Risk Scores",
        "desc": "DNAm-derived risk scores for cardiovascular disease, T2DM, and cancer independent of genetic risk.",
        "markers": [
          "DNAm CVD risk score",
          "DNAm T2DM score",
          "CpG cancer methylation loci",
          "epigenetic immune age"
        ],
        "unit": "Percentile vs population",
        "range": "Elevated: >75th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "blood",
        "name": "Heavy Metal & Toxin Burden Index",
        "desc": "Function Health includes mercury and lead in standard membership. Chronic heavy metal accumulation accelerates aging, impairs cognition, and drives cardiovascular and kidney disease. Lead, mercury, arsenic, and cadmium panel.",
        "markers": [
          "blood lead (Pb)",
          "blood mercury (Hg)",
          "blood arsenic (As)",
          "urine cadmium (Cd)",
          "urine aluminum (Al)",
          "serum thallium"
        ],
        "unit": "\u03bcg/L per metal",
        "range": "Mercury: <5 \u03bcg/L | Lead: <3.5 \u03bcg/dL | Arsenic: <20 \u03bcg/L",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Autoimmune Surveillance Index",
        "desc": "Function Health data shows 23% of members have elevated autoimmune antibodies \u2014 most entirely asymptomatic. ANA screen, anti-dsDNA, TPO, TgAb, and anti-CCP provide early autoimmune detection before clinical symptoms emerge.",
        "markers": [
          "ANA screen",
          "ANA pattern (IF)",
          "anti-dsDNA",
          "TPO antibodies",
          "TgAb",
          "anti-CCP",
          "RF (rheumatoid factor)",
          "complement C3/C4"
        ],
        "unit": "Antibody titer / IU/mL",
        "range": "ANA negative | TPO Ab: <35 IU/mL | Anti-dsDNA: <30 IU/mL",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Blood-Based Biological Age",
        "desc": "Biological age calculated from 18 key blood biomarkers using ML algorithms trained on 42,000+ samples (methodology: InsideTracker InnerAge 2.0 + PhenoAge). Biomarkers weighted by their correlation with chronological aging: glucose, LDL, albumin, hematocrit, lymphocytes, GGT, HbA1c, triglycerides, cortisol, DHEA-S, ferritin, vitamin D, hs-CRP, insulin, MCHC, creatinine, uric acid, WBC.",
        "markers": [
          "fasting glucose",
          "LDL cholesterol",
          "albumin",
          "hematocrit",
          "lymphocyte %",
          "GGT",
          "HbA1c",
          "triglycerides",
          "cortisol AM",
          "DHEA-S",
          "ferritin",
          "25-OH Vitamin D",
          "hs-CRP",
          "fasting insulin",
          "MCHC",
          "creatinine",
          "uric acid",
          "WBC"
        ],
        "unit": "Biological age (years)",
        "range": "Optimal: \u22653 years younger than chronological | Concern: >3 years older",
        "tier": "advanced"
      },
      {
        "src": "epigenetics",
        "insight_type": "health_dashboard",
        "name": "Epigenetic Biological Age (Methylation)",
        "desc": "DNA methylation-based biological age using 4 validated epigenetic clocks: Horvath clock (pan-tissue), GrimAge (strongest all-cause mortality predictor), PhenoAge (phenotypic health proxy), and DunedinPACE (real-time aging speed). GrimAge acceleration >3 years is a major actionable threshold. Covers 850,000 CpG sites.",
        "markers": [
          "Horvath clock age (353 CpGs)",
          "GrimAge acceleration",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking epigenetic score)",
          "DNAmTL (telomere length proxy)",
          "DNAm CRP",
          "EpiTOC2 (cancer stem cell index)"
        ],
        "unit": "Biological age (years) per clock",
        "range": "Ideal: clock age \u2264 chronological | Alert: GrimAge >3 yr acceleration",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Actuarial Age (Lifestyle & Demographic)",
        "desc": "Validated actuarial biological age calculation from lifestyle and demographic inputs, based on RealAge and Levine mortality risk models. Factors: smoking history, alcohol intake, BMI, physical activity level, diet quality score, sleep duration, psychosocial stress, social connectedness, education, income proxy, environmental exposures, and medical history. Each factor is weighted by its effect size on all-cause mortality.",
        "markers": [
          "smoking history (pack-years)",
          "alcohol units/week",
          "BMI",
          "physical activity (MET-hours/week)",
          "diet quality (HEI score)",
          "sleep duration (hours/night)",
          "sleep quality (PSQI)",
          "psychosocial stress (PSS-10)",
          "social connection score",
          "SES proxy",
          "environmental exposure index",
          "medical conditions count"
        ],
        "unit": "Actuarial age (years)",
        "range": "Optimal: \u22655 years younger | Danger zone: >5 years older"
      },
      {
        "src": "wearable",
        "insight_type": "health_dashboard",
        "name": "Physiological Age (HRV \u00b7 VO\u2082Max \u00b7 HR \u00b7 BP)",
        "desc": "Composite physiological age score derived from four objective performance biomarkers: resting heart rate variability (RMSSD \u2014 validated vs. chronological age normative curves), VO\u2082max (cardiorespiratory fitness age from submaximal exercise), resting heart rate trend, and blood pressure index. Each metric is z-scored against age/sex-matched population norms and combined into a single physiological age.",
        "markers": [
          "RMSSD (ms) \u2014 HRV physiological age",
          "VO\u2082max (mL/kg/min) \u2014 cardiorespiratory age",
          "resting heart rate \u2014 cardiovascular age",
          "systolic BP \u2014 vascular age",
          "diastolic BP",
          "HRV trend (30-day)",
          "RHR trend (30-day)",
          "SpO\u2082 resting"
        ],
        "unit": "Physiological age (years)",
        "range": "Optimal: \u22655 years younger | HRV age: RMSSD age-matched percentile >60th"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Cardiovascular System Age",
        "desc": "Dedicated biological age for the cardiovascular system integrating vascular stiffness proxies, lipid particle quality, inflammatory burden, and hemodynamic markers. Based on the Framingham Heart Age model extended with ApoB, Lp(a), NT-proBNP, and hs-CRP weighting. Expresses how much older or younger your cardiovascular system is than your chronological age.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "resting HR",
          "systolic BP",
          "HbA1c",
          "eGFR"
        ],
        "unit": "Cardiovascular age (years)",
        "range": "Optimal: \u22655 yr younger | Alert: >5 yr older | Critical: >10 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic System Age",
        "desc": "Biological age of the metabolic system derived from glucose regulation, insulin sensitivity, lipid metabolism, liver function, and body composition markers. The MetaboAge algorithm weights HOMA-IR, HbA1c, fasting insulin, triglycerides, ALT, GGT, uric acid, and adipokines against age-matched population norms.",
        "markers": [
          "HOMA-IR (insulin resistance)",
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "triglycerides",
          "ALT",
          "GGT",
          "uric acid",
          "ApoB",
          "ferritin",
          "adiponectin",
          "leptin proxy (BMI + TG/HDL)"
        ],
        "unit": "Metabolic age (years)",
        "range": "Optimal: \u22653 yr younger | Metabolic syndrome threshold: >8 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Immune System Age (Immunological Age)",
        "desc": "Immunological age derived from the composition of white blood cell subpopulations, inflammatory cytokines, and autoimmune markers. Based on the iAge (inflammatory age) framework from Stanford and the immunosenescence scoring of Lehallier et al. (2019). Captures both inflammaging (chronic low-grade inflammation) and immunosenescence (loss of adaptive immune capacity).",
        "markers": [
          "neutrophil:lymphocyte ratio",
          "lymphocyte %",
          "CD4:CD8 T-cell ratio (if available)",
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "CXCL9 (iAge cytokine)",
          "WBC differential",
          "eosinophil count",
          "IgG",
          "IgA",
          "IgM",
          "anti-CMV IgG proxy"
        ],
        "unit": "Immune age (years)",
        "range": "iAge optimal: <30 | Alert: >chronological | Immunosenescence: NLR >3.0",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Respiratory System Age",
        "desc": "Biological age of respiratory function integrating blood-based markers of pulmonary capacity and oxygenation with wearable SpO\u2082 and resting respiratory rate. Proxy for FEV1/FVC ratio decline using SERPINA1, CRP, and RBC indices. Validated against NHANES spirometry normative age curves.",
        "markers": [
          "SpO\u2082 resting %",
          "SpO\u2082 exertional",
          "respiratory rate (resting)",
          "hs-CRP (lung inflammation)",
          "WBC (respiratory infection burden)",
          "hemoglobin (O\u2082 carrying capacity)",
          "hematocrit",
          "neutrophil %",
          "eosinophil % (asthma proxy)",
          "SERPINA1 genotype risk"
        ],
        "unit": "Respiratory age (years)",
        "range": "Optimal: \u22653 yr younger | SpO\u2082 <95% resting = significant aging signal",
        "tier": "standard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Musculoskeletal System Age",
        "desc": "Biological age of the musculoskeletal system derived from bone turnover markers, inflammatory burden on joints, muscle catabolism indicators, and hormonal support for lean mass. Integrates vitamin D, testosterone/DHEA-S, IGF-1, and bone resorption/formation markers into a composite MSK age score.",
        "markers": [
          "vitamin D 25-OH",
          "testosterone total",
          "DHEA-S",
          "IGF-1",
          "osteocalcin (bone formation)",
          "CTX-I (bone resorption)",
          "P1NP (bone synthesis)",
          "hs-CRP (joint inflammation)",
          "uric acid (gout risk)",
          "albumin (muscle catabolism proxy)",
          "magnesium RBC",
          "creatine kinase"
        ],
        "unit": "Musculoskeletal age (years)",
        "range": "Optimal: \u22653 yr younger | Osteoporosis risk: CTX-I high + low osteocalcin",
        "tier": "advanced"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Personalized Longevity Exercise Protocol",
        "desc": "Individualized exercise prescription balancing aerobic (VO\u2082max optimization), resistance (lean mass preservation), and flexibility training. Intensity zones set by HRV-derived lactate threshold, adjusted weekly by recovery readiness score and biological age gap.",
        "markers": [
          "VO\u2082max",
          "HRV (RMSSD)",
          "biological age gap",
          "testosterone",
          "IGF-1",
          "cortisol AM",
          "CRP",
          "muscle damage index"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Precision Longevity Nutrition Plan",
        "desc": "Personalized macronutrient ratios and meal timing based on metabolic type (carb/fat response genetics), insulin sensitivity, circadian chronotype, and microbiome composition. Includes intermittent fasting protocol if metabolic markers support it.",
        "markers": [
          "HOMA-IR",
          "chronotype PGS",
          "Firmicutes:Bacteroidetes ratio",
          "HbA1c",
          "omega-3 index",
          "tryptophan:LNAA",
          "diet PGS"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Stress Resilience & Mind-Body Program",
        "desc": "Structured program combining breathwork (HRV biofeedback), mindfulness meditation, and sleep hygiene protocols. Protocol intensity matched to cortisol burden score, HRV baseline, and stress resilience genetics (FKBP5, COMT).",
        "markers": [
          "cortisol AM",
          "DHEA-S",
          "HRV",
          "FKBP5 genotype",
          "COMT genotype",
          "PSS-10 score",
          "sleep efficiency"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Longevity Supplement Stack",
        "desc": "Personalized longevity supplement protocol selected from client product catalog. Matched to identified deficiencies and genetic predispositions: NAD+ precursors (NMN/NR) if mitochondrial markers low, omega-3 if index <6%, vitamin D if <40 ng/mL, magnesium if RBC Mg low, CoQ10 if statin use or mitochondrial panel.",
        "markers": [
          "NAD+ proxy (NMN need)",
          "omega-3 index",
          "25-OH Vit D",
          "magnesium RBC",
          "CoQ10",
          "glutathione",
          "folate",
          "B12",
          "MTHFR genotype",
          "heavy metals"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Biological Age Reversal Program",
        "desc": "12-month structured lifestyle intervention program targeting GrimAge deceleration. Protocol includes caloric restriction mimetics support, time-restricted eating windows, cold exposure, and sauna protocols personalized by epigenetic clock acceleration and physiological age gap.",
        "markers": [
          "GrimAge acceleration",
          "DunedinPACE",
          "blood biological age",
          "actuarial age",
          "physiological age",
          "NLR",
          "CRP",
          "telomere-associated markers"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Allergy Eggs",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Allergy Eggs"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Milk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Allergy Milk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Peanuts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Allergy Peanuts"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "General Food Sensitivities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "General Food Sensitivities"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Gluten Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Gluten Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Lactose Intolerance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Lactose Intolerance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Cockroaches",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Cockroaches"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Dust Mites",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Dust Mites"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Mold",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Mold"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Pets",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Pets"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Birch Pollen Allergy Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Birch Pollen Allergy Resistance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Grass Allergy Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Grass Allergy Resistance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hay Fever",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Hay Fever"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Histamine Intolerance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Histamine Intolerance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Mugwort Allergy Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Mugwort Allergy Resistance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Misophonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Misophonia"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Motion Sickness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Motion Sickness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Noise Induced Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Noise Induced Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Resistance Stomach Flu",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Resistance Stomach Flu"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Seasonality",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Seasonality"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Benzene",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Sensitivity To Chemicals",
        "markers": [
          "Sensitivity Benzene"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Mercury",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Sensitivity To Chemicals",
        "markers": [
          "Sensitivity Mercury"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Pcb",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Sensitivity To Chemicals",
        "markers": [
          "Sensitivity Pcb"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Exercise Benefits Blood Pressure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Exercise Benefits Blood Pressure"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Exercise Benefits Lowering Cholesterol",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Exercise Benefits Lowering Cholesterol"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Exercise Benefits Maximal Oxygen Uptake",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Exercise Benefits Maximal Oxygen Uptake"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Heartbeat Reduction Difficulty",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Heartbeat Reduction Difficulty"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Lower Exercise Benefits Heart Pump",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Lower Exercise Benefits Heart Pump"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Overall Fitness Benefits",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Overall Fitness Benefits"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Aerobic Performance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Aerobic Performance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Elite Endurance Athletes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Elite Endurance Athletes"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Endurance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Endurance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Exercise Aversion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Exercise Aversion"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Joint Flexibility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Joint Flexibility"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Lean Body Mass Potential",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Lean Body Mass Potential"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Power",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Power"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Achilles Tendinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Achilles Tendinopathy"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Anterior Cruciate Ligament Rupture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Anterior Cruciate Ligament Rupture"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Joint Injury Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Joint Injury Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Overall Tendon Ligament Injury Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Overall Tendon Ligament Injury Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Stress Fracture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Stress Fracture"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Cramping",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Cramping"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Damage Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Damage Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Response Resistance Training",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Response Resistance Training"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Soreness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Soreness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Strength Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Strength Loss"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscular Strength",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscular Strength"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Skeletal Muscle Performance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Skeletal Muscle Performance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Slow Muscle Repair",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Slow Muscle Repair"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Bitter Taste Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Bitter Taste Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      }
    ],
    "_marker_count": 296,
    "marker_count": 346,
    "insight_count": 106
  },
  {
    "id": "fertility",
    "name": "Fertility & Pregnancy",
    "sub": "Reproductive Health",
    "color": "#b82050",
    "lt": "#fcedf3",
    "img": "https://images.unsplash.com/photo-1559757175-0eb30cd8c063?w=320&q=75",
    "desc": "Science-backed reproductive health intelligence \u2014 ovarian reserve, hormonal cycle mapping, prenatal risk assessment, and IVF preparation insights.",
    "tags": [
      "ovarian reserve",
      "PCOS",
      "IVF prep",
      "prenatal",
      "endometriosis"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Fertility Lifestyle Risk Score",
        "desc": "Modifiable fertility risk composite from BMI, alcohol, smoking, stress, exercise patterns, and environmental exposures.",
        "markers": [
          "BMI kg/m\u00b2",
          "smoking pack-years",
          "alcohol units/wk",
          "exercise freq",
          "stress score",
          "environmental toxin exposure"
        ],
        "unit": "Fertility risk score 0\u2013100",
        "range": "Low risk: >70 | High risk: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Nutritional Fertility Readiness",
        "desc": "Dietary gap analysis for conception readiness: folate, iron, zinc, and anti-inflammatory diet quality.",
        "markers": [
          "dietary folate mcg/day",
          "iron intake mg/day",
          "omega-3 intake",
          "anti-inflammatory diet score"
        ],
        "unit": "Readiness score 0\u2013100",
        "range": "Optimal: >75 | Deficient: <50",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Ovulation Cycle Detection",
        "desc": "Basal body temperature + HRV + resting HR pattern analysis for fertile window precision prediction.",
        "markers": [
          "basal HR nadir (\u00b0C)",
          "HRV LH-surge pattern",
          "cycle day 1 detection",
          "fertile window days"
        ],
        "unit": "Fertile window days predicted",
        "range": "\u00b11 day accuracy vs LH test",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Luteal Phase Quality Index",
        "desc": "Post-ovulation HRV and temperature elevation duration as luteal phase adequacy proxy.",
        "markers": [
          "post-ovulation temp elevation (\u00b0C)",
          "luteal HRV pattern",
          "luteal phase length (days)"
        ],
        "unit": "Luteal phase days",
        "range": "Optimal: 12\u201316 days | Short: <10 days",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Cycle Length & Regularity",
        "desc": "Smartphone-based AI-assisted cycle tracking with ovulation prediction and irregularity detection.",
        "markers": [
          "cycle length (days)",
          "cycle variability (CV%)",
          "cycle pattern classification"
        ],
        "unit": "Cycle length in days",
        "range": "Normal: 24\u201338 days | Variation: \u22649 days",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "AMH Correlation Index",
        "desc": "Body composition and lifestyle-based AMH estimation proxy from camera and SAQ data.",
        "markers": [
          "BMI",
          "waist circumference",
          "lifestyle AMH correlates"
        ],
        "unit": "Estimated AMH proxy score",
        "range": "Confirm with blood test",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Thyroid-Fertility Panel",
        "desc": "TSH, free T3, free T4 \u2014 subclinical thyroid dysfunction is the #1 reversible treatable fertility cause.",
        "markers": [
          "TSH mIU/L",
          "free T4 ng/dL",
          "free T3 pg/mL",
          "anti-TPO Ab IU/mL"
        ],
        "unit": "TSH mIU/L",
        "range": "Optimal fertility TSH: 0.5\u20132.5 mIU/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Ovarian Reserve Assessment",
        "desc": "AMH + basal FSH + estradiol day 3 \u2014 complete ovarian reserve evaluation panel.",
        "markers": [
          "AMH ng/mL",
          "basal FSH IU/L",
          "estradiol day 3 pg/mL",
          "inhibin B pg/mL",
          "vitamin D ng/mL"
        ],
        "unit": "AMH ng/mL",
        "range": "Good reserve: >1.5 ng/mL | Low: <0.5 ng/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Full Reproductive Hormone Panel",
        "desc": "Complete cycle hormone mapping: E2, LH, progesterone, prolactin, SHBG, testosterone, DHEA-S.",
        "markers": [
          "LH IU/L",
          "FSH IU/L",
          "E2 pg/mL",
          "progesterone ng/mL",
          "prolactin ng/mL",
          "SHBG nmol/L",
          "testosterone ng/dL"
        ],
        "unit": "Progesterone ng/mL (mid-luteal)",
        "range": "Adequate ovulation: >5 ng/mL | Optimal: >10",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "PCOS Diagnostic Panel",
        "desc": "Androgen excess, LH:FSH ratio, and insulin resistance markers for PCOS risk stratification.",
        "markers": [
          "LH:FSH ratio",
          "free testosterone pg/mL",
          "DHEA-S \u00b5g/dL",
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR"
        ],
        "unit": "LH:FSH ratio",
        "range": "Normal: \u22642:1 | PCOS risk: >3:1",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Prenatal Micronutrient Optimization",
        "desc": "Complete nutritional readiness panel for conception and early pregnancy fetal development.",
        "markers": [
          "folate ng/mL",
          "B12 pg/mL",
          "ferritin ng/mL",
          "zinc \u00b5g/dL",
          "omega-3 index %",
          "iodine \u00b5g/L",
          "choline mg/dL",
          "CoQ10 \u00b5g/mL"
        ],
        "unit": "Folate ng/mL",
        "range": "Optimal: >10 ng/mL | Deficient: <4 ng/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Immunological Implantation Panel",
        "desc": "NK cell activity, antiphospholipid antibodies, and immune markers affecting implantation success.",
        "markers": [
          "NK cell % CD56+",
          "antiphospholipid Ab",
          "anti-beta2-glycoprotein Ab",
          "ANA titer",
          "complement C3/C4"
        ],
        "unit": "NK cell %",
        "range": "Elevated: NK >18% may impair implantation",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Reproductive PGS Panel",
        "desc": "Lifenome 19-trait female reproductive genetics: PCOS, endometriosis, AMH variants, implantation PGS.",
        "markers": [
          "PCOS risk SNPs (LHCGR, FSHR)",
          "endometriosis PGS",
          "AMH genetic variants",
          "implantation PGS",
          "miscarriage risk PGS"
        ],
        "unit": "Per-trait percentile",
        "range": "Elevated risk: >80th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Gestational Complication PGS",
        "desc": "Gestational diabetes (GDM), preeclampsia, gestational hypertension polygenic risk scores.",
        "markers": [
          "GDM PGS (TCF7L2, MTNR1B)",
          "preeclampsia PGS (FLT1, ENG)",
          "gestational hypertension PGS",
          "preterm birth PGS"
        ],
        "unit": "OR vs population",
        "range": "High risk: OR >2.0 vs reference",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "MTHFR & Methylation Fertility",
        "desc": "Methylation cycle genetics affecting folate metabolism, homocysteine, and neural tube defect risk.",
        "markers": [
          "MTHFR C677T genotype",
          "MTHFR A1298C genotype",
          "MTR A2756G",
          "MTRR A66G"
        ],
        "unit": "Genotype",
        "range": "TT homozygous: highest risk \u2014 methyl-folate required",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Reproductive Disorder Panel",
        "desc": "Rare variants: Turner syndrome, BRCA1/2, Lynch syndrome \u2014 hereditary reproductive risk genes.",
        "markers": [
          "BRCA1/BRCA2 variants",
          "Lynch syndrome genes (MLH1/MSH2)",
          "FMR1 premutation",
          "POI-associated genes"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = actionable variant",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_wgs",
        "name": "Complete Carrier Screening",
        "desc": "Comprehensive recessive disease carrier status across the full genome \u2014 all 300+ carrier conditions.",
        "markers": [
          "SMA (SMN1)",
          "CF (CFTR)",
          "Fragile X (FMR1)",
          "spinal muscular atrophy",
          "300+ recessive conditions"
        ],
        "unit": "Carrier status (Y/N per gene)",
        "range": "Relevant if partner also carrier",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Vaginal & Gut Microbiome Fertility Index",
        "desc": "Lactobacillus dominance vs. dysbiosis impact on implantation rates and cervical environment.",
        "markers": [
          "Lactobacillus % dominance",
          "Gardnerella vaginalis %",
          "BV-associated anaerobes",
          "Shannon diversity H"
        ],
        "unit": "Lactobacillus %",
        "range": "Optimal: >80% Lactobacillus dominance",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Reproductive Microbiome Function",
        "desc": "Functional analysis of cytokine-modulating species and immune tolerance pathways affecting implantation.",
        "markers": [
          "endometrial flora gene pathways",
          "cytokine-modulating species",
          "immune tolerance functional genes"
        ],
        "unit": "Functional gene abundance (RPKM)",
        "range": "Pro-inflammatory pathway: flag if elevated",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Reproductive Epigenetic Age",
        "desc": "Ovarian epigenetic age \u2014 independent predictor of IVF success rates and ovarian response to stimulation.",
        "markers": [
          "ovarian age acceleration (yr)",
          "methylation fertility loci",
          "reproductive CpG signature"
        ],
        "unit": "Ovarian biological age (yr)",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Fertility Nutrition & Supplement Plan",
        "desc": "Evidence-based fertility nutrition protocol and targeted supplementation matched to identified deficiencies: folate (MTHFR-aware dosing), CoQ10 for oocyte quality, vitamin D, omega-3, iron (if ferritin low), inositol (if PCOS markers present), and prenatal formulation from client catalog.",
        "markers": [
          "folate (RBC)",
          "MTHFR C677T",
          "CoQ10",
          "25-OH Vit D",
          "ferritin",
          "omega-3 index",
          "PCOS markers",
          "homocysteine"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Cycle Optimization & Conception Timing Program",
        "desc": "Personalized ovulation tracking and conception timing program using wearable cycle data, LH surge monitoring, and luteal phase quality scoring. Lifestyle interventions timed to cycle phase.",
        "markers": [
          "LH",
          "FSH",
          "AMH",
          "estradiol (E2)",
          "progesterone",
          "cycle length regularity",
          "HRV luteal phase"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Preconception Health Program",
        "desc": "3\u20136 month preconception preparation program addressing identified fertility blockers: thyroid optimization, BMI/body composition, stress management, sleep protocol, and environmental toxin reduction plan.",
        "markers": [
          "TSH",
          "TPO Ab",
          "BMI",
          "cortisol",
          "sleep efficiency",
          "heavy metals",
          "BPA proxy",
          "AMH",
          "SHBG"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "Breast Cysts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Breast Cysts"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Breast Fibroadenoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Breast Fibroadenoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Breast Lumps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Breast Lumps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Cervical Polyps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Cervical Polyps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Dysmenorrhea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Dysmenorrhea"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Early Menopause",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Early Menopause"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Ectopic Pregnancy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Ectopic Pregnancy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Endometriosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Endometriosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Female Infertility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Female Infertility"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Fibrocystic Breasts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Fibrocystic Breasts"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Menorrhagia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Menorrhagia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Miscarriage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Miscarriage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Ovarian Dysfunction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Ovarian Dysfunction"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Polycystic Ovary Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Polycystic Ovary Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Postmenopausal Osteoporosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Postmenopausal Osteoporosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Premature Menopause",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Premature Menopause"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Uterine Fibroids",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Uterine Fibroids"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Uterine Polyps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Uterine Polyps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Uterine Prolapse",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Uterine Prolapse"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Amelogenesis Imperfecta",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Amelogenesis Imperfecta"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Blomstrand Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Blomstrand Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Buschke Ollendorff Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Buschke Ollendorff Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cenani Lenz Syndactyly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Cenani Lenz Syndactyly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniodiaphyseal Dysplasia, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Craniodiaphyseal Dysplasia, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Diaphyseal Dysplasia Camurati Engelmann",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Diaphyseal Dysplasia Camurati Engelmann"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Eiken Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Eiken Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Failure Of Tooth Eruption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Failure Of Tooth Eruption"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Expansile Osteolysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Familial Expansile Osteolysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperostosis, Endosteal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Hyperostosis, Endosteal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypertrophic Osteoarthropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Hypertrophic Osteoarthropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypophosphatemia, Hyperphosphaturia, Dental Anomalies, Intracerebral Calcifications And Osteosclerosis (Raine Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Hypophosphatemia, Hyperphosphaturia, Dental Anomalies, Intracerebral Calcifications And Osteosclerosis (Raine Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lrp5 Primary Osteoporosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Lrp5 Primary Osteoporosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lenz Majewski Hyperostotic Dwarfism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Lenz Majewski Hyperostotic Dwarfism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Leukocyte Adhesion Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Leukocyte Adhesion Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Chondrodysplasia Jansen Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Metaphyseal Chondrodysplasia Jansen Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Nasu Hakola Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Nasu Hakola Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopathia Striata With Cranial Sclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopathia Striata With Cranial Sclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis Late Onset Form Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis Late Onset Form Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis, Autosomal Recessive 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis, Autosomal Recessive 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis, Autosomal Recessive 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis, Autosomal Recessive 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis, Autosomal Recessive 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis, Autosomal Recessive 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis, Autosomal Recessive 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis, Autosomal Recessive 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis, Severe Neonatal Or Infantile Forms (Optb1)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis, Severe Neonatal Or Infantile Forms (Optb1)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopetrosis, With Renal Tubular Acidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopetrosis, With Renal Tubular Acidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteopoikilosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteopoikilosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteoporosis Pseudoglioma Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteoporosis Pseudoglioma Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteosclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Osteosclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Paget Disease Of Bone",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Paget Disease Of Bone"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Paget Disease Of Bone, Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Paget Disease Of Bone, Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Lipomembranous Osteodysplasia With Sclerosing Leukoencephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Polycystic Lipomembranous Osteodysplasia With Sclerosing Leukoencephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pycnodysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Pycnodysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Sclerosteosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Sclerosteosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Sclerosteosis 1, Van Buchem Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Sclerosteosis 1, Van Buchem Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichodontoosseous Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Trichodontoosseous Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Van Buchem Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Osteopetrosis And Dense Bone Dysplasia",
        "markers": [
          "Van Buchem Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Adult Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Adult Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrocapitofemoral Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Acrocapitofemoral Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrodysostosis 2, With Or Without Hormone Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Acrodysostosis 2, With Or Without Hormone Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acromesomelic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Acromesomelic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Albright Hereditary Osteodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Albright Hereditary Osteodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ankyloblepharon Ectodermal Defects Cleft Lip/Palate",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Ankyloblepharon Ectodermal Defects Cleft Lip/Palate"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly C/Symphalangism Like Pheno",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly C/Symphalangism Like Pheno"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Type A2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly Type A2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Type B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly Type B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Type C",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly Type C"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Type D",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly Type D"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly With Anonychia (Cooks Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly With Anonychia (Cooks Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly, Type E2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly, Type E2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Syndactyly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Brachydactyly Syndactyly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Campomelic Dysplasia, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Campomelic Dysplasia, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Chondrodysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Chondrodysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Demirhan",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Demirhan"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectrodactyly, Ectodermal Dysplasia, And Cleft Lip/Palate Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Ectrodactyly, Ectodermal Dysplasia, And Cleft Lip/Palate Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Feingold Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Feingold Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Fibular Hypoplasia And Complex Brachydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Fibular Hypoplasia And Complex Brachydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Grebe Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Grebe Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Guttmacher Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Guttmacher Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hand Foot Genital Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Hand Foot Genital Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hand Foot Uterus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Hand Foot Uterus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hunter Thompson",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Hunter Thompson"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypertension With Brachydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Hypertension With Brachydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Limb Mammary Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Limb Mammary Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Mccune Albright Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Mccune Albright Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Synostoses Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Multiple Synostoses Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofacial Cleft",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Orofacial Cleft"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Progressive Osseous Heteroplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Progressive Osseous Heteroplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudohypoparathyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Pseudohypoparathyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Arterial Hypertension (Pah)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Pulmonary Arterial Hypertension (Pah)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Rapp Hodgkin Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Rapp Hodgkin Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Roberts Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Roberts Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Robinow Syndrome Recessive Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Robinow Syndrome Recessive Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Sc Phocomelia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Sc Phocomelia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Smith Lemli Opitz Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Smith Lemli Opitz Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Syndactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Syndactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Syndactyly Type Lueken",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Syndactyly Type Lueken"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Synopolydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Synopolydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Synopolydactyly With Clefting",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Synopolydactyly With Clefting"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Toe Syndactyly, Telecanthus, And Anogenital And Renal Malformations (Star Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Toe Syndactyly, Telecanthus, And Anogenital And Renal Malformations (Star Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Xy Sex Reversal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Brachydactyly Syndactyly",
        "markers": [
          "Xy Sex Reversal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Short Bowel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Congenital Short Bowel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Currarino Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Currarino Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Gastrointestinal Defects And Immunodeficiency Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Gastrointestinal Defects And Immunodeficiency Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Martinez Frias Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Martinez Frias Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Syndromic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Microphthalmia, Syndromic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitchell Riley Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Mitchell Riley Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Opitz Gbbb Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Opitz Gbbb Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pancreatic Agenesis 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Pancreatic Agenesis 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pancreatic And Cerebellar Agenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Pancreatic And Cerebellar Agenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pancreatic Hypoplasia, Intestinal Atresia, And Gallbladder Aplasia Or Hypoplasia, With Or Without Tracheoesophageal Fistula",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gastrointestinal Atresia",
        "markers": [
          "Pancreatic Hypoplasia, Intestinal Atresia, And Gallbladder Aplasia Or Hypoplasia, With Or Without Tracheoesophageal Fistula"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Capillary Malformation Arteriovenous Malformation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Capillary Malformation Arteriovenous Malformation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebral Cavernous Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Cerebral Cavernous Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Glaucoma 3, Primary Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Glaucoma 3, Primary Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Glomuvenous Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Glomuvenous Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Hemorrhagic Telangiectasia, Type 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Hereditary Hemorrhagic Telangiectasia, Type 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hydrops Fetalis, Nonimmune, And/Or Atrial Septal Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Hydrops Fetalis, Nonimmune, And/Or Atrial Septal Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypotrichosis Lymphedema Telangiectasia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Hypotrichosis Lymphedema Telangiectasia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypotrichosis Lymphedema Telangiectasia Renal Defect Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Hypotrichosis Lymphedema Telangiectasia Renal Defect Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcephaly Capillary Malformation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Microcephaly Capillary Malformation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Parkes Weber Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Parkes Weber Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spinal Arteriovenous Anomalies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Spinal Arteriovenous Anomalies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Vascular Malformation, Primary Intraosseus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Vascular Malformation, Primary Intraosseus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Venous Malformations, Multiple Cutaneous And Mucosal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vascular Malformations",
        "markers": [
          "Venous Malformations, Multiple Cutaneous And Mucosal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Jawad Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Seckel Syndrome",
        "markers": [
          "Jawad Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcephalic Osteodysplastic Primordial Dwarfism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Seckel Syndrome",
        "markers": [
          "Microcephalic Osteodysplastic Primordial Dwarfism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Meier Gorlin Syndrome (Ear Patella Short Stature Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meier Gorlin Syndrome",
        "markers": [
          "Meier Gorlin Syndrome (Ear Patella Short Stature Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Meier Gorlin Syndrome 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meier Gorlin Syndrome",
        "markers": [
          "Meier Gorlin Syndrome 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis   Renal Dysfunction   Cholestasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis   Renal Dysfunction   Cholestasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis Multiplex Congenita",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis Multiplex Congenita"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis Multiplex Congenita, Neurogenic, With Myelin Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis Multiplex Congenita, Neurogenic, With Myelin Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis, Distal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis, Distal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis, Distal, Type 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis, Distal, Type 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis, Lethal, With Anterior Horn Cell Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis, Lethal, With Anterior Horn Cell Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthrogryposis, Renal Dysfunction, And Cholestasis 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthrogryposis, Renal Dysfunction, And Cholestasis 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthyrgryposis, Distal, Type 2B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Arthyrgryposis, Distal, Type 2B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Bartsocas Papas Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Bartsocas Papas Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Bethlem Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Bethlem Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Bruck Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Bruck Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Bruck Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Bruck Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cap Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Cap Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Carney Complex Variant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Carney Complex Variant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cocoon Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Cocoon Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Contractures Of The Limbs And Face, Hypotonia, And Developmental Delay",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Congenital Contractures Of The Limbs And Face, Hypotonia, And Developmental Delay"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniofacial Dysmorphism, Skeletal Anomalies, And Mental Retardation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Craniofacial Dysmorphism, Skeletal Anomalies, And Mental Retardation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "De Sanctis Cacchione Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "De Sanctis Cacchione Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Distal Arthrogryposis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Distal Arthrogryposis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ehlers Danlos Syndrome, Musculocontractural",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Ehlers Danlos Syndrome, Musculocontractural"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lethal Congenital Contractural Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Lethal Congenital Contractural Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lethal Congenital Contractural Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Lethal Congenital Contractural Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lethal Congenital Contracture Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Lethal Congenital Contracture Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lethal Congenital Contracture Syndrome 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Lethal Congenital Contracture Syndrome 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lethal Congenital Contracture Syndrome 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Lethal Congenital Contracture Syndrome 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lethal Congenital Contracture Syndrome 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Lethal Congenital Contracture Syndrome 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Marden Walker Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Marden Walker Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Centronuclear",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Myopathy, Centronuclear"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Myosclerosis, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Myosclerosis, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Nemaline Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Nemaline Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuroaxonal Neurodegeneration, Infantile, With Facial Dysmophism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Neuroaxonal Neurodegeneration, Infantile, With Facial Dysmophism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Xi",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Osteogenesis Imperfecta, Type Xi"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Popliteal Pterygium Syndrome, Lethal Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Popliteal Pterygium Syndrome, Lethal Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Proliferative Vasculopathy And Hydraencephaly Hydrocephaly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Proliferative Vasculopathy And Hydraencephaly Hydrocephaly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Trismus Pseudocamptodactyly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Trismus Pseudocamptodactyly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ullrich Congenital Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Ullrich Congenital Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Wieacker Wolff Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Wieacker Wolff Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Xeroderma Pigmentosum Cockayne Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Arthrogryposes",
        "markers": [
          "Xeroderma Pigmentosum Cockayne Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Achondrogenesis, Type Ia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Achondrogenesis, Type Ia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrodysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Acrodysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acromesomelic Dysplasia Type Maroteaux",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Acromesomelic Dysplasia Type Maroteaux"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Carney Complex",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Carney Complex"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cranioectodermal Dysplasia (Levin Sensenbrenner) Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Cranioectodermal Dysplasia (Levin Sensenbrenner) Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cranioectodermal Dysplasia (Levin Sensenbrenner) Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Cranioectodermal Dysplasia (Levin Sensenbrenner) Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Epiphyseal Chondrodysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Epiphyseal Chondrodysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Geleophysic Dysplasia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Geleophysic Dysplasia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Glaucoma, Primary Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Glaucoma, Primary Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Langer Mesomelic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Langer Mesomelic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Leri Weill Dyschondrosteosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Leri Weill Dyschondrosteosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Microspherophakia And/Or Megalocornea, With Ectopia Lentis And With Or Without Secondary Glaucoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Microspherophakia And/Or Megalocornea, With Ectopia Lentis And With Or Without Secondary Glaucoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Miura",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Miura"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Cartilagenious Exostoses 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Multiple Cartilagenious Exostoses 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Myxoma, Intracardiac",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Myxoma, Intracardiac"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Opsismodysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Opsismodysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pigmented Nodular Adrenocortical Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Pigmented Nodular Adrenocortical Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Robinow Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Robinow Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Schneckenbecken Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Schneckenbecken Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Schwartz Jampel Type 2 Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Schwartz Jampel Type 2 Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Sensenbrenner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Sensenbrenner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short  Rib Thoracic Dysplasia With Or Without Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Short  Rib Thoracic Dysplasia With Or Without Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Polydactyly Syndrome Type 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Short Rib Polydactyly Syndrome Type 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature With Nonspecific Skeletal Abnormalities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Short Stature With Nonspecific Skeletal Abnormalities"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Stuve Wiedemann Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Stuve Wiedemann Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichorhinophalangeal Syndrome Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Trichorhinophalangeal Syndrome Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichorhinophalangeal Syndrome Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Micromelic Dysplasia",
        "markers": [
          "Trichorhinophalangeal Syndrome Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cornelia De Lange Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cornelia De Lange Syndrome",
        "markers": [
          "Cornelia De Lange Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Anauxetic Dysplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Anauxetic Dysplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Arthropathy, Progressive Pseudorheumatoid, Of Childhood",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Arthropathy, Progressive Pseudorheumatoid, Of Childhood"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Auricular, And Skeletal Anomalies (Codas) Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Auricular, And Skeletal Anomalies (Codas) Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Beukes Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Beukes Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachyolmia 4 With Mild Epiphyseal And Metaphyseal Changes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Brachyolmia 4 With Mild Epiphyseal And Metaphyseal Changes"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebral",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Cerebral"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Dental",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Dental"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Desbuquois Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Desbuquois Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyggve Melchior Clausen Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Dyggve Melchior Clausen Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyggve Melchior Clausen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Dyggve Melchior Clausen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyssegmental Dysplasia Rolland Desbuquis Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Dyssegmental Dysplasia Rolland Desbuquis Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyssegmental Dysplasia Silverman Handmaker Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Dyssegmental Dysplasia Silverman Handmaker Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Epiphyseal Dysplasia, Multiple",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Epiphyseal Dysplasia, Multiple"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Faden Alkuraya Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Faden Alkuraya Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Glomerulopathy With Fibronectin Deposits 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Glomerulopathy With Fibronectin Deposits 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hip Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Hip Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Kimberley Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Kimberley Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Megarbane Dagher Melki Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Megarbane Dagher Melki Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Anadysplasia 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Metaphyseal Anadysplasia 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Metaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Missouri Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Missouri Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Epiphyseal Dysplasia Type 5 (Edm5)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Multiple Epiphyseal Dysplasia Type 5 (Edm5)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ocular",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Ocular"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteochondritis Dissecans, Short Stature, And Early Onset Osteoarthritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Osteochondritis Dissecans, Short Stature, And Early Onset Osteoarthritis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Sed",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Sed"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Semd Papps2 Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Semd Papps2 Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Schwartz Jampel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Schwartz Jampel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Smith Mccort Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Smith Mccort Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Smith Mccort Dysplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Smith Mccort Dysplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spahr Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spahr Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylo Megaepiphyseal Metaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondylo Megaepiphyseal Metaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylodysplastic Ehlers Danlos Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondylodysplastic Ehlers Danlos Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia Genevieve Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia Genevieve Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia Matrilin Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia Matrilin Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia With Joint Laxity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia With Joint Laxity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia, Aggrecan Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia, Aggrecan Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepiphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepiphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepiphyseal Dysplasia Tarda",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepiphyseal Dysplasia Tarda"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepiphyseal Dysplasia Tarda With Progressive Arthropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepiphyseal Dysplasia Tarda With Progressive Arthropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepiphyseal Dysplasia With Congenital Joint Dislocations (Recessive Larsen Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondyloepiphyseal Dysplasia With Congenital Joint Dislocations (Recessive Larsen Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylometaepiphyseal Dysplasia, Short Limb Hand Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondylometaepiphyseal Dysplasia, Short Limb Hand Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylometaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondylometaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylometaphyseal Dysplasia With Cone Rod Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Spondylometaphyseal Dysplasia With Cone Rod Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Wolcott Rallison Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spondylometaphyseal Spondyloepi (Meta) Physeal Dysplasia",
        "markers": [
          "Wolcott Rallison Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cleidocranial Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metaphyseal Dysplasia",
        "markers": [
          "Cleidocranial Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Anadysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metaphyseal Dysplasia",
        "markers": [
          "Metaphyseal Anadysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Chondrodysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metaphyseal Dysplasia",
        "markers": [
          "Metaphyseal Chondrodysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Dysplasia With Maxillary Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metaphyseal Dysplasia",
        "markers": [
          "Metaphyseal Dysplasia With Maxillary Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Schmid",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metaphyseal Dysplasia",
        "markers": [
          "Schmid"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "3 M Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "3 M Syndrome Primordial Dwarfism",
        "markers": [
          "3 M Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Alazami Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "3 M Syndrome Primordial Dwarfism",
        "markers": [
          "Alazami Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Floating Harbor Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "3 M Syndrome Primordial Dwarfism",
        "markers": [
          "Floating Harbor Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature, Onychodysplasia, Facial Dysmorphism, And Hypotrichosis (Soft Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "3 M Syndrome Primordial Dwarfism",
        "markers": [
          "Short Stature, Onychodysplasia, Facial Dysmorphism, And Hypotrichosis (Soft Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Three M Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "3 M Syndrome Primordial Dwarfism",
        "markers": [
          "Three M Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Yakut Short Stature Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "3 M Syndrome Primordial Dwarfism",
        "markers": [
          "Yakut Short Stature Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lymphedema Distichiasis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lymphatic Malformations And Related Disorders",
        "markers": [
          "Lymphedema Distichiasis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Achondrogenesis Type 1B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Achondrogenesis Type 1B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Atelosteogenesis Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Atelosteogenesis Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Atelosteogenesis Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Atelosteogenesis Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Atelosteogenesis Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Atelosteogenesis Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Boomerang Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Boomerang Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Chondrodysplasia Punctata X Linked Recessive, Brachytelephalangic Type (Cdpx1)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Chondrodysplasia Punctata X Linked Recessive, Brachytelephalangic Type (Cdpx1)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "De La Chapelle Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "De La Chapelle Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Desbuquois Dysplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Desbuquois Dysplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Diastrophic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Diastrophic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Greenberg/Hem Skeletal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Greenberg/Hem Skeletal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hydrops Ectopic Calcification Moth Eaten Skeletal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Hydrops Ectopic Calcification Moth Eaten Skeletal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypophosphatasia Perinatal Lethal, Infantile, Juvenile And Adult Forms",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Hypophosphatasia Perinatal Lethal, Infantile, Juvenile And Adult Forms"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypophosphatemic Rickets With Hypercalciuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Hypophosphatemic Rickets With Hypercalciuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Larsen Syndrome (Dominant)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Larsen Syndrome (Dominant)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Epiphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Multiple Epiphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Odontohypophosphatasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Odontohypophosphatasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Vi",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Osteogenesis Imperfecta, Type Vi"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteoporosis And Osteoporotic Fractures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Osteoporosis And Osteoporotic Fractures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pelger Huet Anomaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Pelger Huet Anomaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudoachondroplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Pseudoachondroplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Recessive Multiple Epiphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Recessive Multiple Epiphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Reynolds Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Reynolds Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylo Carpal Tarsal Dyspasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Spondylo Carpal Tarsal Dyspasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylocostal Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Spondylocostal Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Tumoral Calcinosis, Hyperphosphatemic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Tumoral Calcinosis, Hyperphosphatemic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Vitamin D Dependent Rickets",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skeletal Dysplasias Core",
        "markers": [
          "Vitamin D Dependent Rickets"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrofacial Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Acrofacial Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrofacial Dysostosis 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Acrofacial Dysostosis 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Allelic Digital Clubbing, Isolated Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Allelic Digital Clubbing, Isolated Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Aplasia Of Lacrimal And Salivary Glands",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Aplasia Of Lacrimal And Salivary Glands"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Auditory Canal Atresia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Auditory Canal Atresia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Auriculocondylar Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Auriculocondylar Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Auriculocondylar Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Auriculocondylar Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Auriculocondylar Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Auriculocondylar Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Intellectual Disability Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Brachydactyly Intellectual Disability Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataracts, Growth Hormone Deficiency, Sensory Neuropathy, Sensorineural Hearing Loss, And Skeletal Dysplasia (Cagsss)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cataracts, Growth Hormone Deficiency, Sensory Neuropathy, Sensorineural Hearing Loss, And Skeletal Dysplasia (Cagsss)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebrocostomandibular Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cerebrocostomandibular Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cherubism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cherubism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Chitayat Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Chitayat Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Chondrodysplasia With Joint Dislocations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Chondrodysplasia With Joint Dislocations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cincinnati Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cincinnati Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Clubfoot, Congenital, With Or Without Deficiency Of Long Bones And/Or Mirror Image Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Clubfoot, Congenital, With Or Without Deficiency Of Long Bones And/Or Mirror Image Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cold Induced Sweating Syndrome, Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cold Induced Sweating Syndrome, Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cole Carpenter Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cole Carpenter Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cole Carpenter Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cole Carpenter Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cone Rod Dystrophy, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cousin Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cousin Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cranioectodermal Dysplasia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Cranioectodermal Dysplasia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniofrontonasal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Craniofrontonasal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniosynostosis 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Craniosynostosis 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniosynostosis Boston Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Craniosynostosis Boston Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Crisponi Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Crisponi Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Dental Anomalies And Short Stature",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Dental Anomalies And Short Stature"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Diaphanospondylodysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Diaphanospondylodysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Early Onset Dementia Without Bone Cysts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Early Onset Dementia Without Bone Cysts"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Ectrodactyly, And Macular Dystrophy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Ectodermal Dysplasia, Ectrodactyly, And Macular Dystrophy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Even Plus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Even Plus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Filippi Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Filippi Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Frank Ter Haar Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Frank Ter Haar Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Frontometaphyseal Dysplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Frontometaphyseal Dysplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Frontonasal Dysplasia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Frontonasal Dysplasia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Frontonasal Dysplasia Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Frontonasal Dysplasia Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Frontonasal Dysplasia Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Frontonasal Dysplasia Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Fuhrmann Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Fuhrmann Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Gpapp Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Gpapp Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Gollop Wolfgang",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Gollop Wolfgang"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Growth Restriction, Severe, With Distinctive Facies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Growth Restriction, Severe, With Distinctive Facies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypotrichosis, Congenital, With Juvenile Macular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Hypotrichosis, Congenital, With Juvenile Macular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Jeune Asphyxiating Thoracic Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Jeune Asphyxiating Thoracic Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Joint Laxity, Short Stature, And Myopia (Jlsm)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Joint Laxity, Short Stature, And Myopia (Jlsm)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Klippel Feil Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Klippel Feil Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Klippel Feil Syndrome 3, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Klippel Feil Syndrome 3, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Lathosterolosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Lathosterolosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Liebenberg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Liebenberg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Mandibular Hypoplasia, And Skeletal Abnormalities (Sams)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Mandibular Hypoplasia, And Skeletal Abnormalities (Sams)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Mandibuloacral Dysplasia With B Lipodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Mandibuloacral Dysplasia With B Lipodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Meier Gorlin Syndrome 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Meier Gorlin Syndrome 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcephaly 13, Primary, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Microcephaly 13, Primary, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Microphthalmia, Isolated 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multicentric Carpotarsal Osteolysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Multicentric Carpotarsal Osteolysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multicentric Osteolysis, Nodulosis, And Arthropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Multicentric Osteolysis, Nodulosis, And Arthropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Synostoses Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Multiple Synostoses Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Nager",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Nager"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Omodysplasia 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Omodysplasia 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta Type 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteogenesis Imperfecta Type 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Xii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteogenesis Imperfecta, Type Xii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Xiv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteogenesis Imperfecta, Type Xiv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Xv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteogenesis Imperfecta, Type Xv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Xvi",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteogenesis Imperfecta, Type Xvi"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta, Type Xvii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteogenesis Imperfecta, Type Xvii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteoprosis, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Osteoprosis, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Parietal Foramina",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Parietal Foramina"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Parietal Foramina With Cleidocranial Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Parietal Foramina With Cleidocranial Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyle Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Pyle Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Question Mark Ears, Isolated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Question Mark Ears, Isolated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Restrictive Dermopathy, Lethal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Restrictive Dermopathy, Lethal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhizomelic Short Stature With Microcephaly, Micrognathia, And Developmental Delay (Srmmd)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Rhizomelic Short Stature With Microcephaly, Micrognathia, And Developmental Delay (Srmmd)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Richieri Costa Pereira Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Richieri Costa Pereira Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Robinow Syndrome, Autosomal Dominant 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Robinow Syndrome, Autosomal Dominant 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Senior Loken Syndrome 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Senior Loken Syndrome 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Stature"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature With Microcephaly And Distinctive Facies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Stature With Microcephaly And Distinctive Facies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia 15 With Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Rib Thoracic Dysplasia 15 With Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia 16 With Or Without Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Rib Thoracic Dysplasia 16 With Or Without Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia 17 With Or Without Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Rib Thoracic Dysplasia 17 With Or Without Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia 8 With Or Without Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Rib Thoracic Dysplasia 8 With Or Without Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Skeletal Dysplasia And Disorders",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Skeletal Dysplasia And Disorders"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Split Hand Foot Malformation With Long Bone Deficiency (Shfld3)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Split Hand Foot Malformation With Long Bone Deficiency (Shfld3)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Split Hand/Foot Malformation 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Split Hand/Foot Malformation 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylocostal Dysostosis 2, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Spondylocostal Dysostosis 2, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylocostal Dysostosis 4, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Spondylocostal Dysostosis 4, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylocostal Dysostosis 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Spondylocostal Dysostosis 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylocostal Dysostosis, Autosomal Recessive 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Spondylocostal Dysostosis, Autosomal Recessive 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylocostal Dysostosis, Autosomal Recessive 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Spondylocostal Dysostosis, Autosomal Recessive 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Steel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Steel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Syndactyly Malik Percin Type, Mesoaxial Synostotic, With Phalangeal Reduction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Syndactyly Malik Percin Type, Mesoaxial Synostotic, With Phalangeal Reduction"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Tooth Agenesis, Selective, 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Tooth Agenesis, Selective, 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Torg Winchester Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Torg Winchester Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ulna And Fibula, Absence Of, With Severe Limb Deficiency (Al Awadi/Raas Rothschild/Schinzel Phocomelia Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Ulna And Fibula, Absence Of, With Severe Limb Deficiency (Al Awadi/Raas Rothschild/Schinzel Phocomelia Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ulnar Mammary Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Ulnar Mammary Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Vertebral, Cardiac, Renal, And Limb Defects Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Vertebral, Cardiac, Renal, And Limb Defects Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Vitamin D Hydroxylation Deficient Rickets, Type 1B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Vitamin D Hydroxylation Deficient Rickets, Type 1B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Wiedemann Steiner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Skeletal Dysplasias And Disorders",
        "markers": [
          "Wiedemann Steiner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Blepharocheilodontic Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Blepharocheilodontic Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Burn Mckeown Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Burn Mckeown Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cleft Lip",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Cleft Lip"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Cleft Palate With Or Without Ankyloglossia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Cleft Palate With Or Without Ankyloglossia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Facial Clefting, Oblique, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Facial Clefting, Oblique, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Glass Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Glass Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Opitz Gbbb Syndrome, Type Ii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Opitz Gbbb Syndrome, Type Ii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofacial Cleft 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Orofacial Cleft 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Tooth Agenesis, Selective, 1, With/Without Orofacial Cleft",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Tooth Agenesis, Selective, 1, With/Without Orofacial Cleft"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Witkop Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cleft Lip Palate And Associated Syndromes",
        "markers": [
          "Witkop Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Scalp Ear Nipple Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Adams Oliver Syndrome",
        "markers": [
          "Scalp Ear Nipple Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Goldberg Shprintzen Megacolon Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hirschsprung Disease",
        "markers": [
          "Goldberg Shprintzen Megacolon Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Nonsyndromic Hirschsprung Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hirschsprung Disease",
        "markers": [
          "Nonsyndromic Hirschsprung Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ameliogenesis Imperfecta, Hypomaturation Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Ameliogenesis Imperfecta, Hypomaturation Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Amelogenesis Imperfecta, Hypomaturation Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Amelogenesis Imperfecta, Hypomaturation Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Amelogenesis Imperfecta, Type 1E",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Amelogenesis Imperfecta, Type 1E"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Amelogenesis Imperfecta, Type Ih",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Amelogenesis Imperfecta, Type Ih"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Amelogenesis Imperfecta, Type Iia1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Amelogenesis Imperfecta, Type Iia1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Iia2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Iia2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Iia3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Iia3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Iia5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Iia5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Iia6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amelogenesis Imperfecta And Dentinogenesis Imperfecta",
        "markers": [
          "Iia6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenocorticotropic Hormone Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Adrenocorticotropic Hormone Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Growth Hormone Insensitivity Syndrome (Laron Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Growth Hormone Insensitivity Syndrome (Laron Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Insulin Like Growth Factor I Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Insulin Like Growth Factor I Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Insulin Like Growth Factor I, Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Insulin Like Growth Factor I, Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Insulin Like Growth Factor Binding Protein, Acid Labile Subunit, Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Insulin Like Growth Factor Binding Protein, Acid Labile Subunit, Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Kowarski Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Kowarski Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature, Brachydactyly, Intellectual Developmental Disability, And Seizures (Sbidds)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Short Stature, Brachydactyly, Intellectual Developmental Disability, And Seizures (Sbidds)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy With Congenital Bone Fractures 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Growth Disorders Skeletal Dysplasias And Disorders",
        "markers": [
          "Spinal Muscular Atrophy With Congenital Bone Fractures 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Ablepharon Macrostomia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Craniosynostosis",
        "markers": [
          "Ablepharon Macrostomia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Barber Say Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Craniosynostosis",
        "markers": [
          "Barber Say Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniosynostosis 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Craniosynostosis",
        "markers": [
          "Craniosynostosis 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniosynostosis And Dental Anomalies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Craniosynostosis",
        "markers": [
          "Craniosynostosis And Dental Anomalies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Focal Facial Dermal Dysplasia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Craniosynostosis",
        "markers": [
          "Focal Facial Dermal Dysplasia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      },
      {
        "name": "Setleis Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Malformations.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Craniosynostosis",
        "markers": [
          "Setleis Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 521,
    "marker_count": 521,
    "insight_count": 433
  },
  {
    "id": "menopause",
    "name": "Menopause Management",
    "sub": "Perimenopause & Post-Menopause",
    "color": "#d96c1a",
    "lt": "#fdf2e6",
    "img": "https://images.unsplash.com/photo-1506126613408-eca07ce68773?w=320&q=75",
    "desc": "Holistic transition management \u2014 vasomotor symptom tracking, HRT personalization, bone protection, estrobolome insight, and post-menopausal cardiovascular risk monitoring.",
    "tags": [
      "perimenopause",
      "HRT optimization",
      "vasomotor symptoms",
      "bone density",
      "CVD risk"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Menopausal Symptom Burden Score",
        "desc": "Validated lifestyle-correlated composite of vasomotor, mood, sleep, libido, and cognitive symptom severity.",
        "markers": [
          "hot flash freq/day",
          "sleep disruption score",
          "mood/anxiety score",
          "libido index",
          "cognitive complaints score"
        ],
        "unit": "Greene Climacteric Scale proxy",
        "range": "Mild: <15 | Moderate: 15\u201330 | Severe: >30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Cardiometabolic Transition Risk",
        "desc": "Post-menopausal CVD and metabolic syndrome risk from lifestyle modifiers \u2014 estrogen loss amplifies.",
        "markers": [
          "physical activity MET-hr/wk",
          "dietary pattern score",
          "smoking status",
          "BMI trajectory",
          "waist circumference"
        ],
        "unit": "10-year CVD risk %",
        "range": "Low: <10% | Intermediate: 10\u201320% | High: >20%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Vasomotor Episode Quantification",
        "desc": "Automated hot flash and night sweat detection via skin temperature sensor + nocturnal HRV spikes.",
        "markers": [
          "skin temp spike freq/night",
          "nocturnal HRV disruptions/hr",
          "sleep fragmentation index",
          "core temp elevation \u00b0C"
        ],
        "unit": "Episodes per 24 hours",
        "range": "Mild: <7/day | Severe: >14/day",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Cardiovascular Transition Monitor",
        "desc": "Estrogen withdrawal accelerates CVD risk \u2014 continuous wearable cardiac markers tracking.",
        "markers": [
          "HRV 30-day trend (ms)",
          "resting HR elevation bpm",
          "SpO2 %",
          "activity minutes/day"
        ],
        "unit": "HRV RMSSD ms",
        "range": "Optimal: >50 ms | Post-meno concern: <30 ms",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep Architecture Disruption Index",
        "desc": "Menopause-specific sleep staging changes: reduced deep sleep and increased wakefulness quantification.",
        "markers": [
          "deep sleep %",
          "wakefulness %",
          "sleep efficiency %",
          "REM latency min",
          "WASO min"
        ],
        "unit": "WASO minutes per night",
        "range": "Optimal: <30 min WASO | Concern: >60 min",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Menopausal Shift",
        "desc": "Smartphone-derived visceral fat redistribution from gluteo-femoral to central \u2014 characteristic of menopause.",
        "markers": [
          "waist-hip ratio",
          "visceral fat proxy score",
          "body fat %",
          "muscle mass trend"
        ],
        "unit": "Waist-hip ratio",
        "range": "Optimal F: <0.85 | Concern: >0.90",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Menopausal Staging Panel",
        "desc": "E2, FSH, progesterone \u2014 serum-based staging of perimenopause, menopause, and post-menopause.",
        "markers": [
          "E2 pg/mL",
          "FSH IU/L",
          "progesterone ng/mL",
          "TSH mIU/L",
          "vitamin D ng/mL"
        ],
        "unit": "FSH IU/L",
        "range": "Perimenopausal: FSH 10\u201340 | Menopausal: >40 IU/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "HRT Personalization Baseline",
        "desc": "Full hormonal baseline required for bioidentical HRT dosing personalization and safety monitoring.",
        "markers": [
          "E2 pg/mL",
          "testosterone (total/free) ng/dL",
          "SHBG nmol/L",
          "DHEA-S \u00b5g/dL",
          "cortisol AM \u00b5g/dL",
          "IGF-1 ng/mL",
          "prolactin ng/mL"
        ],
        "unit": "E2 pg/mL",
        "range": "HRT target range: E2 50\u2013150 pg/mL",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Post-Menopausal CVD Risk Panel",
        "desc": "ApoB, Lp(a), hs-CRP, homocysteine \u2014 estrogen loss unmasks previously protected cardiovascular risk.",
        "markers": [
          "ApoB mg/dL",
          "Lp(a) nmol/L",
          "hs-CRP mg/L",
          "homocysteine \u00b5mol/L",
          "lipid panel",
          "hsTroponin I ng/L"
        ],
        "unit": "ApoB mg/dL",
        "range": "Optimal: <80 mg/dL | Concern post-meno: >100",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Bone Turnover Markers",
        "desc": "CTX (resorption) and P1NP (formation) for real-time bone loss velocity measurement beyond DXA.",
        "markers": [
          "CTX pg/mL",
          "P1NP ng/mL",
          "calcium mg/dL",
          "phosphorus mg/dL",
          "vitamin D ng/mL",
          "PTH pg/mL",
          "osteocalcin ng/mL"
        ],
        "unit": "CTX pg/mL",
        "range": "Pre-meno: <300 | Accelerated resorption: >600",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Metabolic Syndrome Menopause Panel",
        "desc": "Insulin resistance, uric acid, and liver function as metabolic syndrome risk after estrogen withdrawal.",
        "markers": [
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR",
          "uric acid mg/dL",
          "ALT IU/L",
          "GGT IU/L",
          "adiponectin \u00b5g/mL"
        ],
        "unit": "HOMA-IR",
        "range": "Optimal: <2.0 | Insulin resistant: >3.0",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Menopause Timing & HRT Response PGS",
        "desc": "Early-menopause PGS + ESR1, PGR, VDR variants predicting HRT response and bone protection.",
        "markers": [
          "menopause timing SNPs (BRSK1, TERT)",
          "ESR1 (estrogen receptor alpha)",
          "PGR (progesterone receptor)",
          "VDR (bone response)",
          "CYP1B1 (estrogen metabolism)"
        ],
        "unit": "Menopause age prediction",
        "range": "Early meno PGS: >75th percentile = action",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Osteoporosis Genetic Risk Score",
        "desc": "Fracture risk PGS (RANK/RANKL pathway, VDR, COL1A1) for bone-protective intervention prioritization.",
        "markers": [
          "RANK/RANKL variants",
          "VDR FokI/BsmI/TaqI",
          "COL1A1 Sp1 SNP",
          "LRP5 variants",
          "SOST variants",
          "osteoporosis PGS"
        ],
        "unit": "Fracture risk OR",
        "range": "High risk: OR >2.0 vs population",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Cardiovascular Menopause PGS",
        "desc": "Post-menopausal CVD PGS \u2014 genetic risk amplified by estrogen loss timeline.",
        "markers": [
          "CAD PGS (ChrHRIS)",
          "atrial fibrillation PGS",
          "hypertension PGS",
          "stroke PGS"
        ],
        "unit": "Percentile",
        "range": "High risk: >80th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Breast/Ovarian Cancer Panel",
        "desc": "BRCA1/2, PALB2, ATM, CHEK2 \u2014 mandatory menopause-era hereditary cancer risk assessment.",
        "markers": [
          "BRCA1/BRCA2 variants",
          "PALB2",
          "ATM",
          "CHEK2",
          "RAD51C/D \u2014 hereditary cancer panel"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = immediate referral",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Estrobolome Diversity Index",
        "desc": "Gut bacteria metabolizing estrogen via beta-glucuronidase activity \u2014 directly impacts estrogen availability and hot flash severity.",
        "markers": [
          "beta-glucuronidase activity proxy",
          "Clostridiales diversity",
          "Ruminococcaceae %",
          "Lactobacillaceae % (if gut)"
        ],
        "unit": "Estrobolome diversity score",
        "range": "High beta-glucuronidase = elevated estrogen reactivation",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Bone-Gut Microbiome Axis",
        "desc": "Functional microbiome analysis of secondary bile acids and SCFA affecting osteoblast/osteoclast balance.",
        "markers": [
          "secondary bile acid synthesis genes",
          "butyrate producers %",
          "Akkermansia muciniphila %",
          "calcium absorption pathway genes"
        ],
        "unit": "Functional gene abundance RPKM",
        "range": "Butyrate genes optimal: >1.5 RPKM",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Menopausal Epigenetic Clock",
        "desc": "DNAm-based menopausal staging and post-menopausal biological age acceleration score.",
        "markers": [
          "menopause epigenetic score",
          "AgeAccelGrim (yr)",
          "CpG loci \u2014 menopausal transition",
          "immune epigenetic age"
        ],
        "unit": "Biological age (yr)",
        "range": "Post-meno age acceleration >3 yr = intervention",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "epigenetics",
        "name": "Estrogen-Sensitive Methylation Panel",
        "desc": "ESR1 promoter methylation and estrogen-responsive gene methylation as HRT response biomarkers.",
        "markers": [
          "ESR1 promoter CpG methylation %",
          "breast cancer risk CpG loci",
          "bone-associated methylation marks"
        ],
        "unit": "% methylation at ESR1 promoter",
        "range": "Hypermethylated ESR1 = reduced HRT response",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "HRT / MHT Selection Guide",
        "desc": "Pharmacogenomics-informed hormone therapy recommendations based on COMT/CYP2D6/ESR1 genotype, breast cancer PGS, cardiovascular risk, and symptom burden score. Identifies optimal HRT type (bioidentical vs synthetic), route (oral vs transdermal), and dose from client formulary.",
        "markers": [
          "ESR1 genotype",
          "CYP2D6",
          "COMT Val158Met",
          "breast cancer PGS",
          "NT-proBNP",
          "ApoB",
          "symptom burden score",
          "menopausal staging"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Bone Health & Osteoporosis Prevention Program",
        "desc": "Personalized bone-protective exercise protocol (weight-bearing + resistance training prescriptions), calcium/vitamin D supplementation dosing based on blood levels and genetics, and dietary calcium adequacy scoring.",
        "markers": [
          "25-OH Vit D",
          "osteocalcin",
          "CTX-I",
          "P1NP",
          "calcium",
          "magnesium",
          "osteoporosis PGS",
          "testosterone"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Menopausal Symptom Relief Protocol",
        "desc": "Multimodal symptom management program: vasomotor symptom interventions (dietary phytoestrogens, paced respiration protocol), sleep hygiene for disrupted sleep architecture, libido support strategies, and mood stabilization through exercise and mind-body practices.",
        "markers": [
          "vasomotor episode count",
          "sleep architecture score",
          "SHBG",
          "estradiol",
          "serotonin precursor (Trp:LNAA)",
          "cortisol",
          "progesterone"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Menopausal Supplement & Botanical Protocol",
        "desc": "Evidence-based botanical and supplement recommendations from client catalog: black cohosh (if phytoestrogen responder genetics), magnesium glycinate, ashwagandha (cortisol support), omega-3, probiotics (estrobolome support), and collagen peptides.",
        "markers": [
          "estrobolome diversity",
          "cortisol AM",
          "omega-3 index",
          "magnesium RBC",
          "gut microbiome diversity",
          "estradiol"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Breast Cysts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Breast Cysts"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Breast Fibroadenoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Breast Fibroadenoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Breast Lumps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Breast Lumps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Cervical Polyps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Cervical Polyps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Dysmenorrhea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Dysmenorrhea"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Early Menopause",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Early Menopause"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Ectopic Pregnancy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Ectopic Pregnancy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Endometriosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Endometriosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Female Infertility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Female Infertility"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Fibrocystic Breasts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Fibrocystic Breasts"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Menorrhagia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Menorrhagia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Miscarriage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Miscarriage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Ovarian Dysfunction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Ovarian Dysfunction"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Polycystic Ovary Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Polycystic Ovary Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Postmenopausal Osteoporosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Postmenopausal Osteoporosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Premature Menopause",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Premature Menopause"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Uterine Fibroids",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Uterine Fibroids"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Uterine Polyps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Uterine Polyps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Uterine Prolapse",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Female Reproductive System Breasts Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Female Reproductive System Breasts Disorders",
        "markers": [
          "Uterine Prolapse"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "fertility",
          "menopause",
          "prevention"
        ]
      },
      {
        "name": "Achalasia Addisonianism Alacrimia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Achalasia Addisonianism Alacrimia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucocorticoid Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Glucocorticoid Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucocorticoid Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Glucocorticoid Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipoid Adrenal Hyperplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Lipoid Adrenal Hyperplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Proopiomelanocortin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Proopiomelanocortin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenal Hyperplasia, Congenital, Due To 17 Alpha Hydroxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Adrenal Hyperplasia, Congenital, Due To 17 Alpha Hydroxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenocortical Insufficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Adrenocortical Insufficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Antley Bixler Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Antley Bixler Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Aromatase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Aromatase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Aromatase Excess Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Aromatase Excess Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Blepharophimosis, Epicanthus Inversus, And Ptosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Blepharophimosis, Epicanthus Inversus, And Ptosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Denys Drash Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Denys Drash Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Fragile X Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Fragile X Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Fragile X Tremor/Ataxia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Fragile X Tremor/Ataxia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Frasier Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Frasier Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Leydig Cell Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Leydig Cell Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Luteinizing Hormone Resistance, Female",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Luteinizing Hormone Resistance, Female"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrotic Syndrome, Type 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Nephrotic Syndrome, Type 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovarian Dysgenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Ovarian Dysgenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovarian Dysgenesis 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Ovarian Dysgenesis 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 167,
    "marker_count": 207,
    "insight_count": 74
  },
  {
    "id": "athlete",
    "name": "Elite Athlete Performance",
    "sub": "Peak Performance & Recovery",
    "color": "#0a7c6e",
    "lt": "#e5f4f2",
    "img": "https://images.unsplash.com/photo-1530549387789-4c1017266635?w=320&q=75",
    "desc": "Data-driven performance optimization integrating Lifenome 26-trait fitness PGS with real-time readiness, recovery, overtraining prevention, and genetic injury risk.",
    "tags": [
      "VO2max",
      "HRV readiness",
      "overtraining prevention",
      "injury genetics",
      "performance PGS"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Training Load & Recovery Balance",
        "desc": "Sleep, nutrition timing, training volume, stress load, and recovery practice quality composite score.",
        "markers": [
          "sleep hrs/night",
          "protein g/kg/day",
          "alcohol units/wk",
          "training hrs/wk",
          "recovery practice score"
        ],
        "unit": "Recovery quality score 0\u2013100",
        "range": "Optimal: >75 | Overreach risk: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Nutritional Performance Readiness",
        "desc": "Carbohydrate periodization, protein adequacy, and micronutrient sufficiency for performance.",
        "markers": [
          "carb intake g/kg",
          "protein timing",
          "iron dietary intake",
          "hydration L/day",
          "caffeine mg/day"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal protein: 1.6\u20132.2 g/kg/day",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Daily Recovery Readiness Score",
        "desc": "Go/no-go training decision signal from overnight HRV, sleep quality, and acute:chronic load balance.",
        "markers": [
          "HRV RMSSD ms",
          "deep sleep %",
          "resting HR bpm",
          "7-day training load AU",
          "acute:chronic load ratio"
        ],
        "unit": "Readiness score 0\u2013100",
        "range": "Green: >70 | Yellow: 40\u201370 | Red: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "VO2 Max Trajectory",
        "desc": "Continuous VO2 max tracking, periodization response curve, and training zone calibration.",
        "markers": [
          "VO2 max mL/kg/min",
          "zone 2 weekly hrs",
          "lactate threshold HR bpm",
          "FTP watts or pace"
        ],
        "unit": "mL/kg/min",
        "range": "Elite M: >60 | Recreational: 40\u201355 | Sedentary: <35",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Overtraining Risk Index",
        "desc": "HRV 7-day decline + ACWR spike early warning \u2014 validated overtraining syndrome predictor.",
        "markers": [
          "7-day HRV trend % decline",
          "ACWR (acute:chronic workload ratio)",
          "nocturnal HR elevation bpm",
          "mood score (POMS proxy)"
        ],
        "unit": "ACWR ratio",
        "range": "Optimal: 0.8\u20131.3 | Overtraining risk: >1.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Lactate Threshold & Aerobic Base",
        "desc": "HR-derived lactate threshold (LT1/LT2) estimation for precision training zone assignment.",
        "markers": [
          "LT1 HR bpm",
          "LT2 HR bpm",
          "aerobic decoupling %",
          "cardiac drift %"
        ],
        "unit": "LT1 heart rate bpm",
        "range": "Well-trained LT2: 85\u201392% HRmax",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Sleep & Circadian Performance Impact",
        "desc": "Sleep architecture quality and circadian timing effect on same-day performance output.",
        "markers": [
          "total sleep hrs",
          "deep sleep %",
          "sleep regularity index",
          "circadian phase offset hr"
        ],
        "unit": "Sleep score 0\u2013100",
        "range": "Optimal athlete: 8\u20139 hrs | Deep: >20%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Movement Quality & Asymmetry",
        "desc": "Smartphone-based gait analysis, postural asymmetry detection, and compensatory movement pattern flagging.",
        "markers": [
          "gait symmetry index %",
          "postural alignment score",
          "ROM proxy score",
          "limb asymmetry %"
        ],
        "unit": "Symmetry index %",
        "range": "Optimal: >95% symmetry | Injury risk: <90%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Athletic Profile",
        "desc": "Smartphone lean mass, body fat %, and muscle distribution for sport-specific optimization.",
        "markers": [
          "body fat %",
          "muscle mass kg",
          "lean mass ratio",
          "sport-specific comp target"
        ],
        "unit": "Body fat %",
        "range": "Elite endurance M: 6\u201312% | Power: 10\u201315%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Iron & Oxygen Transport Panel",
        "desc": "Ferritin, transferrin, CBC \u2014 foundational endurance performance and altitude adaptation markers.",
        "markers": [
          "ferritin ng/mL",
          "serum iron \u00b5g/dL",
          "transferrin saturation %",
          "hemoglobin g/dL",
          "hematocrit %",
          "reticulocytes %"
        ],
        "unit": "Ferritin ng/mL",
        "range": "Optimal athlete: >50 ng/mL | Deficient: <20 ng/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Vitamin D & Bone Health",
        "desc": "Vitamin D and bone remodeling markers for injury prevention and muscle function optimization.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "PTH pg/mL",
          "calcium mg/dL",
          "ALP IU/L"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal athlete: 50\u201380 ng/mL | Deficient: <30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Hormonal Performance Profile",
        "desc": "Testosterone:cortisol ratio \u2014 gold-standard overtraining biomarker and anabolic:catabolic balance.",
        "markers": [
          "testosterone total ng/dL",
          "testosterone free pg/mL",
          "cortisol AM \u00b5g/dL",
          "T:C ratio",
          "DHEA-S \u00b5g/dL",
          "IGF-1 ng/mL"
        ],
        "unit": "Testosterone:Cortisol ratio",
        "range": "Optimal: >0.035 | Overtrained: <0.015",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Muscle Damage & Recovery Panel",
        "desc": "CK, LDH, myoglobin as muscle stress markers for session intensity calibration and recovery timing.",
        "markers": [
          "CK IU/L",
          "LDH IU/L",
          "myoglobin \u00b5g/L",
          "hsCRP mg/L",
          "IL-6 pg/mL"
        ],
        "unit": "CK IU/L",
        "range": "Post-exercise normal: <500 | Concern: >1000 IU/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Mitochondrial Performance Panel",
        "desc": "CoQ10, NAD+, amino acid panel, omega-3 index for cellular energy and anti-inflammatory optimization.",
        "markers": [
          "CoQ10 \u00b5g/mL",
          "NAD+ \u00b5mol/L",
          "amino acid panel",
          "omega-3 index %",
          "GSH \u00b5mol/L",
          "carnitine \u00b5mol/L"
        ],
        "unit": "CoQ10 \u00b5g/mL",
        "range": "Optimal: >0.8 \u00b5g/mL | Deficient: <0.5 \u00b5g/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Gut Health & Absorption Panel",
        "desc": "Gut permeability and nutrient absorption capacity \u2014 performance-limiting factor in elite athletes.",
        "markers": [
          "zonulin ng/mL",
          "calprotectin \u00b5g/g",
          "secretory IgA mg/dL",
          "lactulose:mannitol ratio"
        ],
        "unit": "Calprotectin \u00b5g/g stool",
        "range": "Normal: <50 \u00b5g/g | Elevated: >200 \u00b5g/g",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Athletic Performance PGS (26 Traits)",
        "desc": "Lifenome 26-trait fitness genetics: aerobic capacity, power, endurance, VO2 max trainability, elite endurance potential.",
        "markers": [
          "ACTN3 R577X (power)",
          "ACE I/D (endurance)",
          "PPARGC1A (mitochondria)",
          "HIF1A (hypoxia)",
          "ADRB2 (beta-2 adrenergic)",
          "26 fitness traits total"
        ],
        "unit": "Performance percentile",
        "range": "Top 10%: elite potential | Avg: 40\u201360th %ile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Injury Risk Genetic Profile",
        "desc": "ACL rupture, Achilles tendinopathy, stress fracture, and joint laxity polygenic risk scores.",
        "markers": [
          "ACL rupture PGS (COL5A1, MMP3)",
          "Achilles tendinopathy PGS",
          "stress fracture PGS",
          "joint laxity (COL1A1, COL3A1)",
          "muscle injury risk PGS"
        ],
        "unit": "Per-injury OR vs population",
        "range": "High risk: OR >2.5",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Recovery & Adaptation Genetics",
        "desc": "Muscle recovery speed, DOMS susceptibility, muscle-damage-risk, and sleep genetics affecting adaptation.",
        "markers": [
          "DOMS PGS (CK elevation genetics)",
          "muscle-repair speed PGS",
          "slow-muscle-recovery PGS",
          "MSTN (myostatin variants)",
          "sleep depth genetics"
        ],
        "unit": "Recovery percentile",
        "range": "Fast recovery: >70th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Caffeine & Stimulant Metabolism",
        "desc": "CYP1A2 caffeine metabolism status \u2014 determines ergogenic benefit vs. cardiovascular risk.",
        "markers": [
          "CYP1A2 *1F genotype",
          "ADORA2A (adenosine receptor)",
          "caffeine sensitivity variants"
        ],
        "unit": "Metabolizer phenotype",
        "range": "Fast metabolizer: ergogenic benefit confirmed",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Cardiac Genetic Screening (SCD Risk)",
        "desc": "HCM, ARVC, Brugada, long-QT syndrome \u2014 mandatory pre-participation cardiac clearance gene panel.",
        "markers": [
          "MYH7 (HCM)",
          "MYBPC3 (HCM)",
          "PKP2 (ARVC)",
          "SCN5A (Brugada/long-QT)",
          "KCNQ1/KCNH2 (LQTS)",
          "cardiology exome panel"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = disqualify pending cardiology review",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_exome",
        "name": "Rare Metabolic Performance Variants",
        "desc": "AMPD1, ACADVL, CPT1/2 \u2014 rare variants causing exertional myopathy and rhabdomyolysis.",
        "markers": [
          "AMPD1 Q12X (exercise fatigue)",
          "ACADVL (fatty acid oxidation)",
          "CPT2 (carnitine metabolism)",
          "GSD-related genes"
        ],
        "unit": "Variant classification",
        "range": "Pathogenic = modify training protocol",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_wgs",
        "name": "Full Athletic Genome Panel",
        "desc": "WGS-level resolution of all performance, injury, cardiac, and rare metabolic athletic variants.",
        "markers": [
          "All array PGS enhanced",
          "structural variants",
          "rare INDELs",
          "doping gene variants (EPOR, EPO)"
        ],
        "unit": "Enhanced PRS percentile",
        "range": "WGS improves PRS by ~30%",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Athletic Gut Microbiome Profile",
        "desc": "Prevotella, Veillonella propionate pathway, and lactate metabolism \u2014 performance-enhancing species abundance.",
        "markers": [
          "Prevotella % (carb fermentation)",
          "Veillonella % (lactate-to-propionate)",
          "Shannon diversity H",
          "butyrate producers %",
          "Akkermansia %"
        ],
        "unit": "Shannon diversity index H",
        "range": "Athletic optimal H: >3.2 | Poor gut: <2.5",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_16s",
        "name": "Inflammatory Load & Gut Integrity",
        "desc": "Gut permeability and systemic inflammation markers via microbiome composition as performance limiter.",
        "markers": [
          "LPS-producing bacteria %",
          "mucosal barrier species",
          "Faecalibacterium prausnitzii %",
          "zonulin-correlated species"
        ],
        "unit": "Dysbiosis score 0\u201310",
        "range": "Optimal: <3 | Performance-limiting: >6",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Performance Metabolomics (Functional)",
        "desc": "Propionate synthesis, NO precursor capacity, and BCAA metabolism from shotgun functional analysis.",
        "markers": [
          "propionate synthesis gene count",
          "nitric oxide precursor genes",
          "BCAA catabolism pathway",
          "secondary bile acid genes"
        ],
        "unit": "Functional gene RPKM",
        "range": "Propionate genes optimal: >1.8 RPKM",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Training Adaptability & Aging Clock",
        "desc": "Epigenetic age acceleration as cumulative training stress marker and adaptation capacity predictor.",
        "markers": [
          "GrimAge acceleration (yr)",
          "DunedinPACE",
          "muscle-tissue methylation CpGs",
          "mTOR pathway methylation"
        ],
        "unit": "DunedinPACE (yr/yr)",
        "range": "Optimal athlete: <1.0 yr/yr | Overtrained: >1.15",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "blood",
        "name": "Endurance Healthspan Category Score",
        "desc": "InsideTracker's endurance category: ferritin (3\u00d7 more impactful than serum iron), hemoglobin, hematocrit, vitamin B12, folate, and transferrin saturation \u2014 the complete oxygen-transport and energy-substrate picture for aerobic performance.",
        "markers": [
          "ferritin",
          "hemoglobin",
          "hematocrit",
          "serum iron",
          "transferrin saturation",
          "TIBC",
          "vitamin B12",
          "folate",
          "reticulocyte count"
        ],
        "unit": "Score 0\u2013100",
        "range": "Ferritin optimal (athletes): men >50 ng/mL | women >30 ng/mL",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Recovery & Muscle Damage Index",
        "desc": "InsideTracker's recovery healthspan category: ALT, AST, CK, magnesium RBC (gold standard), and LDH. RBC magnesium is the most sensitive marker for true magnesium status \u2014 critical for muscle recovery, nerve function, and 300+ enzymatic reactions.",
        "markers": [
          "CK (creatine kinase)",
          "ALT",
          "AST",
          "LDH",
          "magnesium RBC",
          "magnesium serum",
          "myoglobin",
          "uric acid"
        ],
        "unit": "CK IU/L + composite",
        "range": "CK resting: <200 IU/L | Overtrained: >500 | Mg RBC: 4.2\u20136.8 mg/dL",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Periodized Training Program",
        "desc": "Science-backed periodized training plan generated from VO\u2082max trajectory, overtraining risk index, injury genetics, and recovery readiness score. Prescribes volume, intensity, frequency, and modality (power vs endurance ratio) matched to genetic profile (power:endurance PGS).",
        "markers": [
          "VO\u2082max",
          "HRV recovery score",
          "overtraining risk index",
          "power:endurance PGS",
          "CK (muscle damage)",
          "cortisol AM",
          "injury genetics",
          "sleep architecture"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Performance Supplement Protocol",
        "desc": "Evidence-rated performance supplements from client catalog personalized by blood status and genetic response: creatine monohydrate (responder genetics), beta-alanine, caffeine (CYP1A2 metabolizer status), iron (if ferritin <30 ng/mL athletes), magnesium, vitamin D, omega-3, and electrolyte profile.",
        "markers": [
          "ferritin",
          "CYP1A2 caffeine genotype",
          "creatine response genetics",
          "magnesium RBC",
          "vitamin D",
          "omega-3 index",
          "sodium sweat loss proxy"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Sport Nutrition & Fueling Plan",
        "desc": "Periodized sport nutrition protocol: carbohydrate loading timing matched to glycogen depletion signals and race schedule, protein distribution for muscle protein synthesis (1.6\u20132.2g/kg/day), pre/during/post-exercise fueling matched to sweat rate and GI tolerance genetics.",
        "markers": [
          "ferritin",
          "HbA1c",
          "blood glucose trend",
          "GI tolerance genetics",
          "lean body mass",
          "VO\u2082max",
          "daily energy expenditure (wearable)"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Injury Prevention Protocol",
        "desc": "Targeted injury prevention program based on genetic injury risk (ACL, tendon, stress fracture PGS): proprioception training for high ACL-risk individuals, collagen synthesis protocol (Vitamin C + gelatin timing), load management schedule, and movement quality intervention.",
        "markers": [
          "ACL risk PGS",
          "tendinopathy PGS",
          "stress fracture PGS",
          "vitamin D",
          "collagen stability genotype",
          "CK baseline",
          "asymmetry score"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Exercise Benefits Blood Pressure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Exercise Benefits Blood Pressure"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Exercise Benefits Lowering Cholesterol",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Exercise Benefits Lowering Cholesterol"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Exercise Benefits Maximal Oxygen Uptake",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Exercise Benefits Maximal Oxygen Uptake"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Heartbeat Reduction Difficulty",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Heartbeat Reduction Difficulty"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Lower Exercise Benefits Heart Pump",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Lower Exercise Benefits Heart Pump"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Overall Fitness Benefits",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Benefits",
        "markers": [
          "Overall Fitness Benefits"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Aerobic Performance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Aerobic Performance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Elite Endurance Athletes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Elite Endurance Athletes"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Endurance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Endurance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Exercise Aversion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Exercise Aversion"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Joint Flexibility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Joint Flexibility"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Lean Body Mass Potential",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Lean Body Mass Potential"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Power",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fitness Profile",
        "markers": [
          "Power"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Achilles Tendinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Achilles Tendinopathy"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Anterior Cruciate Ligament Rupture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Anterior Cruciate Ligament Rupture"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Joint Injury Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Joint Injury Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Overall Tendon Ligament Injury Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Overall Tendon Ligament Injury Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Stress Fracture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Injury Potential",
        "markers": [
          "Stress Fracture"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Cramping",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Cramping"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Damage Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Damage Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Response Resistance Training",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Response Resistance Training"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Soreness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Soreness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscle Strength Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscle Strength Loss"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Muscular Strength",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Muscular Strength"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Skeletal Muscle Performance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Skeletal Muscle Performance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Slow Muscle Repair",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Fitness.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Muscle Characteristics",
        "markers": [
          "Slow Muscle Repair"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "athlete",
          "longevity",
          "weightloss"
        ]
      },
      {
        "name": "Ankylosing Spondylitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Ankylosing Spondylitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Arthritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Arthritis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Back Pain",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Back Pain"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Bursitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Bursitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Carpal Tunnel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Carpal Tunnel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Cervical Spondylosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Cervical Spondylosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Gout",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Gout"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Herniated Disk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Herniated Disk"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Hip Fracture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Hip Fracture"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Mixed Connective Tissue Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Mixed Connective Tissue Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Osteoarthritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Osteoarthritis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Osteomyelitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Osteomyelitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Osteoporosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Osteoporosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Plantar Fasciitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Plantar Fasciitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Polymyalgia Rheumatica",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Polymyalgia Rheumatica"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Rheumatoid Arthritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Rheumatoid Arthritis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Sciatica",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Sciatica"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Scoliosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Scoliosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Spinal Stenosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Spinal Stenosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Tendinitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Musculoskeletal System Connective Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal System Connective Tissue Disorders",
        "markers": [
          "Tendinitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "longevity",
          "prevention"
        ]
      },
      {
        "name": "Asthma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Asthma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Bronchitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Bronchitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Chronic Obstructive Pulmonary Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Chronic Obstructive Pulmonary Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Chronic Sinusitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Chronic Sinusitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Emphysema",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Emphysema"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Interstitial Lung Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Interstitial Lung Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Nasal Polyps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Nasal Polyps"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Pleurisy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Pleurisy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Pneumonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Pneumonia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Pulmonary Embolism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Pulmonary Embolism"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Respiratory Infection Unspecified Acute Lower",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Respiratory Infection Unspecified Acute Lower"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Whooping Cough",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Respiratory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Respiratory System Disorders",
        "markers": [
          "Whooping Cough"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention"
        ]
      },
      {
        "name": "Alpha 1 Antitrypsin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Lung Disease",
        "markers": [
          "Alpha 1 Antitrypsin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Lung Disease",
        "markers": [
          "Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lymphangioleiomyomatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Lung Disease",
        "markers": [
          "Lymphangioleiomyomatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Degeneration, Age Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Lung Disease",
        "markers": [
          "Macular Degeneration, Age Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Supravalvular Aortic Stenosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Lung Disease",
        "markers": [
          "Supravalvular Aortic Stenosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tuberous Sclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Lung Disease",
        "markers": [
          "Tuberous Sclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hermansky Pudlak Syndrome 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hermansky Pudlak Syndrome",
        "markers": [
          "Hermansky Pudlak Syndrome 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rajab Interstitial Lung Disease With Brain Calcifications 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hermansky Pudlak Syndrome",
        "markers": [
          "Rajab Interstitial Lung Disease With Brain Calcifications 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Idiopathic Pulmonary Fibrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interstitial Lung Disease",
        "markers": [
          "Familial Idiopathic Pulmonary Fibrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Idiopathic Pulmonary Fibrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interstitial Lung Disease",
        "markers": [
          "Idiopathic Pulmonary Fibrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Alveolar Microlithiasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interstitial Lung Disease",
        "markers": [
          "Pulmonary Alveolar Microlithiasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Fibrosis, Idiopathic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Pulmonology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interstitial Lung Disease",
        "markers": [
          "Pulmonary Fibrosis, Idiopathic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "athlete",
          "prevention",
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 278,
    "marker_count": 278,
    "insight_count": 113
  },
  {
    "id": "prevention",
    "name": "Chronic Disease Prevention",
    "sub": "Primary Prevention",
    "color": "#5730b8",
    "lt": "#f0ecff",
    "img": "https://images.unsplash.com/photo-1576671081837-49000212a370?w=320&q=75",
    "desc": "Proactive population-scale health \u2014 detecting cardiometabolic, oncological, and neurological risk years before clinical onset using Lifenome full 213-trait medical PGS.",
    "tags": [
      "CVD prevention",
      "T2DM prevention",
      "hereditary cancer",
      "dementia risk",
      "ASCVD"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "10-Year Multi-Disease Risk Index",
        "desc": "Modifiable risk factor composite for CVD, T2DM, cancer, and dementia onset in the next decade.",
        "markers": [
          "diet quality score",
          "physical activity MET-hr/wk",
          "smoking pack-years",
          "sleep hrs",
          "BMI",
          "alcohol units/wk"
        ],
        "unit": "10-year composite risk %",
        "range": "Low: <5% | Intermediate: 5\u201315% | High: >15%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Framingham-Adjusted Lifestyle Score",
        "desc": "Lifestyle modifier applied to genetic CVD risk \u2014 quantifies how much behavior attenuates or amplifies PGS risk.",
        "markers": [
          "DASH diet compliance",
          "Mediterranean diet score",
          "exercise min/wk",
          "smoking status",
          "BP category"
        ],
        "unit": "Lifestyle risk adjustment factor",
        "range": "Protective: <1.0 | Harmful: >1.0 multiplier",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Resting HR Cardiometabolic Signal",
        "desc": "Long-term resting HR elevation as early cardiometabolic deterioration marker.",
        "markers": [
          "resting HR bpm 30-day avg",
          "7-day HR trend",
          "nocturnal HR dip %",
          "activity mins/day"
        ],
        "unit": "Resting HR bpm",
        "range": "Optimal: 50\u201365 bpm | Cardiometabolic concern: >75",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Activity & Sedentary Behavior Index",
        "desc": "Sitting hours, activity breaks, and moderate intensity minutes as cancer and metabolic disease modifiers.",
        "markers": [
          "sedentary hours/day",
          "MVPA min/week",
          "step count",
          "standing breaks/hr"
        ],
        "unit": "MVPA min/week",
        "range": "WHO target: \u2265150 min/wk | Cancer risk: <75 min/wk",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep Duration & Quality Index",
        "desc": "Sleep duration and quality as T2DM, CVD, and cancer risk modifiers \u2014 U-shaped relationship.",
        "markers": [
          "sleep duration hrs",
          "sleep efficiency %",
          "HRV overnight",
          "sleep regularity index"
        ],
        "unit": "Sleep duration hrs",
        "range": "Optimal: 7\u20139 hrs | Risk zones: <6 or >9 hrs",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "BMI & Adiposity Risk Classification",
        "desc": "Smartphone-derived body composition risk stratification with visceral adiposity index.",
        "markers": [
          "BMI kg/m\u00b2",
          "waist circumference cm",
          "visceral fat index",
          "waist:height ratio"
        ],
        "unit": "Waist:height ratio",
        "range": "Optimal: <0.5 | High risk: >0.6",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Cardiometabolic Screening Panel",
        "desc": "Foundational 6-marker CVD and diabetes risk panel \u2014 recommended annually for all adults >35.",
        "markers": [
          "fasting glucose mg/dL",
          "HbA1c %",
          "total cholesterol mg/dL",
          "LDL mg/dL",
          "HDL mg/dL",
          "TG mg/dL",
          "TSH mIU/L"
        ],
        "unit": "10-year ASCVD risk %",
        "range": "Low: <7.5% | Intermediate: 7.5\u201320% | High: >20%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Enhanced CVD Risk Panel",
        "desc": "hs-CRP and homocysteine-enhanced ASCVD risk calculation beyond standard lipid panel.",
        "markers": [
          "hs-CRP mg/L",
          "homocysteine \u00b5mol/L",
          "vitamin D ng/mL",
          "ferritin ng/mL",
          "B12 pg/mL"
        ],
        "unit": "hs-CRP mg/L",
        "range": "Optimal: <1.0 | Elevated risk: 1.0\u20133.0 | High: >3.0 mg/L",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Advanced Lipid & Insulin Resistance",
        "desc": "ApoB, Lp(a), HOMA-IR \u2014 the three most underused but predictive metabolic disease biomarkers.",
        "markers": [
          "ApoB mg/dL",
          "Lp(a) nmol/L",
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR",
          "oxidized LDL U/L",
          "uric acid mg/dL"
        ],
        "unit": "ApoB mg/dL",
        "range": "Optimal: <80 mg/dL | Statin indication: >100",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Organ Function Longevity Panel",
        "desc": "Liver, kidney, and cardiovascular organ-specific function as disease burden and aging markers.",
        "markers": [
          "ALT IU/L",
          "AST IU/L",
          "GGT IU/L",
          "eGFR mL/min",
          "cystatin-C mg/L",
          "albumin g/dL",
          "bilirubin mg/dL"
        ],
        "unit": "eGFR mL/min/1.73m\u00b2",
        "range": "Optimal eGFR: >90 | Mild CKD: 60\u201389",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Cancer & Immune Surveillance Panel",
        "desc": "IL-6, TNF-\u03b1, BDNF, and early cancer immune signature markers for proactive oncology screening.",
        "markers": [
          "IL-6 pg/mL",
          "TNF-\u03b1 pg/mL",
          "BDNF ng/mL",
          "hsTroponin I ng/L",
          "CEA ng/mL",
          "PSA ng/mL (M)",
          "CA-125 IU/mL (F)"
        ],
        "unit": "IL-6 pg/mL",
        "range": "Optimal IL-6: <3.0 pg/mL | Elevated: >5.0",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Micronutrient Prevention Panel",
        "desc": "Vitamin D, omega-3 index, magnesium, selenium \u2014 deficiencies linked to cancer and CVD risk.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "omega-3 index %",
          "magnesium RBC mg/dL",
          "selenium \u00b5g/L",
          "zinc \u00b5g/dL",
          "folate ng/mL"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal: 50\u201380 ng/mL | Deficient: <30 ng/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Medical PGS \u2014 213 Conditions",
        "desc": "Full Lifenome medical PGS: 27 cancers, 24 circulatory, 16 endocrine, 22 digestive, 15 neurological, 18 mental-behavioural.",
        "markers": [
          "cancer PGS (27 conditions)",
          "CVD PGS (24 conditions)",
          "T2DM PGS",
          "neurological PGS (15)",
          "mental health PGS (18)",
          "213 medical traits total"
        ],
        "unit": "Per-disease percentile",
        "range": "Elevated risk: >75th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "APOE & Neurodegeneration Risk",
        "desc": "APOE4 genotyping plus full nervous-system PGS for Alzheimer, Parkinson, and dementia stratification.",
        "markers": [
          "APOE E2/E3/E4 genotype",
          "Alzheimer PGS (CLU, BIN1, CR1)",
          "Parkinson PGS (SNCA, LRRK2)",
          "BDNF Val66Met",
          "15 neurological PGS traits"
        ],
        "unit": "APOE genotype + AD PGS percentile",
        "range": "APOE E4/E4: 8\u201312x risk vs E3/E3",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Hypertension & Stroke PGS",
        "desc": "Polygenic hypertension risk and ischemic/hemorrhagic stroke PGS \u2014 actionable early lifestyle intervention.",
        "markers": [
          "hypertension PGS (SBP/DBP loci)",
          "coronary artery disease PGS",
          "stroke PGS",
          "atrial fibrillation PGS",
          "CKD PGS"
        ],
        "unit": "Systolic BP genetic score",
        "range": "High PGS: +10\u201315 mmHg genetic SBP lift",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Cancer Panel (Tier 1)",
        "desc": "BRCA1/2, Lynch syndrome, PALB2, ATM \u2014 clinically actionable Tier 1 cancer predisposition variants.",
        "markers": [
          "BRCA1/BRCA2 (breast/ovarian)",
          "MLH1/MSH2/MSH6/PMS2 (Lynch)",
          "PALB2",
          "ATM",
          "APC (FAP)",
          "VHL",
          "hereditary-cancer exome panel"
        ],
        "unit": "ACMG classification",
        "range": "P/LP = immediate genetic counseling referral",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_exome",
        "name": "Cardiovascular Rare Variants",
        "desc": "Familial hypercholesterolemia, HCM, Marfan syndrome \u2014 clinically actionable cardiac exome panel.",
        "markers": [
          "LDLR/APOB/PCSK9 (FH)",
          "MYH7/MYBPC3 (HCM)",
          "FBN1 (Marfan)",
          "SCN5A/KCNQ1 (arrhythmia)",
          "cardiology exome panel"
        ],
        "unit": "Variant classification",
        "range": "P/LP FH: LDL >190 + genetic = statin imperative",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_wgs",
        "name": "WGS Population Prevention Scan",
        "desc": "WGS enhances all PRS and discovers ultra-rare, population-frequency <0.01% pathogenic variants.",
        "markers": [
          "All array + exome enhanced",
          "structural variants",
          "ultra-rare coding variants",
          "pharmacogenomics refinement"
        ],
        "unit": "Enhanced PRS percentile",
        "range": "WGS adds ~15% sensitivity for rare disease",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Cancer-Protective Microbiome Score",
        "desc": "Butyrate producers and anti-inflammatory species linked to colorectal and systemic cancer prevention.",
        "markers": [
          "Faecalibacterium prausnitzii %",
          "Roseburia intestinalis %",
          "Akkermansia muciniphila %",
          "Shannon diversity H",
          "LPS-producing species %"
        ],
        "unit": "Protective species %",
        "range": "F. prausnitzii optimal: >5% | Concern: <2%",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_16s",
        "name": "Metabolic Disease Microbiome Risk",
        "desc": "Firmicutes:Bacteroidetes ratio and Prevotella abundance as T2DM and obesity risk correlates.",
        "markers": [
          "Firmicutes:Bacteroidetes ratio",
          "Prevotella copri %",
          "Ruminococcus gnavus %",
          "total SCFA producers %"
        ],
        "unit": "F:B ratio",
        "range": "Optimal: F:B 1:1 to 2:1 | T2DM risk: >3:1",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Metabolic Pathway Disease Map",
        "desc": "Functional SCFA, bile acid, and glucose regulatory gene abundance as metabolic disease prevention markers.",
        "markers": [
          "SCFA synthesis gene count",
          "primary-to-secondary bile acid ratio",
          "GLP-1 stimulating gene pathways",
          "LPS biosynthesis genes"
        ],
        "unit": "Functional diversity score",
        "range": "LPS genes: optimal low | SCFA genes: high",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Multi-Disease Epigenetic Risk Clock",
        "desc": "PhenoAge and GrimAge \u2014 the most validated predictors of multi-disease onset and all-cause mortality.",
        "markers": [
          "PhenoAge (yr)",
          "GrimAge (yr)",
          "DNAmTL (kb) \u2014 telomere length",
          "AgeAccelGrim (yr)",
          "disease-specific CpG loci"
        ],
        "unit": "GrimAge biological age (yr)",
        "range": "GrimAge > chronological + 5 yr = high risk",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "blood",
        "name": "Advanced Cardiovascular Risk Score",
        "desc": "Goes beyond standard lipid panel: ApoB, Lp(a), LDL particle number and size, and oxidized LDL \u2014 the biomarkers Function Health and InsideTracker both highlight as far superior to total cholesterol for predicting MI risk. ApoB has >2\u00d7 the predictive weight of total cholesterol (InsideTracker data).",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL particle number (LDL-P)",
          "small dense LDL",
          "oxidized LDL",
          "HDL-P",
          "lipoprotein particle size",
          "ApoA1"
        ],
        "unit": "ApoB mg/dL + nmol/L",
        "range": "ApoB optimal: <80 mg/dL | High risk: >100 | Lp(a): <75 nmol/L",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Insulin Resistance & Pre-Diabetes Index",
        "desc": "InsideTracker's metabolism category: fasting glucose, insulin, and HbA1c with HOMA-IR composite. Early insulin resistance is detectable 10\u201315 years before T2DM diagnosis. HOMA-IR is 3\u00d7 more sensitive than glucose alone.",
        "markers": [
          "fasting glucose",
          "fasting insulin",
          "HbA1c",
          "HOMA-IR",
          "1,5-anhydroglucitol (1,5-AG)",
          "triglycerides:HDL ratio",
          "c-peptide"
        ],
        "unit": "HOMA-IR score",
        "range": "Optimal: <1.5 | Pre-resistance: 1.5\u20132.5 | Resistant: >2.5",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Organ Function Surveillance Panel",
        "desc": "Function Health reports >80% of members have in-range liver and kidney results, >90% in-range pancreas \u2014 but outliers are caught only through regular testing. Comprehensive organ health panel including GGT, cystatin-C, and lipase.",
        "markers": [
          "ALT",
          "AST",
          "GGT",
          "alkaline phosphatase",
          "total bilirubin",
          "albumin",
          "creatinine",
          "cystatin-C",
          "eGFR",
          "BUN",
          "uric acid",
          "lipase"
        ],
        "unit": "Multi-organ score",
        "range": "GGT optimal: <25 U/L | Cystatin-C: <0.95 mg/L | eGFR: >90",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Blood-Based Biological Age",
        "desc": "Biological age calculated from 18 key blood biomarkers using ML algorithms trained on 42,000+ samples (methodology: InsideTracker InnerAge 2.0 + PhenoAge). Biomarkers weighted by their correlation with chronological aging: glucose, LDL, albumin, hematocrit, lymphocytes, GGT, HbA1c, triglycerides, cortisol, DHEA-S, ferritin, vitamin D, hs-CRP, insulin, MCHC, creatinine, uric acid, WBC.",
        "markers": [
          "fasting glucose",
          "LDL cholesterol",
          "albumin",
          "hematocrit",
          "lymphocyte %",
          "GGT",
          "HbA1c",
          "triglycerides",
          "cortisol AM",
          "DHEA-S",
          "ferritin",
          "25-OH Vitamin D",
          "hs-CRP",
          "fasting insulin",
          "MCHC",
          "creatinine",
          "uric acid",
          "WBC"
        ],
        "unit": "Biological age (years)",
        "range": "Optimal: \u22653 years younger than chronological | Concern: >3 years older",
        "tier": "advanced"
      },
      {
        "src": "epigenetics",
        "insight_type": "health_dashboard",
        "name": "Epigenetic Biological Age (Methylation)",
        "desc": "DNA methylation-based biological age using 4 validated epigenetic clocks: Horvath clock (pan-tissue), GrimAge (strongest all-cause mortality predictor), PhenoAge (phenotypic health proxy), and DunedinPACE (real-time aging speed). GrimAge acceleration >3 years is a major actionable threshold. Covers 850,000 CpG sites.",
        "markers": [
          "Horvath clock age (353 CpGs)",
          "GrimAge acceleration",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking epigenetic score)",
          "DNAmTL (telomere length proxy)",
          "DNAm CRP",
          "EpiTOC2 (cancer stem cell index)"
        ],
        "unit": "Biological age (years) per clock",
        "range": "Ideal: clock age \u2264 chronological | Alert: GrimAge >3 yr acceleration",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Actuarial Age (Lifestyle & Demographic)",
        "desc": "Validated actuarial biological age calculation from lifestyle and demographic inputs, based on RealAge and Levine mortality risk models. Factors: smoking history, alcohol intake, BMI, physical activity level, diet quality score, sleep duration, psychosocial stress, social connectedness, education, income proxy, environmental exposures, and medical history. Each factor is weighted by its effect size on all-cause mortality.",
        "markers": [
          "smoking history (pack-years)",
          "alcohol units/week",
          "BMI",
          "physical activity (MET-hours/week)",
          "diet quality (HEI score)",
          "sleep duration (hours/night)",
          "sleep quality (PSQI)",
          "psychosocial stress (PSS-10)",
          "social connection score",
          "SES proxy",
          "environmental exposure index",
          "medical conditions count"
        ],
        "unit": "Actuarial age (years)",
        "range": "Optimal: \u22655 years younger | Danger zone: >5 years older"
      },
      {
        "src": "wearable",
        "insight_type": "health_dashboard",
        "name": "Physiological Age (HRV \u00b7 VO\u2082Max \u00b7 HR \u00b7 BP)",
        "desc": "Composite physiological age score derived from four objective performance biomarkers: resting heart rate variability (RMSSD \u2014 validated vs. chronological age normative curves), VO\u2082max (cardiorespiratory fitness age from submaximal exercise), resting heart rate trend, and blood pressure index. Each metric is z-scored against age/sex-matched population norms and combined into a single physiological age.",
        "markers": [
          "RMSSD (ms) \u2014 HRV physiological age",
          "VO\u2082max (mL/kg/min) \u2014 cardiorespiratory age",
          "resting heart rate \u2014 cardiovascular age",
          "systolic BP \u2014 vascular age",
          "diastolic BP",
          "HRV trend (30-day)",
          "RHR trend (30-day)",
          "SpO\u2082 resting"
        ],
        "unit": "Physiological age (years)",
        "range": "Optimal: \u22655 years younger | HRV age: RMSSD age-matched percentile >60th"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Cardiovascular System Age",
        "desc": "Dedicated biological age for the cardiovascular system integrating vascular stiffness proxies, lipid particle quality, inflammatory burden, and hemodynamic markers. Based on the Framingham Heart Age model extended with ApoB, Lp(a), NT-proBNP, and hs-CRP weighting. Expresses how much older or younger your cardiovascular system is than your chronological age.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "resting HR",
          "systolic BP",
          "HbA1c",
          "eGFR"
        ],
        "unit": "Cardiovascular age (years)",
        "range": "Optimal: \u22655 yr younger | Alert: >5 yr older | Critical: >10 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic System Age",
        "desc": "Biological age of the metabolic system derived from glucose regulation, insulin sensitivity, lipid metabolism, liver function, and body composition markers. The MetaboAge algorithm weights HOMA-IR, HbA1c, fasting insulin, triglycerides, ALT, GGT, uric acid, and adipokines against age-matched population norms.",
        "markers": [
          "HOMA-IR (insulin resistance)",
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "triglycerides",
          "ALT",
          "GGT",
          "uric acid",
          "ApoB",
          "ferritin",
          "adiponectin",
          "leptin proxy (BMI + TG/HDL)"
        ],
        "unit": "Metabolic age (years)",
        "range": "Optimal: \u22653 yr younger | Metabolic syndrome threshold: >8 yr older",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Immune System Age (Immunological Age)",
        "desc": "Immunological age derived from the composition of white blood cell subpopulations, inflammatory cytokines, and autoimmune markers. Based on the iAge (inflammatory age) framework from Stanford and the immunosenescence scoring of Lehallier et al. (2019). Captures both inflammaging (chronic low-grade inflammation) and immunosenescence (loss of adaptive immune capacity).",
        "markers": [
          "neutrophil:lymphocyte ratio",
          "lymphocyte %",
          "CD4:CD8 T-cell ratio (if available)",
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "CXCL9 (iAge cytokine)",
          "WBC differential",
          "eosinophil count",
          "IgG",
          "IgA",
          "IgM",
          "anti-CMV IgG proxy"
        ],
        "unit": "Immune age (years)",
        "range": "iAge optimal: <30 | Alert: >chronological | Immunosenescence: NLR >3.0",
        "tier": "advanced"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Respiratory System Age",
        "desc": "Biological age of respiratory function integrating blood-based markers of pulmonary capacity and oxygenation with wearable SpO\u2082 and resting respiratory rate. Proxy for FEV1/FVC ratio decline using SERPINA1, CRP, and RBC indices. Validated against NHANES spirometry normative age curves.",
        "markers": [
          "SpO\u2082 resting %",
          "SpO\u2082 exertional",
          "respiratory rate (resting)",
          "hs-CRP (lung inflammation)",
          "WBC (respiratory infection burden)",
          "hemoglobin (O\u2082 carrying capacity)",
          "hematocrit",
          "neutrophil %",
          "eosinophil % (asthma proxy)",
          "SERPINA1 genotype risk"
        ],
        "unit": "Respiratory age (years)",
        "range": "Optimal: \u22653 yr younger | SpO\u2082 <95% resting = significant aging signal",
        "tier": "standard"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Musculoskeletal System Age",
        "desc": "Biological age of the musculoskeletal system derived from bone turnover markers, inflammatory burden on joints, muscle catabolism indicators, and hormonal support for lean mass. Integrates vitamin D, testosterone/DHEA-S, IGF-1, and bone resorption/formation markers into a composite MSK age score.",
        "markers": [
          "vitamin D 25-OH",
          "testosterone total",
          "DHEA-S",
          "IGF-1",
          "osteocalcin (bone formation)",
          "CTX-I (bone resorption)",
          "P1NP (bone synthesis)",
          "hs-CRP (joint inflammation)",
          "uric acid (gout risk)",
          "albumin (muscle catabolism proxy)",
          "magnesium RBC",
          "creatine kinase"
        ],
        "unit": "Musculoskeletal age (years)",
        "range": "Optimal: \u22653 yr younger | Osteoporosis risk: CTX-I high + low osteocalcin",
        "tier": "advanced"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Personalized Prevention Supplement Stack",
        "desc": "Preventive supplements from client catalog matched to identified risk factors: omega-3 (CVD risk), vitamin D (cancer + immune risk), magnesium (metabolic + MSK), berberine/bergamot (lipid optimization), and CoQ10 if statin likely. Dosed against blood levels and genetic metabolizer status.",
        "markers": [
          "ApoB",
          "25-OH Vit D",
          "magnesium RBC",
          "omega-3 index",
          "homocysteine",
          "hs-CRP",
          "MTHFR",
          "CoQ10"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Prevention Lifestyle Program",
        "desc": "Comprehensive primary prevention program: Mediterranean diet implementation, progressive aerobic exercise ramp (target VO\u2082max improvement by 20%), stress reduction protocol, and 7\u20139 hour sleep optimization. All elements personalized to genetic risk profile.",
        "markers": [
          "10-year risk index",
          "biological age gap",
          "physical activity level",
          "diet quality score",
          "chronotype",
          "cortisol AM",
          "HRV"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Allergy Eggs",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Allergy Eggs"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Milk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Allergy Milk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Peanuts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Allergy Peanuts"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "General Food Sensitivities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "General Food Sensitivities"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Gluten Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Gluten Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Lactose Intolerance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Food Allergies",
        "markers": [
          "Lactose Intolerance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Cockroaches",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Cockroaches"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Dust Mites",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Dust Mites"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Mold",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Mold"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Pets",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Indoor Allergies",
        "markers": [
          "Allergy Pets"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Birch Pollen Allergy Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Birch Pollen Allergy Resistance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Grass Allergy Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Grass Allergy Resistance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hay Fever",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Hay Fever"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Histamine Intolerance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Histamine Intolerance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Mugwort Allergy Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Outdoor Allergies",
        "markers": [
          "Mugwort Allergy Resistance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Misophonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Misophonia"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Motion Sickness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Motion Sickness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Noise Induced Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Noise Induced Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Resistance Stomach Flu",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Resistance Stomach Flu"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Seasonality",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Physiological Sensitivities",
        "markers": [
          "Seasonality"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Benzene",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Sensitivity To Chemicals",
        "markers": [
          "Sensitivity Benzene"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Mercury",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Sensitivity To Chemicals",
        "markers": [
          "Sensitivity Mercury"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Pcb",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Sensitivites.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Sensitivity To Chemicals",
        "markers": [
          "Sensitivity Pcb"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Anaphylactic Reaction Drug",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Allergy Anaphylactic Reaction Drug"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Anaphylactic Reaction Food",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Allergy Anaphylactic Reaction Food"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy House Dust Mite",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Allergy House Dust Mite"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Allergy Hypersensitivity Anaphylaxis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Allergy Hypersensitivity Anaphylaxis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hayfever Allergic Rhinitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Hayfever Allergic Rhinitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Lupus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Lupus"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sjogrens Sicca Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Allergies Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Allergies Immune System Disorders",
        "markers": [
          "Sjogrens Sicca Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Blood Organs Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Blood Organs Immune System Disorders",
        "markers": [
          "Anemia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Iron Deficiency Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Blood Organs Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Blood Organs Immune System Disorders",
        "markers": [
          "Iron Deficiency Anemia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Pernicious Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Blood Organs Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Blood Organs Immune System Disorders",
        "markers": [
          "Pernicious Anemia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Sarcoidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Blood Organs Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Blood Organs Immune System Disorders",
        "markers": [
          "Sarcoidosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Blood Organs Immune System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Blood Organs Immune System Disorders",
        "markers": [
          "Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Basal Cell Carcinoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Basal Cell Carcinoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bladder Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Bladder Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bone Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Bone Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Breast Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Breast Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cervical Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Cervical Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chronic Lymphocytic Leukemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Chronic Lymphocytic Leukemia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colon Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Colon Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Endometrial Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Endometrial Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Esophageal Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Esophageal Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hodgkins Lymphoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Hodgkins Lymphoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kidney Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Kidney Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leukemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Leukemia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lung Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Lung Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Melanoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Melanoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Myeloma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Multiple Myeloma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Non Hodgkins Lymphoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Non Hodgkins Lymphoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nonmelanoma Skin Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Nonmelanoma Skin Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovarian Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Ovarian Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Prostate Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Prostate Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rectal Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Rectal Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sarcoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Sarcoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Skin Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Skin Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Squamous Cell Carcinoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Squamous Cell Carcinoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Stomach Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Stomach Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Testicular Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Testicular Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Throat Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Throat Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thyroid Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cancer",
        "markers": [
          "Thyroid Cancer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acute Ischeamic Heart Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Acute Ischeamic Heart Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Angina",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Angina"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Atrial Fibrillation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Atrial Fibrillation"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Coronary Atherosclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Coronary Atherosclerosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Deep Vein Thrombosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Deep Vein Thrombosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Gestational Hypertension",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Gestational Hypertension"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Heart Attack Myocardial Infarction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Heart Attack Myocardial Infarction"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Heart Beat Abnormalities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Heart Beat Abnormalities"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Heart Cardiac Problem",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Heart Cardiac Problem"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Heart Failure Pulmonary Odema",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Heart Failure Pulmonary Odema"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Heart Valve Problem Heart Murmur",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Heart Valve Problem Heart Murmur"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hemorrhoids",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Hemorrhoids"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hypertension",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Hypertension"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Leg Claudication",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Leg Claudication"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Peripheral Artery Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Peripheral Artery Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Preeclampsia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Preeclampsia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Raynauds Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Raynauds Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Rheumatic Fever",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Rheumatic Fever"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Stroke",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Stroke"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Subarachnoid Hemorrhage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Subarachnoid Hemorrhage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Supraventricular Tachycardia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Supraventricular Tachycardia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Varicose Veins",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Varicose Veins"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Vasculitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Circulatory System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Circulatory System Disorders",
        "markers": [
          "Vasculitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Acute Liver Failure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Acute Liver Failure"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Anal Fissure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Anal Fissure"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Appendicitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Appendicitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Celiac Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Celiac Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Cholecystitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Cholecystitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Constipation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Constipation"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Crohns Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Crohns Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Functional Dyspepsia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Functional Dyspepsia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Gastritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Gastritis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Gastroesophageal Reflux Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Gastroesophageal Reflux Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Gastrointestinal Bleeding",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Gastrointestinal Bleeding"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Helicobacter Pylori Infection",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Helicobacter Pylori Infection"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Hiatal Hernia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Hiatal Hernia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Inguinal Hernia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Inguinal Hernia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Intestinal Obstruction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Intestinal Obstruction"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Irritable Bowel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Irritable Bowel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Pancreatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Pancreatitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Peptic Ulcer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Peptic Ulcer"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Peritonitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Peritonitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Rectal Prolapse",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Rectal Prolapse"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Ulcerative Colitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Ulcerative Colitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Umbilical Hernia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Digestive System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Digestive System Disorders",
        "markers": [
          "Umbilical Hernia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "mental_health"
        ]
      },
      {
        "name": "Benign Paroxysmal Positional Vertigo",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Mastoid Process Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ear Mastoid Process Disorders",
        "markers": [
          "Benign Paroxysmal Positional Vertigo"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Menieres Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Mastoid Process Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ear Mastoid Process Disorders",
        "markers": [
          "Menieres Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Tinnitus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Mastoid Process Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ear Mastoid Process Disorders",
        "markers": [
          "Tinnitus"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Blepharitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Eye Adnexa Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Eye Adnexa Disorders",
        "markers": [
          "Blepharitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Dry Eyes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Eye Adnexa Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Eye Adnexa Disorders",
        "markers": [
          "Dry Eyes"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Glaucoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Eye Adnexa Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Eye Adnexa Disorders",
        "markers": [
          "Glaucoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Iritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Eye Adnexa Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Eye Adnexa Disorders",
        "markers": [
          "Iritis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Macular Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Eye Adnexa Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Eye Adnexa Disorders",
        "markers": [
          "Macular Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Retinal Detachment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Eye Adnexa Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Eye Adnexa Disorders",
        "markers": [
          "Retinal Detachment"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Cystitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Cystitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "End Stage Renal Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "End Stage Renal Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Erectile Dysfunction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Erectile Dysfunction"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Hydronephrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Hydronephrosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Kidney Ureter Bladder Stone",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Kidney Ureter Bladder Stone"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Polycystic Kidney Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Polycystic Kidney Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Undescended Testicle",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Undescended Testicle"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Urinary Incontinence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Urinary Incontinence"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Urinary Tract Infection",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Genitourinary System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Genitourinary System Disorders",
        "markers": [
          "Urinary Tract Infection"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Shingles",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Infectious Parasitic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Infectious Parasitic Disorders",
        "markers": [
          "Shingles"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Tuberculosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Infectious Parasitic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Infectious Parasitic Disorders",
        "markers": [
          "Tuberculosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Bleeding Gums",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Oral Health.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oral Health",
        "markers": [
          "Bleeding Gums"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Loose Teeth",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Oral Health.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oral Health",
        "markers": [
          "Loose Teeth"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Mouth Ulcers",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Oral Health.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oral Health",
        "markers": [
          "Mouth Ulcers"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Painful Gums",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Oral Health.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oral Health",
        "markers": [
          "Painful Gums"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "Toothache",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Oral Health.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oral Health",
        "markers": [
          "Toothache"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention"
        ]
      },
      {
        "name": "3 Methylglutaconic Aciduria With Cataracts, Neurologic Involvement, And Neutropenia (Megcann)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "3 Methylglutaconic Aciduria With Cataracts, Neurologic Involvement, And Neutropenia (Megcann)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acute Myeloid Leukemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Acute Myeloid Leukemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acute Myeloid Leukemia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Acute Myeloid Leukemia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenocortical Carcinoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Adrenocortical Carcinoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Amegakaryocytic Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Amegakaryocytic Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Dyserythropoietic Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Anemia, Dyserythropoietic Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Sideroblastic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Anemia, Sideroblastic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Sideroblastic 2, Pyridoxine Refractory",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Anemia, Sideroblastic 2, Pyridoxine Refractory"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Without Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Anemia, Without Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aplastic Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Aplastic Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aplastic Anemia, Adult Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Aplastic Anemia, Adult Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ataxia Telangiectasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Ataxia Telangiectasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ataxia Pancytopenia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Ataxia Pancytopenia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Lymphoproliferative Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Autoimmune Lymphoproliferative Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Lymphoproliferative Syndrome, Type Ib",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Autoimmune Lymphoproliferative Syndrome, Type Ib"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammatory Pancytopenia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Autoinflammatory Pancytopenia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Baller Gerold Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Baller Gerold Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Baraitser Winter Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Baraitser Winter Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bernard Soulier Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Bernard Soulier Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bloom Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Bloom Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bone Marrow Failure Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Bone Marrow Failure Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bone Marrow Failure Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Bone Marrow Failure Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bone Marrow Failure Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Bone Marrow Failure Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Breast Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Breast Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Breast Cancer, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Breast Cancer, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Breast Ovarian Cancer, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Breast Ovarian Cancer, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiofaciocutaneous Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Cardiofaciocutaneous Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebroretinal Microangiopathy With Calcifications And Cysts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Cerebroretinal Microangiopathy With Calcifications And Cysts"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chediak Higashi Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Chediak Higashi Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Choroid Plexus Papilloma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Choroid Plexus Papilloma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chronic Neutropenia Associated With Monocytopenia, Evolving To Myelodysplasia And Acute Myeloid Leukemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Chronic Neutropenia Associated With Monocytopenia, Evolving To Myelodysplasia And Acute Myeloid Leukemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cohen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Cohen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colorectal Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Colorectal Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colorectal Cancer, Hereditary Nonpolyposis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Colorectal Cancer, Hereditary Nonpolyposis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colorectal Cancer, Hereditary Nonpolyposis,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Colorectal Cancer, Hereditary Nonpolyposis,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Dyserythropoietic Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Congenital Dyserythropoietic Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Myopathy With Excess Of Muscle Spindles",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Congenital Myopathy With Excess Of Muscle Spindles"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Costello Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Costello Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cutaneous Telangiectasia And Cancer Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Cutaneous Telangiectasia And Cancer Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Deafness, Autosomal Dominant 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dehydrated Hereditary Stomatocytosis 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Dehydrated Hereditary Stomatocytosis 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diamond Blackfan Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Diamond Blackfan Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diamond Blackfan Anemia 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Diamond Blackfan Anemia 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diamond Blackfan Anemia 15 With Mandibulofacial Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Diamond Blackfan Anemia 15 With Mandibulofacial Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diamond Blackfan Anemia 16",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Diamond Blackfan Anemia 16"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diarrhea 5, With Tufting Enteropathy, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Diarrhea 5, With Tufting Enteropathy, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dursun Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Dursun Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyserythropoietic Anemia With Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Dyserythropoietic Anemia With Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyskeratosis Congenita",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Dyskeratosis Congenita"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyskeratosis Congenita, Autosomal Dominant 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Dyskeratosis Congenita, Autosomal Dominant 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyskeratosis Congenita, Autosomal Recessive 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Dyskeratosis Congenita, Autosomal Recessive 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Elejalde Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Elejalde Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Emberger Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Emberger Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Endometrial Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Endometrial Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ependymoma, Intracranial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Ependymoma, Intracranial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Epstein Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Epstein Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Epstein Barr Virus Infection And Neoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Epstein Barr Virus Infection And Neoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Myeloproliferative/Lymphoproliferative Neoplasms, Multiple Types, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Familial Myeloproliferative/Lymphoproliferative Neoplasms, Multiple Types, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Fanconi Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Anemia, Complementation Group T",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Fanconi Anemia, Complementation Group T"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconia Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Fanconia Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fechtner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Fechtner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ghosal Hematodiaphyseal Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Ghosal Hematodiaphyseal Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glanzmann Thrombasthenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Glanzmann Thrombasthenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glioma Susceptibility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Glioma Susceptibility"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glioma Susceptibility 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Glioma Susceptibility 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glycogen Storage Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Glycogen Storage Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Griscelli Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Griscelli Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Haim Munk Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Haim Munk Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemophagocytic Lymphohistiocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Hemophagocytic Lymphohistiocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemophagocytic Lymphohistiocytosis, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Hemophagocytic Lymphohistiocytosis, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hepatoblastoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Hepatoblastoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Breast Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Hereditary Breast Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hermansky Pudlak Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Hermansky Pudlak Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hoyeraal Hreidarsson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Hoyeraal Hreidarsson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 23",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Immunodeficiency 23"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency Due To Defect In Mapbp Interacting Protein",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Immunodeficiency Due To Defect In Mapbp Interacting Protein"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable, 13",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Immunodeficiency, Common Variable, 13"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, With Magnesium Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Immunodeficiency, With Magnesium Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Infections, Recurrent, With Encephalopathy, Hepatic Dysfunction, And Cardiovascular Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Infections, Recurrent, With Encephalopathy, Hepatic Dysfunction, And Cardiovascular Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leopard Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Leopard Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Li Fraumeni Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Li Fraumeni Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lymphoma, Non Hodgkin",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Lymphoma, Non Hodgkin"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lymphoproliferative Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Lymphoproliferative Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macrothrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Macrothrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macrothrombocytopenia And Progressive Sensorineural Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Macrothrombocytopenia And Progressive Sensorineural Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "May Hegglin Anomaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "May Hegglin Anomaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Medulloblastoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Medulloblastoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Melanoma, Cutaneous Malignant, Susceptibility To 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Melanoma, Cutaneous Malignant, Susceptibility To 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Melanoma, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Melanoma, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Melanoma Pancreatic Cancer Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Melanoma Pancreatic Cancer Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mental Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Mental Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Metachondromatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Metachondromatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mirage Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Mirage Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mismatch Repair Cancer Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Mismatch Repair Cancer Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Muir Torre Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Muir Torre Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myelodysplastic Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Myelodysplastic Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neurofibromatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neurofibromatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neurofibromatosis Noonan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neurofibromatosis Noonan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutropenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutropenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutropenia, Nonimmune Chronic Idiopathic, Of Adults",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutropenia, Nonimmune Chronic Idiopathic, Of Adults"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutropenia, Severe Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutropenia, Severe Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutropenia, Severe Congenital, 2 Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutropenia, Severe Congenital, 2 Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutropenia, Severe Congenital, 5, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutropenia, Severe Congenital, 5, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutrophil Immunodeficiency Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutrophil Immunodeficiency Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neutrophilia, Hereditary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Neutrophilia, Hereditary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nijmegen Breakage Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Nijmegen Breakage Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Non Hodgkin Lymphoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Non Hodgkin Lymphoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Noonan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Noonan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Noonan Syndrome Like Disorder With Or Without Juvenile Myelomonocytic Leukemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Noonan Syndrome Like Disorder With Or Without Juvenile Myelomonocytic Leukemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenic Sarcoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Osteogenic Sarcoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pancreatic Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Pancreatic Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Papillon Lefevre Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Papillon Lefevre Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Periodontitis, Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Periodontitis, Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Platelet Disorder, Familial, With Associated Myeloid Malignancy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Platelet Disorder, Familial, With Associated Myeloid Malignancy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Poikiloderma With Neutropenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Poikiloderma With Neutropenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pre B Cell Acute Lymphoblastic Leukemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Pre B Cell Acute Lymphoblastic Leukemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Primary Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Primary Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Protoporphyria, Erythropoietic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Protoporphyria, Erythropoietic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudo Von Willebrand Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Pseudo Von Willebrand Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Fibrosis And/Or Bone Marrow Failure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Pulmonary Fibrosis And/Or Bone Marrow Failure"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Fibrosis And/Or Bone Marrow Failure, Telomere Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Pulmonary Fibrosis And/Or Bone Marrow Failure, Telomere Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rapadilino Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Rapadilino Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Radioulnar Synostosis With Amegakaryocytic Thrombocytopenia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Radioulnar Synostosis With Amegakaryocytic Thrombocytopenia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Reticular Dysgenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Reticular Dysgenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Revesz Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Revesz Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rothmund Thomson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Rothmund Thomson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sebastian Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Sebastian Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Seckel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Seckel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Spondylometaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Severe Spondylometaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Shwachman Diamond Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Shwachman Diamond Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Spasticity, Childhood Onset, With Hyperglycinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Spasticity, Childhood Onset, With Hyperglycinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Specific Granule Defiency 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Specific Granule Defiency 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Surfactant Metabolism Dysfunction, Pulmonary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Surfactant Metabolism Dysfunction, Pulmonary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thiamine Responsive Megaloblastic Anemia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thiamine Responsive Megaloblastic Anemia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocythemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thrombocythemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocythemia 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thrombocythemia 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia   Absent Radius",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thrombocytopenia   Absent Radius"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thrombocytopenia 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia With Beta Thalessemia,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Thrombocytopenia With Beta Thalessemia,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tumoral Calcinosis, Normophosphatemic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Tumoral Calcinosis, Normophosphatemic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Warts, Hypogammaglobulinemia, Infections, And Myelokathexis (Whim) Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Warts, Hypogammaglobulinemia, Infections, And Myelokathexis (Whim) Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Watson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Watson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wilms Tumor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Wilms Tumor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wiskott Aldrich Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Wiskott Aldrich Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wiskott Aldrich Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Wiskott Aldrich Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Xfe Progeroid Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Xfe Progeroid Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Xeroderma Pigmentosum",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bone Marrow Failure Syndrome",
        "markers": [
          "Xeroderma Pigmentosum"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Achondrogenesis Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Achondrogenesis Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Acromicric Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Acromicric Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Aneurysms Osteoarthritis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Aneurysms Osteoarthritis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Aortic Aneurysm, Familial Thoracic 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Aortic Aneurysm, Familial Thoracic 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Arterial Tortuosity Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Arterial Tortuosity Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Avascular Necrosis Of Femoral Head",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Avascular Necrosis Of Femoral Head"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Birt Hogg Dube Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Birt Hogg Dube Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Caffey Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Caffey Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement System",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Complement System"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Contractural Arachnodactyly (Beals Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Congenital Contractural Arachnodactyly (Beals Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects And Skeletal Malformations Syndrome (Chdskm)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Congenital Heart Defects And Skeletal Malformations Syndrome (Chdskm)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniosynostosis 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Craniosynostosis 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cutis Laxa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Cutis Laxa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Czech Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Czech Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectopia Lentis, Isolated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Ectopia Lentis, Isolated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ehlers Danlos Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Ehlers Danlos Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ehlers Danlos Syndrome, Cardiac Valvular Form",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Ehlers Danlos Syndrome, Cardiac Valvular Form"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Epiphyseal Dysplasia, With Myopia And Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Epiphyseal Dysplasia, With Myopia And Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Fg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Fg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Fibrochondrogenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Fibrochondrogenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Geleophysic Dysplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Geleophysic Dysplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Homocystinuria Due To Cystathionine Beta Synthase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Homocystinuria Due To Cystathionine Beta Synthase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypochondrogenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Hypochondrogenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Intellectual Disability With Marfanoid Habitus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Intellectual Disability With Marfanoid Habitus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Intellectual Disability, Syndromic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Intellectual Disability, Syndromic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Kniest Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Kniest Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Loeys Dietz Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Loeys Dietz Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Loeys Dietz Syndrome (Reinhoff Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Loeys Dietz Syndrome (Reinhoff Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lujan Fryns Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Lujan Fryns Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mass Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Mass Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Marfan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Marfan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Marshall Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Marshall Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Meester Loeys Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Meester Loeys Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mental Retardation, Syndromic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Mental Retardation, Syndromic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mild Sed With Premature Onset Arthrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Mild Sed With Premature Onset Arthrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Joint Dislocations, Short Stature, Craniofacial Dysmorphism, And Congenital Heart Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Multiple Joint Dislocations, Short Stature, Craniofacial Dysmorphism, And Congenital Heart Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ohdo Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Ohdo Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Opitz Kaveggia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Opitz Kaveggia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Osteogenesis Imperfecta Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Osteogenesis Imperfecta Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Osteogenesis Imperfecta Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta Type 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Osteogenesis Imperfecta Type 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Otospondylomegaepiphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Otospondylomegaepiphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Platyspondylic Dysplasia Torrance Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Platyspondylic Dysplasia Torrance Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pneumothorax, Primary Spontaneous",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Pneumothorax, Primary Spontaneous"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Raymond",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Raymond"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhegmatogenous Retinal Detachment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Rhegmatogenous Retinal Detachment"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sed With Metatarsal Shortening",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Sed With Metatarsal Shortening"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Shprintzen Goldberg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Shprintzen Goldberg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepimetaphyseal Dysplasia (Semd) Strudwick Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Spondyloepimetaphyseal Dysplasia (Semd) Strudwick Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloepiphyseal Dysplasia Congenital (Sedc)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Spondyloepiphyseal Dysplasia Congenital (Sedc)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloperipheral Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Spondyloperipheral Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Stickler Syndrome Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Stickler Syndrome Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Stickler Syndrome Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Stickler Syndrome Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Stickler Syndrome Type 3 (Non Ocular)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Stickler Syndrome Type 3 (Non Ocular)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Wagner Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Wagner Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Weill Marchesani Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Weill Marchesani Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Weill Marchesani Like Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Weill Marchesani Like Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Weissenbacher Zweymuller Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Marfan Syndrome",
        "markers": [
          "Weissenbacher Zweymuller Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bardet Biedl Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Bardet Biedl Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Coach Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Coach Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Joubert Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Joubert Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leber Congenital Amaurosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Leber Congenital Amaurosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Meckel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Meckel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Meckel Syndrome 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Meckel Syndrome 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephronophthisis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Nephronophthisis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Hepatic Pancreatic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Renal Hepatic Pancreatic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Degeneration In Ciliopathy, Modifier",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Retinal Degeneration In Ciliopathy, Modifier"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Senior Loken Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Meckel Syndrome",
        "markers": [
          "Senior Loken Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Achromatopsia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Achromatopsia",
        "markers": [
          "Achromatopsia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bradyopsia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Achromatopsia",
        "markers": [
          "Bradyopsia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Achromatopsia",
        "markers": [
          "Cone Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Degeneration, Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Achromatopsia",
        "markers": [
          "Macular Degeneration, Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Cone Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Achromatopsia",
        "markers": [
          "Retinal Cone Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrocallosal Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Acrocallosal Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Al Gazali Bakalinova Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Al Gazali Bakalinova Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Asphyxiating Thoracic Dysplasia (Atd; Jeune)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Asphyxiating Thoracic Dysplasia (Atd; Jeune)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hydrolethalus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Hydrolethalus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Jeune Asphyxiating Thoracic Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Jeune Asphyxiating Thoracic Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Joubert Syndrome 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Joubert Syndrome 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Joubert Syndrome 22",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Joubert Syndrome 22"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Joubert Syndrome 26",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Joubert Syndrome 26"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Joubert Syndrome 30",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Joubert Syndrome 30"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mental Retardation, Truncal Obesity, Retinal Dystrophy, And Micropenis (Morm Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Mental Retardation, Truncal Obesity, Retinal Dystrophy, And Micropenis (Morm Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofaciodigital Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Orofaciodigital Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofaciodigital Syndrome (Mohr Majewski Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Orofaciodigital Syndrome (Mohr Majewski Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofaciodigital Syndrome Vi",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Orofaciodigital Syndrome Vi"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofaciodigital Syndrome Xv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Orofaciodigital Syndrome Xv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy With Or Without Macular Staphyloma (Rdms)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Retinal Dystrophy With Or Without Macular Staphyloma (Rdms)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Retinitis Pigmentosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia With Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Short Rib Thoracic Dysplasia With Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Short Rib Thoracic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Rib Thoracic Dysplasia 13 With Or Without Polydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Short Rib Thoracic Dysplasia 13 With Or Without Polydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Simpson Golabi Behmel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Simpson Golabi Behmel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondylometaphyseal Dysplasia, Axial (Smdax)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Joubert Syndrome",
        "markers": [
          "Spondylometaphyseal Dysplasia, Axial (Smdax)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3Mc Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "3Mc Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Abcd Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Abcd Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Achondroplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Achondroplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acro Renal Ocular Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Acro Renal Ocular Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenoleukodystrophy, Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Adrenoleukodystrophy, Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Albinism, Oculocutaneous",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Albinism, Oculocutaneous"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alport Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Alport Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alstr\u00f6m Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Alstr\u00f6m Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Antley Bixler Syndrome Without Genital Anomalies Or Disordered Steroidogenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Antley Bixler Syndrome Without Genital Anomalies Or Disordered Steroidogenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Apert Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Apert Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Arts Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Arts Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Fibrillation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Atrial Fibrillation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Auditory Neuropathy And Optic Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Auditory Neuropathy And Optic Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aural Atresia, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Aural Atresia, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Axenfeld Rieger Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Axenfeld Rieger Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bartter Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Bartter Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Beare Stevenson Cutis Gyrata Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Beare Stevenson Cutis Gyrata Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Beckwith Wiedemann Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Beckwith Wiedemann Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bent Bone Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Bent Bone Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bosch Boonstra Optic Atrophy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Bosch Boonstra Optic Atrophy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Brachydactyly Type B2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Brachydactyly Type B2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Branchiooculofacial Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Branchiooculofacial Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Branchiootic Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Branchiootic Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Branchiootorenal Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Branchiootorenal Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Brown Vialetto Van Laere Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Brown Vialetto Van Laere Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Charge Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Charge Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Calcium Pyrophosphate Deposition Disease (Familial Chondrocalcinosis Type 2)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Calcium Pyrophosphate Deposition Disease (Familial Chondrocalcinosis Type 2)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Camptodactyly, Tall Stature, And Hearing Loss (Catshl) Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Camptodactyly, Tall Stature, And Hearing Loss (Catshl) Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 41",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Cataract 41"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Central Hypoventilation Syndrome, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Central Hypoventilation Syndrome, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebellar Ataxia, Deafness, And Narcolepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Cerebellar Ataxia, Deafness, And Narcolepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chanarin Dorfman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Chanarin Dorfman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease, Axonal, Type 2W",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Charcot Marie Tooth Disease, Axonal, Type 2W"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cholestasis, Progressive Familial Intrahepatic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Cholestasis, Progressive Familial Intrahepatic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chronic Infantile Neurologic Cutaneous Articular (Cinca) Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Chronic Infantile Neurologic Cutaneous Articular (Cinca) Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chudley Mccullough Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Chudley Mccullough Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Coffin Lowry Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Coffin Lowry Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Coloboma, Ocular",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Coloboma, Ocular"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, And Deafness (Commad)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, And Deafness (Commad)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency, 13",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency, 13"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy And Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Cone Rod Dystrophy And Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Anomalies Of The Kidney And Urinary Tract",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Congenital Anomalies Of The Kidney And Urinary Tract"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects, Dysmorphic Facial Features, And Intellectual Developmental Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Congenital Heart Defects, Dysmorphic Facial Features, And Intellectual Developmental Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Hypothyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Congenital Hypothyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Conotruncal Anomaly Face Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Conotruncal Anomaly Face Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Corneal Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy, Posterior Polymorphous",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Corneal Dystrophy, Posterior Polymorphous"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Endothelial Dystrophy 2, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Corneal Endothelial Dystrophy 2, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Endothelial Dystrophy And Perceptive Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Corneal Endothelial Dystrophy And Perceptive Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cowchock Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Cowchock Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniofacial Deafness Hand Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Craniofacial Deafness Hand Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniofacial Skeletal Dermatological Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Craniofacial Skeletal Dermatological Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniometaphyseal Dysplasia Autosomal Dominant Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Craniometaphyseal Dysplasia Autosomal Dominant Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Crouzon Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Crouzon Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Crouzon Syndrome With Acanthosis Nigricans",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Crouzon Syndrome With Acanthosis Nigricans"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cryohydrocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Cryohydrocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "D Bifunctional Protein Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "D Bifunctional Protein Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness And Myopia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness And Myopia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 23",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 23"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 28",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 28"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 2A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 2A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 2B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 2B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 36",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 36"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 51",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 51"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 6/14/38",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 6/14/38"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 66",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 66"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 69",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 69"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 70",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 70"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 73",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 73"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 8/12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant 8/12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant, 22",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant, 22"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant, 65",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant, 65"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant, 71",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant, 71"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant, 72",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Dominant, 72"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 104",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 104"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 105",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 105"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 106",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 106"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 107",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 107"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 108",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 108"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 16",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 16"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 24",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 24"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 31",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 31"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 36",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 36"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 37",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 37"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 42",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 42"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 61",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 61"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 63",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 63"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 68",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 68"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 70",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 70"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 77",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 77"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 79",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 79"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 84",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 84"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 84B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 84B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 86",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 86"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Autosomal Recessive 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Congenital With Inner Ear Agenesis, Microtia, And Microdontia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Congenital With Inner Ear Agenesis, Microtia, And Microdontia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Congenital, With Onychodystrophy, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Congenital, With Onychodystrophy, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, And Seizures (Doors) Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, And Seizures (Doors) Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, With Cochlear Malformation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, With Cochlear Malformation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, With Dentinogenesis Imperfecta",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Deafness, With Dentinogenesis Imperfecta"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dejerine Sottas Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Dejerine Sottas Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dentin Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Dentin Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dentinogenesis Imperfecta",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Dentinogenesis Imperfecta"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Developmental Delay With Or Without Dysmorphic Facies And Autism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Developmental Delay With Or Without Dysmorphic Facies And Autism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Donnai Barrow Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Donnai Barrow Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Duane Radial Ray/Okihiro Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Duane Radial Ray/Okihiro Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dysosteosclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Dysosteosclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia/Short Stature Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Ectodermal Dysplasia/Short Stature Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Enlarged Vestibular Aqueduct",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Enlarged Vestibular Aqueduct"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Epilepsy, Hearing Loss, And Mental Retardation Syndrome (Ehlmrs)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Epilepsy, Hearing Loss, And Mental Retardation Syndrome (Ehlmrs)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 16",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 16"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrokeratodermia Variabilis Et Progressiva 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Erythrokeratodermia Variabilis Et Progressiva 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Esophageal Atresia, Syndromic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Esophageal Atresia, Syndromic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Exudative Vitreoretinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Exudative Vitreoretinopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Facial Paresis, Hereditary Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Facial Paresis, Hereditary Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Faciooculoacousticorenal Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Faciooculoacousticorenal Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Cold Induced Autoinflammatory Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Familial Cold Induced Autoinflammatory Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fazio Londe Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Fazio Londe Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fibromatosis, Gingival, 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Fibromatosis, Gingival, 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Focal Segmental Glomerulosclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Focal Segmental Glomerulosclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fuchs Endothelial 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Fuchs Endothelial 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gastrointestinal Stromal Tumor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Gastrointestinal Stromal Tumor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Heimler Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Heimler Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hematuria, Benign Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hematuria, Benign Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Hemorrhagic Telangiectasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hereditary Hemorrhagic Telangiectasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hirschsprung Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hirschsprung Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Histiocytosis Lymphadenopathy Plus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Histiocytosis Lymphadenopathy Plus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hydrops, Lactic Acidosis, And Sideroblastic Anemia (Hlasa)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hydrops, Lactic Acidosis, And Sideroblastic Anemia (Hlasa)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypercholanemia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hypercholanemia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperpigmentation With Or Without Hypopigementation, Familial Progressive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hyperpigmentation With Or Without Hypopigementation, Familial Progressive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypochondroplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hypochondroplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypomagnesemia, Renal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hypomagnesemia, Renal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoparathyroidism, Sensorineural Deafness, And Renal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Hypoparathyroidism, Sensorineural Deafness, And Renal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Image Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Image Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Intellectual Disability, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Intellectual Disability, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Iridogoniodysgenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Iridogoniodysgenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Isolated Gonadotropin Releasing Hormone Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Isolated Gonadotropin Releasing Hormone Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Jackson Weiss Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Jackson Weiss Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Jensen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Jensen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Jervell And Lange Nielsen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Jervell And Lange Nielsen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Johanson Blizzard Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Johanson Blizzard Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Juvenile Polyposis/Hereditary Hemorrhagic Telangiectasia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Juvenile Polyposis/Hereditary Hemorrhagic Telangiectasia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kabuki Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Kabuki Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kallmann Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Kallmann Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Keutel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Keutel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Klippel Feil Syndrome 1, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Klippel Feil Syndrome 1, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lacrimoauriculodentodigital Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Lacrimoauriculodentodigital Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leber Congenital Amaurosis 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Leber Congenital Amaurosis 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leukoencephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Leukoencephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Liver Failure, Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Liver Failure, Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mandibulofacial Dysostosis With Alopecia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Mandibulofacial Dysostosis With Alopecia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mandibulofacial Dysostosis With Microcephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Mandibulofacial Dysostosis With Microcephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mannosidosis, Alpha B, Lysosomal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Mannosidosis, Alpha B, Lysosomal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mannosidosis, Lysosomal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Mannosidosis, Lysosomal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Microphthalmia, Isolated 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated, With Coloboma 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Microphthalmia, Isolated, With Coloboma 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microtia, Hearing Impairment, And Cleft Palate",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Microtia, Hearing Impairment, And Cleft Palate"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Midface Hypoplasia, Hearing Impairment, Elliptocytosis, And Nephrocalcinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Midface Hypoplasia, Hearing Impairment, Elliptocytosis, And Nephrocalcinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mohr Tranebjaerg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Mohr Tranebjaerg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mononeuropathy Of The Median Nerve",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Mononeuropathy Of The Median Nerve"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Muckle Wells Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Muckle Wells Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Muenke Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Muenke Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Epihyseal Dysplasia Type 3 (Edm3)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Multiple Epihyseal Dysplasia Type 3 (Edm3)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Epiphyseal Dysplasia Type 2 (Edm2)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Multiple Epiphyseal Dysplasia Type 2 (Edm2)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Epiphyseal Dysplasia Type 6 (Edm6)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Multiple Epiphyseal Dysplasia Type 6 (Edm6)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Synostosis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Multiple Synostosis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myasthenic Syndrome, Congenital 7, Presynaptic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Myasthenic Syndrome, Congenital 7, Presynaptic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myhre Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Myhre Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myoclonic Epilepsy, Infantile, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Myoclonic Epilepsy, Infantile, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neonatal Onset Multisystem Inflammatory Disease (Nomid)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Neonatal Onset Multisystem Inflammatory Disease (Nomid)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephropathy With Pretibial Epidermolysis Bullosa And Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Nephropathy With Pretibial Epidermolysis Bullosa And Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuropathy, Hereditary, With Liability To Pressurve Palsies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Neuropathy, Hereditary, With Liability To Pressurve Palsies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuropathy, Inflammatory Demyelinating",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Neuropathy, Inflammatory Demyelinating"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Non Syndromic Sensorineural Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Non Syndromic Sensorineural Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Noonan Syndrome Like Phenotype",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Noonan Syndrome Like Phenotype"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Norrie Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Norrie Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Oculodentodigital Dysplasia Mild Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Oculodentodigital Dysplasia Mild Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Oculodentodigital Dysplasia Severe Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Oculodentodigital Dysplasia Severe Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Opticoacoustic Nerve Atrophy With Dementia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Opticoacoustic Nerve Atrophy With Dementia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteofibrous Dysplasia, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Osteofibrous Dysplasia, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Otofaciocervical Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Otofaciocervical Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Otofaciocervical Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Otofaciocervical Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pendred Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Pendred Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peripheral Demyelinating Neuropathy, Central Dysmyelination",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peripheral Demyelinating Neuropathy, Central Dysmyelination"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peripheral Neuropathy, Myopathy, Hoarseness, And Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peripheral Neuropathy, Myopathy, Hoarseness, And Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisomal Acyl Coa Oxidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisomal Acyl Coa Oxidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisome Biogenesis Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Disorder 4A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisome Biogenesis Disorder 4A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Disorder 4B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisome Biogenesis Disorder 4B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Factor Disorder 14",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisome Biogenesis Factor Disorder 14"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Factor Disorder 1A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisome Biogenesis Factor Disorder 1A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Factor Disorder 1B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peroxisome Biogenesis Factor Disorder 1B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peters Anomaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Peters Anomaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pfeiffer Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Pfeiffer Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Phosphoribosylpyrophosphate Synthetase I Superactivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Phosphoribosylpyrophosphate Synthetase I Superactivity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Piebaldism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Piebaldism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pituitary Hormone Deficiency, Combined",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Pituitary Hormone Deficiency, Combined"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polyendocrine Polyneuropathy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Polyendocrine Polyneuropathy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polyposis, Juvenile Intestinal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Polyposis, Juvenile Intestinal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Primary Aldosteronism, Seizures, And Neurologic Abnormalities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Primary Aldosteronism, Seizures, And Neurologic Abnormalities"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Raph Blood Group",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Raph Blood Group"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Refsum Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Refsum Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Cell Carcinoma, Papillary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Renal Cell Carcinoma, Papillary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Hypodysplasia/Aplasia 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Renal Hypodysplasia/Aplasia 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Tubular Acidosis With Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Renal Tubular Acidosis With Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Tubular Acidosis, Distal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Renal Tubular Acidosis, Distal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 39",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Retinitis Pigmentosa 39"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Reversible Infantile Respiratory Chain Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Reversible Infantile Respiratory Chain Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhizomelic Cdp Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Rhizomelic Cdp Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhizomelic Chondrodysplasia Punctata",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Rhizomelic Chondrodysplasia Punctata"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Roussy Levy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Roussy Levy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Saddan",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Saddan"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Schwannomatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Schwannomatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sclerosing Cholangitis, Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Sclerosing Cholangitis, Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Seizures, Cortical Blindness, And Microcephaly Syndrome (Scbms)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Seizures, Cortical Blindness, And Microcephaly Syndrome (Scbms)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, And Electrolyte Imbalance (Sesame Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, And Electrolyte Imbalance (Sesame Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sensorineural Deafness With Mild Renal Dysfunction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Sensorineural Deafness With Mild Renal Dysfunction"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sensorineural Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Sensorineural Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Qt Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Short Qt Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sinoatrial Node Dysfunction And Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Sinoatrial Node Dysfunction And Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Smith Magenis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Smith Magenis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Split Hand/Foot Malformation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Split Hand/Foot Malformation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Split Hand/Foot Malformation With Sensorineural Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Split Hand/Foot Malformation With Sensorineural Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloocular Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Spondyloocular Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Stapes Ankylosis With Broad Thumb And Toes (Teunissen Cremers Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Stapes Ankylosis With Broad Thumb And Toes (Teunissen Cremers Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Stickler Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Stickler Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Stickler Syndrome Recessive Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Stickler Syndrome Recessive Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Stickler Syndrome, Type Iv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Stickler Syndrome, Type Iv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Symphalangism, Proximal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Symphalangism, Proximal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Syndactyly Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Syndactyly Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Takenouchi Kosaki Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Takenouchi Kosaki Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tarsal Carpal Coalition Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Tarsal Carpal Coalition Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Temtamy Preaxial Brachydactyly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Temtamy Preaxial Brachydactyly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thanatophoric Dysplasia Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Thanatophoric Dysplasia Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thanatophoric Dysplasia Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Thanatophoric Dysplasia Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tietz Albinism Deafness Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Tietz Albinism Deafness Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Townes Brocks Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Townes Brocks Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Treacher Collins Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Treacher Collins Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Turnpenny Fry Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Turnpenny Fry Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Sydnrome, Type 3A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Sydnrome, Type 3A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome Type Ij",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome Type Ij"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type 1D",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type 1D"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type 1G",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type 1G"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type 2A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type 2A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type 2D",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type 2D"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type 3B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type 3B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type I",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type I"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type Ic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type Ic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type Iic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type Iic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Usher Syndrome, Type Iv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Usher Syndrome, Type Iv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Waardenburg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Waardenburg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Waardenburg Syndrome, And Hirschsprung Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Waardenburg Syndrome, And Hirschsprung Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Waardenburg Syndrome, Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Waardenburg Syndrome, Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Waardenburg Syndrome, Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Waardenburg Syndrome, Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wilms Tumor 6, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Wilms Tumor 6, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wolfram Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Wolfram Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wolfram Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Wolfram Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wolfram Like Syndrome, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Wolfram Like Syndrome, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Woodhouse Sakati Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Woodhouse Sakati Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Zellweger Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Zellweger Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Zimmermann Laband Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ear Nose Throat.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hearing Loss And Deafness",
        "markers": [
          "Zimmermann Laband Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Methylglutaconic Aciduria, (Barth Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "3 Methylglutaconic Aciduria, (Barth Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Methylglutaconic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "3 Methylglutaconic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Amyloidosis, Hereditary, Transthyretin Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Amyloidosis, Hereditary, Transthyretin Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Amyloidosis, Systemic Nonneuronopathic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Amyloidosis, Systemic Nonneuronopathic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Arrhythmogenic Right Ventricular Cardiomyopathy (Arvc)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Arrhythmogenic Right Ventricular Cardiomyopathy (Arvc)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Arrhythmogenic Right Ventricular Dysplasia With Palmoplantar Keratoderma And Woolly Hair",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Arrhythmogenic Right Ventricular Dysplasia With Palmoplantar Keratoderma And Woolly Hair"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Fibrillation, Familial, 18",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Atrial Fibrillation, Familial, 18"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Septal Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Atrial Septal Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Septal Defect 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Atrial Septal Defect 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Septal Defect 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Atrial Septal Defect 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Septal Defect 9, Atrioventricular Septal Defect 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Atrial Septal Defect 9, Atrioventricular Septal Defect 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrioventricular Septal Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Atrioventricular Septal Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bronchiectasis With Or Without Elevated Sweat Chloride",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Bronchiectasis With Or Without Elevated Sweat Chloride"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Brugada Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Brugada Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cantu Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cantu Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiac Conduction Disease With Or Without Dilated Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiac Conduction Disease With Or Without Dilated Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Dilated, 1Gg",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiomyopathy, Dilated, 1Gg"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Familial Hypertrophic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiomyopathy, Familial Hypertrophic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Familial Hypertrophic, 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiomyopathy, Familial Hypertrophic, 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Fatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiomyopathy, Fatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Restrictive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cardiomyopathy, Restrictive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 16, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cataract 16, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 38",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cataract 38"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 46, Juvenile Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cataract 46, Juvenile Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract, Myofibrillar Myopathy And Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Cataract, Myofibrillar Myopathy And Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Centronuclear Myopathy 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Centronuclear Myopathy 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Choreoacanthocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Choreoacanthocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 23",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 23"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 31",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 31"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Abnormalities Of The Kidney And Urinary Tract",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Congenital Abnormalities Of The Kidney And Urinary Tract"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Cataract And Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Congenital Cataract And Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Congenital Heart Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects, Multiple Types, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Congenital Heart Defects, Multiple Types, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Congenital Heart Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Conotruncal Heart Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Conotruncal Heart Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Conotruncal Heart Malformations, Variable",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Conotruncal Heart Malformations, Variable"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dilated Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Dilated Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dilated Cardiomyopathy (Dcm), Left Ventricular Noncompaction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Dilated Cardiomyopathy (Dcm), Left Ventricular Noncompaction"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dopamine Beta Hydroxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Dopamine Beta Hydroxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dystransthyretinemic Hyperthyroxinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Dystransthyretinemic Hyperthyroxinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Emery Dreiffus Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Emery Dreiffus Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Epidermolysis Bullosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Simplex, Generalized, With Scarring And Hair Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Epidermolysis Bullosa Simplex, Generalized, With Scarring And Hair Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Fabry Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Fabry Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Facioscapulohumeral Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Facioscapulohumeral Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Facioscapulohumeral Muscular Dystrophy, Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Facioscapulohumeral Muscular Dystrophy, Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Dilated Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Familial Dilated Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Gm1 Gangliosidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Gm1 Gangliosidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Glycogen Storage Disease Of Heart, Lethal Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Glycogen Storage Disease Of Heart, Lethal Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heart Block, Nonprogressive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Heart Block, Nonprogressive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heart Block, Progressive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Heart Block, Progressive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heart Defects, Congenital, And Other Congenital Anomalies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Heart Defects, Congenital, And Other Congenital Anomalies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heart Hand Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Heart Hand Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemochromatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Hemochromatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Myopathy With Early Respiratory Failure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Hereditary Myopathy With Early Respiratory Failure"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Holt Oram Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Holt Oram Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypertrophic Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Hypertrophic Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoalphalipoproteinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Hypoalphalipoproteinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypothyroidism, Congenital Nongoitrous,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Hypothyroidism, Congenital Nongoitrous,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Inclusion Body Myopathy With Early Onset Paget Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Inclusion Body Myopathy With Early Onset Paget Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Infantile Type I Muscle Fibre Disease And Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Infantile Type I Muscle Fibre Disease And Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Kaeser Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Kaeser Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lmna Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Lmna Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Left Ventricular Non Compaction Cardiomyopathy (Lvnc)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Left Ventricular Non Compaction Cardiomyopathy (Lvnc)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Left Ventricular Noncompaction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Left Ventricular Noncompaction"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Left Ventricular Noncompaction 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Left Ventricular Noncompaction 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Legius Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Legius Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Leigh Syndrome/Mitochondrial Respiratory Chain Complex Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Leigh Syndrome/Mitochondrial Respiratory Chain Complex Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Leukoencephalopathy, Progressive, With Ovarian Failure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Leukoencephalopathy, Progressive, With Ovarian Failure"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Liddle Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Liddle Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Limb Girdle Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Limb Girdle Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Linear Skin Defects With Multiple Congenital Anomalies 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Linear Skin Defects With Multiple Congenital Anomalies 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipodystrophy (Dunnigan)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Lipodystrophy (Dunnigan)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Malouf Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Malouf Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mandibuloacral Dysplasia Type A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Mandibuloacral Dysplasia Type A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mcleod Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Mcleod Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitochondrial Complex Iv Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Mitochondrial Complex Iv Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mucopolysaccharidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Mucopolysaccharidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mucopolysaccharidosis (Morquio Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Mucopolysaccharidosis (Morquio Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Muscular Dystrophy With Progressive Weakness, Distal Contractures And Rigid Spine",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Muscular Dystrophy With Progressive Weakness, Distal Contractures And Rigid Spine"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Muscular Dystrophy, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Muscular Dystrophy, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Muscular Dystrophy, Limb Girdle, 1A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Muscular Dystrophy, Limb Girdle, 1A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Muscular Dystrophy, Limb Girdle, Type 2J",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Muscular Dystrophy, Limb Girdle, Type 2J"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Muscular Dystrophy, Rigid Spine",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Muscular Dystrophy, Rigid Spine"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Congenital, With Fiber  Disproportion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Myopathy, Congenital, With Fiber  Disproportion"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Early Onset, With Fatal Cardiomyopathy (Salih Myopathy)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Myopathy, Early Onset, With Fatal Cardiomyopathy (Salih Myopathy)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Myofibrillar",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Myopathy, Myofibrillar"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Myofibrillar, Fatal Infantile Hypertonic, Alpha B Crystallin Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Myopathy, Myofibrillar, Fatal Infantile Hypertonic, Alpha B Crystallin Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Myosin Storage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Myopathy, Myosin Storage"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Spheroid Body",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Myopathy, Spheroid Body"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Nemaline Myopathy 11, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Nemaline Myopathy 11, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Neurodevelopmental Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Neurodevelopmental Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Noonan Syndrome 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Noonan Syndrome 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Noonan Syndrome Like Disorder With Loose Anagen Hair 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Noonan Syndrome Like Disorder With Loose Anagen Hair 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Noonan Like Syndrome With Loose Anagen Hair",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Noonan Like Syndrome With Loose Anagen Hair"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Paragangliomas",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Paragangliomas"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pediatric Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Pediatric Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Persistent Truncus Arteriosus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Persistent Truncus Arteriosus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Progeria Hutchinson Gilford Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Progeria Hutchinson Gilford Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudohypoaldosteronism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Pseudohypoaldosteronism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudoxanthoma Elasticum",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Pseudoxanthoma Elasticum"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Scapuloperoneal Syndrome, Neurogenic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Scapuloperoneal Syndrome, Neurogenic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sengers Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Sengers Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sick Sinus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Sick Sinus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Slovenian",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Slovenian"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sudden Cardiac Failure, Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Sudden Cardiac Failure, Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Testicular Anomalies With Or Without Congenital Heart Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Testicular Anomalies With Or Without Congenital Heart Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Tetralogy Of Fallot",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Tetralogy Of Fallot"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Tibial Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Tibial Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Timothy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Timothy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventricular Fibrillation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Ventricular Fibrillation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventricular Septal Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Ventricular Septal Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventricular Septal Defect 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Ventricular Septal Defect 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventricular Tachycardia, Catecholaminergic Polymorphic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Ventricular Tachycardia, Catecholaminergic Polymorphic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventricular Tachycardia, Catecholaminergic, Polymorphic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Ventricular Tachycardia, Catecholaminergic, Polymorphic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Vici Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Vici Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Wolff Parkinson White Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiomyopathy",
        "markers": [
          "Wolff Parkinson White Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Afibrinogenemia, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Afibrinogenemia, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alpha 2 Plasmin Inhibitor Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Alpha 2 Plasmin Inhibitor Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Angioedema",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Angioedema"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Antithrombin Iii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Antithrombin Iii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bleeding Disorder, Platelet Type 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Bleeding Disorder, Platelet Type 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bleeding Disorder, Platelet Type 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Bleeding Disorder, Platelet Type 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bleeding Disorder, Platelet Type, 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Bleeding Disorder, Platelet Type, 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bleeding Disorder, Platelet Type, 18",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Bleeding Disorder, Platelet Type, 18"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bleeding Disorder, Platelet Type, 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Bleeding Disorder, Platelet Type, 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiac Valvular Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Cardiac Valvular Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Factor V And Viii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Combined Factor V And Viii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Drug Metabolism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Drug Metabolism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dysfibrinogenemia, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Dysfibrinogenemia, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor V & Factor Viii, Combined Deficiency Of",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor V & Factor Viii, Combined Deficiency Of"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor V Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor V Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor Vii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor Vii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor X Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor X Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor Xi Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor Xi Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor Xii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor Xii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor Xiiia Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Factor Xiiia Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Visceral Amyloidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Familial Visceral Amyloidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fetal And Neonatal Alloimmune Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Fetal And Neonatal Alloimmune Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Frontometaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Frontometaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gaucher Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Gaucher Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Giant Platelet Disorder, Isolated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Giant Platelet Disorder, Isolated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gray Platelet Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Gray Platelet Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemolytic Uremic Syndrome, Atypical",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Hemolytic Uremic Syndrome, Atypical"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemophilia A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Hemophilia A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemophilia B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Hemophilia B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypodysfibrinogenemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Hypodysfibrinogenemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypodysfibrinogenemia, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Hypodysfibrinogenemia, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Intestinal Pseudoobstruction, Neuronal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Intestinal Pseudoobstruction, Neuronal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Melnick Needles Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Melnick Needles Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteodysplasty Melnick Needles",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Osteodysplasty Melnick Needles"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Otopalatodigital Syndrome Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Otopalatodigital Syndrome Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Otopalatodigital Syndrome Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Otopalatodigital Syndrome Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Paris Trousseau Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Paris Trousseau Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Periventricular Nodular Heterotopia 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Periventricular Nodular Heterotopia 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Platelet Abnormalities With Eosinophilia And Immune Mediated Inflammatory Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Platelet Abnormalities With Eosinophilia And Immune Mediated Inflammatory Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Prothrombin Deficiency, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Prothrombin Deficiency, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudoxanthoma Elasticum Like Disorder With Multiple Coagulation Factor Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Pseudoxanthoma Elasticum Like Disorder With Multiple Coagulation Factor Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Radioulnar Synostosis With Amegakaryocytic Thrombocytopenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Radioulnar Synostosis With Amegakaryocytic Thrombocytopenia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Schulman Upshaw Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Schulman Upshaw Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sitosterolemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Sitosterolemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Terminal Osseous Dysplasia With Pigmentary Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Terminal Osseous Dysplasia With Pigmentary Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombocytopenia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia, Autosomal Dominant, 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombocytopenia, Autosomal Dominant, 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocytopenia, Neonatal Alloimmune",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombocytopenia, Neonatal Alloimmune"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombophilia Due To Activated Protein C Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombophilia Due To Activated Protein C Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombophilia Due To Thrombin Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombophilia Due To Thrombin Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombophilia Due To Thrombomodulin Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombophilia Due To Thrombomodulin Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombophilia, Due To Factor Ix Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombophilia, Due To Factor Ix Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombophilia, Hereditary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombophilia, Hereditary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombotic Thrombocytopenic Purpura, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Thrombotic Thrombocytopenic Purpura, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Vkorc1 Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Vkorc1 Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Vitamin K Dependent Clotting Factors, Combined Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Vitamin K Dependent Clotting Factors, Combined Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Von Willebrand Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Von Willebrand Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Warfarin Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bleeding Disorder Coagulopathy",
        "markers": [
          "Warfarin Sensitivity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Kidney And/Or Polycystic Liver Disease 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polycystic Liver Disease",
        "markers": [
          "Polycystic Kidney And/Or Polycystic Liver Disease 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Kidney Disease 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polycystic Liver Disease",
        "markers": [
          "Polycystic Kidney Disease 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Kidney Disease 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polycystic Liver Disease",
        "markers": [
          "Polycystic Kidney Disease 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Liver Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polycystic Liver Disease",
        "markers": [
          "Polycystic Liver Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alpha/Beta T Cell Lymphopenia With Gamma/Delta T Cell Expansion, Severe Cytomegalovirus Infection, And Autoimmunity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Alpha/Beta T Cell Lymphopenia With Gamma/Delta T Cell Expansion, Severe Cytomegalovirus Infection, And Autoimmunity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Anauxetic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Anauxetic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Disease, Multisystem, Infantile Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Autoimmune Disease, Multisystem, Infantile Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "B Cell Negative, Natural Killer Cell Positive Severe Combined Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "B Cell Negative, Natural Killer Cell Positive Severe Combined Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "B Cell Positive, Natural Killer Cell Negative",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "B Cell Positive, Natural Killer Cell Negative"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "B Cell Expansion With Nfkb And T Cell Anergy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "B Cell Expansion With Nfkb And T Cell Anergy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "B Cell Positive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "B Cell Positive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bare Lymphocyte Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Bare Lymphocyte Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cd8 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Cd8 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cartilage Hair Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Cartilage Hair Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Cellular And Humoral Immune Defects With Granulomas",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Combined Cellular And Humoral Immune Defects With Granulomas"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Combined Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Common Variable Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Common Variable Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Cone Rod Dystrophy 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Facial Dysmorphism, Immunodeficiency, Livedo, And Short Stature Syndrome (Fils Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Facial Dysmorphism, Immunodeficiency, Livedo, And Short Stature Syndrome (Fils Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Growth Hormone Insensitivity With Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Growth Hormone Insensitivity With Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hepatic Venoocclusive Disease With Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Hepatic Venoocclusive Disease With Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyper Ige Recurrent Infection Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Hyper Ige Recurrent Infection Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 32A (Cd11C Positive/Cd1C Positive Dendritic Cell Deficiency)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 32A (Cd11C Positive/Cd1C Positive Dendritic Cell Deficiency)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 32B (Monocyte And Dendritic Cell Deficiency)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 32B (Monocyte And Dendritic Cell Deficiency)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 49",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 49"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 50",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 50"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 52",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency 52"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency With Hyper Igm",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency With Hyper Igm"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, With Hyper Igm",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency, With Hyper Igm"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency Centromeric Instability Facial Anomalies Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Immunodeficiency Centromeric Instability Facial Anomalies Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Interleukin 2 Receptor, Alpha, Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Interleukin 2 Receptor, Alpha, Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lig4 Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Lig4 Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lung Disease, Immunodeficiency, And Chromosome Breakage Syndrome (Lics)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Lung Disease, Immunodeficiency, And Chromosome Breakage Syndrome (Lics)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mhc Class Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Mhc Class Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Mental Retardation, Autosomal Dominant 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Metaphyseal Dysplasia Without Hypotrichosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Metaphyseal Dysplasia Without Hypotrichosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Tubular Aggregate 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Myopathy, Tubular Aggregate 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Tubular Aggregate, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Myopathy, Tubular Aggregate, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Nk Cell Positive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Nk Cell Positive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Netherton Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Netherton Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Omenn Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Omenn Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Primary Immunodeficiency With Multifaceted Aberrant Lymphoid Immunity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Primary Immunodeficiency With Multifaceted Aberrant Lymphoid Immunity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Purine Nucleoside Phosphorylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Purine Nucleoside Phosphorylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Schimke Immunoosseous Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Schimke Immunoosseous Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Selective T Cell Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Selective T Cell Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Combined Immunodeficiency Due To Adenosine Deaminase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Severe Combined Immunodeficiency Due To Adenosine Deaminase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Combined Immunodeficiency With Microcephaly, Growth Retardation, And Sensitivity To Ionizing Radiation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Severe Combined Immunodeficiency With Microcephaly, Growth Retardation, And Sensitivity To Ionizing Radiation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Combined Immunodeficiency With Sensitivity To Ionizing Radiation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Severe Combined Immunodeficiency With Sensitivity To Ionizing Radiation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Combined Immunodeficiency,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Severe Combined Immunodeficiency,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Stormorken Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "Stormorken Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "T Cell Negative",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "T Cell Negative"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "T Cell Immunodeficiency Syndrome, Recurrent Infections, Autoimmunity,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "T Cell Immunodeficiency Syndrome, Recurrent Infections, Autoimmunity,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "T Cell Immunodeficiency With Epidermodysplasia Verruciformis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "T Cell Immunodeficiency With Epidermodysplasia Verruciformis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "T Cell Immunodeficiency, Congenital Alopecia, And Nail Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "T Cell Immunodeficiency, Congenital Alopecia, And Nail Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "T Cell Negative",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Severe Combined Immunodeficiency",
        "markers": [
          "T Cell Negative"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypercholesterolemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia Core",
        "markers": [
          "Hypercholesterolemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypobetalipoproteinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia Core",
        "markers": [
          "Hypobetalipoproteinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebrooculofacioskeletal Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hereditary Melanoma And Skin Cancer",
        "markers": [
          "Cerebrooculofacioskeletal Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichothiodystrophy, Photosensitive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hereditary Melanoma And Skin Cancer",
        "markers": [
          "Trichothiodystrophy, Photosensitive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tumor Predisposition Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hereditary Melanoma And Skin Cancer",
        "markers": [
          "Tumor Predisposition Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Werner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hereditary Melanoma And Skin Cancer",
        "markers": [
          "Werner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Xeroderma Pigmentosum/Cockayne Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hereditary Melanoma And Skin Cancer",
        "markers": [
          "Xeroderma Pigmentosum/Cockayne Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adams Oliver Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Adams Oliver Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Alagille Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Alagille Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Aortic Aneurysm, Familial Thoracic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Aortic Aneurysm, Familial Thoracic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Aortic Valve Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Aortic Valve Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Athabaskan Brainstem Dysgenesis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Athabaskan Brainstem Dysgenesis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Standstill, Digenic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Atrial Standstill, Digenic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrioventricular Septal Defect, Partial, With Or Without Heterotaxy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Atrioventricular Septal Defect, Partial, With Or Without Heterotaxy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Au Kline Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Au Kline Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bosley Salih Alorainy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Bosley Salih Alorainy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiac Valvular Defect, Developmental",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Cardiac Valvular Defect, Developmental"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Carpenter Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Carpenter Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Carpenter Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Carpenter Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Catel Manzke Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Catel Manzke Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Char Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Char Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cleft Palate, Cardiac Defects, And Mental Retardation (Cpcmr)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Cleft Palate, Cardiac Defects, And Mental Retardation (Cpcmr)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Coffin Siris Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Coffin Siris Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cognitive Impairment, Coarse Facies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Cognitive Impairment, Coarse Facies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects And Ectodermal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Congenital Heart Defects And Ectodermal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects And Intellectual Disability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Congenital Heart Defects And Intellectual Disability"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects, Multiple Types, 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Congenital Heart Defects, Multiple Types, 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects, Nonsyndromic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Congenital Heart Defects, Nonsyndromic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Craniosynostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Craniosynostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Diaphragmatic Hernia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Diaphragmatic Hernia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Double Outlet Right Ventricle",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Double Outlet Right Ventricle"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ellis Van Creveld Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Ellis Van Creveld Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Atrial Fibrillation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Familial Atrial Fibrillation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Fibrodysplasia Ossificans Progressiva",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Fibrodysplasia Ossificans Progressiva"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hajdu Cheney Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Hajdu Cheney Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heart Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Heart Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heterotaxy, Visceral",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Heterotaxy, Visceral"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heterotaxy, Visceral, 4, Autosomal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Heterotaxy, Visceral, 4, Autosomal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heterotaxy, Visceral, 6, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Heterotaxy, Visceral, 6, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heterotaxy, Visceral, 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Heterotaxy, Visceral, 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heterotaxy, Visceral, 8, Autosomal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Heterotaxy, Visceral, 8, Autosomal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Holoprosencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Holoprosencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hydroxykynureninuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Hydroxykynureninuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Kleefstra Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Kleefstra Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Klippel Feil Syndrome 4, Autosomal Recessive, With Myopathy And Facial Dysmorphism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Klippel Feil Syndrome 4, Autosomal Recessive, With Myopathy And Facial Dysmorphism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Left Right Axis Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Left Right Axis Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lymphedema, Hereditary I (Milroy Disease)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Lymphedema, Hereditary I (Milroy Disease)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mental Retardation And Distinctive Facial Features With Or Without Cardiac Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Mental Retardation And Distinctive Facial Features With Or Without Cardiac Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mental Retardation With Language Impairment And Autistic Features",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Mental Retardation With Language Impairment And Autistic Features"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated, With Coloboma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Microphthalmia, Isolated, With Coloboma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Moyamoya Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Moyamoya Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Multisystemic Smooth Muscle Dysfunction Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Multisystemic Smooth Muscle Dysfunction Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Obesity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Obesity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Oculofaciocardiodental Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Oculofaciocardiodental Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofaciodigital Syndrome Xiv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Orofaciodigital Syndrome Xiv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Patent Ductus Arteriosus 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Patent Ductus Arteriosus 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Patent Ductus Arteriosus, Nonsyndromic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Patent Ductus Arteriosus, Nonsyndromic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Progressive Familial Heart Block",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Progressive Familial Heart Block"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Hypertension, Primary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Pulmonary Hypertension, Primary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Involvement",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Pulmonary Involvement"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Venoocclusive Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Pulmonary Venoocclusive Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhabdoid Tumor Predisposition Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Rhabdoid Tumor Predisposition Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ring Dermoid Of Cornea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Ring Dermoid Of Cornea"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Robinow Sorauf Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Robinow Sorauf Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Rubinstein Taybi Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Rubinstein Taybi Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Saethre Chotzen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Saethre Chotzen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Short Stature"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature, And Skeletal Dysplasia (Chops Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Short Stature, And Skeletal Dysplasia (Chops Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sifrim Hitz Weiss Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Sifrim Hitz Weiss Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Single Ventricular Septal Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Single Ventricular Septal Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Tarp Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Tarp Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Transposition Of The Great Arteries, Dextro Looped 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Transposition Of The Great Arteries, Dextro Looped 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Transposition Of The Great Arteries, Dextro Looped 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Transposition Of The Great Arteries, Dextro Looped 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Vacterl Association",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Vacterl Association"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Vertebral, Cardiac, Renal, And Limb Defects Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Vertebral, Cardiac, Renal, And Limb Defects Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Weyers Acrodental Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Weyers Acrodental Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Weyers Acrofacial Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Structural Heart Disease",
        "markers": [
          "Weyers Acrofacial Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Andersen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Short Qt Syndrome (Sqts)",
        "markers": [
          "Andersen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bietti Crystalline Corneoretinal Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Bietti Crystalline Corneoretinal Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bothnia Retinal Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Bothnia Retinal Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Choriodal Dystrophy, Central Areolar",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Choriodal Dystrophy, Central Areolar"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Choroideremia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Choroideremia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Cone Rod Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fleck Retina, Familial Benign",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Fleck Retina, Familial Benign"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fundus Albipunctatus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Fundus Albipunctatus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fundus Flavimaculatus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Fundus Flavimaculatus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Icthyosis, Spastic Quadriplegia, And Mental Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Icthyosis, Spastic Quadriplegia, And Mental Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macula Dystrophy, Patterned",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Macula Dystrophy, Patterned"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Retinal,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Macular Dystrophy, Retinal,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Vitelliform",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Macular Dystrophy, Vitelliform"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Newfoundland Rod Cone Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Newfoundland Rod Cone Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Night Blindness, Congenital Stationary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Night Blindness, Congenital Stationary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy, Early Onset Severe",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Retinal Dystrophy, Early Onset Severe"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Punctata Albescens",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Retinitis Punctata Albescens"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinoschisis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Retinoschisis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Stargardt Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Flecked Retina Disorders",
        "markers": [
          "Stargardt Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aarskog Scott Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Noonan Syndrome",
        "markers": [
          "Aarskog Scott Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dubowitz Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Noonan Syndrome",
        "markers": [
          "Dubowitz Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dyschromatosis Universalis Hereditaria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Noonan Syndrome",
        "markers": [
          "Dyschromatosis Universalis Hereditaria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Genitopatellar Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Noonan Syndrome",
        "markers": [
          "Genitopatellar Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Non Syndromic Intellectual Disability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Noonan Syndrome",
        "markers": [
          "Non Syndromic Intellectual Disability"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sbbys Variant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Noonan Syndrome",
        "markers": [
          "Sbbys Variant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ada2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ada2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Acne Inversa, Familial 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Acne Inversa, Familial 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Acne Inversa, Familial, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Acne Inversa, Familial, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Agammaglobulinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Agammaglobulinemia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Agammaglobulinemia 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Agammaglobulinemia 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia 8, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Agammaglobulinemia 8, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia And Isolated Hormone Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Agammaglobulinemia And Isolated Hormone Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Amyloidosis, Systemic Visceral",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Amyloidosis, Systemic Visceral"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Asplenia, Isolated Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Asplenia, Isolated Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ataxia Telangiectasia Like Disorder 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ataxia Telangiectasia Like Disorder 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Interstitial Lung, Joint, And Kidney Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoimmune Interstitial Lung, Joint, And Kidney Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Lymphoproliferative Syndrome Type Iii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoimmune Lymphoproliferative Syndrome Type Iii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Lymphoproliferative Syndrome, Type V",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoimmune Lymphoproliferative Syndrome, Type V"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Polyendocrinopathy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoimmune Polyendocrinopathy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammation With Arthritis And Dyskeratosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoinflammation With Arthritis And Dyskeratosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammation With Infantile Enterocolitis (Aifec)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoinflammation With Infantile Enterocolitis (Aifec)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammation, Antibody Deficiency, And Immune Dysregulation Syndrome (Aplaid)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoinflammation, Antibody Deficiency, And Immune Dysregulation Syndrome (Aplaid)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammation, Lipodystrophy, And Dermatosis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoinflammation, Lipodystrophy, And Dermatosis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammation, Panniculitis, And Dermatosis Syndrome (Aipds)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoinflammation, Panniculitis, And Dermatosis Syndrome (Aipds)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoinflammatory Syndrome, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Autoinflammatory Syndrome, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bach2 Related Immunodeficiency And Autoimmunity (Brida)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Bach2 Related Immunodeficiency And Autoimmunity (Brida)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Basal Laminar Drusen",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Basal Laminar Drusen"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Behcet Like",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Behcet Like"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Blau Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Blau Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Blood Group",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Blood Group"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "C1Q Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "C1Q Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cd59 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Cd59 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Camptodactyly Arthropathy Coxa Vara Pericarditis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Camptodactyly Arthropathy Coxa Vara Pericarditis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Candiasis, Familial, 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Candiasis, Familial, 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Candidiasis, Familial 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Candidiasis, Familial 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Candidiasis, Familial, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Candidiasis, Familial, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Caspase 8 Defiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Caspase 8 Defiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy And Elevated Temperature Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy And Elevated Temperature Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Chronic Granulomatous Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Chronic Granulomatous Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia  Lethal Ciliopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia  Lethal Ciliopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 20",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 20"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 30",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 30"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 32",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 32"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 33",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 33"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 34",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 34"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 35",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 35"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 36",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 36"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ciliary Dyskinesia, Primary, 37",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ciliary Dyskinesia, Primary, 37"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 3 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 3 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 4, Partial Deficiency Of",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 4, Partial Deficiency Of"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 5 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 5 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 6 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 6 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 7 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 7 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 8 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 8 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component 9 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component 9 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Component C1S Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Component C1S Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Factor B Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Factor B Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Factor D Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Factor D Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Factor H Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Factor H Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Complement Factor I Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Complement Factor I Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Cone Rod Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Bilateral Absence Of The Vas Deferens",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Congenital Bilateral Absence Of The Vas Deferens"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cromer System",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Cromer System"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cystic Fibrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Cystic Fibrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Diarrhea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Diarrhea"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Anhidrotic, With T Cell Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Ectodermal Dysplasia, Anhidrotic, With T Cell Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Eculizumab, Poor Response To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Eculizumab, Poor Response To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Encephalopathy, Acute, Infection Induced, 3, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Encephalopathy, Acute, Infection Induced, 3, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermodysplasia Verruciformis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Epidermodysplasia Verruciformis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Mediterranean Fever",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Familial Mediterranean Fever"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Cold Autoinflammatory Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Familial Cold Autoinflammatory Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Cold Autoinflammatory Syndrome 3 (Plaid)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Familial Cold Autoinflammatory Syndrome 3 (Plaid)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Cold Autoinflammatory Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Familial Cold Autoinflammatory Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Generalized Verrucosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Generalized Verrucosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucose 6 Phosphate Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Glucose 6 Phosphate Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Granulomatous Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Granulomatous Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hoip And Lubac Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Hoip And Lubac Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hpv Susceptibility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Hpv Susceptibility"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Heme Oxygenase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Heme Oxygenase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hennekam Lymphangiectasia Lymphedema Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Hennekam Lymphangiectasia Lymphedema Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Herpes Simplex Encephalitis, Susceptibility To, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Herpes Simplex Encephalitis, Susceptibility To, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Herpes Simplex Encephalitis, Susceptibility To, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Herpes Simplex Encephalitis, Susceptibility To, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyper Igd Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Hyper Igd Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperuricemic Nephropathy, Familial Juvenile 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Hyperuricemic Nephropathy, Familial Juvenile 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogammaglobulinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Hypogammaglobulinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Il21R Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Il21R Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Irak4 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Irak4 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Idiopathic Bronchiectasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Idiopathic Bronchiectasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiencies With Antibody Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiencies With Antibody Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 20",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 20"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 24",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 24"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 28",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 28"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 29",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 29"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 37",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 37"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 39",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 39"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 42",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 42"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 45",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 45"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 47",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 47"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 51",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 51"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency 53",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency 53"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency With Hyper Igm",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency With Hyper Igm"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency With Hyper Igm, Type 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency With Hyper Igm, Type 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, Common Variable"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, Common Variable, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable, 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, Common Variable, 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable, 14",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, Common Variable, 14"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable, 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, Common Variable, 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Primary, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, Primary, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, With Basal Ganglia Calcification",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency, With Basal Ganglia Calcification"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency Centromeric Instability Facial Anomalies 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency Centromeric Instability Facial Anomalies 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency Centromeric Instability Facial Anomalies Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency Centromeric Instability Facial Anomalies Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency Centromeric Instability Facial Anomalies Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodeficiency Centromeric Instability Facial Anomalies Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodysregulation, Polyendocrinopathy, And Enteropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunodysregulation, Polyendocrinopathy, And Enteropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunoglobulin A Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunoglobulin A Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunoskeletal Dysplasia With Neurodevelopmental Abnormalities (Isdna)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Immunoskeletal Dysplasia With Neurodevelopmental Abnormalities (Isdna)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Inflammatory Bowel Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Inflammatory Bowel Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Inflammatory Skin And Bowel Disease, Neonatal 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Inflammatory Skin And Bowel Disease, Neonatal 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Interleukin 7 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Interleukin 7 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Invasive Pneumococcal Disease, Recurrent, Isolated, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Invasive Pneumococcal Disease, Recurrent, Isolated, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Joint Contractures, Muscular Atrophy, Microcytic Anemia, And Panniculitis Induced Lipodystrophy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Joint Contractures, Muscular Atrophy, Microcytic Anemia, And Panniculitis Induced Lipodystrophy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratosis Linearis With Ichthyosis Congenita And Sclerosing Keratoderma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Keratosis Linearis With Ichthyosis Congenita And Sclerosing Keratoderma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Myd88 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Myd88 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Macular Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Majeed Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Majeed Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mandibular Hypoplasia, Deafness, Progeroid Features, And Lipodystrophy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Mandibular Hypoplasia, Deafness, Progeroid Features, And Lipodystrophy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Meconium Ileus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Meconium Ileus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mevalonic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Mevalonic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcephalic Osteodysplastic Primordial Dwarfism Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Microcephalic Osteodysplastic Primordial Dwarfism Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcephalic Osteodysplastic Primordial Dwarfism Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Microcephalic Osteodysplastic Primordial Dwarfism Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Nakajo Nishimura Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Nakajo Nishimura Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Natural Killer Cell And Glucocorticoid Deficiency With Dna Repair Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Natural Killer Cell And Glucocorticoid Deficiency With Dna Repair Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Okt4 Epitope Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Okt4 Epitope Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteomyelitis, Sterile Multifocal, With Periostitis And Pustulosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Osteomyelitis, Sterile Multifocal, With Periostitis And Pustulosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Carcinoma, Multiple Self Healing",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Palmoplantar Carcinoma, Multiple Self Healing"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Periodic Fever (Tnf Receptor Associated Periodic Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Periodic Fever (Tnf Receptor Associated Periodic Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pigmentary Disorder, Reticulate, With Systemic Manifestations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Pigmentary Disorder, Reticulate, With Systemic Manifestations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Polyarteritis Nodosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Polyarteritis Nodosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Porokeratosis 3, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Porokeratosis 3, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Primary Ciliary Dyskinesia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Primary Ciliary Dyskinesia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Properdin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Properdin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudo Torch Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Pseudo Torch Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Psoriasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Psoriasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pustular Psoriasis, Generalized",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Pustular Psoriasis, Generalized"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, And Acne",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, And Acne"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Riddle Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Riddle Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Retinitis Pigmentosa 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa And Erythrocytic Microcytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Retinitis Pigmentosa And Erythrocytic Microcytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Roifman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Roifman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Short Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sting Associated Vasculopathy, Infantile Onsent (Savi)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Sting Associated Vasculopathy, Infantile Onsent (Savi)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sarcoidosis, Early Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Sarcoidosis, Early Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Combined Immunodeficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Severe Combined Immunodeficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Shaheen Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Shaheen Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sideroblastic Anemia With B Cell Immunodeficiency, Periodic Fevers, And Developmental Delay",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Sideroblastic Anemia With B Cell Immunodeficiency, Periodic Fevers, And Developmental Delay"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Skin/Hair/Eye Pigmentation, Variation In, 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Skin/Hair/Eye Pigmentation, Variation In, 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Specific Granule Deficiency 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Specific Granule Deficiency 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Spermatogenic Failure 18",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Spermatogenic Failure 18"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Spondyloenchondrodysplasia With Immune Dysregulation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Spondyloenchondrodysplasia With Immune Dysregulation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Surfactant Metabolism Dysfunction, Pulmonary, 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Surfactant Metabolism Dysfunction, Pulmonary, 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Systemic Lupus Erythematosus 16",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Systemic Lupus Erythematosus 16"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichohepatoenteric Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Trichohepatoenteric Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Van Maldergem Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Van Maldergem Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Van Der Woude Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Primary Immunodeficiency (Pid) And Primary Ciliary Dyskinesia (Pcd)",
        "markers": [
          "Van Der Woude Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atypical Hemolytic Uremic Syndrome With Anti Factor H Antibodies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hemolytic Uremic Syndrome",
        "markers": [
          "Atypical Hemolytic Uremic Syndrome With Anti Factor H Antibodies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "C3 Glomerulonephritis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hemolytic Uremic Syndrome",
        "markers": [
          "C3 Glomerulonephritis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency Due To Ficolin 3 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Complement System Disorder",
        "markers": [
          "Immunodeficiency Due To Ficolin 3 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Masp2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Immunology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Complement System Disorder",
        "markers": [
          "Masp2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Amyloidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Amyloidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anterior Segment Mesenchymal Dysgenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Anterior Segment Mesenchymal Dysgenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aphakia, Congenital Primary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Aphakia, Congenital Primary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Avellino",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Avellino"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ayme Gripp Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Ayme Gripp Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Brittle Cornea Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Brittle Cornea Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Brittle Cornea Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Brittle Cornea Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Cataract"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 21, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Cataract 21, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 34",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Cataract 34"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cornea Plana 2, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Cornea Plana 2, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy Of Bowman Layer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy Of Bowman Layer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy Polymorphous Posterior, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy Polymorphous Posterior, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy, Congenital Stromal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy, Congenital Stromal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy, Crystalline, Of Schnyder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy, Crystalline, Of Schnyder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy, Epithelial Basement Membrane",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy, Epithelial Basement Membrane"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy, Gelatinous Drop Like",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy, Gelatinous Drop Like"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Dystrophy, Posterior Polymorphous, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Dystrophy, Posterior Polymorphous, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Corneal Fleck Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Corneal Fleck Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Junctional, Non Herlitz",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Epidermolysis Bullosa, Junctional, Non Herlitz"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Epithelial Recurrent Erosion Dystrophy (Ered)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Epithelial Recurrent Erosion Dystrophy (Ered)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Finnish Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Finnish Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fish Eye Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Fish Eye Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fuchs Endothelial, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Fuchs Endothelial, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Groenouw",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Groenouw"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lecithin:Cholesterol Acyltransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Lecithin:Cholesterol Acyltransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Corneal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Macular Dystrophy, Corneal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Meesmann Corneal Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Meesmann Corneal Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Megalocornea 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Megalocornea 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Reis Bucklers",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Reis Bucklers"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thiel Behnke",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Corneal Dystrophy",
        "markers": [
          "Thiel Behnke"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Fibrillation 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Atrial Fibrillation 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrial Fibrillation, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Atrial Fibrillation, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiac Arrhythmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Cardiac Arrhythmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Catecholaminergic Polymorphic Ventricular Tachycardia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Catecholaminergic Polymorphic Ventricular Tachycardia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Channelopathy Associated Congenital Insensitivity To Pain",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Channelopathy Associated Congenital Insensitivity To Pain"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 20",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 20"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Gitelman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Gitelman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperaldosteronism, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Hyperaldosteronism, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Intellectual Developmental Disorder With Cardiac Arrhythmia (Iddca)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Intellectual Developmental Disorder With Cardiac Arrhythmia (Iddca)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Language Delay And Attention Deficit Hyperactivity Disorder/Cognitive Impairment With Or Without Cardiac Arrhythmia (Ladci)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Language Delay And Attention Deficit Hyperactivity Disorder/Cognitive Impairment With Or Without Cardiac Arrhythmia (Ladci)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Micochondrial Phosphate Carrier Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Micochondrial Phosphate Carrier Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitochondrial Complex V (Atp Synthase) Deficiency, Nuclear Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Mitochondrial Complex V (Atp Synthase) Deficiency, Nuclear Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Primary Erythermalgia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Primary Erythermalgia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Recurrent Cardiac Arrest, Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Recurrent Cardiac Arrest, Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Romano Ward Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Romano Ward Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sodium Channelopathy Related Small Fiber Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Sodium Channelopathy Related Small Fiber Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Tyrosinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Tyrosinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventricular Tachycardia, Catecholaminergic Polymorphic, 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Cardiology",
        "markers": [
          "Ventricular Tachycardia, Catecholaminergic Polymorphic, 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Chronic Pancreatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pancreatitis",
        "markers": [
          "Hereditary Chronic Pancreatitis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperchylomicronemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pancreatitis",
        "markers": [
          "Hyperchylomicronemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperlipoproteinemia, Type Id",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pancreatitis",
        "markers": [
          "Hyperlipoproteinemia, Type Id"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperlipoproteinemia, Type Ib",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pancreatitis",
        "markers": [
          "Hyperlipoproteinemia, Type Ib"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pancreatitis, Hereditary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pancreatitis",
        "markers": [
          "Pancreatitis, Hereditary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tropical Pancreatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pancreatitis",
        "markers": [
          "Tropical Pancreatitis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Insipidus, Nephrogenic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diabetes Insipidus",
        "markers": [
          "Diabetes Insipidus, Nephrogenic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Insipidus, Neurohypophyseal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diabetes Insipidus",
        "markers": [
          "Diabetes Insipidus, Neurohypophyseal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acanthocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Acanthocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adenylate Kinase Deficiency, Hemolytic Anemia Due To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Adenylate Kinase Deficiency, Hemolytic Anemia Due To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alpha Thalassemia (Hemoglobin Bart Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Alpha Thalassemia (Hemoglobin Bart Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alpha Thalassemia (Hemoglobin H Disease)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Alpha Thalassemia (Hemoglobin H Disease)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Hemolytic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Anemia, Hemolytic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Hypochromic Microcytic, With Iron Overload",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Anemia, Hypochromic Microcytic, With Iron Overload"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Neonatal Hemolytic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Anemia, Neonatal Hemolytic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anemia, Sideroblastic, And Spinocerebellar Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Anemia, Sideroblastic, And Spinocerebellar Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Atransferrinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Atransferrinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Band 3 Memphis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Band 3 Memphis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Beta Thalassemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Beta Thalassemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dehydrated Hereditary Stomatocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Dehydrated Hereditary Stomatocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Elevation Of Red Blood Cell Atp Levels, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Elevation Of Red Blood Cell Atp Levels, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ellipsocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Ellipsocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gamma Glutamylcysteine Synthetase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Gamma Glutamylcysteine Synthetase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glutathione Synthetase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Glutathione Synthetase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemolytic Anemia, Nonspherocytic Due To Glucose Phosphate Isomerase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Hemolytic Anemia, Nonspherocytic Due To Glucose Phosphate Isomerase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Persistence Of Fetal Hemoglobin",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Hereditary Persistence Of Fetal Hemoglobin"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Persistence Of Fetal Hemogoblin",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Hereditary Persistence Of Fetal Hemogoblin"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperproreninemia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Hyperproreninemia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperuricemic Nephropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Hyperuricemic Nephropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Iron Refractory Iron Deficiency Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Iron Refractory Iron Deficiency Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lutheran Inhibitor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Lutheran Inhibitor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lympehedema, Hereditary Iii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Lympehedema, Hereditary Iii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Methemoglobinemia Due To Methemoglobin Reductase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Methemoglobinemia Due To Methemoglobin Reductase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitochondrial Myopathy And Sideroblastic Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Mitochondrial Myopathy And Sideroblastic Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, Lactic Acidosis, And Sideroblastic Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Myopathy, Lactic Acidosis, And Sideroblastic Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Other Thalassemias/Hemoglobinopathies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Other Thalassemias/Hemoglobinopathies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovalcytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Ovalcytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Overhydrated Hereditary Stomatocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Overhydrated Hereditary Stomatocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyropoikilocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Pyropoikilocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyruvate Dehydrogenase E1 Alpha Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Pyruvate Dehydrogenase E1 Alpha Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyruvate Dehydrogenase E3 Binding Protein Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Pyruvate Dehydrogenase E3 Binding Protein Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyruvate Kinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Pyruvate Kinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhag Blood Group",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Rhag Blood Group"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Tubular Acidosis, Distal, With Hemolytic Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Renal Tubular Acidosis, Distal, With Hemolytic Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Tubular Dysgenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Renal Tubular Dysgenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rh Mod Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Rh Mod Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rh Null, Regulator Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Rh Null, Regulator Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sickle Cell Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Sickle Cell Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Spherocytosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Spherocytosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thalassemia Beta, Dominant Inclusion Body",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Thalassemia Beta, Dominant Inclusion Body"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Triosephosphate Isomerase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Triosephosphate Isomerase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Uridine 5 Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia Due To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Anemia",
        "markers": [
          "Uridine 5 Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia Due To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephronophthisis 20",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephronophthisis",
        "markers": [
          "Nephronophthisis 20"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Blepharocheilodontic Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Blepharocheilodontic Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Breast Cancer, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Breast Cancer, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cdh1 Related Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Cdh1 Related Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Carcinoid Tumors, Intestinal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Carcinoid Tumors, Intestinal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Carcinoma, Parathyroid",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Carcinoma, Parathyroid"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebrooculofacioskeletal Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Cerebrooculofacioskeletal Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease, Type 2A1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Charcot Marie Tooth Disease, Type 2A1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colorectal Adenomatous Polyposis, Autosomal Recessive, With Pilomatricomas",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Colorectal Adenomatous Polyposis, Autosomal Recessive, With Pilomatricomas"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colorectal Adenomatous Polyposis, With Pilomatricomas",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Colorectal Adenomatous Polyposis, With Pilomatricomas"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Colorectal Cancer, Susceptibility To, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Colorectal Cancer, Susceptibility To, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cowden Like Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Cowden Like Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cylindromatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Cylindromatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dicer1 Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Dicer1 Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Desmoid Disease, Hereditary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Desmoid Disease, Hereditary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ellipsocytosis 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Ellipsocytosis 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Endometrial Carcinoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Endometrial Carcinoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Erthyrocytosis, Familial 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Erthyrocytosis, Familial 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrocytosis, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Erythrocytosis, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrocytosis, Familial, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Erythrocytosis, Familial, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Factor Xiiib Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Factor Xiiib Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Adenomatous Polyposis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Familial Adenomatous Polyposis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Adenomatous Polyposis 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Familial Adenomatous Polyposis 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Adenomatous Polyposis,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Familial Adenomatous Polyposis,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Prostate Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Familial Prostate Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gardner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Gardner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemoglobin, High Altitude Adapation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hemoglobin, High Altitude Adapation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hemolytic Anemia, Nonspherocytic, Due To Hexokinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hemolytic Anemia, Nonspherocytic, Due To Hexokinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Fibrosing Poikiloderma With Tendon Contracture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hereditary Fibrosing Poikiloderma With Tendon Contracture"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Mixed Polyposis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hereditary Mixed Polyposis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hereditary Nonpolyposis Colon Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hereditary Nonpolyposis Colon Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperparathyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hyperparathyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperparathyroidism, Familial Primary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hyperparathyroidism, Familial Primary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperparathyroidism Jaw Tumor Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Hyperparathyroidism Jaw Tumor Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Inflammatory Skin And Bowel Disease, Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Inflammatory Skin And Bowel Disease, Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lung Cancer, Familial, Susceptibilty To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Lung Cancer, Familial, Susceptibilty To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lynch Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Lynch Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Patterned 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Macular Dystrophy, Patterned 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Maturity Onset Diabetes Of The Young",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Maturity Onset Diabetes Of The Young"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Medullary Thyroid Carcinoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Medullary Thyroid Carcinoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mosaic Variegated Aneuploidy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Mosaic Variegated Aneuploidy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mosaic Variegated Aneuploidy Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Mosaic Variegated Aneuploidy Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Cartilagenious Exostoses 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Multiple Cartilagenious Exostoses 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Endocrine Neoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Multiple Endocrine Neoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopathy, And Pulmonary Fibrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Myopathy, And Pulmonary Fibrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuroblastoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Neuroblastoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuroblastoma With Hirschsprung Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Neuroblastoma With Hirschsprung Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuroblastoma, Susceptiblity To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Neuroblastoma, Susceptiblity To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuropathy, Motor And Sensory",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Neuropathy, Motor And Sensory"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nijmegen Breakage Syndrome Like Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Nijmegen Breakage Syndrome Like Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Oligodontia Colorectal Cancer Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Oligodontia Colorectal Cancer Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Oligondontia, Isolated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Oligondontia, Isolated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Paraganglioma And Gastric Stromal Sarcoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Paraganglioma And Gastric Stromal Sarcoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peutz Jeghers Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Peutz Jeghers Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pheochromocytoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Pheochromocytoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pituitary Adenoma, Familial Isolated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Pituitary Adenoma, Familial Isolated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pituitary Adenoma, Growth Hormone Secreting, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Pituitary Adenoma, Growth Hormone Secreting, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Premature Chromatid Separation Trait",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Premature Chromatid Separation Trait"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 79",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Retinitis Pigmentosa 79"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinoblastoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Retinoblastoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Russe Type (Charcot Marie Tooth Disease Type 4G)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Russe Type (Charcot Marie Tooth Disease Type 4G)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Seizures, Scoliosis, And Macrocephaly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Seizures, Scoliosis, And Macrocephaly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Spiegler Brooke Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Spiegler Brooke Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thrombocythemia 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Thrombocythemia 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichoepithelioma, Multiple",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Trichoepithelioma, Multiple"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tylosis With Esophageal Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Tylosis With Esophageal Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Von Hippel Lindau Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Von Hippel Lindau Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Xeroderma Pigmentosum, Variant Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hereditary Cancer.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Hematology And Hereditary Cancer",
        "markers": [
          "Xeroderma Pigmentosum, Variant Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cholestasis, Progressive Familial Intrahepatic 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Hepatic Fibrosis",
        "markers": [
          "Cholestasis, Progressive Familial Intrahepatic 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Kidney Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Hepatic Fibrosis",
        "markers": [
          "Polycystic Kidney Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cortisol 11 Beta Ketoreductase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pseudohypoaldosteronism",
        "markers": [
          "Cortisol 11 Beta Ketoreductase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypertension, Early Onset, With Exacerbation In Pregnancy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pseudohypoaldosteronism",
        "markers": [
          "Hypertension, Early Onset, With Exacerbation In Pregnancy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neuropathy, Hereditary Sensory And Autonomic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pseudohypoaldosteronism",
        "markers": [
          "Neuropathy, Hereditary Sensory And Autonomic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anterior Segment Dysgenesis 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Anterior Segment Dysgenesis 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glaucoma, Primary Open Angle",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Glaucoma, Primary Open Angle"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glaucoma, Primary Open Angle Glaucoma, Juvenile Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Glaucoma, Primary Open Angle Glaucoma, Juvenile Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glaucoma, Primary Open Angle, Adult Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Glaucoma, Primary Open Angle, Adult Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Herpes Simplex Encephalitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Herpes Simplex Encephalitis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nail Patella Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glaucoma",
        "markers": [
          "Nail Patella Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Partial Lipodystrophy, Congenital Cataracts, And Neurodegeneration Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pulmonary Artery Hypertension (Pah)",
        "markers": [
          "Partial Lipodystrophy, Congenital Cataracts, And Neurodegeneration Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Artery Hypertension",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pulmonary Artery Hypertension (Pah)",
        "markers": [
          "Pulmonary Artery Hypertension"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Hypertension, Primary 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pulmonary Artery Hypertension (Pah)",
        "markers": [
          "Pulmonary Hypertension, Primary 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Pulmonary Hypertension, Primary 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pulmonary Artery Hypertension (Pah)",
        "markers": [
          "Pulmonary Hypertension, Primary 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Small Patella Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pulmonary Artery Hypertension (Pah)",
        "markers": [
          "Small Patella Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Cutis Laxa, Autosomal Recessive, Type Iic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ehlers Danlos Syndrome",
        "markers": [
          "Cutis Laxa, Autosomal Recessive, Type Iic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ehlers Danlos Syndrome With Progressive Kyphoscoliosis, Myopathy, And Hearing Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ehlers Danlos Syndrome",
        "markers": [
          "Ehlers Danlos Syndrome With Progressive Kyphoscoliosis, Myopathy, And Hearing Loss"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ehlers Danlos Syndrome, Musculocontractural Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ehlers Danlos Syndrome",
        "markers": [
          "Ehlers Danlos Syndrome, Musculocontractural Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Ehlers Danlos Syndrome, Progeroid Form",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ehlers Danlos Syndrome",
        "markers": [
          "Ehlers Danlos Syndrome, Progeroid Form"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Leber Congenital Amaurosis With Muscle Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Leber Congenital Amaurosis With Muscle Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pigmented Paravenous Chorioretinal Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Pigmented Paravenous Chorioretinal Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy, Early Onset Severe",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Retinal Dystrophy, Early Onset Severe"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa With Or Without Skeletal Anomalies (Rpska)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Retinitis Pigmentosa With Or Without Skeletal Anomalies (Rpska)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa, Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Retinitis Pigmentosa, Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retitinitis Pigmentosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Retitinitis Pigmentosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Snowflake Vitreoretinal Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leber Congenital Amaurosis",
        "markers": [
          "Snowflake Vitreoretinal Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Autosomal Dominant Polycystic Kidney Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polycystic Kidney Disease",
        "markers": [
          "Autosomal Dominant Polycystic Kidney Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Polycystic Kidney Disease 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polycystic Kidney Disease",
        "markers": [
          "Polycystic Kidney Disease 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Abca1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Abca1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Apolipoprotein C Iii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Apolipoprotein C Iii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Hyperlipidemia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Combined Hyperlipidemia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Lipase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Combined Lipase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Dysbetalipoproteinemia, Familial (Hyperlipoproteinemia)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Dysbetalipoproteinemia, Familial (Hyperlipoproteinemia)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Hypoalphalipoproteinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Familial Hypoalphalipoproteinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hdl Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Hdl Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperlipoproteinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Hyperlipoproteinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypertriglyceridaemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Hypertriglyceridaemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypertriglyceridemia, Transient Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Hypertriglyceridemia, Transient Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipoprotein Glomerulopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Lipoprotein Glomerulopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipoprotein Lipase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Lipoprotein Lipase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Sea Blue Histiocyte Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Sea Blue Histiocyte Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Tangier Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperlipidemia",
        "markers": [
          "Tangier Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Aland Island Eye Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Aland Island Eye Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bardet Biedl Syndrome 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Bardet Biedl Syndrome 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Best Macular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Best Macular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bestrophinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Bestrophinopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bestrophinopathy, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Bestrophinopathy, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Dystrophy 3/Cone Rod Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Cone Dystrophy 3/Cone Rod Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 18",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Cone Rod Dystrophy 18"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Cone Rod Dystrophy 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 20",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Cone Rod Dystrophy 20"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Cone Rod Dystrophy 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Cone Rod Dystrophy 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Knobloch Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Knobloch Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Vitelliform 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Macular Dystrophy, Vitelliform 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Vitelliform, Adult Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Macular Dystrophy, Vitelliform, Adult Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcornea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Microcornea"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microcornea, Myopic Chorioretinal Atrophy, And Telecanthus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Microcornea, Myopic Chorioretinal Atrophy, And Telecanthus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Posterior Staphyloma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Posterior Staphyloma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy, Early Onset, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Retinal Dystrophy, Early Onset, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 50",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Retinitis Pigmentosa 50"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 78",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Retinitis Pigmentosa 78"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rod Cone Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Rod Cone Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Vitelliform Macular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Vitelliform Macular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Vitreoretinochoroidopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cone Rod Dystrophy",
        "markers": [
          "Vitreoretinochoroidopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Night Blindness, Congenital Stationary, Type 1D",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Stationary Night Blindness",
        "markers": [
          "Night Blindness, Congenital Stationary, Type 1D"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Night Blindness, Congenital Stationary, Type 1H",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Stationary Night Blindness",
        "markers": [
          "Night Blindness, Congenital Stationary, Type 1H"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Oguchi Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Stationary Night Blindness",
        "markers": [
          "Oguchi Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ace Serum Levels",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Ace Serum Levels"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bifid Nose",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Bifid Nose"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Anomalies Of The Kidney And Urinary Tract Syndrome With Or Without Hearing Loss, Abnormal Ears, Or Developmental Delay (Cakuthed)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Congenital Anomalies Of The Kidney And Urinary Tract Syndrome With Or Without Hearing Loss, Abnormal Ears, Or Developmental Delay (Cakuthed)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Focal Segmental Glomerulosclerosis 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Focal Segmental Glomerulosclerosis 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fraser Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Fraser Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Isolated Renal Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Isolated Renal Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Manitoba Oculotrichoanal Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Manitoba Oculotrichoanal Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Megacystis Microcolon Intestinal Hypoperistalsis Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Megacystis Microcolon Intestinal Hypoperistalsis Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Papillorenal Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Papillorenal Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Vesicoureteral Reflux 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Vesicoureteral Reflux 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Visceral Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Malformation",
        "markers": [
          "Visceral Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Benign Recurrent Intrahepatic Cholestasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Benign Recurrent Intrahepatic Cholestasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bile Acid Synthesis Defect, Congenital, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Bile Acid Synthesis Defect, Congenital, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bile Acid Synthesis Defect, Congenital, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Bile Acid Synthesis Defect, Congenital, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Breast Milk Jaundice",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Breast Milk Jaundice"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cholestasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Cholestasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cholestasis, Benign Recurrent Intrahepatic, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Cholestasis, Benign Recurrent Intrahepatic, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Crigler Najjar Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Crigler Najjar Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diarrhea, Malabsorptive, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Diarrhea, Malabsorptive, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diarrhea, Secretory Chloride, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Diarrhea, Secretory Chloride, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diarrhea, Secretory Sodium, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Diarrhea, Secretory Sodium, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diarrhea, With Microvillus Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Diarrhea, With Microvillus Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dubin Johnson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Dubin Johnson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Intrahepatic Cholestasis, Recurrent",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Familial Intrahepatic Cholestasis, Recurrent"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gallbladder Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Gallbladder Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gilbert Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Gilbert Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperbilirubinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Hyperbilirubinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Intrahepatic Cholestasis Of Pregnancy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Intrahepatic Cholestasis Of Pregnancy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Low Phospholipid Associated Cholelithiasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Low Phospholipid Associated Cholelithiasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rotor Type, Digenic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Gastroenterology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cholestasis",
        "markers": [
          "Rotor Type, Digenic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adult I Pheno Without Cataract",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Adult I Pheno Without Cataract"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 10, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 10, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 13 With Adult I Pheno",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 13 With Adult I Pheno"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 15, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 15, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 23",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 23"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 30, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 30, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 31, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 31, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 33",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 33"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 45",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 45"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 47",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 47"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract 6, Multiple Types",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract 6, Multiple Types"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cataract, Progressive Polymorphic Cortical",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cataract, Progressive Polymorphic Cortical"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cockayne Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Cockayne Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Knobloch Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Knobloch Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Langereis System",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Langereis System"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Martsolf Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Martsolf Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Microphthalmia, Isolated 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated, With Coloboma 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Microphthalmia, Isolated, With Coloboma 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated, With Coloboma 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Microphthalmia, Isolated, With Coloboma 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myopia, High, With Cataract And Vitreoretinal Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Myopia, High, With Cataract And Vitreoretinal Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pseudohyperkalemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Pseudohyperkalemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinopathy Of Prematurity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Retinopathy Of Prematurity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Uv Sensitive Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Uv Sensitive Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Warburg Micro Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Warburg Micro Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Warburg Micro Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cataract",
        "markers": [
          "Warburg Micro Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Clumped Pigmentary Retinal Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Clumped Pigmentary Retinal Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cold Induced Sweating Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Cold Induced Sweating Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Enhanced S Cone Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Enhanced S Cone Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Exudative Vitreoretinopathy 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Exudative Vitreoretinopathy 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Exudative Vitreoretinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Familial Exudative Vitreoretinopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Late Onset Retinal Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Late Onset Retinal Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Microphthalmia, Isolated 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated, With Coloboma 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Microphthalmia, Isolated, With Coloboma 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nanophthalmos 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Nanophthalmos 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Occult Macular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Occult Macular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinal Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy With Or Without Extraocular Anomalies (Rdeoa)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinal Dystrophy With Or Without Extraocular Anomalies (Rdeoa)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy, Iris Coloboma, And Comedogenic Acne Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinal Dystrophy, Iris Coloboma, And Comedogenic Acne Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 42",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 42"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 60",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 60"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 67",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 67"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 68",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 68"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 69",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 69"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 7, Digenic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 7, Digenic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 70",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 70"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 72",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 72"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 75",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 75"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa 77",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa 77"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa With Or Without Situs Inversus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa With Or Without Situs Inversus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinitis Pigmentosa, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Retinitis Pigmentosa, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sorsby Fundus Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinitis Pigmentosa",
        "markers": [
          "Sorsby Fundus Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bardet Biedl Syndrome 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bardet Biedl Syndrome",
        "markers": [
          "Bardet Biedl Syndrome 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bardet Biedl Syndrome 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bardet Biedl Syndrome",
        "markers": [
          "Bardet Biedl Syndrome 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bardet Biedl Syndrome 18",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Bardet Biedl Syndrome",
        "markers": [
          "Bardet Biedl Syndrome 18"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebellar Atrophy, Visual Impairment, And Psychomotor Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Cerebellar Atrophy, Visual Impairment, And Psychomotor Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cone Rod Dystrophy 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Cone Rod Dystrophy 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Doyne Honeycomb Degeneration Of Retina",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Doyne Honeycomb Degeneration Of Retina"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Macular Dystrophy, Retinal 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Macular Dystrophy, Retinal 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Malattia Leventinese",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Malattia Leventinese"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "North Carolina Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "North Carolina Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Oculoauricular Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Oculoauricular Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Persistent Hyperplastic Primary Vitreous, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Persistent Hyperplastic Primary Vitreous, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dysplasia And Severe Familial Exudative Vitreoretinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Retinal Dysplasia And Severe Familial Exudative Vitreoretinopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy, Juvenile Cataracts, And Short Stature Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Retinal Dystrophy, Juvenile Cataracts, And Short Stature Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sveinsson Choreoretinal Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Sveinsson Choreoretinal Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tritanopia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Tritanopia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Vitreoretinopathy, Neovascular Inflammatory",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Retinal Dystrophy",
        "markers": [
          "Vitreoretinopathy, Neovascular Inflammatory"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ventriculomegaly With Cystic Kidney Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystic Kidney Disease",
        "markers": [
          "Ventriculomegaly With Cystic Kidney Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aortic Aneurysm, Familial Thoracic 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Aorta",
        "markers": [
          "Aortic Aneurysm, Familial Thoracic 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Aortic Aneurysm, Familial Thoracic 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Aorta",
        "markers": [
          "Aortic Aneurysm, Familial Thoracic 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bone Fragility With Contractures, Arterial Rupture, And Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Cardiology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Aorta",
        "markers": [
          "Bone Fragility With Contractures, Arterial Rupture, And Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "longevity",
          "precision_medicine"
        ]
      },
      {
        "name": "Bardet Biedl Syndrome 20",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ciliopathy",
        "markers": [
          "Bardet Biedl Syndrome 20"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Interstitial Nephritis, Karyomegalic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ciliopathy",
        "markers": [
          "Interstitial Nephritis, Karyomegalic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia And Hydranencephaly (March)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ciliopathy",
        "markers": [
          "Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia And Hydranencephaly (March)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephronophthisis Like Nephropathy 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ciliopathy",
        "markers": [
          "Nephronophthisis Like Nephropathy 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Orofaciodigital Syndrome V",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ciliopathy",
        "markers": [
          "Orofaciodigital Syndrome V"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Agammaglobulinemia 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Agammaglobulinemia 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Autoimmune Disease, Syndromic Multisystem",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Autoimmune Disease, Syndromic Multisystem"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bile Acid Malabsorption, Primary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Bile Acid Malabsorption, Primary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Candidiasis, Familial, 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Candidiasis, Familial, 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Candidiasis, Familial, 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Candidiasis, Familial, 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chylomicron Retention Disease (Anderson Disease)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Chylomicron Retention Disease (Anderson Disease)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diamond Blackfan Anemia 14 With Mandibulofacial Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Diamond Blackfan Anemia 14 With Mandibulofacial Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diamond Blackfan Anemia 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Diamond Blackfan Anemia 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Anemia, Complementation Group R",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Fanconi Anemia, Complementation Group R"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Anemia, Complementation Group V",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Fanconi Anemia, Complementation Group V"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Herpes Simplex Encephalitis, Susceptibility To, 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Herpes Simplex Encephalitis, Susceptibility To, 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Herpes Simplex Encephalitis, Susceptibility To, 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Herpes Simplex Encephalitis, Susceptibility To, 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Herpes Simplex Encephalitis, Susceptibility To, 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Herpes Simplex Encephalitis, Susceptibility To, 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Immunodeficiency, Common Variable 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Immunodeficiency, Common Variable, 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Immunodeficiency, Common Variable, 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Intellectual Developmental Disorder With Dysmorphic Facies, Seizures, And Distal Limb Anomalies (Iddfsda)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Intellectual Developmental Disorder With Dysmorphic Facies, Seizures, And Distal Limb Anomalies (Iddfsda)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mannose Binding Protein Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Mannose Binding Protein Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microvillus Inclusion Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Microvillus Inclusion Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mirror Movements 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Mirror Movements 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myeloperoxidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Myeloperoxidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Plasminogen Deficiency, Type I",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Plasminogen Deficiency, Type I"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Psoriasis 15, Pustular, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Psoriasis 15, Pustular, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Seckel Syndrome 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Seckel Syndrome 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sporadic Idiopathic Steroid Resistant Nephrotic Syndrome With Focal Segmental Hyalinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Sporadic Idiopathic Steroid Resistant Nephrotic Syndrome With Focal Segmental Hyalinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "T Cell Receptor Alpha/Beta Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "T Cell Receptor Alpha/Beta Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichohepatoenteric Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Trichohepatoenteric Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichothiodystrophy 3, Photosensitive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Trichothiodystrophy 3, Photosensitive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Warsaw Breakage Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Hematology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Immune And Cytopenia",
        "markers": [
          "Warsaw Breakage Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Tubular Acidosis, Proximal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Renal Tubular Acidosis",
        "markers": [
          "Renal Tubular Acidosis, Proximal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anophthalmia, Microphthalmia, And Variable Brain, Ear, Palate, And Skeletal Anomalies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Anophthalmia, Microphthalmia, And Variable Brain, Ear, Palate, And Skeletal Anomalies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Anterior Segement Dysgenesis 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Anterior Segement Dysgenesis 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Linear Skin Defects With Multiple Congenital Anomalies 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Linear Skin Defects With Multiple Congenital Anomalies 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia With Limb Anomalies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia With Limb Anomalies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia, Isolated 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia, Isolated 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia, Isolated 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Isolated, With Cataract 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia, Isolated, With Cataract 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Syndromic 1 (Lenz Microphthalmia)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia, Syndromic 1 (Lenz Microphthalmia)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia, Syndromic 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia, Syndromic 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Microphthalmia/Coloboma And Skeletal Dysplasia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Microphthalmia/Coloboma And Skeletal Dysplasia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "N Terminal Acetyltransferase Deficiency (Ogden Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "N Terminal Acetyltransferase Deficiency (Ogden Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ocular Coloboma With Or Without Hearing Impairment, Cleft Lip/Palate, And/Or Mental Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Ocular Coloboma With Or Without Hearing Impairment, Cleft Lip/Palate, And/Or Mental Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Optic Disc Anomalies With Retinal And/Or Macular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microphthalmia Anophthalmia And Anterior Segment Dysgenesis",
        "markers": [
          "Optic Disc Anomalies With Retinal And/Or Macular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Amyloidosis, Systemic Nonneuropathic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Amyloidosis, Systemic Nonneuropathic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cerebral Palsy, Spastic Quadriplegic, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Cerebral Palsy, Spastic Quadriplegic, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Idiopathic Steroid Resistant Nephrotic Syndrome With Focal Segmental Hyalinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Familial Idiopathic Steroid Resistant Nephrotic Syndrome With Focal Segmental Hyalinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glomerulosclerosis, Focal Segmental",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Glomerulosclerosis, Focal Segmental"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrotic Syndrome, Type 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Nephrotic Syndrome, Type 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrotic Syndrome, Type 13",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Nephrotic Syndrome, Type 13"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma And Woolly Hair",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nephrology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrotic Syndrome",
        "markers": [
          "Palmoplantar Keratoderma And Woolly Hair"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Facial Dysmorphism, Lens Dislocation, Anterior Segment Abnormalities, And Spontaneous Filtering Blebs (Fdlab)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectopia Lentis",
        "markers": [
          "Facial Dysmorphism, Lens Dislocation, Anterior Segment Abnormalities, And Spontaneous Filtering Blebs (Fdlab)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperlysinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Ophthalmology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectopia Lentis",
        "markers": [
          "Hyperlysinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "prevention",
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 1829,
    "marker_count": 1829,
    "insight_count": 1608
  },
  {
    "id": "weightloss",
    "name": "Weight Loss",
    "sub": "Precision Nutrition & Metabolic Health",
    "color": "#1a6a8a",
    "lt": "#e5f2f8",
    "img": "https://images.unsplash.com/photo-1490645935967-10de6ba17061?w=320&q=75",
    "desc": "Metabolic phenotyping meets genomics \u2014 precision weight management using Lifenome 51-trait nutrition PGS, gut microbiome, CGM-guided optimization, and hormonal metabolic profiling.",
    "tags": [
      "metabolic phenotyping",
      "nutrition PGS",
      "low-carb vs low-fat",
      "satiety genetics",
      "CGM"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Dietary Habit & Adherence Profile",
        "desc": "Eating patterns, meal timing, snacking behavior, caloric awareness, and diet quality composite scoring.",
        "markers": [
          "meal timing regularity",
          "snacking freq/day",
          "alcohol cals/wk",
          "ultra-processed %",
          "diet quality score",
          "caloric awareness"
        ],
        "unit": "Diet adherence score 0\u2013100",
        "range": "Good adherence: >70 | Poor: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Caloric Balance Estimation",
        "desc": "TDEE estimation from lifestyle questionnaire with activity factor adjustment.",
        "markers": [
          "activity factor (1.2\u20131.9)",
          "dietary intake estimate kcal/day",
          "meal frequency",
          "eating window hrs"
        ],
        "unit": "Estimated TDEE kcal/day",
        "range": "Reference by gender/age/activity level",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Energy Expenditure & NEAT",
        "desc": "BMR estimation, TDEE, and non-exercise activity thermogenesis \u2014 the key variable in weight management.",
        "markers": [
          "TDEE kcal/day",
          "BMR kcal/day",
          "NEAT kcal/day estimate",
          "active calories",
          "step count"
        ],
        "unit": "TDEE kcal/day",
        "range": "NEAT: 200\u2013900 kcal/day range",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "CGM Metabolic Response Profile",
        "desc": "Time-in-range, glucose variability, and postprandial spike patterns for diet optimization.",
        "markers": [
          "TIR % (70\u2013140 mg/dL)",
          "glucose CV %",
          "postprandial peak mg/dL",
          "fasting glucose trend mg/dL",
          "dawn phenomenon"
        ],
        "unit": "TIR %",
        "range": "Optimal non-diabetic TIR: >90% | Concern: <70%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep-Weight Axis Monitor",
        "desc": "Short sleep duration and poor sleep quality correlation with weight gain and insulin resistance.",
        "markers": [
          "sleep hrs/night",
          "deep sleep %",
          "cortisol-HRV coupling",
          "sleep debt cumulative hrs"
        ],
        "unit": "Sleep debt hrs/week",
        "range": "Optimal: 0 hr debt | Weight risk: >5 hr debt/wk",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Body Composition Trajectory",
        "desc": "Smartphone-based longitudinal fat mass vs. lean mass tracking with visceral fat proxy.",
        "markers": [
          "body fat %",
          "muscle mass kg",
          "visceral fat proxy score",
          "waist circumference cm"
        ],
        "unit": "Body fat %",
        "range": "Healthy M: 8\u201319% | F: 21\u201333% | Obese M: >25%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Metabolic Health Baseline",
        "desc": "Glucose, HbA1c, lipids \u2014 foundational cardiometabolic weight-loss targets and starting point.",
        "markers": [
          "fasting glucose mg/dL",
          "HbA1c %",
          "lipid panel",
          "TSH mIU/L",
          "ALT IU/L"
        ],
        "unit": "HbA1c %",
        "range": "Normal: <5.7% | Prediabetes: 5.7\u20136.4% | T2DM: \u22656.5%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Insulin Resistance Panel",
        "desc": "Fasting insulin, HOMA-IR, and vitamin D \u2014 the top 3 metabolic weight-loss blockers.",
        "markers": [
          "fasting insulin \u00b5IU/mL",
          "HOMA-IR",
          "vitamin D ng/mL",
          "TSH mIU/L",
          "adiponectin \u00b5g/mL"
        ],
        "unit": "HOMA-IR",
        "range": "Optimal: <1.5 | Insulin resistant: >2.9 | High: >4.0",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Full Metabolic & Hormonal Profile",
        "desc": "Cortisol, DHEA-S, testosterone, IGF-1, leptin \u2014 stress-driven and hormonal obesity drivers.",
        "markers": [
          "cortisol AM \u00b5g/dL",
          "DHEA-S \u00b5g/dL",
          "testosterone ng/dL",
          "IGF-1 ng/mL",
          "leptin ng/mL",
          "prolactin ng/mL"
        ],
        "unit": "Cortisol AM \u00b5g/dL",
        "range": "Optimal: 10\u201320 \u00b5g/dL | Elevated (stress): >25",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Thyroid Metabolic Panel",
        "desc": "Full thyroid panel including antibodies \u2014 subclinical hypothyroidism causes 15\u201320% BMR reduction.",
        "markers": [
          "TSH mIU/L",
          "free T3 pg/mL",
          "free T4 ng/dL",
          "reverse T3 ng/dL",
          "anti-TPO IU/mL",
          "anti-Tg IU/mL"
        ],
        "unit": "Free T3 pg/mL",
        "range": "Optimal T3: 3.2\u20134.2 pg/mL | Low: <2.8",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Micronutrient Weight-Loss Blockers",
        "desc": "All micronutrient deficiencies that directly block weight loss: magnesium, zinc, omega-3, B vitamins.",
        "markers": [
          "magnesium RBC mg/dL",
          "zinc \u00b5g/dL",
          "omega-3 index %",
          "B12 pg/mL",
          "folate ng/mL",
          "CoQ10 \u00b5g/mL",
          "chromium \u00b5g/L"
        ],
        "unit": "Magnesium RBC mg/dL",
        "range": "Optimal: 5.0\u20136.5 mg/dL | Deficient: <4.5",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Nutrition PGS \u2014 51 Traits",
        "desc": "Lifenome 51-trait nutrition genetics: carb/fat sensitivity, satiety, overweight potential, 16 vitamin PGS, 13 mineral PGS.",
        "markers": [
          "FTO rs9939609 (obesity risk)",
          "MC4R (satiety signal)",
          "TCF7L2 (carb metabolism)",
          "PPARG Pro12Ala (fat metabolism)",
          "16 vitamin PGS",
          "13 mineral PGS",
          "51 nutrition traits total"
        ],
        "unit": "Per-trait percentile",
        "range": "High overweight potential: >75th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Diet Response Predictor",
        "desc": "Which diet works best for this individual: low-carb, low-fat, Mediterranean, protein-rich, fasting.",
        "markers": [
          "low-carb effectiveness PGS",
          "low-fat effectiveness PGS",
          "Mediterranean diet PGS",
          "protein sensitivity PGS",
          "intermittent fasting response"
        ],
        "unit": "Diet match score",
        "range": "High match: >80% concordance",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Satiety & Appetite Genetics",
        "desc": "FTO, MC4R, LEPR, NPY \u2014 genetic satiety signaling variants driving hunger and portion control.",
        "markers": [
          "FTO obesity risk allele",
          "MC4R satiety variants",
          "LEPR (leptin receptor)",
          "NPY (neuropeptide Y)",
          "CCK satiety PGS"
        ],
        "unit": "Satiety deficit score",
        "range": "High deficit: >75th percentile = structured meal planning",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "MTHFR & Metabolic Methylation",
        "desc": "Methylation genetics affecting homocysteine, B vitamin needs, and metabolic enzyme efficiency.",
        "markers": [
          "MTHFR C677T",
          "MTHFR A1298C",
          "COMT Val158Met",
          "CBS variants",
          "methylation efficiency score"
        ],
        "unit": "Methylation capacity score",
        "range": "TT homozygous C677T: highest need for methyl-B9/B12",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Rare Obesity Gene Discovery",
        "desc": "MC4R frameshift/truncating, LEP, LEPR, PCSK1 \u2014 monogenic obesity genes missed by array testing.",
        "markers": [
          "MC4R rare variants",
          "LEP/LEPR pathogenic variants",
          "PCSK1 variants",
          "SIM1 (hypothalamic obesity)",
          "rare obesity gene exome panel"
        ],
        "unit": "Variant classification",
        "range": "Monogenic obesity: rare (<1%) but fully penetrant",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "dna_wgs",
        "name": "WGS Metabolic Risk Refinement",
        "desc": "WGS improves all metabolic PGS and discovers rare regulatory variants affecting energy metabolism.",
        "markers": [
          "Enhanced nutrition PGS (all 51)",
          "rare regulatory variants",
          "structural variants in metabolic genes",
          "CNV affecting energy genes"
        ],
        "unit": "Enhanced PRS percentile",
        "range": "WGS PRS improves prediction by ~20%",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Caloric Extraction Microbiome",
        "desc": "Firmicutes:Bacteroidetes ratio and caloric extraction capacity \u2014 same calories, different absorption.",
        "markers": [
          "Firmicutes:Bacteroidetes ratio",
          "Akkermansia muciniphila %",
          "Prevotella vs Ruminococcus dominance",
          "Bifidobacterium %"
        ],
        "unit": "F:B ratio",
        "range": "High F:B (>3:1) = increased caloric extraction",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_16s",
        "name": "Satiety Hormone Microbiome Score",
        "desc": "GLP-1 and PYY-stimulating species abundance affecting post-meal satiety duration.",
        "markers": [
          "Bifidobacterium %",
          "GLP-1-stimulating Akkermansia %",
          "SCFA producers %",
          "serotonin pathway species"
        ],
        "unit": "GLP-1 stimulating species %",
        "range": "High GLP-1 stimulators: >15% = better satiety",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Metabolic Functional Capacity Map",
        "desc": "Functional gene pathways for fat storage, SCFA fermentation, and energy harvest from diet.",
        "markers": [
          "butyryl-CoA transferase gene count",
          "acetate/propionate balance",
          "secondary bile acid synthesis",
          "short-chain fatty acid gene diversity"
        ],
        "unit": "Functional metabolic score",
        "range": "High SCFA capacity: protective vs obesity",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Metabolic Epigenetic Age",
        "desc": "Epigenetic age acceleration in metabolic pathways \u2014 HbA1c-associated CpG sites as targets.",
        "markers": [
          "HbA1c-associated CpGs methylation",
          "adiposity methylation score",
          "lipid-associated CpG loci",
          "AgeAccelGrim metabolic component"
        ],
        "unit": "Metabolic epigenetic age (yr)",
        "range": "Target: \u2264 chronological age",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "blood",
        "name": "Metabolism Healthspan Score",
        "desc": "InsideTracker's metabolism category combining sugar biomarkers (glucose, HbA1c, fasting insulin) and lipid biomarkers (LDL, HDL, TG, ApoB) into a composite metabolism optimization score \u2014 predicts T2DM risk and weight trajectory.",
        "markers": [
          "fasting glucose",
          "HbA1c",
          "fasting insulin",
          "HOMA-IR",
          "LDL",
          "HDL",
          "triglycerides",
          "ApoB",
          "total cholesterol"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >70 | At-risk metabolism: <45",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Genotype-Matched Diet Plan",
        "desc": "Personalized macronutrient prescription derived from dietary genetics: low-carb vs low-fat diet effectiveness genes, saturated fat sensitivity, trans-fat sensitivity, Mediterranean diet response, and monounsaturated fat benefit profile. Includes food lists, meal templates, and shopping guides.",
        "markers": [
          "low-carb diet effectiveness PGS",
          "low-fat diet effectiveness PGS",
          "saturated fat sensitivity",
          "Mediterranean diet PGS",
          "HOMA-IR",
          "HbA1c",
          "triglycerides"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Metabolic Optimization Exercise Plan",
        "desc": "Exercise prescription optimized for fat loss and metabolic health: HIIT vs steady-state ratio based on cardiovascular age, resistance training volume for lean mass preservation, NEAT enhancement strategies, and activity timing by chronotype.",
        "markers": [
          "resting metabolic rate PGS",
          "HOMA-IR",
          "cortisol AM",
          "chronotype PGS",
          "lean body mass",
          "VO\u2082max",
          "physical activity level"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Weight Loss Supplement Protocol",
        "desc": "Evidence-based supplements from client catalog matched to metabolic blockers: magnesium for insulin sensitivity, chromium for glucose regulation, berberine proxy biomarkers, omega-3 for triglyceride reduction, fiber/prebiotic for satiety microbiome, and protein formulation.",
        "markers": [
          "magnesium RBC",
          "triglycerides",
          "HOMA-IR",
          "omega-3 index",
          "Firmicutes:Bacteroidetes ratio",
          "vitamin D"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Adrenal Insufficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Adrenal Insufficiency"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Diabetic Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Diabetic Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Diabetic Retinopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Diabetic Retinopathy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Gestational Diabetes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Gestational Diabetes"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Gestational Diabetes Only During Pregnancy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Gestational Diabetes Only During Pregnancy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hepatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Hepatitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hepatitis A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Hepatitis A"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "High Cholesterol",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "High Cholesterol"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hyperthyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Hyperthyroidism"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hypopituitarism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Hypopituitarism"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Hypothyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Hypothyroidism"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Pituitary Tumor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Pituitary Tumor"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Thyroid Goiter",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Thyroid Goiter"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Thyroiditis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Thyroiditis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Type 1 Diabetes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Type 1 Diabetes"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Type 2 Diabetes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrine Nutritional Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Endocrine Nutritional Metabolic Disorders",
        "markers": [
          "Type 2 Diabetes"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "2 Methylbutyryl Coa Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "2 Methylbutyryl Coa Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Methylcrotonyl Coa Carboxylase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "3 Methylcrotonyl Coa Carboxylase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Methylcrotonyl Coa Carboxylase 2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "3 Methylcrotonyl Coa Carboxylase 2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Hydroxy 3 Methylglutaryl Coa Lyase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "3 Hydroxy 3 Methylglutaryl Coa Lyase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Hydroxyisobutryl Coa Hydrolase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "3 Hydroxyisobutryl Coa Hydrolase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Methylglutaconic Aciduria With Deafness, Encephalopathy, And Leigh Like Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "3 Methylglutaconic Aciduria With Deafness, Encephalopathy, And Leigh Like Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alpha Methylacetoacetic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Alpha Methylacetoacetic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bjornstad Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Bjornstad Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined D 2  And L 2 Hydroxyglutaric Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Combined D 2  And L 2 Hydroxyglutaric Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Malonic And Methylmalonic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Combined Malonic And Methylmalonic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Combined Methylmalonic Acidemia And Hyperhomocysteinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Combined Methylmalonic Acidemia And Hyperhomocysteinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cystathioninuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Cystathioninuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "D 2 Hydroxyglutaric Aciduria 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "D 2 Hydroxyglutaric Aciduria 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "D 2 Hydroxyglutaric Aciduria 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "D 2 Hydroxyglutaric Aciduria 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Dihydrolipoyl Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Dihydrolipoyl Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Finnish",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Finnish"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gracile Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Gracile Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glutaric Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Glutaric Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glutaric Aciduria Iii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Glutaric Aciduria Iii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glycine N Methyltransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Glycine N Methyltransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Homocystinuria Due To Mthfr Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Homocystinuria Due To Mthfr Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Homocystinuria Megaloblastic Anemia, Cobalamin E",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Homocystinuria Megaloblastic Anemia, Cobalamin E"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypermethioninemia Due To Adenosine Kinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Hypermethioninemia Due To Adenosine Kinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypermethioninemia With S Adenosylhomocysteine Hydrolase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Hypermethioninemia With S Adenosylhomocysteine Hydrolase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Intrinsic Factor Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Intrinsic Factor Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Isovaleric Acidemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Isovaleric Acidemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "L 2 Hydroxyglutaric Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "L 2 Hydroxyglutaric Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipid Storage Myopathy Due To Flad1 Deficiency (Lsmflad)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Lipid Storage Myopathy Due To Flad1 Deficiency (Lsmflad)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Malonyl Coa Decarboxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Malonyl Coa Decarboxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Maple Syrup Urine Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Maple Syrup Urine Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Megaloblastic Anemia 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Megaloblastic Anemia 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Methylmalonic Acidemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Methylmalonic Acidemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Methylmalonic Acidemia Due To Methylmalonyl Coa Mutase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Methylmalonic Acidemia Due To Methylmalonyl Coa Mutase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Methylmalonic Aciduria And Homocystinuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Methylmalonic Aciduria And Homocystinuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Methylmalonic Aciduria Due To Transcobalamin Receptor Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Methylmalonic Aciduria Due To Transcobalamin Receptor Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Methylmalonyl Coa Epimerase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Methylmalonyl Coa Epimerase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitochondrial Dna Depletion Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Mitochondrial Dna Depletion Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitochondrial Complex Iii Deficiency, Nuclear Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Mitochondrial Complex Iii Deficiency, Nuclear Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Acyl Coa Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Multiple Acyl Coa Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Norwegian",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Norwegian"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Orotic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Orotic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Prolidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Prolidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Propionic Acidemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Propionic Acidemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Transcobalamin Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Organic Acidemia Aciduria & Cobalamin Deficiency",
        "markers": [
          "Transcobalamin Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Achalasia Addisonianism Alacrimia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Achalasia Addisonianism Alacrimia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucocorticoid Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Glucocorticoid Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucocorticoid Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Glucocorticoid Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipoid Adrenal Hyperplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Lipoid Adrenal Hyperplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Proopiomelanocortin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glucocorticoid Deficiency",
        "markers": [
          "Proopiomelanocortin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Hydroxy 3 Methylglutaryl Coa Synthase 2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "3 Hydroxy 3 Methylglutaryl Coa Synthase 2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acyl Coa Dehydrogenase, Short Chain, Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Acyl Coa Dehydrogenase, Short Chain, Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Argininosuccinic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Argininosuccinic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Carbamoylphosphate Synthetase I Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Carbamoylphosphate Synthetase I Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Carbonic Anhydrase Va Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Carbonic Anhydrase Va Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Carnitine Palmitoyltransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Carnitine Palmitoyltransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Citrin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Citrin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Citrullinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Citrullinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glutamine Deficiency, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Glutamine Deficiency, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gyrate Atrophy Of Choroid And Retina",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Gyrate Atrophy Of Choroid And Retina"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Holocarboxylase Synthetase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Holocarboxylase Synthetase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperammonemia Hyperinsulinism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Hyperammonemia Hyperinsulinism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperinsulinemic Hypoglycemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Hyperinsulinemic Hypoglycemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Infantile Liver Failure Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Infantile Liver Failure Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lysinuric Protein Intolerance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Lysinuric Protein Intolerance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mitochondrial Complex V (Atp Synthase) Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Mitochondrial Complex V (Atp Synthase) Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "N Acetylglutamate Synthase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "N Acetylglutamate Synthase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ornithine Transcarbamylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Ornithine Transcarbamylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyruvate Carboxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Pyruvate Carboxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Short Stature, Optic Nerve Atrophy, And Pelger Huet Anomaly (Soph Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperammonemia And Urea Cycle Disorder",
        "markers": [
          "Short Stature, Optic Nerve Atrophy, And Pelger Huet Anomaly (Soph Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "6Q16 Deletion Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "6Q16 Deletion Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Abdominal Obesity Metabolic Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Abdominal Obesity Metabolic Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Borjeson Forssman Lehmann Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Borjeson Forssman Lehmann Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cabezas",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Cabezas"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Heart Defects, Hamartomas Of Tongue, And Polysyndactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Congenital Heart Defects, Hamartomas Of Tongue, And Polysyndactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Developmental Delay, Intellectual Disability, Obesity, And Dysmorphism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Developmental Delay, Intellectual Disability, Obesity, And Dysmorphism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Insulin Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Insulin Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leptin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Leptin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Leptin Receptor Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Leptin Receptor Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipodystrophy, Familial, Partial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Lipodystrophy, Familial, Partial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mckusick Kaufman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Mckusick Kaufman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Meckel Gruber Syndrome, Modifier",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Meckel Gruber Syndrome, Modifier"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Monogenic Obesity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Monogenic Obesity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Morbid Obesity And Spermatogenic Failure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Morbid Obesity And Spermatogenic Failure"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Obesity Due To Mc3R Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Obesity Due To Mc3R Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Obesity Due To Sim1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Obesity Due To Sim1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Obesity, Hyperphagia, And Developmental Delay",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Obesity, Hyperphagia, And Developmental Delay"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Obesity, Mild, Early Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Obesity, Mild, Early Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Obesity, Severe, And Type Ii Diabetes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Obesity, Severe, And Type Ii Diabetes"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Prader Willi Like Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Prader Willi Like Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Proprotein Convertase 1/3 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Proprotein Convertase 1/3 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Retinal Dystrophy And Obesity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Retinal Dystrophy And Obesity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Schaaf Yang Syndrome (Prader Willi Like Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Monogenic Obesity",
        "markers": [
          "Schaaf Yang Syndrome (Prader Willi Like Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Bickel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Fanconi Bickel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fructose Intolerance, Hereditary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Fructose Intolerance, Hereditary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Galactokinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Galactokinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Galactose Epimerase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Galactose Epimerase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Galactosemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Galactosemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucose/Galactose Malabsorption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Glucose/Galactose Malabsorption"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lactase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Lactase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Neonatal Diabetes Mellitus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Neonatal Diabetes Mellitus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sucrase Isomaltase Deficiency, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Mono And Disaccharide Disorders",
        "markers": [
          "Sucrase Isomaltase Deficiency, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenal Hyperplasia, Congenital, Due To 17 Alpha Hydroxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Adrenal Hyperplasia, Congenital, Due To 17 Alpha Hydroxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenocortical Insufficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Adrenocortical Insufficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Antley Bixler Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Antley Bixler Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Aromatase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Aromatase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Aromatase Excess Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Aromatase Excess Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Blepharophimosis, Epicanthus Inversus, And Ptosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Blepharophimosis, Epicanthus Inversus, And Ptosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Denys Drash Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Denys Drash Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Disordered Steroidogenesis Due To Cytochrome P450 Oxidoreductase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Fragile X Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Fragile X Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Fragile X Tremor/Ataxia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Fragile X Tremor/Ataxia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Frasier Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Frasier Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Leydig Cell Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Leydig Cell Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Luteinizing Hormone Resistance, Female",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Luteinizing Hormone Resistance, Female"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrotic Syndrome, Type 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Nephrotic Syndrome, Type 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovarian Dysgenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Ovarian Dysgenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovarian Dysgenesis 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Ovarian Dysgenesis 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Ovarian Hyperstimulation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Ovarian Hyperstimulation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Precocious Puberty, Male",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Precocious Puberty, Male"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Premature Ovarian Failure",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Premature Ovarian Failure"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Premature Ovarian Failure 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Premature Ovarian Failure 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Premature Ovarian Failure 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Premature Ovarian Failure 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Premature Ovarian Failure 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Premature Ovarian Failure 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Premature Ovarian Failure, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Premature Ovarian Failure With Fmr1 Repeat Expansion",
        "markers": [
          "Premature Ovarian Failure, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperuricemia, Pulmonary Hypertension, Renal Failure, And Alkalosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Hyperuricemia, Pulmonary Hypertension, Renal Failure, And Alkalosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypomagnesemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Hypomagnesemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypomagnesemia, Intestinal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Hypomagnesemia, Intestinal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypomagnesemia, Seizures, And Mental Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Hypomagnesemia, Seizures, And Mental Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Jalili Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Jalili Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kenny Caffey Syndrome, Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Kenny Caffey Syndrome, Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Cell Carcinoma, Nonpapillary Chromophobe",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Renal Cell Carcinoma, Nonpapillary Chromophobe"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Renal Cysts And Diabetes Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypomagnesemia",
        "markers": [
          "Renal Cysts And Diabetes Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Chondrodysplasia Punctata",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Peroxisomal Disorders",
        "markers": [
          "Chondrodysplasia Punctata"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperoxaluria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Peroxisomal Disorders",
        "markers": [
          "Hyperoxaluria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Male Ebp Disorder With Neurologic Defects (Mend)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Peroxisomal Disorders",
        "markers": [
          "Male Ebp Disorder With Neurologic Defects (Mend)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mulibrey Nanism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Peroxisomal Disorders",
        "markers": [
          "Mulibrey Nanism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhizomelic Chondrodysplasia Punctata Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Peroxisomal Disorders",
        "markers": [
          "Rhizomelic Chondrodysplasia Punctata Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rhizomelic Chondrodysplasia Punctata, Rhizomelic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Peroxisomal Disorders",
        "markers": [
          "Rhizomelic Chondrodysplasia Punctata, Rhizomelic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Aicar Transformylase/Imp Cyclohydrolase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Aicar Transformylase/Imp Cyclohydrolase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Adenine Phosphoribosyltransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Adenine Phosphoribosyltransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Beta Ureidopropionase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Beta Ureidopropionase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Juvenile Hyperuricemic Nephropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Familial Juvenile Hyperuricemic Nephropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glomerulocystic Kidney Disease With Hyperuricemia And Isosthenuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Glomerulocystic Kidney Disease With Hyperuricemia And Isosthenuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kelley Seegmiller Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Kelley Seegmiller Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lesch Nyhan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Lesch Nyhan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Medullary Cystic Kidney Disease 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Medullary Cystic Kidney Disease 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Postaxial Acrofacial Dysostosis (Miller Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Postaxial Acrofacial Dysostosis (Miller Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Thiopurine S Methyltransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Thiopurine S Methyltransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Xanthinuria, Type I",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Xanthinuria, Type I"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Xanthinuria, Type Ii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Purine And Pyrimidine Metabolism Disorders",
        "markers": [
          "Xanthinuria, Type Ii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fructose 1,6 Bisphosphatase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glycogen Storage Disorder",
        "markers": [
          "Fructose 1,6 Bisphosphatase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glycogen Storage Disease, Type Ixa1/Glycogen Storage Disease, Type Ixa2 (Phosphorylase Kinase Deficiency)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glycogen Storage Disorder",
        "markers": [
          "Glycogen Storage Disease, Type Ixa1/Glycogen Storage Disease, Type Ixa2 (Phosphorylase Kinase Deficiency)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Increased Glyogen Content In Skeletal Muscle",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Glycogen Storage Disorder",
        "markers": [
          "Increased Glyogen Content In Skeletal Muscle"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cholesterol Ester Storage Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Liver Failure",
        "markers": [
          "Cholesterol Ester Storage Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Niemann Pick Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Liver Failure",
        "markers": [
          "Niemann Pick Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Niemann Pick Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Liver Failure",
        "markers": [
          "Niemann Pick Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wilson Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Liver Failure",
        "markers": [
          "Wilson Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Wolman Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Liver Failure",
        "markers": [
          "Wolman Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hawksinuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Tyrosinemia",
        "markers": [
          "Hawksinuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Tyrosinemia, Type Ii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Tyrosinemia",
        "markers": [
          "Tyrosinemia, Type Ii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Ab Variant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Ab Variant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alpha N Acetylgalactosaminidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Alpha N Acetylgalactosaminidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease, Axonal, Type 2V",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Charcot Marie Tooth Disease, Axonal, Type 2V"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Cystinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Cystinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Mellitus, Transient Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Diabetes Mellitus, Transient Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes, Permanent Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Diabetes, Permanent Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fibromatosis, Juveline Hyaline",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Fibromatosis, Juveline Hyaline"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Finnish (Salla Disease)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Finnish (Salla Disease)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fucosidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Fucosidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Galactosialidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Galactosialidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyalinosis, Infantile Systemic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Hyalinosis, Infantile Systemic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoglycemia, Leucine Induced",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Hypoglycemia, Leucine Induced"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Infantile Sialic Acid Storage Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Infantile Sialic Acid Storage Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kanzaki Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Kanzaki Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mucolipidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Mucolipidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Mucopolysaccharidosis (Maroteaux Lamy)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Mucopolysaccharidosis (Maroteaux Lamy)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Sandhoff Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Sandhoff Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Schindler Disease Type I",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Schindler Disease Type I"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Schindler Disease Type Iii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lysosomal Disorders And Mucopolysaccharidosis",
        "markers": [
          "Schindler Disease Type Iii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Beta Hydroxysteroid Dehydrogenase",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "3 Beta Hydroxysteroid Dehydrogenase"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenal Hyperplasia, Congenital, Due To 11 Beta Hydroxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Adrenal Hyperplasia, Congenital, Due To 11 Beta Hydroxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenal Hyperplasia, Congenital, Due To 21 Hydroxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Adrenal Hyperplasia, Congenital, Due To 21 Hydroxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenal Hypoplasia, Congenital, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Adrenal Hypoplasia, Congenital, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Adrenal Insufficiency, Congenital, With 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Adrenal Insufficiency, Congenital, With 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Androgen Insensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Androgen Insensitivity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Central Precocious Puberty",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Central Precocious Puberty"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Fraser Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Fraser Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Glucocorticoid Remediable Aldosteronism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Glucocorticoid Remediable Aldosteronism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hartsfield Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hartsfield Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperandrogenism, Nonclassic , Due To 21 Hydroxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hyperandrogenism, Nonclassic , Due To 21 Hydroxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadism, Hypogonadotropic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadism, Hypogonadotropic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 12 With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 12 With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 13 With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 13 With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 15, With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 15, With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 20, With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 20, With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 22 With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 22 With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 23 With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 23 With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 24 Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 24 Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypogonadotropic Hypogonadism 9 With Or Without Anosmia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypogonadotropic Hypogonadism 9 With Or Without Anosmia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypospadias 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypospadias 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypospadias 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Hypospadias 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Methemoglobinemia, Type Iv",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Methemoglobinemia, Type Iv"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrotic Syndrome 14",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Nephrotic Syndrome 14"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Neurodevelopmental Disorder With Hypotonia, Neonatal Respiratory Insufficiency, And Thermodysregulation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Neurodevelopmental Disorder With Hypotonia, Neonatal Respiratory Insufficiency, And Thermodysregulation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteoglophonic Dwarfism   Craniostenosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Osteoglophonic Dwarfism   Craniostenosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Hyperkeratosis With Squamous Cell Carcinoma Of Skin And 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Palmoplantar Hyperkeratosis With Squamous Cell Carcinoma Of Skin And 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Persistent Mullerian Duct Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Persistent Mullerian Duct Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Polymicrogyria, Bilateral Occipital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Polymicrogyria, Bilateral Occipital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Pontocerebellar Hypoplasia Type 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Pontocerebellar Hypoplasia Type 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Popliteal Pterygium Syndrome, Van Der Woude Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Popliteal Pterygium Syndrome, Van Der Woude Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Precocious Puberty, Central 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Precocious Puberty, Central 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Srps Type 2 (Majewski)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Srps Type 2 (Majewski)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Short  Rib Thoracic Dysplasia With Or Without Polydactyly Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Short  Rib Thoracic Dysplasia With Or Without Polydactyly Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Short  Rib Thoracic Dysplasia With Or Without Polydactyly Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Short  Rib Thoracic Dysplasia With Or Without Polydactyly Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Steroid 5 Alpha Reductase 2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Steroid 5 Alpha Reductase 2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Sudden Infant Death With Dysgenesis Of The Testes Syndrome, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Sudden Infant Death With Dysgenesis Of The Testes Syndrome, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Trigonocephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Trigonocephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xx Disorder Of Sex Development, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xx Disorder Of Sex Development, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xx Sex Reversal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xx Sex Reversal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xy Disorder Of Sex Development",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xy Disorder Of Sex Development"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xy Partial Gonadal Dysgenesis, With Minifascicular Neuropathy, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xy Partial Gonadal Dysgenesis, With Minifascicular Neuropathy, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xy Sex Reversal 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xy Sex Reversal 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xy Sex Reversal 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xy Sex Reversal 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Xy Sex Reversal, Partial Or Complete",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Xy Sex Reversal, Partial Or Complete"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Yunis Varon Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Abnormal Genitalia Disorders Of Sex Development",
        "markers": [
          "Yunis Varon Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Familial Isolated Hyperparathyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Familial Isolated Hyperparathyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperparathyroidism 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Hyperparathyroidism 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypocalciuric Hypercalcemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Hypocalciuric Hypercalcemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypocalciuric Hypercalcemia, Familial, Type Iii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Hypocalciuric Hypercalcemia, Familial, Type Iii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoparathyroidism, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Hypoparathyroidism, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoparathyroidism, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Hypoparathyroidism, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoparathyroidism, Familial Isolated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Hypoparathyroidism, Familial Isolated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Endocrine Neoplasia Type I",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hyperparathyroidism",
        "markers": [
          "Multiple Endocrine Neoplasia Type I"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Cystinuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cystinuria",
        "markers": [
          "Cystinuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Central Hypothyroidism And Testicular Enlargement",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Central Hypothyroidism And Testicular Enlargement"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperthyroidism, Familial, Gestational",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Hyperthyroidism, Familial, Gestational"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperthyroidism, Nonautoimmune",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Hyperthyroidism, Nonautoimmune"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypothyroidism, Congenital, Nongoitrous",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Hypothyroidism, Congenital, Nongoitrous"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypothyroidism, Congenital, Nongoitrous,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Hypothyroidism, Congenital, Nongoitrous,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypothyroidism, Congenital, Nongoitrous, 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Hypothyroidism, Congenital, Nongoitrous, 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate (Bamforth Lazarus Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate (Bamforth Lazarus Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Selenoprotein Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Selenoprotein Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Thyroid Cancer, Nonmedullary 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Thyroid Cancer, Nonmedullary 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Thyroid Dyshormonogenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Thyroid Dyshormonogenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Thyroid Dyshormonogenesis 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Thyroid Dyshormonogenesis 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Thyroid Hormone Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypothyroidism And Resistance To Thyroid Hormone",
        "markers": [
          "Thyroid Hormone Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "3 Hydroxyacyl Coa Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "3 Hydroxyacyl Coa Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Hyperinsulinism, Diazoxide Responsive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Congenital Hyperinsulinism, Diazoxide Responsive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Mellitus, Permanent Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Diabetes Mellitus, Permanent Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Donohoe Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Donohoe Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrocyte Lactate Transporter Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Erythrocyte Lactate Transporter Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Renotubular Syndrome 4 With Maturity Onset Diabetes Of The Young",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Fanconi Renotubular Syndrome 4 With Maturity Onset Diabetes Of The Young"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperinsulinemic Hypoglycemia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Hyperinsulinemic Hypoglycemia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperinsulinism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Hyperinsulinism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lactic Acidemia Due To Pdx1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Lactic Acidemia Due To Pdx1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Maturity Onset Diabetes Of The Young 13",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Maturity Onset Diabetes Of The Young 13"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Maturity Onset Diabetes Of The Young, Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Maturity Onset Diabetes Of The Young, Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Maturity Onset Diabetes Of The Young, Type 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Maturity Onset Diabetes Of The Young, Type 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Monocarboxylate Transporter 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Monocarboxylate Transporter 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Myoclonic Atonic Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Myoclonic Atonic Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pancreatic Agenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Pancreatic Agenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Paternally Inherited Mutations Can Cause Focal Adenomatous Hyperplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Paternally Inherited Mutations Can Cause Focal Adenomatous Hyperplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Phosphoenolpyruvate Carboxykinase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Phosphoenolpyruvate Carboxykinase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Rabson Mendenhall Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Rabson Mendenhall Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Succinyl Coa:3 Oxoacid Coa Transferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hypoglycemia Hyperinsulinism And Ketone Metabolism",
        "markers": [
          "Succinyl Coa:3 Oxoacid Coa Transferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Absorptive Hypercalciuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Absorptive Hypercalciuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Amelogenesis Imperfecta (Enamel Renal Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Amelogenesis Imperfecta (Enamel Renal Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bartter Syndrome Type 5, Antenatal Transient",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Bartter Syndrome Type 5, Antenatal Transient"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Bartter Syndrome, Antenatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Bartter Syndrome, Antenatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Fanconi Renotubular Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Fanconi Renotubular Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypercalcemia, Infantile 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Hypercalcemia, Infantile 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypercalcemia, Infantile 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Hypercalcemia, Infantile 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypophosphatemic Rickets,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Hypophosphatemic Rickets,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypouricemia, Renal 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Hypouricemia, Renal 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypouricemia, Renal, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Hypouricemia, Renal, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrolithiasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Nephrolithiasis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrolithiasis, Calcium Oxalate",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Nephrolithiasis, Calcium Oxalate"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrolithiasis/Osteoporosis, Hypophosphatemic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Nephrolithiasis/Osteoporosis, Hypophosphatemic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Nephrolithiasis/Osteoporosis, Hypophosphatemic, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Nephrolithiasis/Osteoporosis, Hypophosphatemic, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Proteinuria, Low Molecular Weight, With Hypercalciuric Nephrocalcinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nephrolithiasis",
        "markers": [
          "Proteinuria, Low Molecular Weight, With Hypercalciuric Nephrocalcinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Isobutyryl Coa Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Fatty Acid Oxidation Syndrome",
        "markers": [
          "Isobutyryl Coa Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Abdominal Obesity Metabolic Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Abdominal Obesity Metabolic Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acrodermatitis Enteropathica",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Acrodermatitis Enteropathica"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alacrima, Achalasia, And Mental Retardation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Alacrima, Achalasia, And Mental Retardation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Alkaptonuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Alkaptonuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Congenital Disorder Of Deglycosylation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Congenital Disorder Of Deglycosylation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Mellitus, Noninsulin Dependent",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Diabetes Mellitus, Noninsulin Dependent"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Gillessen Kaesbach Nishimura Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Gillessen Kaesbach Nishimura Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Glycine Encephalopathy With Normal Serum Glycine",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Glycine Encephalopathy With Normal Serum Glycine"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hartnup Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Hartnup Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypoinsulinemic Hypoglycemia With Hemihypertrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Hypoinsulinemic Hypoglycemia With Hemihypertrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Kahrizi Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Kahrizi Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipodystrophy, Familial Partial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Lipodystrophy, Familial Partial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipodystrophy, Familial Partial, Type 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Lipodystrophy, Familial Partial, Type 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Lipoyltransferase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Lipoyltransferase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Multiple Mitochondrial Dysfunctions Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Multiple Mitochondrial Dysfunctions Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Peters Plus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Peters Plus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Pyruvate Dehydrogensae E1 Beta Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Pyruvate Dehydrogensae E1 Beta Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Transaldolase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Transaldolase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Trimethylaminuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Metabolic Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Metabolism",
        "markers": [
          "Trimethylaminuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "prevention",
          "precision_medicine"
        ]
      },
      {
        "name": "Acth Independent Macronodular Adrenal Hyperplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Adrenal Hyperplasia",
        "markers": [
          "Acth Independent Macronodular Adrenal Hyperplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Corticosterone Methyloxidase Type I Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Adrenal Hyperplasia",
        "markers": [
          "Corticosterone Methyloxidase Type I Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Corticosterone Methyloxidase Type Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Adrenal Hyperplasia",
        "markers": [
          "Corticosterone Methyloxidase Type Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Pigmented Nodular Adrenocortical Disease, Primary, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Adrenal Hyperplasia",
        "markers": [
          "Pigmented Nodular Adrenocortical Disease, Primary, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Mellitus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mody",
        "markers": [
          "Diabetes Mellitus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Hyperproinsulinemia, Familial, With Or Without Diabetes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mody",
        "markers": [
          "Hyperproinsulinemia, Familial, With Or Without Diabetes"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Maturity Onset Diabetes Of The Young, Type 14",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mody",
        "markers": [
          "Maturity Onset Diabetes Of The Young, Type 14"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Maturity Onset Diabetes Of The Young, Type 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mody",
        "markers": [
          "Maturity Onset Diabetes Of The Young, Type 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Mellitus, Neonatal, With Congenital Hypothyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Monogenic Diabetes",
        "markers": [
          "Diabetes Mellitus, Neonatal, With Congenital Hypothyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      },
      {
        "name": "Diabetes Mellitus, Transient Neonatal, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Endocrinology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Monogenic Diabetes",
        "markers": [
          "Diabetes Mellitus, Transient Neonatal, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "weightloss",
          "menopause",
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 497,
    "marker_count": 497,
    "insight_count": 364
  },
  {
    "id": "glp1",
    "name": "GLP-1 Weight Loss",
    "sub": "Pharmacotherapy Monitoring & Optimization",
    "color": "#7a4090",
    "lt": "#f5eeff",
    "img": "https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=320&q=75",
    "desc": "Precision monitoring for semaglutide and tirzepatide \u2014 responder prediction, lean mass protection, dose optimization, contraindication screening, and side-effect management.",
    "tags": [
      "semaglutide",
      "tirzepatide",
      "responder PGS",
      "lean mass protection",
      "PGx side effects"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "GLP-1 Candidacy Assessment",
        "desc": "Lifestyle baseline, BMI trajectory, comorbidity profile, and GLP-1 indication evaluation.",
        "markers": [
          "BMI kg/m\u00b2",
          "BMI trajectory (5-yr)",
          "T2DM/prediabetes status",
          "previous weight-loss attempts",
          "NAFLD risk"
        ],
        "unit": "Candidacy score (Yes/Conditional/No)",
        "range": "BMI \u226530 or \u226527 + comorbidity = FDA indication",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Adherence & Lifestyle Co-Intervention",
        "desc": "Readiness assessment for behavioral co-intervention required alongside GLP-1 therapy.",
        "markers": [
          "dietary change readiness",
          "physical activity readiness",
          "support system score",
          "adherence history",
          "health literacy"
        ],
        "unit": "Readiness score 0\u2013100",
        "range": "Optimal co-intervention: >65",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Body Composition Response Monitor",
        "desc": "Continuous lean vs. fat mass loss tracking during GLP-1 therapy \u2014 muscle preservation alert.",
        "markers": [
          "weight kg (weekly)",
          "body fat % trend",
          "muscle mass trend",
          "visceral fat reduction proxy"
        ],
        "unit": "Fat mass lost vs lean mass lost ratio",
        "range": "Optimal: >80% fat loss | Alert: muscle loss >25%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Cardiovascular Improvement Tracking",
        "desc": "HR, HRV, and activity improvement \u2014 quantifying GLP-1 cardioprotective benefit.",
        "markers": [
          "resting HR change bpm",
          "HRV trend change ms",
          "systolic BP proxy change",
          "activity increase steps/day"
        ],
        "unit": "Resting HR reduction bpm",
        "range": "Expected: -5 to -10 bpm over 12 wks",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "wearable",
        "name": "Nausea & Tolerability Biomarker",
        "desc": "HRV vagal tone as proxy for GI tolerability \u2014 low HF-HRV predicts higher nausea burden.",
        "markers": [
          "HF-HRV ms\u00b2",
          "nocturnal HRV",
          "heart rate variability frequency domain",
          "sleep disruption index"
        ],
        "unit": "HF-HRV ms\u00b2",
        "range": "High vagal tone: better GI tolerability predicted",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Visceral Fat Reduction Tracking",
        "desc": "Smartphone-estimated visceral fat change \u2014 primary GLP-1 target independent of total weight.",
        "markers": [
          "waist circumference cm",
          "visceral fat proxy score",
          "waist-height ratio",
          "abdominal protrusion index"
        ],
        "unit": "Waist circumference cm",
        "range": "Target: \u22655 cm reduction at 12 weeks",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "GLP-1 Pre-Treatment Baseline",
        "desc": "Metabolic benchmark panel before starting GLP-1 therapy for responder monitoring.",
        "markers": [
          "HbA1c %",
          "fasting glucose mg/dL",
          "weight kg",
          "BMI",
          "lipid panel",
          "liver panel (ALT/AST)"
        ],
        "unit": "HbA1c %",
        "range": "T2DM response target: HbA1c reduction \u22651.0%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "GLP-1 Safety Monitoring Panel",
        "desc": "Pancreatitis markers, thyroid, and kidney function \u2014 mandatory GLP-1 safety monitoring protocol.",
        "markers": [
          "amylase IU/L",
          "lipase IU/L",
          "TSH mIU/L",
          "calcitonin pg/mL",
          "creatinine mg/dL",
          "eGFR mL/min",
          "ALT IU/L"
        ],
        "unit": "Lipase IU/L",
        "range": "Pancreatitis concern: lipase >3x ULN (>180 IU/L)",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Lean Mass Protection Panel",
        "desc": "IGF-1, albumin, testosterone, and amino acids \u2014 muscle preservation monitoring during rapid weight loss.",
        "markers": [
          "IGF-1 ng/mL",
          "albumin g/dL",
          "testosterone ng/dL",
          "SHBG nmol/L",
          "amino acid panel",
          "creatinine (muscle mass proxy) mg/dL"
        ],
        "unit": "IGF-1 ng/mL",
        "range": "Maintain IGF-1: >100 ng/mL during therapy",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Metabolic Improvement Velocity Panel",
        "desc": "ApoB, hs-CRP, liver panel \u2014 tracking comprehensive cardiometabolic benefit of GLP-1.",
        "markers": [
          "ApoB mg/dL",
          "hs-CRP mg/L",
          "ALT IU/L (NAFLD marker)",
          "uric acid mg/dL",
          "adiponectin \u00b5g/mL",
          "IL-6 pg/mL"
        ],
        "unit": "ApoB mg/dL change",
        "range": "Expected ApoB reduction: 15\u201325% at 6 months",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Bone Density Monitoring Panel",
        "desc": "Bone turnover markers \u2014 GLP-1 is associated with increased bone resorption at high doses.",
        "markers": [
          "CTX pg/mL",
          "P1NP ng/mL",
          "vitamin D ng/mL",
          "PTH pg/mL",
          "calcium mg/dL",
          "osteocalcin ng/mL"
        ],
        "unit": "CTX pg/mL",
        "range": "Monitor: CTX should not exceed 600 pg/mL during therapy",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "GLP-1 Responder PGS",
        "desc": "GLP1R and metabolic pathway variants predicting semaglutide/tirzepatide weight loss magnitude.",
        "markers": [
          "GLP1R Ala316Thr (rs3765467)",
          "TCF7L2 (glycemic response)",
          "MC4R (satiety enhancement)",
          "ADCY3 variants",
          "metabolic response PGS"
        ],
        "unit": "Predicted weight loss %",
        "range": "High PGS responder: >15% weight loss expected",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Lean Mass Preservation Genetics",
        "desc": "Lean-body-mass potential, myostatin variants, and muscle-strength-loss resistance PGS.",
        "markers": [
          "lean body mass PGS",
          "MSTN (myostatin)",
          "ACTN3 R577X",
          "muscle-strength PGS",
          "anabolic response PGS"
        ],
        "unit": "Muscle loss risk score",
        "range": "High risk: >75th percentile = resistance training imperative",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "GLP-1 Pharmacogenomics Panel",
        "desc": "193-trait PGx: CYP metabolism, GI tolerability genetics, nausea susceptibility, and side-effect risk.",
        "markers": [
          "CYP3A4/2D6 metabolizer status",
          "serotonin receptor (5-HT3) variants",
          "substance P (NK1R) nausea variants",
          "gastric emptying rate variants",
          "GI motility genetics"
        ],
        "unit": "Tolerability risk score",
        "range": "High nausea risk genotype: dose titration essential",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "GLP-1 Absolute Contraindication Screen",
        "desc": "MEN2A/B, medullary thyroid carcinoma risk \u2014 RET proto-oncogene variants are absolute contraindications.",
        "markers": [
          "RET proto-oncogene (MEN2A/B)",
          "PTEN (Cowden syndrome)",
          "VHL syndrome",
          "MEN1",
          "endocrine exome panel"
        ],
        "unit": "ACMG classification",
        "range": "Any P/LP RET variant = absolute contraindication",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "GLP-1 Microbiome Response Predictor",
        "desc": "Gut microbiome composition predicts GLP-1 weight loss magnitude \u2014 Akkermansia abundance is key predictor.",
        "markers": [
          "Akkermansia muciniphila %",
          "Bifidobacterium %",
          "Shannon diversity H",
          "Prevotella %",
          "Bacteroidetes % change"
        ],
        "unit": "Predicted response modifier",
        "range": "High Akkermansia (>1%): enhanced GLP-1 response",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_16s",
        "name": "GI Side Effect Microbiome Risk",
        "desc": "Microbiome dysbiosis patterns predicting nausea, vomiting, and constipation on GLP-1 therapy.",
        "markers": [
          "Proteobacteria % (dysbiosis marker)",
          "Bacteroides fragilis %",
          "motility-associated species",
          "intestinal transit-associated species"
        ],
        "unit": "GI symptom risk score 0\u201310",
        "range": "High risk: >6 | Low risk: <3",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Functional GLP-1 Response Map",
        "desc": "GLP-1 secretion-stimulating functional gene abundance and gut hormone pathway capacity.",
        "markers": [
          "GLP-1 secretion-stimulating species genes",
          "PYY stimulating pathway",
          "CCK-releasing gene capacity",
          "enteroendocrine function score"
        ],
        "unit": "GLP-1 stimulating gene RPKM",
        "range": "High functional capacity: enhanced drug response",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Metabolic Reprogramming Biomarker",
        "desc": "GLP-1-induced methylation changes at metabolic loci as biomarkers of durable therapeutic benefit.",
        "markers": [
          "HbA1c-associated CpGs methylation",
          "adipogenesis pathway methylation",
          "pancreatic beta-cell methylation marks",
          "AgeAccelGrim metabolic component"
        ],
        "unit": "Epigenetic metabolic age change",
        "range": "Target: reduction in metabolic CpG methylation age",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "GLP-1 Lean Mass Protection Program",
        "desc": "Structured resistance training and protein optimization protocol to minimize muscle loss during GLP-1 treatment. Resistance training 3\u00d7/week minimum, protein target 1.6\u20132.2g/kg lean mass, creatine supplementation if responder, and lean mass monitoring schedule.",
        "markers": [
          "lean mass (DEXA/impedance)",
          "testosterone",
          "IGF-1",
          "albumin",
          "creatine kinase",
          "protein intake (24h recall)",
          "resistance training volume"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "GLP-1 Nutritional Support Protocol",
        "desc": "Micronutrient supplementation protocol for GLP-1 users experiencing reduced food intake: vitamin B12 (absorption risk), iron, zinc, calcium, vitamin D, and omega-3. Products matched from client catalog, dosed against measured deficiency.",
        "markers": [
          "vitamin B12",
          "ferritin",
          "zinc",
          "25-OH Vit D",
          "omega-3 index",
          "calcium",
          "albumin"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "GLP-1 Side Effect Management Plan",
        "desc": "Personalized nausea/GI side effect mitigation: meal timing adjustment, food texture modification, ginger supplementation, probiotic selection based on microbiome composition, and hydration optimization during dose titration.",
        "markers": [
          "GI tolerance genetics",
          "nausea biomarker proxy",
          "microbiome composition",
          "Lactobacillus spp.",
          "gut permeability markers"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      }
    ],
    "_marker_count": 162,
    "marker_count": 162,
    "insight_count": 33
  },
  {
    "id": "supplements",
    "name": "Personalized Supplementation",
    "sub": "Evidence-Based Protocols",
    "color": "#1a6630",
    "lt": "#e8f5ec",
    "img": "data:image/jpeg;base64,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",
    "desc": "Biomarker and genomic-driven supplement protocols using Lifenome 51-trait nutrition PGS, MTHFR methylation genetics, and 193-trait PGx for absorption optimization and dosing.",
    "tags": [
      "vitamin deficiency PGS",
      "mineral PGS",
      "MTHFR",
      "absorption genetics",
      "longevity stacks"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Dietary Gap & Deficiency Risk",
        "desc": "SAQ-derived nutrient shortfalls from dietary patterns, cooking habits, sun exposure, and lifestyle.",
        "markers": [
          "dietary vitamin D intake IU/day",
          "animal protein intake g/day",
          "fruit/veg servings/day",
          "sun exposure hrs/day",
          "vegan/vegetarian status"
        ],
        "unit": "Deficiency risk score per nutrient",
        "range": "High deficiency probability: >70%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Supplement Interaction Risk Screen",
        "desc": "Current medication and supplement combinations flagged for potential interactions.",
        "markers": [
          "current medications list",
          "current supplements",
          "alcohol use",
          "smoking status",
          "renal/hepatic function proxy"
        ],
        "unit": "Interaction flag (Y/N per pair)",
        "range": "High-risk interactions: require physician review",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Recovery Micronutrient Demand",
        "desc": "Magnesium, zinc, and electrolyte needs estimated from training load, sweat rate, and recovery quality.",
        "markers": [
          "training load AU/week",
          "sleep quality score",
          "HRV 7-day trend",
          "exercise sweat rate proxy",
          "recovery score %"
        ],
        "unit": "Estimated demand (% increase over RDA)",
        "range": "Heavy training: +20\u201360% Mg/Zn demand above RDA",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Deficiency Symptom Biomarker Score",
        "desc": "Smartphone-assisted fatigue visual scale, hair/nail quality analysis, and cognitive performance proxy.",
        "markers": [
          "fatigue VAS score 0\u201310",
          "hair loss severity proxy",
          "nail quality score",
          "cognitive performance proxy"
        ],
        "unit": "Symptom burden score 0\u201330",
        "range": "High deficiency burden: >15",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Core Deficiency Panel",
        "desc": "Vitamin D, CBC (hemoglobin/MCV), TSH \u2014 three most common supplement-responsive deficiencies.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "hemoglobin g/dL",
          "MCV fL",
          "TSH mIU/L",
          "fasting glucose mg/dL"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal: 50\u201380 ng/mL | Deficient: <20 ng/mL | Toxic: >150",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Comprehensive Micronutrient Panel",
        "desc": "B12, folate, iron, ferritin, zinc \u2014 essential micronutrient deficiency status battery.",
        "markers": [
          "B12 pg/mL",
          "folate ng/mL",
          "ferritin ng/mL",
          "serum iron \u00b5g/dL",
          "transferrin saturation %",
          "zinc \u00b5g/dL",
          "vitamin D ng/mL"
        ],
        "unit": "B12 pg/mL",
        "range": "Optimal B12: 400\u2013900 pg/mL | Deficient: <200 pg/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Advanced Nutrient Status Panel",
        "desc": "Magnesium RBC, selenium, CoQ10, omega-3 index \u2014 advanced depletion markers not in standard panel.",
        "markers": [
          "magnesium RBC mg/dL",
          "selenium \u00b5g/L",
          "CoQ10 \u00b5g/mL",
          "omega-3 index %",
          "GSH \u00b5mol/L",
          "alpha-tocopherol (vit E) mg/L"
        ],
        "unit": "Omega-3 index %",
        "range": "Optimal: 8\u201312% | Deficient: <4% | Cardiovascular risk: <6%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Longevity Stack Target Panel",
        "desc": "NAD+, BDNF, IGF-1, cortisol \u2014 anti-aging supplementation protocol optimization targets.",
        "markers": [
          "NAD+ \u00b5mol/L",
          "BDNF ng/mL",
          "IGF-1 ng/mL",
          "cortisol AM \u00b5g/dL",
          "IL-6 pg/mL",
          "sirtuin activity proxy"
        ],
        "unit": "NAD+ \u00b5mol/L",
        "range": "Optimal: >40 \u00b5mol/L | Decline: <25 \u00b5mol/L (>40 yrs)",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Fat-Soluble Vitamin Panel",
        "desc": "Full fat-soluble vitamin status: A, D, E, K2 \u2014 often neglected but critical for bone, immune, and vascular health.",
        "markers": [
          "retinol \u00b5g/L (vit A)",
          "25-OH D3 ng/mL",
          "alpha-tocopherol mg/L (vit E)",
          "K2 (MK-7) ng/mL",
          "K1 ng/mL"
        ],
        "unit": "K2 (MK-7) ng/mL",
        "range": "Optimal K2: >0.5 ng/mL | Most adults deficient",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Nutrigenomics PGS \u2014 51 Traits",
        "desc": "All 16 vitamin deficiency PGS + 13 mineral deficiency PGS + 22 diet/metabolism traits \u2014 complete nutrition genome.",
        "markers": [
          "vitamin D PGS (GC, CYP2R1, DHCR7)",
          "B12 PGS (FUT2, CUBN)",
          "iron PGS (HFE, TMPRSS6)",
          "magnesium PGS (TRPM6)",
          "omega-3 PGS (FADS1/2)",
          "51 nutrition traits total"
        ],
        "unit": "Per-nutrient percentile",
        "range": "High deficiency genetics: >80th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "MTHFR Methylation Panel",
        "desc": "Complete methylation cycle genetics driving folate form requirements (methyl vs folic acid), B12 form, and betaine.",
        "markers": [
          "MTHFR C677T genotype",
          "MTHFR A1298C genotype",
          "MTR A2756G",
          "MTRR A66G",
          "BHMT variants",
          "CBS variants"
        ],
        "unit": "Methylation capacity category",
        "range": "TT + A1298C compound: severe methylation deficit",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "PGx Absorption & Toxicity Panel",
        "desc": "193-trait PGx: VDR (vitamin D absorption), BCMO1 (beta-carotene conversion), SLC19A1 (folate), CYP metabolism.",
        "markers": [
          "VDR FokI/BsmI (D absorption)",
          "BCMO1 (beta-carotene to A)",
          "SLC19A1 (folate transporter)",
          "SLCO1B1 (supplement transport)",
          "FMO3 (choline/TMAO)",
          "193 PGx traits"
        ],
        "unit": "Absorption phenotype",
        "range": "Poor converter: 2\u20134x higher supplement dose needed",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Rare Inborn Metabolic Deficiency",
        "desc": "Rare inborn errors of metabolism in vitamin/mineral pathways \u2014 exome panel for treatment-refractory deficiencies.",
        "markers": [
          "PCCA/PCCB (B12-responsive MMA)",
          "biotinidase deficiency",
          "G6PD (antioxidant risk)",
          "Wilson disease (ATP7B)",
          "metabolic disorders exome panel"
        ],
        "unit": "Variant classification",
        "range": "P/LP = specific medical supplementation protocol",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Microbiome Nutrient Synthesis",
        "desc": "B vitamin synthesis (B12, folate, K2, biotin), and mineral bioavailability from gut microbial communities.",
        "markers": [
          "B12-producing species (Propionibacterium)",
          "K2-synthesizing species (Bacteroides, Fusobacterium)",
          "folate-producing Bifidobacterium %",
          "biotin-synthesizing species",
          "Lactobacillus % (B vitamin producers)"
        ],
        "unit": "Synthesis capacity score",
        "range": "High synthesis: reduces supplement dose needs",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Nutrient Absorption Efficiency Map",
        "desc": "Functional genomics of nutrient transporter gene expression from gut microbiome.",
        "markers": [
          "folate transport gene count (folate operon)",
          "zinc transporter species (znuABC)",
          "cobalamin biosynthesis genes",
          "calcium absorption pathway (cbsT)"
        ],
        "unit": "Transporter gene RPKM",
        "range": "Low transporter genes: enhanced oral dosing required",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Methylation Cycle Epigenetic Status",
        "desc": "DNAm-based global methylation capacity assessment \u2014 directly drives B9/B12 supplementation protocol.",
        "markers": [
          "global DNA methylation index (% 5mC)",
          "LINE-1 methylation %",
          "SAM/SAH ratio proxy (CpG pattern)",
          "DNMT3A methylation marks"
        ],
        "unit": "Global methylation %",
        "range": "Hypomethylation (<70% LINE-1): methyl-donor deficiency",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "blood",
        "name": "Electrolyte & Mineral Optimization Panel",
        "desc": "InsideTracker's Ultimate test includes sodium and potassium as critical electrolyte biomarkers. Low sodium increases risk of irregular heartbeat, poor kidney function, and muscle spasms. High dietary sodium increases cardiovascular risk. Full electrolyte panel for precision supplementation.",
        "markers": [
          "sodium",
          "potassium",
          "chloride",
          "bicarbonate",
          "calcium",
          "phosphorus",
          "magnesium serum",
          "magnesium RBC"
        ],
        "unit": "mEq/L per electrolyte",
        "range": "Sodium: 136\u2013145 mEq/L | Potassium: 3.8\u20135.0 mEq/L | Mg RBC: 4.2\u20136.8",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "name": "Omega-3 Index & Essential Fatty Acid Profile",
        "desc": "Function Health and InsideTracker both highlight omega-3 as critical for brain, heart, and mood. Omega-3 index (EPA+DHA as % of RBC total fatty acids) below 8% doubles cardiovascular and depression risk.",
        "markers": [
          "omega-3 index (EPA+DHA %)",
          "EPA (eicosapentaenoic acid)",
          "DHA (docosahexaenoic acid)",
          "AA:EPA ratio",
          "omega-6 total",
          "trans fatty acids"
        ],
        "unit": "% of RBC fatty acids",
        "range": "Optimal: >8% | Deficient: <4% | Depression risk: <6%",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Precision Vitamin & Mineral Stack",
        "desc": "Personalized supplement stack from client product catalog addressing confirmed deficiencies (blood + genetic). Priority ranking: (1) D3+K2 if Vit D <30 ng/mL, (2) methylfolate vs folic acid based on MTHFR genotype, (3) methylcobalamin for B12 if low/MTHFR+, (4) magnesium glycinate if RBC Mg low, (5) zinc if deficient, (6) omega-3 if index <6%.",
        "markers": [
          "25-OH Vit D",
          "MTHFR C677T/A1298C",
          "vitamin B12",
          "folate RBC",
          "magnesium RBC",
          "zinc",
          "omega-3 index",
          "iron/ferritin"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Longevity & Performance Supplement Protocol",
        "desc": "Personalized longevity supplement protocol from catalog based on advanced biomarkers: CoQ10 (statin use or mitochondrial markers), NAD+ precursor (biologic age gap), glutathione (oxidative stress), berberine (insulin resistance), ashwagandha (cortisol), and adaptogens.",
        "markers": [
          "CoQ10 blood level",
          "NAD+ proxy",
          "glutathione (TAC)",
          "HOMA-IR",
          "cortisol AM",
          "GrimAge acceleration",
          "CRP"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Supplement Timing & Absorption Optimization Plan",
        "desc": "Personalized supplement timing protocol based on absorption genetics (MTHFR, VDR, FUT2, BCMO1), meal composition, and interaction screening. Identifies morning vs evening optimal dosing, fat-soluble vitamin timing with meals, and iron-calcium separation requirements.",
        "markers": [
          "MTHFR genotype",
          "VDR BsmI/FokI",
          "FUT2 (B12 absorption)",
          "BCMO1 (beta-carotene)",
          "iron + calcium interaction",
          "supplement interaction screen"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "Bitter Taste Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Bitter Taste Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Caffeine Metabolism Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Caffeine Metabolism Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Carb Overconsumption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Carb Overconsumption"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Difficulty Losing Weight",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Difficulty Losing Weight"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Fat Overconsumption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Fat Overconsumption"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Fat Taste Perception",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Fat Taste Perception"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Low Carb Diet Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Low Carb Diet Effectiveness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Low Fat Diet Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Low Fat Diet Effectiveness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Low Protein Intake Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Low Protein Intake Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Low Resting Metabolic Rate",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Low Resting Metabolic Rate"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Low Vegetable Intake",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Low Vegetable Intake"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Mediterranean Diet Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Mediterranean Diet Effectiveness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Monounsaturated Fats Increased Benefits",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Monounsaturated Fats Increased Benefits"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Overweight Potential",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Overweight Potential"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Polyunsaturated Fats Increased Benefits",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Polyunsaturated Fats Increased Benefits"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Risk Saturated Fats",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Risk Saturated Fats"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Satiety Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Satiety Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Snacking",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Snacking"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Starch Metabolism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Starch Metabolism"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Sweet Snack Preference",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Sweet Snack Preference"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Sweet Tooth",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Sweet Tooth"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Trans Fats Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Diet And Metabolism",
        "markers": [
          "Trans Fats Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Lutein Zeaxanthin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Lutein Zeaxanthin Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Lycopene Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Lycopene Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitamina Carotene Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitamina Carotene Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitamina Retinol Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitamina Retinol Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb12 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb12 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb2 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb2 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb3 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb3 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb5 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb5 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb6 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb6 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb7 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb7 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminb9 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminb9 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitaminc Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitaminc Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitamind Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitamind Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitamine Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitamine Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Vitamink Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutrition.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Vitamins",
        "markers": [
          "Vitamink Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Calcium Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Calcium Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Choline Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Choline Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Coenzymeq10 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Coenzymeq10 Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Copper Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Copper Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Glutathione Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Glutathione Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Iron Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Iron Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Iron Overload",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Iron Overload"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Magnesium Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Magnesium Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Phosphorus Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Phosphorus Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Phytosterols Imbalance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Phytosterols Imbalance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Selenium Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Selenium Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Sensitivity Salt",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Sensitivity Salt"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      },
      {
        "name": "Zinc Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nutriton.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Minerals",
        "markers": [
          "Zinc Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "supplements",
          "weightloss",
          "longevity"
        ]
      }
    ],
    "_marker_count": 169,
    "marker_count": 169,
    "insight_count": 72
  },
  {
    "id": "skincare",
    "name": "Personalized Skin Care",
    "sub": "Precision Dermatology",
    "color": "#8a3060",
    "lt": "#fce8f0",
    "img": "https://images.unsplash.com/photo-1556228720-195a672e8a03?w=320&q=75",
    "desc": "Genomic and biomarker-driven skincare using Lifenome 20-trait skincare PGS covering collagen breakdown, glycation, photoaging, barrier sensitivity, rosacea, acne, and stretch marks.",
    "tags": [
      "collagen genetics",
      "photoaging PGS",
      "barrier function",
      "acne PGS",
      "rosacea",
      "sebum genetics"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Skin Aging Lifestyle Score",
        "desc": "UV exposure dose, sleep quality, smoking, alcohol, dietary antioxidants, and skin care habit composite.",
        "markers": [
          "UV exposure hrs/day (lifetime)",
          "sleep hrs/night",
          "smoking pack-years",
          "alcohol units/wk",
          "dietary antioxidant score"
        ],
        "unit": "Skin aging risk score 0\u2013100",
        "range": "High risk (accelerated aging): >65 | Optimal: <30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Dietary Skin Health Profile",
        "desc": "Anti-glycation, omega-3 intake, and collagen-supporting micronutrient dietary assessment.",
        "markers": [
          "glycemic load/day",
          "omega-3 intake g/day",
          "vitamin C dietary intake mg/day",
          "collagen precursor intake (glycine, proline)",
          "carotenoid intake"
        ],
        "unit": "Skin nutrition score 0\u2013100",
        "range": "Optimal: >70 | Skin-aging diet pattern: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep-Collagen Synthesis Index",
        "desc": "Deep sleep and overnight HRV as proxies for nocturnal collagen synthesis and skin barrier repair.",
        "markers": [
          "deep sleep % ",
          "sleep efficiency %",
          "overnight HRV RMSSD ms",
          "sleep duration hrs"
        ],
        "unit": "Collagen synthesis opportunity score",
        "range": "Optimal: deep sleep >20%, efficiency >85%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Facial Skin Biological Age",
        "desc": "Lifenome smartphone camera-based facial biological age with wrinkle depth, texture, and pigmentation analysis.",
        "markers": [
          "wrinkle depth score",
          "skin texture roughness index",
          "periorbital area aging",
          "hyperpigmentation map",
          "pore size proxy"
        ],
        "unit": "Facial skin age (yr)",
        "range": "Target: facial age \u2264 chronological age",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Sebum Rate & Skin Hydration",
        "desc": "Smartphone camera sebum and TEWL proxy measurement for oiliness/barrier function classification.",
        "markers": [
          "sebum sheen index",
          "pore visibility score",
          "skin redness index (rosacea proxy)",
          "skin hydration proxy"
        ],
        "unit": "Sebum rate classification",
        "range": "Oily: high sheen | Dry: low sheen + barrier concern",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Pigmentation & Photo-Damage Map",
        "desc": "AI analysis of sun damage, melasma, solar lentigines, and UV-related hyperpigmentation.",
        "markers": [
          "UV spot count",
          "melasma distribution score",
          "skin tone evenness index",
          "solar lentigo proxy"
        ],
        "unit": "Photo-damage score 0\u201310",
        "range": "Minimal: 0\u20132 | Moderate: 3\u20135 | Severe: 6\u201310",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Skin Hormonal Foundation",
        "desc": "Vitamin D, thyroid, iron \u2014 the three foundational skin hormone and micronutrient drivers.",
        "markers": [
          "25-OH vitamin D ng/mL",
          "TSH mIU/L",
          "ferritin ng/mL",
          "B12 pg/mL",
          "zinc \u00b5g/dL"
        ],
        "unit": "25-OH vitamin D ng/mL",
        "range": "Optimal skin D: 50\u201380 ng/mL | Deficient: <30 = dull skin",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Collagen & Hormonal Skin Panel",
        "desc": "Estradiol, DHEA-S, DHT, testosterone, SHBG \u2014 hormonal drivers of collagen synthesis and sebum production.",
        "markers": [
          "estradiol pg/mL",
          "DHEA-S \u00b5g/dL",
          "testosterone total ng/dL",
          "DHT pg/mL",
          "SHBG nmol/L",
          "IGF-1 ng/mL"
        ],
        "unit": "DHT pg/mL",
        "range": "Acne-driving DHT: >300 pg/mL (F) | >850 pg/mL (M)",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Glycation & Oxidative Stress Panel",
        "desc": "HbA1c, uric acid, and antioxidant capacity as skin glycation and oxidative stress biomarkers.",
        "markers": [
          "HbA1c % (glycation proxy)",
          "uric acid mg/dL",
          "8-OHdG (oxidative DNA damage)",
          "total antioxidant capacity",
          "malondialdehyde (MDA) \u00b5mol/L"
        ],
        "unit": "HbA1c % (glycation risk)",
        "range": "Skin glycation accelerates: HbA1c >5.5% | Visible: >6.0%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Skin Antioxidant & Collagen Panel",
        "desc": "GSH, CoQ10, vitamin C, selenium, and omega-3 \u2014 complete anti-aging skin antioxidant/collagen optimization.",
        "markers": [
          "GSH \u00b5mol/L",
          "CoQ10 \u00b5g/mL",
          "vitamin C mg/dL",
          "selenium \u00b5g/L",
          "omega-3 index %",
          "hydroxyproline (collagen turnover)"
        ],
        "unit": "Omega-3 index %",
        "range": "Optimal skin omega-3: >8% | Deficient: <4%",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "Skincare PGS \u2014 20 Traits",
        "desc": "Lifenome 20-trait skincare genetics: collagen-breakdown rate, glycation propensity, youthfulness, photoaging, barrier sensitivity, acne, rosacea, stretch marks.",
        "markers": [
          "COL1A1/COL3A1 (collagen structure)",
          "MMP1/MMP3 (collagen breakdown)",
          "GSTP1 (antioxidant capacity)",
          "MC1R (pigmentation/sun sensitivity)",
          "FLG (barrier function)",
          "20 skincare traits total"
        ],
        "unit": "Per-trait aging risk percentile",
        "range": "Accelerated collagen breakdown PGS: >80th %ile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Acne & Sebum Genetics",
        "desc": "DHT receptor sensitivity, IGF-1 pathway, and sebum overproduction genetic risk for acne.",
        "markers": [
          "androgen receptor (AR) CAG repeats",
          "SRD5A2 (5-alpha reductase)",
          "IGF-1 pathway variants",
          "CYP17A1 (androgen synthesis)",
          "sebum overproduction PGS"
        ],
        "unit": "Acne genetic risk score",
        "range": "High acne risk PGS: >80th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Rosacea & Vascular Reactivity PGS",
        "desc": "Rosacea genetic predisposition, skin vascular reactivity, and flush response PGS.",
        "markers": [
          "HLA variants (rosacea)",
          "KLK5/7 (stratum corneum serine proteases)",
          "vascular reactivity PGS",
          "flush response variants (ALDH2)"
        ],
        "unit": "Rosacea risk percentile",
        "range": "High genetic risk: >75th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Monogenic Skin Disorder Screen",
        "desc": "Rare variants: ichthyosis vulgaris (FLG), epidermolysis bullosa (KRT5/14), albinism \u2014 dermatology exome panel.",
        "markers": [
          "FLG loss-of-function (atopic dermatitis)",
          "KRT1/KRT5/KRT14 (ichthyosis/EB)",
          "ABCA4 (skin photosensitivity)",
          "SLC45A2 (pigmentation)",
          "dermatology exome panel"
        ],
        "unit": "Variant classification",
        "range": "FLG null allele carrier: 3\u20135x atopic dermatitis risk",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Gut-Skin Axis Inflammation Score",
        "desc": "Gut dysbiosis driving systemic inflammation manifesting as acne, rosacea, psoriasis, and atopic dermatitis.",
        "markers": [
          "gut Shannon diversity H",
          "Akkermansia muciniphila %",
          "Bifidobacterium %",
          "LPS-producing Proteobacteria %",
          "Clostridiales diversity"
        ],
        "unit": "Gut-skin inflammation score 0\u201310",
        "range": "High gut-skin axis: >6 = systemic inflammatory load",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "SCFA Skin Immunomodulation Score",
        "desc": "Butyrate and propionate-producing functional gene abundance affecting skin immune regulation.",
        "markers": [
          "butyrate synthesis gene count (but pathway)",
          "propionate producers RPKM",
          "acetate producers RPKM",
          "skin-immune modulating pathway genes"
        ],
        "unit": "Butyrate gene RPKM",
        "range": "Optimal: >1.5 RPKM | Low: <0.8 (inflammation risk)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Skin-Specific Epigenetic Age",
        "desc": "Skin-specific methylation clock based on sun-damage-associated CpG sites \u2014 photoaging biological age.",
        "markers": [
          "skin epigenetic age (yr)",
          "UV-damage CpG loci methylation",
          "collagen gene promoter methylation",
          "skin barrier methylation marks"
        ],
        "unit": "Skin epigenetic age (yr)",
        "range": "Accelerated: skin age > chronological + 3 yr",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Personalized Skincare Product Selection",
        "desc": "AI-matched skincare product recommendations from client catalog based on genetic skin type (oily/dry/combination), sun sensitivity genetics, acne predisposition, rosacea risk, collagen synthesis capacity, and current glycation/oxidative stress markers. Products matched by active ingredient mechanism.",
        "markers": [
          "skin type PGS",
          "sebum rate",
          "collagen stability genotype",
          "acne PGS",
          "rosacea PGS",
          "glycation markers",
          "UV sensitivity genetics",
          "skin hydration score"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Anti-Aging Skin Protocol",
        "desc": "Personalized anti-aging skin health program: dietary collagen precursors (glycine, proline, vitamin C timing), blue light exposure reduction, sleep position optimization, targeted antioxidant supplementation (astaxanthin, coenzyme Q10 topical, retinol timing by CYP genotype).",
        "markers": [
          "collagen stability genotype",
          "retinoic acid metabolism (CYP26A1)",
          "glycation index",
          "Vit C status",
          "skin biological age",
          "oxidative stress markers"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Skin Supplement Stack",
        "desc": "Skin-targeted nutritional supplements from client catalog: marine collagen peptides (dosed by collagen synthesis genetics), biotin (if hair/nail markers suggest deficiency), vitamin E + selenium as antioxidants, hyaluronic acid precursors, and astaxanthin.",
        "markers": [
          "collagen stability genotype",
          "biotin deficiency risk",
          "glutathione (TAC)",
          "selenium",
          "vitamin E",
          "skin biological age"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "Collagen Breakdown",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Aging",
        "markers": [
          "Collagen Breakdown"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Sagging Eyelids Risk",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Aging",
        "markers": [
          "Sagging Eyelids Risk"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Glycation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Aging",
        "markers": [
          "Skin Glycation"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Youthfulness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Aging",
        "markers": [
          "Youthfulness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Contact Skin Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Environment",
        "markers": [
          "Contact Skin Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Dermal Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Environment",
        "markers": [
          "Dermal Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Pollution Defense Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Environment",
        "markers": [
          "Pollution Defense Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Barrier Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Environment",
        "markers": [
          "Skin Barrier Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Detoxification Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Environment",
        "markers": [
          "Skin Detoxification Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Facial Pigmented Spots",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Sun",
        "markers": [
          "Facial Pigmented Spots"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Photoaging",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Sun",
        "markers": [
          "Photoaging"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Poor Tanning Ability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Sun",
        "markers": [
          "Poor Tanning Ability"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Sensitivity Sun",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin And Sun",
        "markers": [
          "Sensitivity Sun"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Acne",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Acne"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Dryness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Dryness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Protection Skin Cellulite",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Protection Skin Cellulite"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Antioxidant Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Skin Antioxidant Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Inflammation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Skin Inflammation"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Rosacea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Skin Rosacea"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Skin Stretch Marks",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skincare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Profile",
        "markers": [
          "Skin Stretch Marks"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "skincare"
        ]
      },
      {
        "name": "Acne Vulgaris",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Acne Vulgaris"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Atopic Dermatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Atopic Dermatitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Cellulitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Cellulitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Chronic Hives Urticaria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Chronic Hives Urticaria"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Dupuytrens Contracture",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Dupuytrens Contracture"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Lichen Planus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Lichen Planus"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Psoriasis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Psoriasis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Rosacea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Rosacea"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Scleroderma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Scleroderma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Vitiligo",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Skin Subcutaneous Tissue Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Skin Subcutaneous Tissue Disorders",
        "markers": [
          "Vitiligo"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "prevention"
        ]
      },
      {
        "name": "Adermatoglyphia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Adermatoglyphia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Arrhythmogenic Right Ventricular Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Arrhythmogenic Right Ventricular Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Arrhythmogenic Right Ventricular Dysplasia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Arrhythmogenic Right Ventricular Dysplasia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Arterial Calcification",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Arterial Calcification"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Bart Pumphrey Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Bart Pumphrey Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Basan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Basan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Bothnian Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Bothnian Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Dilated, With Wooly Hair And Keratoderma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Cardiomyopathy, Dilated, With Wooly Hair And Keratoderma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Cardiomyopathy, Dilated, With Wooly Hair, Keratoderma, And Tooth Agenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Cardiomyopathy, Dilated, With Wooly Hair, Keratoderma, And Tooth Agenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Curth Macklin",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Curth Macklin"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Dominant 3B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Deafness, Autosomal Dominant 3B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 1A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Deafness, Autosomal Recessive 1A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Deafness, Autosomal Recessive 1B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Deafness, Autosomal Recessive 1B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Dermatopathia Pigmentosa Reticularis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Dermatopathia Pigmentosa Reticularis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Dowling Meara",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Dowling Meara"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Hidrotic (Clouston Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Ectodermal Dysplasia, Hidrotic (Clouston Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia/Skin Fragility Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Ectodermal Dysplasia/Skin Fragility Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Simplex",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Epidermolysis Bullosa Simplex"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Lethal Acantholytic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Epidermolysis Bullosa, Lethal Acantholytic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolytic Hyperkeratosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Epidermolytic Hyperkeratosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrokeratodermia Variabilis Et Progressiva",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Erythrokeratodermia Variabilis Et Progressiva"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrokeratodermia Variabilis With Erythema Gyratum Repens",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Erythrokeratodermia Variabilis With Erythema Gyratum Repens"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypophosphatemic Rickets",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Hypophosphatemic Rickets"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Hystrix Like Ichthyosis With Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Hystrix Like Ichthyosis With Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ifap Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Ifap Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis Histrix",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Ichthyosis Histrix"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Cyclic, With Epidermolytic Hyperkeratosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Ichthyosis, Cyclic, With Epidermolytic Hyperkeratosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratitis Icthyosis Deafness Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratitis Icthyosis Deafness Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratoderma, Palmoplantar, Punctate",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratoderma, Palmoplantar, Punctate"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratoderma, Palmoplantar, With Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratoderma, Palmoplantar, With Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratosis Follicularis Spinulosa Decalvans",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratosis Follicularis Spinulosa Decalvans"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratosis Palmoplantaris Striata",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratosis Palmoplantaris Striata"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratosis Palmoplantaris Striata I",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratosis Palmoplantaris Striata I"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Keratosis Palmoplantaris Striata Ii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Keratosis Palmoplantaris Striata Ii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Knuckle Pads",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Knuckle Pads"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Koebner",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Koebner"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Mal De Meleda",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Mal De Meleda"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Naegeli Franceschetti Jadassohn Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Naegeli Franceschetti Jadassohn Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Nagashima Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Nagashima Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Naxos Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Naxos Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Odontoonychodermal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Odontoonychodermal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Olmsted Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Olmsted Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Osteogenesis Imperfecta",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Osteogenesis Imperfecta"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Pachyonychia Congenita",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Pachyonychia Congenita"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma, Epidermolytic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma, Epidermolytic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma, Mutilating, With Periorificial Keratotic Plaques",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma, Mutilating, With Periorificial Keratotic Plaques"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma, Nonepidermolytic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma, Nonepidermolytic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma, Nonepidermolytic Focal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma, Nonepidermolytic Focal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma, Nonepidermolytic, Focal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma, Nonepidermolytic, Focal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Palmoplantar Keratoderma, Nonepidermolytic, Focal Or Diffuse",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Palmoplantar Keratoderma, Nonepidermolytic, Focal Or Diffuse"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Schopf Schulz Passarge Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Schopf Schulz Passarge Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Severe Dermatitis, Multiple Allergies, And Metabolic Wasting Syndrome (Sam Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Severe Dermatitis, Multiple Allergies, And Metabolic Wasting Syndrome (Sam Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Steatocystoma Multiplex",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Steatocystoma Multiplex"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Tooth Agenesis, Selective",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Tooth Agenesis, Selective"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Vohwinkel Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Vohwinkel Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Vohwinkel Syndrome, Variant Form",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Vohwinkel Syndrome, Variant Form"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Weber Cockayne",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Palmoplantar Keratoderma",
        "markers": [
          "Weber Cockayne"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Cutis Laxa Ar Type 2B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cutis Laxa",
        "markers": [
          "Cutis Laxa Ar Type 2B"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Geroderma Osteodysplasticum",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cutis Laxa",
        "markers": [
          "Geroderma Osteodysplasticum"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Wrinkly Skin Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cutis Laxa",
        "markers": [
          "Wrinkly Skin Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Albinism, Brown Oculocutaneous",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Albinism, Brown Oculocutaneous"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Albinism, Oculocutaneous, Type Vi",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Albinism, Oculocutaneous, Type Vi"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Albinism, Oculocutaneous, Type Vii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Albinism, Oculocutaneous, Type Vii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Foveal Hypoplasia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Foveal Hypoplasia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Griscelli Syndrome, Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Griscelli Syndrome, Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Increased Analgesia From Kappa Opioid Receptor Agonist",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Increased Analgesia From Kappa Opioid Receptor Agonist"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Melanoma, Cutaneous Malignant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Melanoma, Cutaneous Malignant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Nystagmus, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Nystagmus, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ocular Albinism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Ocular Albinism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Oculocutaneous Albinism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Oculocutaneous Albinism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Skin/Hair/Eye Pigmentation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Skin/Hair/Eye Pigmentation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Skin/Hair/Eye Pigmentation, Variation In, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Albinism",
        "markers": [
          "Skin/Hair/Eye Pigmentation, Variation In, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Aaru Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Aaru Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Amyloidosis, Primary Localized Cutaneous, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Amyloidosis, Primary Localized Cutaneous, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythroderma, Ichthyosiform, Congenital Reticular",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Erythroderma, Ichthyosiform, Congenital Reticular"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Erythrokeratodermia Variabilis Et Progressiva 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Erythrokeratodermia Variabilis Et Progressiva 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypotrichosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Hypotrichosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosiform Erythroderma, Congenital, Nonbullous",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosiform Erythroderma, Congenital, Nonbullous"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis Bullosa Of Siemens",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis Bullosa Of Siemens"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis Exfoliativa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis Exfoliativa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis Prematurity Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis Prematurity Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis With Confetti",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis With Confetti"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive 13",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive 13"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Congenital, Autosomal Recessive 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Congenital, Autosomal Recessive 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Harlequin",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Harlequin"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ichthyosis, Lamellar",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Ichthyosis, Lamellar"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Icthyosis Vulgaris",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Icthyosis Vulgaris"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Peeling Skin Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Peeling Skin Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Peeling Skin Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Peeling Skin Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Trichothiodystrophy 4, Nonphotosensitive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ichthyosis",
        "markers": [
          "Trichothiodystrophy 4, Nonphotosensitive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Benign Chronic Pemphigus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Benign Chronic Pemphigus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Dowling Degos Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Dowling Degos Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Dystrophica",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa Dystrophica"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Pruriginosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa Pruriginosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Simplex With Migratory Circinate Erythema",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa Simplex With Migratory Circinate Erythema"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Simplex With Mottled Pigmentation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa Simplex With Mottled Pigmentation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa Simplex, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa Simplex, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Generalized Atrophic Benign",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa, Generalized Atrophic Benign"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Junctional",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa, Junctional"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Junctional, With Pyloric Atresia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa, Junctional, With Pyloric Atresia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Junctional, With Pyloric Stenosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa, Junctional, With Pyloric Stenosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Epidermolysis Bullosa, Pretibial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Epidermolysis Bullosa, Pretibial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Herlitz",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Herlitz"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Interstitial Lung Disease With Nephrotic Syndrome And Epidermolysis Bullosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Interstitial Lung Disease With Nephrotic Syndrome And Epidermolysis Bullosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Kindler Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Kindler Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Laryngoonychocutaneous Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Laryngoonychocutaneous Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Nail Disorder, Nonsyndromic Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Nail Disorder, Nonsyndromic Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Transient Bullous Dermolysis Of The Newborn",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Epidermolysis Bullosa",
        "markers": [
          "Transient Bullous Dermolysis Of The Newborn"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Alopecia Universalis Congenita",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Alopecia Universalis Congenita"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Atrichia With Papular Lesions",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Atrichia With Papular Lesions"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Anhidrotic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia, Anhidrotic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Anhidrotic, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia, Anhidrotic, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Anhidrotic, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia, Anhidrotic, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Hypohidrotic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia, Hypohidrotic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Hypohidrotic, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia, Hypohidrotic, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Ectodermal Dysplasia Syndactyly Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Ectodermal Dysplasia Syndactyly Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Hair Morphology",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Hair Morphology"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Hypotrichosis 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Hypotrichosis 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Tooth Agenesis, Selective, 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Tooth Agenesis, Selective, 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Tooth Agenesis, Selective, 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ectodermal Dysplasia",
        "markers": [
          "Tooth Agenesis, Selective, 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      },
      {
        "name": "Zinc Deficiency, Transient Neonata",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Dermatology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hereditary Acrodermatitis Enteropathica",
        "markers": [
          "Zinc Deficiency, Transient Neonata"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "skincare",
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 260,
    "marker_count": 260,
    "insight_count": 181
  },
  {
    "id": "hairloss",
    "name": "Hair Loss Solutions",
    "sub": "Alopecia Diagnostics & Treatment",
    "color": "#b03020",
    "lt": "#fdeaea",
    "img": "https://images.unsplash.com/photo-1522337360788-8b13dee7a37e?w=320&q=75",
    "desc": "Multi-dimensional alopecia diagnostics \u2014 AGA genetics, DHT pathway, telogen effluvium triggers, scalp microbiome, and PGx for minoxidil/finasteride treatment response.",
    "tags": [
      "AGA PGS",
      "DHT genetics",
      "minoxidil PGx",
      "finasteride response",
      "telogen effluvium"
    ],
    "insights": [
      {
        "src": "lifestyle",
        "name": "Hair Loss Trigger Risk Assessment",
        "desc": "Comprehensive modifiable trigger profile: nutritional deficits, stress, hormonal disruption, medications.",
        "markers": [
          "chronic stress score",
          "recent weight loss kg/month",
          "protein intake g/day",
          "recent illness/surgery",
          "scalp hygiene habits",
          "hair styling trauma index"
        ],
        "unit": "Trigger risk score 0\u201310",
        "range": "High trigger burden: >6 | Low: <3",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Scalp Health Lifestyle Score",
        "desc": "UV scalp exposure, product chemical load, hair washing frequency, and sebum management habits.",
        "markers": [
          "scalp UV exposure score",
          "chemical exposure (dyes/bleach freq)",
          "washing frequency/week",
          "physical tension (tight hairstyles)"
        ],
        "unit": "Scalp health score 0\u2013100",
        "range": "Optimal: >70 | Damaging: <40",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Chronic Stress & Cortisol Proxy",
        "desc": "HRV-derived chronic stress index as telogen effluvium trigger quantification.",
        "markers": [
          "HRV RMSSD 30-day trend ms",
          "resting HR elevation bpm",
          "sleep disruption index",
          "nocturnal cortisol proxy",
          "recovery score trend"
        ],
        "unit": "Chronic stress score 0\u201310",
        "range": "Telogen effluvium trigger: sustained score >6",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "physiological",
        "name": "Scalp Density & Miniaturization Analysis",
        "desc": "Smartphone AI trichoscopy proxy \u2014 hair density mapping, miniaturization detection, and scalp coverage score.",
        "markers": [
          "hair density estimate (hairs/cm\u00b2)",
          "follicular miniaturization %",
          "scalp coverage score",
          "hair shaft diameter proxy",
          "terminal:vellus ratio"
        ],
        "unit": "Hairs/cm\u00b2",
        "range": "Normal scalp: 180\u2013300 hairs/cm\u00b2 | AGA: declining",
        "insight_type": "health_dashboard"
      },
      {
        "src": "physiological",
        "name": "Hair Shaft Quality Analysis",
        "desc": "Smartphone optical analysis of hair shaft diameter, breakage index, and luster score.",
        "markers": [
          "hair shaft diameter \u00b5m proxy",
          "breakage score",
          "luster/shine index",
          "porosity proxy",
          "texture uniformity"
        ],
        "unit": "Breakage score 0\u201310",
        "range": "High breakage (>6): nutritional or structural cause",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "tier": "basic",
        "name": "Primary Hair Loss Triage Panel",
        "desc": "Ferritin, TSH, CBC \u2014 the three most common reversible and treatable hair loss causes.",
        "markers": [
          "ferritin ng/mL",
          "TSH mIU/L",
          "hemoglobin g/dL",
          "MCV fL",
          "WBC x10\u00b3/\u00b5L"
        ],
        "unit": "Ferritin ng/mL",
        "range": "Optimal hair ferritin: >70 ng/mL | Critical: <12 ng/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "standard",
        "name": "Nutritional Hair Growth Panel",
        "desc": "B12, zinc, vitamin D, folate, biotin \u2014 complete micronutrient hair growth foundation.",
        "markers": [
          "B12 pg/mL",
          "folate ng/mL",
          "25-OH vitamin D ng/mL",
          "zinc \u00b5g/dL",
          "selenium \u00b5g/L",
          "biotin pg/mL"
        ],
        "unit": "Zinc \u00b5g/dL",
        "range": "Optimal zinc: 70\u2013120 \u00b5g/dL | Hair loss: <60 \u00b5g/dL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Androgenic Alopecia Hormone Panel",
        "desc": "DHT, free testosterone, SHBG, DHEA-S \u2014 complete androgen-driven AGA diagnostic panel.",
        "markers": [
          "DHT pg/mL",
          "testosterone (free) pg/mL",
          "SHBG nmol/L",
          "DHEA-S \u00b5g/dL",
          "cortisol AM \u00b5g/dL",
          "prolactin ng/mL"
        ],
        "unit": "DHT pg/mL",
        "range": "AGA-associated: DHT M >500 pg/mL | F >45 pg/mL",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "advanced",
        "name": "Thyroid & Autoimmune Hair Panel",
        "desc": "Full thyroid panel plus alopecia areata-associated autoimmune markers.",
        "markers": [
          "TSH mIU/L",
          "free T3/T4",
          "anti-TPO IU/mL",
          "anti-Tg IU/mL",
          "ANA titer",
          "anti-dsDNA",
          "complement C3/C4"
        ],
        "unit": "Anti-TPO IU/mL",
        "range": "Positive anti-TPO (>35 IU/mL) = thyroid autoimmunity",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "tier": "comprehensive",
        "name": "Inflammatory & Scarring Alopecia Panel",
        "desc": "IL-6, hs-CRP, IL-17, autoimmune panel \u2014 lichen planopilaris and scarring alopecia immune markers.",
        "markers": [
          "IL-6 pg/mL",
          "hs-CRP mg/L",
          "IL-17 pg/mL",
          "TNF-\u03b1 pg/mL",
          "ANA/anti-dsDNA",
          "ANCA panel",
          "complement C3/C4"
        ],
        "unit": "IL-6 pg/mL",
        "range": "Scarring alopecia flag: IL-6 >5 pg/mL + ANA positive",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "dna_array",
        "name": "AGA Polygenic Risk Score",
        "desc": "Lifenome androgenetic alopecia PGS: male pattern A/B/C stages, female pattern hair loss \u2014 strongest single predictor.",
        "markers": [
          "AR gene (X-linked primary)",
          "SRD5A2 (5-alpha reductase)",
          "PAX1 (frontal hairline)",
          "HDAC4",
          "WNT10A",
          "20+ AGA SNPs",
          "FPHL-specific PGS"
        ],
        "unit": "AGA risk percentile",
        "range": "High risk: >85th percentile (NW III+ predicted by 50)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Treatment Response PGx",
        "desc": "Pharmacogenomics for minoxidil (SULT1A1/1A2), finasteride (SRD5A2), dutasteride, and PRP response.",
        "markers": [
          "SULT1A1 *2 allele (minoxidil sulfation)",
          "SULT1A2 variants",
          "SRD5A2 V89L (finasteride)",
          "CYP3A4 (dutasteride)",
          "androgen receptor sensitivity"
        ],
        "unit": "Treatment response prediction",
        "range": "SULT1A1 poor sulfater: minoxidil ~50% less effective",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Scalp & Hair Condition PGS",
        "desc": "Seborrheic dermatitis genetic risk, scalp irritability, sebum overproduction \u2014 scalp environment genetics.",
        "markers": [
          "seborrheic dermatitis PGS",
          "scalp-irritability PGS",
          "sebum overproduction genetics",
          "atopic dermatitis FLG variants",
          "inflammatory PGS"
        ],
        "unit": "Scalp condition risk score",
        "range": "High SD risk: >70th percentile = medical shampoo first",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_exome",
        "name": "Hereditary Alopecia Gene Panel",
        "desc": "Rare alopecia universalis (HR gene), monilethrix (KRT81/83/86), and genodermatoses.",
        "markers": [
          "HR gene (alopecia universalis)",
          "KRT81/KRT83/KRT86 (monilethrix)",
          "LAMA3 (junctional EB)",
          "LIPH (LAH)",
          "FZD6 (nail/hair dystrophies)",
          "dermatology exome panel"
        ],
        "unit": "Variant classification",
        "range": "Alopecia universalis (HR LOF): no current cure",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "src": "micro_16s",
        "name": "Scalp Microbiome Dysbiosis Profile",
        "desc": "Malassezia spp. vs. Cutibacterium balance \u2014 dandruff, seborrheic dermatitis, and folliculitis risk.",
        "markers": [
          "Malassezia globosa % ",
          "Malassezia restricta %",
          "Cutibacterium acnes %",
          "Staphylococcus % ",
          "commensal diversity score"
        ],
        "unit": "Malassezia % dominance",
        "range": "Dandruff-associated: Malassezia >50% | Healthy: <35%",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_16s",
        "name": "Gut-Hair Axis Inflammation",
        "desc": "Systemic gut-derived inflammation affecting scalp immune environment \u2014 telogen effluvium driver.",
        "markers": [
          "gut Shannon diversity H",
          "LPS-producing Proteobacteria %",
          "Akkermansia %",
          "Bifidobacterium %",
          "butyrate producers %"
        ],
        "unit": "Gut inflammation score 0\u201310",
        "range": "Hair loss amplification: gut score >6",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Androgen-Microbiome Metabolism",
        "desc": "Gut bacterial androgen conversion and 5-alpha reductase activity \u2014 DHT modulation via enterolignans.",
        "markers": [
          "androgen-metabolizing bacterial genes",
          "5AR pathway functional genes",
          "enterolignin-processing gene count",
          "equol-producing capacity (Slackia isoflavoniconvertens)"
        ],
        "unit": "Androgen conversion functional score",
        "range": "High conversion: increases DHT availability",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "epigenetics",
        "name": "Hair Follicle Epigenetic Age",
        "desc": "Follicular biological age and WNT pathway methylation \u2014 predicts miniaturization velocity and treatment window.",
        "markers": [
          "follicular methylation age (yr)",
          "androgen receptor promoter methylation %",
          "WNT pathway CpG methylation",
          "AgeAccelGrim scalp component"
        ],
        "unit": "Follicular biological age (yr)",
        "range": "Follicular age acceleration >5 yr: reduced treatment response",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Hair Loss Treatment Product Matching",
        "desc": "Evidence-based hair loss treatment recommendations from client catalog matched by genetic profile and biomarkers: minoxidil response genetics (SULT1A1), finasteride/dutasteride metabolism (SRD5A2, CYP3A4), spironolactone for female AGA (hormone markers), and topical peptides (copper peptides, GHK-Cu) for non-androgenic loss.",
        "markers": [
          "AGA PGS",
          "SULT1A1 (minoxidil response)",
          "SRD5A2 genotype",
          "DHT:testosterone ratio",
          "finasteride metabolism genotype",
          "scalp inflammation score",
          "thyroid panel"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Hair Nutrition & Supplement Protocol",
        "desc": "Targeted hair health supplement stack from client catalog: iron (critical threshold ferritin >70 ng/mL for hair), zinc, biotin (if deficient \u2014 note: biotin artifacts in thyroid testing), vitamin D, selenium, and marine collagen for hair matrix support.",
        "markers": [
          "ferritin",
          "zinc",
          "biotin deficiency genetics",
          "25-OH Vit D",
          "selenium",
          "thyroid panel",
          "protein intake estimate"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Scalp Health & Hair Growth Program",
        "desc": "Multimodal hair and scalp health intervention: stress management protocol (cortisol-linked telogen effluvium), scalp microbiome rebalancing (probiotic selection from microbiome dysbiosis profile), dietary protein optimization, and DHT-reducing dietary interventions.",
        "markers": [
          "cortisol AM",
          "scalp microbiome dysbiosis score",
          "protein intake",
          "DHT proxy",
          "Malassezia spp. abundance",
          "gut-hair axis inflammation"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "Male Balding Pattern A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hairloss Profile",
        "markers": [
          "Male Balding Pattern A"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Male Balding Pattern B",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hairloss Profile",
        "markers": [
          "Male Balding Pattern B"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Male Balding Pattern C",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hairloss Profile",
        "markers": [
          "Male Balding Pattern C"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Female Pattern Hair Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hairloss Profile",
        "markers": [
          "Female Pattern Hair Loss"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Hair Dryness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Hair Dryness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Hair Greying",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Hair Greying"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Hair Growth Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Hair Growth Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Hair Lipids",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Hair Lipids"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Hair Loss",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Hair Loss"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Hair Thickness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Hair Thickness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Keratin Type2 Imbalance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Hair Profile",
        "markers": [
          "Keratin Type2 Imbalance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Antioxidant Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Antioxidant Deficiency"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Barrier Function",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Barrier Function"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Collagen Breakdown",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Collagen Breakdown"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Glycation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Glycation"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Hydration Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Hydration Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Irritability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Irritability"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Pollution Defense Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Pollution Defense Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Sensitivity Sun",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Sensitivity Sun"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Scalp Thinning",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Scalp Thinning"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Seborrheic Dermatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Seborrheic Dermatitis"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Sebum Overproduction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Scalp Profile",
        "markers": [
          "Sebum Overproduction"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Antiinflammatory Glucocorticoids Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Antiinflammatory Glucocorticoids Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Biotin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Biotin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Cetirizine Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cetirizine Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Collagen Stability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Collagen Stability"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Dutasteride Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Dutasteride Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Dutasteride Metabolism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Dutasteride Metabolism"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Estradiol Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Estradiol Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Finasteride Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Finasteride Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Finasteride Metabolism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Finasteride Metabolism"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Igf1 Bioavailibility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Igf1 Bioavailibility"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Latanoprost Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Latanoprost Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Minoxidil Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Minoxidil Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Retinoic Acid Topical Usage Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Retinoic Acid Topical Usage Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Prostaglandinreceptor Expression",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Prostaglandinreceptor Expression"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      },
      {
        "name": "Spironolactone Effectiveness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Haircare.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Spironolactone Effectiveness"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "hairloss"
        ]
      }
    ],
    "_marker_count": 151,
    "marker_count": 151,
    "insight_count": 58
  },
  {
    "id": "mental_health",
    "name": "Mental Health & Brain Wellness",
    "sub": "Mood \u00b7 Cognition \u00b7 Stress \u00b7 Neuroinflammation",
    "color": "#6b3fa0",
    "lt": "#f0eaff",
    "img": "https://images.unsplash.com/photo-1544367567-0f2fcb009e0b?w=300&q=75",
    "desc": "Comprehensive mental wellness intelligence combining blood biomarkers, DNA risk, wearable psychophysiology, lifestyle assessment, and epigenetics to produce actionable indices for mood, cognition, stress resilience, neuroinflammation, and sleep quality.",
    "tags": [
      "Mood & Depression Risk",
      "Cognitive Performance",
      "Stress & HPA Axis",
      "Neuroinflammation",
      "Sleep Architecture",
      "Brain Aging",
      "Anxiety Biomarkers",
      "Gut-Brain Axis"
    ],
    "insights": [
      {
        "src": "blood",
        "name": "Neuroinflammation Index",
        "desc": "Composite of hs-CRP, IL-6, TNF-\u03b1, and homocysteine to quantify systemic and central nervous system inflammatory burden linked to depression, cognitive decline, and anxiety disorders.",
        "markers": [
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "homocysteine",
          "WBC count",
          "neutrophil/lymphocyte ratio"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: <25 | Elevated: 25\u201360 | High burden: >60",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Cortisol Stress Burden Score",
        "desc": "Morning cortisol and DHEA-S ratio reflecting HPA-axis dysregulation, burnout risk, and chronic stress load. Chronically elevated cortisol is causal in anxiety, depression, memory impairment, and sleep disruption.",
        "markers": [
          "cortisol AM",
          "DHEA-S",
          "cortisol/DHEA-S ratio"
        ],
        "unit": "Ratio + Score",
        "range": "Healthy ratio: 5\u201310 | Burnout risk: >15 | Adrenal fatigue: <3",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Serotonin Precursor Availability",
        "desc": "Tryptophan and its ratio to competing large neutral amino acids (LNAAs) determines CNS serotonin synthesis capacity. Low ratio is a validated biological marker for depression vulnerability and carbohydrate craving.",
        "markers": [
          "tryptophan",
          "tyrosine",
          "phenylalanine",
          "leucine",
          "isoleucine",
          "valine",
          "tryptophan:LNAA ratio"
        ],
        "unit": "Ratio (Trp:LNAA)",
        "range": "Optimal: >0.12 | Depleted: <0.08",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Dopamine & Catecholamine Balance",
        "desc": "Tyrosine availability (dopamine precursor), phenylalanine, and plasma catecholamine proxies reflecting reward circuitry, motivation, focus, and ADHD-related pathways.",
        "markers": [
          "tyrosine",
          "phenylalanine",
          "Tyr:Phe ratio",
          "homovanillic acid (HVA)"
        ],
        "unit": "Tyr:Phe ratio",
        "range": "Optimal: >1.5 | Depleted: <1.0",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Mood-Nutrient Deficiency Panel",
        "desc": "Critical neuronutrients whose deficiency is causally linked to depression, anxiety, fatigue, and cognitive impairment. Inspired by Function Health's finding that 38% of users are deficient in \u22651 key brain nutrient.",
        "markers": [
          "25-OH Vitamin D",
          "Vitamin B12",
          "folate",
          "Omega-3 index (EPA+DHA)",
          "magnesium RBC",
          "zinc",
          "iron/ferritin"
        ],
        "unit": "Multi-marker panel",
        "range": "Vit D optimal: 40\u201380 ng/mL | B12: >400 pg/mL | Omega-3: >8%",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "src": "blood",
        "name": "Thyroid-Mood Connection Score",
        "desc": "Subclinical hypothyroidism and thyroid autoimmunity are strongly associated with depression, brain fog, fatigue, and anxiety. Full thyroid panel including TPO antibodies (elevated in ~23% of population per Function Health data).",
        "markers": [
          "TSH",
          "Free T3",
          "Free T4",
          "TPO antibodies",
          "TgAb",
          "reverse T3"
        ],
        "unit": "Composite score",
        "range": "TSH optimal: 1.0\u20132.5 mIU/L | TPO Ab: <35 IU/mL",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Brain Aging & Alzheimer's Risk Score",
        "desc": "Blood-based neurodegenerative biomarker panel including p-tau217 (AUC 0.93\u20130.96 for Alzheimer's per Nature Medicine 2025), GFAP, and NfL. Function Health reports 14% of members have elevated p-tau217. Integrated with APOE genotype from DNA.",
        "markers": [
          "p-tau217",
          "GFAP (glial fibrillary acidic protein)",
          "NfL (neurofilament light chain)",
          "A\u03b242/40 ratio",
          "p-tau181"
        ],
        "unit": "Risk score + pg/mL",
        "range": "p-tau217 low risk: <0.4 pg/mL | High risk: >1.0 pg/mL",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "HPA-Axis Resilience Index",
        "desc": "Combined cortisol, ACTH, and adrenal reserve markers reflecting hypothalamic-pituitary-adrenal function. Predicts stress resilience, post-traumatic recovery capacity, and treatment response in anxiety and depression.",
        "markers": [
          "cortisol AM",
          "ACTH (adrenocorticotropic hormone)",
          "DHEA-S",
          "aldosterone",
          "salivary cortisol awakening response"
        ],
        "unit": "Index 0\u2013100",
        "range": "Resilient: >65 | Vulnerable: 35\u201365 | Depleted: <35",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Gut-Brain Axis Health Score",
        "desc": "Validated blood proxies of gut microbiome health (InsideTracker methodology: hsCRP, cortisol, HDL, triglycerides, glucose, HbA1c) plus LPS and zonulin markers of intestinal permeability linked to mood disorders via vagus nerve signaling.",
        "markers": [
          "hs-CRP",
          "cortisol",
          "HDL cholesterol",
          "triglycerides",
          "fasting glucose",
          "HbA1c",
          "LPS (lipopolysaccharides)",
          "zonulin"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >70 | Dysbiosis risk: <45",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Metabolic-Psychiatric Risk Index",
        "desc": "Insulin resistance, blood sugar dysregulation, and lipid imbalance are bidirectionally linked to depression, anxiety, and cognitive decline. Adapted from InsideTracker's metabolism + cognition cross-category scoring.",
        "markers": [
          "fasting insulin",
          "fasting glucose",
          "HbA1c",
          "HOMA-IR",
          "ApoB",
          "triglycerides",
          "HDL"
        ],
        "unit": "HOMA-IR + composite",
        "range": "HOMA-IR optimal: <1.5 | Insulin resistance: >2.5",
        "tier": "standard",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Oxidative Stress & Antioxidant Capacity",
        "desc": "Excessive reactive oxygen species (ROS) damage neuronal membranes and mitochondria, driving neuroinflammation, depression, and cognitive aging. Panel includes 8-OHdG, glutathione, and uric acid.",
        "markers": [
          "8-OHdG (8-hydroxy-2-deoxyguanosine)",
          "glutathione (GSH)",
          "uric acid",
          "total antioxidant capacity (TAC)",
          "superoxide dismutase (SOD)"
        ],
        "unit": "TAC \u03bcmol/L",
        "range": "Optimal: >1.1 mmol/L | Depleted: <0.8",
        "tier": "comprehensive",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Sex Hormone-Mental Health Bridge",
        "desc": "Testosterone, estradiol, and progesterone fluctuations modulate serotonin, GABA, and dopamine systems. Critical for premenstrual dysphoric disorder (PMDD), postpartum depression, perimenopause mood, and male testosterone-related depression.",
        "markers": [
          "total testosterone",
          "free testosterone",
          "estradiol (E2)",
          "progesterone",
          "SHBG",
          "LH",
          "FSH"
        ],
        "unit": "Multi-hormone profile",
        "range": "E2 optimal (women): 30\u2013200 pg/mL | Testosterone (men): 400\u2013700 ng/dL",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "blood",
        "name": "Sleep Quality Biomarker Score",
        "desc": "Blood markers correlated with deep sleep, REM quality, and sleep architecture. Inspired by InsideTracker's sleep healthspan category. Melatonin pathway markers, magnesium, and circadian cortisol profiling.",
        "markers": [
          "magnesium RBC",
          "cortisol PM (evening)",
          "melatonin (AM draw)",
          "vitamin D",
          "glucose",
          "TSH"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >70 | Poor sleep biology: <45",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "src": "dna_array",
        "name": "Polygenic Depression & Anxiety Risk",
        "desc": "Multi-locus genetic risk score aggregating 100+ validated SNPs across serotonin transporter (5-HTTLPR), BDNF Val66Met, COMT Val158Met, FKBP5, CRHR1, and other stress-response and neurotransmitter genes.",
        "markers": [
          "5-HTTLPR (SLC6A4)",
          "BDNF Val66Met",
          "COMT Val158Met",
          "FKBP5 rs1360780",
          "CRHR1 haplotype",
          "MAOA uVNTR",
          "TPH2 SNPs",
          "HTR2A rs6311"
        ],
        "unit": "PRS percentile",
        "range": "Low risk: <40th percentile | High risk: >80th percentile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Neurotransmitter Metabolism Genotype",
        "desc": "MTHFR, COMT, MAO-A/B, and CBS gene variants affecting methylation, serotonin/dopamine breakdown, and folate-homocysteine cycle \u2014 the genetic backbone of psychiatric vulnerability and psychotropic drug response.",
        "markers": [
          "MTHFR C677T",
          "MTHFR A1298C",
          "COMT rs4680",
          "MAO-A rs6323",
          "MAO-B rs1799836",
          "CBS rs234706",
          "BHMT rs3733890"
        ],
        "unit": "Genotype call",
        "range": "Risk: homozygous MTHFR TT or COMT met/met",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "APOE & Neurodegeneration Risk Score",
        "desc": "APOE \u03b54 genotyping combined with CLU, CR1, PICALM, and BIN1 polygenic risk for late-onset Alzheimer's. APOE \u03b54 carriers have 3\u201312\u00d7 elevated risk. Critical for proactive brain health planning.",
        "markers": [
          "APOE \u03b52/\u03b53/\u03b54",
          "CLU rs11136000",
          "CR1 rs3818361",
          "PICALM rs3851179",
          "BIN1 rs744373",
          "TOMM40 poly-T"
        ],
        "unit": "Risk tier (\u03b52/\u03b53/\u03b54)",
        "range": "\u03b53/\u03b53: average | \u03b53/\u03b54: 3\u00d7 | \u03b54/\u03b54: 8\u201312\u00d7",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "dna_array",
        "name": "Stress Resilience & PTSD Genetic Profile",
        "desc": "Genetic variants in glucocorticoid receptor (NR3C1), FKBP5, CRHR1, and neuropeptide Y pathways that determine individual variation in stress sensitivity, trauma recovery, and resilience to adverse childhood experiences.",
        "markers": [
          "NR3C1 BclI polymorphism",
          "FKBP5 rs1360780",
          "CRHR1 haplotype",
          "NPY rs16139",
          "PACAP rs2267735",
          "RORA rs4774388"
        ],
        "unit": "Resilience tier",
        "range": "High resilience | Average | Sensitized stress response",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "src": "lifestyle",
        "name": "Validated Mental Health Risk Assessment",
        "desc": "Standardized psychometric tools (PHQ-9, GAD-7, PSQI, PSS-10) combined with adverse life events, sleep diary, and substance use questionnaire producing clinical-grade mental health risk stratification.",
        "markers": [
          "PHQ-9 score",
          "GAD-7 score",
          "PSQI sleep quality score",
          "PSS-10 stress score",
          "adverse life events",
          "substance use",
          "social support index"
        ],
        "unit": "Multi-scale composite",
        "range": "PHQ-9: <5 minimal | 5\u201314 moderate | \u226515 severe",
        "insight_type": "health_dashboard"
      },
      {
        "src": "lifestyle",
        "name": "Circadian Disruption & Sleep Chronotype",
        "desc": "Lifestyle questionnaire mapping sleep timing, circadian misalignment (social jetlag), light exposure, and shift work patterns \u2014 major modifiable drivers of mood disorders, metabolic dysfunction, and cognitive decline.",
        "markers": [
          "chronotype (MEQ score)",
          "sleep midpoint",
          "social jetlag hours",
          "light exposure score",
          "screen time evening",
          "caffeine timing"
        ],
        "unit": "Circadian score",
        "range": "Aligned: score >70 | Moderate misalignment | Severely misaligned: <30",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "HRV-Based Stress & Recovery Index",
        "desc": "Heart rate variability (RMSSD, SDNN) and resting heart rate as objective psychophysiological markers of autonomic nervous system balance, stress burden, and mental recovery quality \u2014 validated against cortisol and burnout scales.",
        "markers": [
          "RMSSD (ms)",
          "SDNN (ms)",
          "resting HR",
          "HRV trend 30-day",
          "stress score",
          "recovery score"
        ],
        "unit": "RMSSD ms + Score",
        "range": "Optimal RMSSD: >60 ms | Stressed: <30 ms",
        "insight_type": "health_dashboard"
      },
      {
        "src": "wearable",
        "name": "Sleep Architecture & Restorative Sleep Score",
        "desc": "Deep sleep (N3) percentage, REM latency, sleep efficiency, and nocturnal HRV from wearable device correlated with cognitive performance, emotional regulation, and mood stability next-day.",
        "markers": [
          "deep sleep %",
          "REM %",
          "sleep efficiency",
          "sleep latency (min)",
          "nocturnal HRV",
          "awakenings/night"
        ],
        "unit": "Sleep score 0\u2013100",
        "range": "Optimal: >80 | Poor: <55 | Deep sleep: ideal >15%",
        "insight_type": "health_dashboard"
      },
      {
        "src": "epigenetics",
        "name": "Brain Epigenetic Age (DNAmAge)",
        "desc": "DNA methylation-based biological age clocks (Horvath, GrimAge, PhenoAge) applied to brain-relevant CpG sites. GrimAge is the strongest predictor of mortality and cognitive aging; acceleration >3 years indicates elevated risk.",
        "markers": [
          "Horvath clock age",
          "GrimAge",
          "PhenoAge",
          "DNAmPhenoAge acceleration",
          "GrimAge acceleration",
          "DunedinPACE aging rate"
        ],
        "unit": "Biological age (years)",
        "range": "Ideal: chronological age | Concern: >3 years accelerated",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "epigenetics",
        "name": "Stress Epigenome & Trauma Methylation",
        "desc": "Methylation patterns at NR3C1 (glucocorticoid receptor), FKBP5, and BDNF promoters that are modified by chronic stress, early adversity, and trauma \u2014 providing an epigenetic readout of the lived stress history.",
        "markers": [
          "NR3C1 promoter methylation",
          "FKBP5 intron 7 methylation",
          "BDNF promoter methylation",
          "SLC6A4 methylation",
          "OXTR methylation"
        ],
        "unit": "Methylation %",
        "range": "NR3C1 hypermethylation \u2192 HPA hyper-reactivity",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "micro_16s",
        "name": "Gut-Brain Microbiome Mental Health Index",
        "desc": "Microbiome diversity, Lactobacillus/Bifidobacterium abundance, and dysbiosis markers linked to the gut-brain axis. Low Firmicutes:Bacteroidetes ratio and reduced SCFA producers correlate with depression and anxiety in clinical studies.",
        "markers": [
          "Shannon diversity index",
          "Lactobacillus spp. abundance",
          "Bifidobacterium spp. abundance",
          "Firmicutes:Bacteroidetes ratio",
          "Akkermansia muciniphila %",
          "SCFA-producing bacteria %",
          "Prevotella spp."
        ],
        "unit": "Diversity + dysbiosis score",
        "range": "Shannon diversity optimal: >3.5 | Dysbiosis: <2.5",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "src": "micro_wgs",
        "name": "Psychobiotic Functional Profile",
        "desc": "Metagenomics quantification of GABA-producing bacteria (Lactobacillus rhamnosus), serotonin-pathway microbes, and neurotransmitter precursor synthesis genes (aromatic amino acid decarboxylase pathways) in the gut.",
        "markers": [
          "GABA-producing taxa (L. rhamnosus, L. brevis)",
          "tryptophan-catabolizing taxa",
          "aromatic amino acid decarboxylase genes",
          "kynurenine pathway microbes",
          "LPS-producing bacteria (endotoxin burden)"
        ],
        "unit": "Functional gene count",
        "range": "High psychobiotic richness vs. pro-inflammatory profile",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "bacteria": "10,000+"
        }
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Precision Psychiatry Supplement Protocol",
        "desc": "Evidence-based nutraceutical protocol for mental health from client catalog, personalized by neurotransmitter genetics and biomarkers: methylfolate (MTHFR carriers with depression), omega-3 EPA (neuroinflammation index), saffron extract (serotonin), ashwagandha (cortisol), magnesium glycinate (anxiety/sleep), and probiotics for gut-brain axis.",
        "markers": [
          "MTHFR genotype",
          "omega-3 index",
          "cortisol AM",
          "Trp:LNAA ratio",
          "magnesium RBC",
          "gut-brain axis score",
          "NLR",
          "hs-CRP"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Personalized Mental Wellness Program",
        "desc": "Structured lifestyle-based mental health intervention: exercise protocol (aerobic \u2192 BDNF upregulation, matched to depression PGS), sleep architecture optimization, circadian realignment program, stress resilience practices (HRV biofeedback intensity by autonomic baseline), and social prescribing guide.",
        "markers": [
          "PHQ-9 score",
          "HRV baseline",
          "sleep efficiency",
          "BDNF Val66Met",
          "circadian misalignment score",
          "cortisol AM",
          "FKBP5 genotype"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Gut-Brain Axis Restoration Protocol",
        "desc": "Targeted microbiome intervention to improve gut-brain signaling: psychobiotic selection (L. rhamnosus, B. longum \u2014 by gut microbiome profile), dietary fiber and prebiotic plan, elimination of gut permeability triggers identified by individual profile, and fermented food recommendations.",
        "markers": [
          "gut-brain microbiome score",
          "Lactobacillus spp.",
          "GABA-producing bacteria",
          "Shannon diversity",
          "zonulin",
          "LPS",
          "tryptophan-catabolizing taxa"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Alcohol And Nicotine Co Dependence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Alcohol Dependence",
        "markers": [
          "Alcohol And Nicotine Co Dependence"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Alcohol Consumption Drinks Per Week Mtag",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Alcohol Dependence",
        "markers": [
          "Alcohol Consumption Drinks Per Week Mtag"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Alcohol Dependence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Alcohol Dependence",
        "markers": [
          "Alcohol Dependence"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Alcohol Dependence Age At Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Alcohol Dependence",
        "markers": [
          "Alcohol Dependence Age At Onset"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Alcoholic Chronic Pancreatitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Alcohol Dependence",
        "markers": [
          "Alcoholic Chronic Pancreatitis"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Caffeine Consumption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Coffee Caffein Consumption",
        "markers": [
          "Caffeine Consumption"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Coffee Consumption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Coffee Caffein Consumption",
        "markers": [
          "Coffee Consumption"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Coffee Consumption Cups Per Day",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Coffee Caffein Consumption",
        "markers": [
          "Coffee Consumption Cups Per Day"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Gambling",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Gambling",
        "markers": [
          "Gambling"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Cannabis Dependence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oploids Dependence",
        "markers": [
          "Cannabis Dependence"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Cannabis Use Initiation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oploids Dependence",
        "markers": [
          "Cannabis Use Initiation"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Cocaine Dependence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oploids Dependence",
        "markers": [
          "Cocaine Dependence"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Methadone Dose In Opioid Dependence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oploids Dependence",
        "markers": [
          "Methadone Dose In Opioid Dependence"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Opioid Sensitivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Oploids Dependence",
        "markers": [
          "Opioid Sensitivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Nicotine Glucouronidation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Nicotine Glucouronidation"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Nicotine Use",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Nicotine Use"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Smoking Cessation In Chronic Obstructive Pulmonary Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Smoking Cessation In Chronic Obstructive Pulmonary Disease"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Smoking Cessation Mtag",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Smoking Cessation Mtag"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Smoking Initiation Age Mtag",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Smoking Initiation Age Mtag"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Smoking Initiation Ever Regular Vs Never Regular Mtag",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Smoking Initiation Ever Regular Vs Never Regular Mtag"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Smoking Quantity Cigarettes Per Day Mtag",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Addiction Potential.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Smoking Nicotine",
        "markers": [
          "Smoking Quantity Cigarettes Per Day Mtag"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Agreeableness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interpersonal Characteristics",
        "markers": [
          "Agreeableness"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Empathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interpersonal Characteristics",
        "markers": [
          "Empathy"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Extraversion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interpersonal Characteristics",
        "markers": [
          "Extraversion"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Leadership Potential",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interpersonal Characteristics",
        "markers": [
          "Leadership Potential"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Sociability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Interpersonal Characteristics",
        "markers": [
          "Sociability"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Creativity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Creativity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Experiential Learning Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Experiential Learning Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Mathematical Aptitude",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Mathematical Aptitude"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Memory Performance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Memory Performance"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Music Performance Aptitude",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Music Performance Aptitude"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Musical Creativity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Musical Creativity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Reading Aptitude",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Learning Personality",
        "markers": [
          "Reading Aptitude"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Addictive Personality",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Addictive Personality"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Anger Response",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Anger Response"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Exploratory Behavior",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Exploratory Behavior"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Impulsivity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Impulsivity"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Morning Person",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Morning Person"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Optimism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Optimism"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Pleasure Response Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Pleasure Response Impairment"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Warrior Personality",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Warrior Personality"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Worrier Personality",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Personality.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_array",
        "insight_type": "biomarker_assessment",
        "subcategory": "Personality Profile",
        "markers": [
          "Worrier Personality"
        ],
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        },
        "verticals": [
          "mental_health",
          "longevity"
        ]
      },
      {
        "name": "Bipolar Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Bipolar Disorder"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Chronic Fatigue Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Chronic Fatigue Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Depression",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Depression"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Eating Disorders",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Eating Disorders"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Fibromyalgia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Fibromyalgia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Insomnia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Insomnia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Panic Attacks Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Panic Attacks Disorder"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Post Traumatic Stress Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Post Traumatic Stress Disorder"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Postpartum Depression",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Postpartum Depression"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Schizophrenia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Schizophrenia"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Sleep Apnea",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Mental Behavioural Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Mental Behavioural Disorders",
        "markers": [
          "Sleep Apnea"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention"
        ]
      },
      {
        "name": "Alzheimers Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Alzheimers Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Bells Palsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Bells Palsy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Benign Peripheral Nerve Tumor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Benign Peripheral Nerve Tumor"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Brain Aneurysm",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Brain Aneurysm"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Palsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Cerebral Palsy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Encephalitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Encephalitis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Essential Tremor Benign",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Essential Tremor Benign"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Guillain Barre Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Guillain Barre Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Intracranial Hematoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Intracranial Hematoma"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Migraine",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Migraine"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Multiple Sclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Multiple Sclerosis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Myasthenia Gravis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Myasthenia Gravis"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Parkinsons Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Parkinsons Disease"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Peripheral Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Nervous System Disorders.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Nervous System Disorders",
        "markers": [
          "Peripheral Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "prevention",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophic Lateral Sclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Amyotrophic Lateral Sclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Brachyolmia (Autosomal Dominant Type)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Brachyolmia (Autosomal Dominant Type)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cardioencephalomyopathy, Fatal Infantile, Due To Cytochrome C Oxidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Cardioencephalomyopathy, Fatal Infantile, Due To Cytochrome C Oxidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Charcot Marie Tooth Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Charcot Marie Tooth Disease Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Childhood Onset Proximal Spinal Muscular Atrophy With Contractures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Childhood Onset Proximal Spinal Muscular Atrophy With Contractures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Distal Hereditary Motor Neuronopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Distal Hereditary Motor Neuronopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Encephalopathy, Progressive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Encephalopathy, Progressive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Familial Digital Arthropathy With Brachydactyly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Familial Digital Arthropathy With Brachydactyly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Farber Lipogranulomatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Farber Lipogranulomatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Finkel",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Finkel"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gm2 Gangliosidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Gm2 Gangliosidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hereditary Motor And Sensory Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Hereditary Motor And Sensory Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hexosaminidase A Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Hexosaminidase A Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypertrophic Cardiomyopathy (Hcm)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Hypertrophic Cardiomyopathy (Hcm)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Intellectual Developmental Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Intellectual Developmental Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Jokela Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Jokela Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leigh Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Leigh Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lipodystrophy, Congenital Generalized",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Lipodystrophy, Congenital Generalized"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Menkes Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Menkes Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Metatropic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Metatropic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myasthenic Syndrome, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Myasthenic Syndrome, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Isolated Mitochondrial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Myopathy, Isolated Mitochondrial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Myopia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronopathy, Distal Hereditary Motor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Neuronopathy, Distal Hereditary Motor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronopathy, Distal Hereditary Motor, Type Viia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Neuronopathy, Distal Hereditary Motor, Type Viia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Distal Hereditary Motor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Neuropathy, Distal Hereditary Motor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Distal Hereditary Motor, Type Va",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Neuropathy, Distal Hereditary Motor, Type Va"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Occipital Horn Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Occipital Horn Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parastremmatic Dwarfism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Parastremmatic Dwarfism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Perry Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Perry Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pontocerebellar Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Pontocerebellar Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Progressive Encephalopathy With Amyotrophy And Optic Atrophy (Peamo)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Progressive Encephalopathy With Amyotrophy And Optic Atrophy (Peamo)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Silver Spastic Paraplegia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Silver Spastic Paraplegia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Silver Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Silver Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spastic Paraplegia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spastic Paraplegia 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spinal Muscular Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy With Respiratory Distress",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spinal Muscular Atrophy With Respiratory Distress"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy, Distal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spinal Muscular Atrophy, Distal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy, Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spinal Muscular Atrophy, Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinal Muscular Atrophy, Late Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spinal Muscular Atrophy, Late Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spondyloepiphyseal Dysplasia Maroteaux Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spondyloepiphyseal Dysplasia Maroteaux Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spondylometaphyseal Dysplasia Kozlowski Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Spondylometaphyseal Dysplasia Kozlowski Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Tay Sachs Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spinal Muscular Atrophy",
        "markers": [
          "Tay Sachs Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Adrenoleukodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Adrenoleukodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Allan Herndon Dudley Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Allan Herndon Dudley Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophic Lateral Sclerosis, Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Amyotrophic Lateral Sclerosis, Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia With Oculomotor Apraxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Ataxia With Oculomotor Apraxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Bh4 Deficient",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Bh4 Deficient"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Bile Acid Synthesis Defect",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Bile Acid Synthesis Defect"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Biotinidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Biotinidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Boucher Neuhauser Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Boucher Neuhauser Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Crash Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Crash Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebellar Ataxia With Spasticity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Cerebellar Ataxia With Spasticity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebrotendinous Xanthomatosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Cerebrotendinous Xanthomatosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charlevoix Saguenay",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Charlevoix Saguenay"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Claes Jensen",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Claes Jensen"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 14",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 14"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Cataracts, Hearing Loss, And Neurodegeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Congenital Cataracts, Hearing Loss, And Neurodegeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Corpus Callosum, Partial Agenesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Corpus Callosum, Partial Agenesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dopa Responsive Dystonia Hyperphenylalaninemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Dopa Responsive Dystonia Hyperphenylalaninemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dopa Responsive, Due To Sepiapterin Reductase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Dopa Responsive, Due To Sepiapterin Reductase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Dystonia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Exudative Vitreoretinopathy 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Exudative Vitreoretinopathy 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Friedreich Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Friedreich Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gtp Cyclohydrolase 1 Deficient Dopa Responsive Dystonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Gtp Cyclohydrolase 1 Deficient Dopa Responsive Dystonia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Harel Yoon Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Harel Yoon Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hereditary Motor And Sensory Neuropathy, Proximal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Hereditary Motor And Sensory Neuropathy, Proximal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hydrocephalus Due To Congenital Stenosis Of Aqueduct Of Sylvius",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Hydrocephalus Due To Congenital Stenosis Of Aqueduct Of Sylvius"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperargininemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Hyperargininemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperornithinemia Hyperammonemia Homocitrullinemia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Hyperornithinemia Hyperammonemia Homocitrullinemia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperphenylalaninemia, Non Pku Mild",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Hyperphenylalaninemia, Non Pku Mild"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypomyelination With Brainstem And Spinal Cord Involvement And Leg Spasticity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Hypomyelination With Brainstem And Spinal Cord Involvement And Leg Spasticity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Krabbe Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Krabbe Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Laurence Moon Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Laurence Moon Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukodystrophy, Hypomyelinating",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Leukodystrophy, Hypomyelinating"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukodystrophy, Hypomyelinating 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Leukodystrophy, Hypomyelinating 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lymphedema, Hereditary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Lymphedema, Hereditary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Aphasia, Shuffling Gait, And Adducted Thumbs (Masa) Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Mental Retardation, Aphasia, Shuffling Gait, And Adducted Thumbs (Masa) Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Mental Retardation, Autosomal Dominant 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 49",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Mental Retardation, Autosomal Recessive 49"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Microcephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Mitochondrial Dysfunctions Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Multiple Mitochondrial Dysfunctions Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neurodegeneration With Brain Iron Accumulation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Neurodegeneration With Brain Iron Accumulation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neurodegeneration With Brain Iron Accumulation 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Neurodegeneration With Brain Iron Accumulation 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neurodevelopmental Disorder With Hypotonia, Seizures, And Absent Language",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Neurodevelopmental Disorder With Hypotonia, Seizures, And Absent Language"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Hereditary Sensory",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Neuropathy, Hereditary Sensory"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pelizaeus Merzbacher Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Pelizaeus Merzbacher Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Phenylketonuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Phenylketonuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ritscher Schinzel Syndrome (3C Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Ritscher Schinzel Syndrome (3C Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Segawa Syndrome, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Segawa Syndrome, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Ataxia 8, Autosomal Recessive, With Hypomyelinating Leukodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Ataxia 8, Autosomal Recessive, With Hypomyelinating Leukodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paralysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paralysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia (Troyer Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia (Troyer Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 12, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 12, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 18, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 18, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 39",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 39"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 42, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 42, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 45",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 45"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 47, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 47, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 48, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 48, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 49, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 49, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 50, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 50, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 51, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 51, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 52, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 52, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 56, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 56, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 5A, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 5A, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 61",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 61"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 74, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 74, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 76, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 76, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 77, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia 77, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia And Psychomotor Retardation With Or Without Seizures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia And Psychomotor Retardation With Or Without Seizures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia, Intellectual Disability, Nystagmus, And Obesity (Sino)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Paraplegia, Intellectual Disability, Nystagmus, And Obesity (Sino)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Tetraplegia, Thin Corpus Callosum, And Progressive Microcephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spastic Tetraplegia, Thin Corpus Callosum, And Progressive Microcephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spinocerebellar Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia 42",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Spinocerebellar Ataxia 42"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Stuttering, Familial Persistent, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Spastic Paraplegia",
        "markers": [
          "Stuttering, Familial Persistent, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Acyl Coa Dehydrogenase Family, Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Acyl Coa Dehydrogenase Family, Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Acyl Coa Dehydrogenase, Medium Chain, Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Acyl Coa Dehydrogenase, Medium Chain, Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Acyl Coa Dehydrogenase, Very Long Chain, Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Acyl Coa Dehydrogenase, Very Long Chain, Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alpers Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Alpers Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Arthrogryposis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Arthrogryposis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia And Polyneuropathy, Adult Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Ataxia And Polyneuropathy, Adult Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Becker Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Becker Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Behr Synrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Behr Synrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Brody Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Brody Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cardiomyopathy, Apical Hypertrophic, And Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Cardiomyopathy, Apical Hypertrophic, And Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cardiomyopathy, Infantile Hypertrophic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Cardiomyopathy, Infantile Hypertrophic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Carnitine Deficiency, Systemic Primary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Carnitine Deficiency, Systemic Primary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Carnitine Palmitoyltransferase Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Carnitine Palmitoyltransferase Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Carnitine Acylcarnitine Translocase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Carnitine Acylcarnitine Translocase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Central Core Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Central Core Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Centronuclear Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Centronuclear Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Chloramphenicol Toxicity/Resistance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Chloramphenicol Toxicity/Resistance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Coenzyme Q10 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Coenzyme Q10 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Cataracts, Facial Dysmorphism, And Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Congenital Cataracts, Facial Dysmorphism, And Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Disorder Of Glycosylation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Congenital Disorder Of Glycosylation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Muscular Dystrophy Dystroglycanopathy With Brain And Eye Anomalies, Type A, 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Congenital Muscular Dystrophy Dystroglycanopathy With Brain And Eye Anomalies, Type A, 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Muscular Dystrophy Dystroglycanopathy With Brain And Eye Anomalies, Type C, 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Congenital Muscular Dystrophy Dystroglycanopathy With Brain And Eye Anomalies, Type C, 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Creatine Phosphokinase, Elevated Serum",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Creatine Phosphokinase, Elevated Serum"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cyclic Vomiting Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Cyclic Vomiting Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cytochrome C Oxidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Cytochrome C Oxidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cytochrome C Oxidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Cytochrome C Oxidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Danon Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Danon Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Deafness, Mitochondrial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Deafness, Mitochondrial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Diabetes Deafness Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Diabetes Deafness Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dilated Cardiomyopathy (Dcm)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Dilated Cardiomyopathy (Dcm)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Duchenne Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Duchenne Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Emery Dreifuss Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Emery Dreifuss Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Encephalopathy, Mitochondrial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Encephalopathy, Mitochondrial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Eosinophilic Myositis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Eosinophilic Myositis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Mitochondrial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Epilepsy, Mitochondrial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gnathodiaphyseal Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Gnathodiaphyseal Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperkalemic Periodic Paralysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Hyperkalemic Periodic Paralysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lgmd2L And Distal Mmd3 Muscular Dystrophies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Lgmd2L And Distal Mmd3 Muscular Dystrophies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leber Hereditary Optic Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Leber Hereditary Optic Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leber Optic Atrophy And Dystonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Leber Optic Atrophy And Dystonia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Limb Girdle Muscular Dystrophy Dystroglycanopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Limb Girdle Muscular Dystrophy Dystroglycanopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Long Qt Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Long Qt Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Long Chain Acyl Coa Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Long Chain Acyl Coa Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Long Chain 3 Hydroxyacyl Coa Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Long Chain 3 Hydroxyacyl Coa Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Malignant Hyperthermia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Malignant Hyperthermia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Marinesco Sjogren Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Marinesco Sjogren Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Metabolic Encephalomyopathic Crises, Recurrent, With Rhabdomyolysis, Cardiac Arrhythmias, And Neurodegeneration (Mecrcn)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Metabolic Encephalomyopathic Crises, Recurrent, With Rhabdomyolysis, Cardiac Arrhythmias, And Neurodegeneration (Mecrcn)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Minicore Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Minicore Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Minicore Myopathy With External Ophthalmoplegia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Minicore Myopathy With External Ophthalmoplegia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Dna Depletion Syndrome 14",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Dna Depletion Syndrome 14"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Complex I Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Complex I Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Encephalomyopathy With Lactic Acidosis And Stroke Like Episodes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Encephalomyopathy With Lactic Acidosis And Stroke Like Episodes"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Multisystemic Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Multisystemic Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Myopathy With Diabetes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Myopathy With Diabetes"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke Like Episodes",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke Like Episodes"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Myopathy, Infantile, Transient",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Mitochondrial Myopathy, Infantile, Transient"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Miyoshi Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Miyoshi Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multicore Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Multicore Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscle Eye Brain Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscle Eye Brain Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Congenital Merosin Deficient",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy, Congenital Merosin Deficient"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Congenital, Megaconial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy, Congenital, Megaconial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Limb Girdle",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy, Limb Girdle"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Limb Girdle, Type Ic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy, Limb Girdle, Type Ic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy Dystroglycanopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy Dystroglycanopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy Dystroglycanopathy (Congenital With Brain And Eye Anomalies)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy Dystroglycanopathy (Congenital With Brain And Eye Anomalies)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 13",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 13"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy Dystroglycanopathy (Limb Girdle)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Muscular Dystrophy Dystroglycanopathy (Limb Girdle)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myoadenylate Deaminase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myoadenylate Deaminase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myoclonic Epilepsy With Ragged Red Fibers",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myoclonic Epilepsy With Ragged Red Fibers"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myoglobinuria, Acute, Recurrent",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myoglobinuria, Acute, Recurrent"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myoglobinuria, Recurrent",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myoglobinuria, Recurrent"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy With Lactic Acidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy With Lactic Acidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy With Postural Muscle Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy With Postural Muscle Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Distal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy, Distal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Distal, With Anterior Tibial Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy, Distal, With Anterior Tibial Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Mitochondrial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy, Mitochondrial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Vacuolar, With Casq1 Aggregates",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myopathy, Vacuolar, With Casq1 Aggregates"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myotonia, Potassium Aggravated",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Myotonia, Potassium Aggravated"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Native American Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Native American Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nephropathy, Tubulointerstitial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Nephropathy, Tubulointerstitial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Ataxia, And Retinitis Pigmentosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Neuropathy, Ataxia, And Retinitis Pigmentosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neutral Lipid Storage Disease With Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Neutral Lipid Storage Disease With Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Normokalemic Potassium Sensitive Periodic Paralysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Normokalemic Potassium Sensitive Periodic Paralysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Oncocytoma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Oncocytoma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ophthalmoplegia, Myopathy, Ataxia, And Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Ophthalmoplegia, Myopathy, Ataxia, And Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Optic Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Atrophy 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Optic Atrophy 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Atrophy With Or Without Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Optic Atrophy With Or Without Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Atrophy, 3 Methylglutaconic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Optic Atrophy, 3 Methylglutaconic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polg Related Ataxia Neuropathy Spectrum Disorders",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Polg Related Ataxia Neuropathy Spectrum Disorders"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Paramyotonia Congenita",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Paramyotonia Congenita"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Perrault Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Perrault Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Phosphoglycerate Kinase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Phosphoglycerate Kinase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polyglucosan Body Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Polyglucosan Body Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polyglucosan Body Myopathy 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Polyglucosan Body Myopathy 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Portal Hypertension, Noncirrhotic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Portal Hypertension, Noncirrhotic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Progressive Cerebellar Ataxia And Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Progressive Cerebellar Ataxia And Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Progressive External Ophthalmoplegia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Progressive External Ophthalmoplegia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Recessive 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Recessive 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Reducing Bod Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Reducing Bod Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Rippling Muscle Disease 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Rippling Muscle Disease 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sids, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Sids, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sensory Ataxia, Dysarthria, And Ophthalmoparesis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Sensory Ataxia, Dysarthria, And Ophthalmoparesis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sideroblastic Anemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Sideroblastic Anemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Striatonigral Degeneration, Infantile, Mitochondrial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Striatonigral Degeneration, Infantile, Mitochondrial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Tateyama Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Tateyama Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Trifunctional Protein Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Trifunctional Protein Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Walker Warburg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Myopathy And Rhabdomyolysis",
        "markers": [
          "Walker Warburg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alexander Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Alexander Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aspartoacylase Deficiency (Canavan Disease)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Aspartoacylase Deficiency (Canavan Disease)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Autism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Autism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Bannayan Riley Ruvalcaba Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Bannayan Riley Ruvalcaba Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Basal Cell Nevus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Basal Cell Nevus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cloves",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Cloves"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cleft Palate, Psychomotor Retardation, And Distinctive Facial Features",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Cleft Palate, Psychomotor Retardation, And Distinctive Facial Features"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cohen Gibson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Cohen Gibson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cowden Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Cowden Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Desmosterolosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Desmosterolosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, With Variable Learning Disabilities And Behavior Disorders",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Epilepsy, With Variable Learning Disabilities And Behavior Disorders"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Grieg Cephalopolysndactyly Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Grieg Cephalopolysndactyly Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hydrocephalus, Nonsyndromic, Autosomal Recessive 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Hydrocephalus, Nonsyndromic, Autosomal Recessive 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukoencephalopathy With Vanishing White Matter",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Leukoencephalopathy With Vanishing White Matter"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lhermitte Duclos Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Lhermitte Duclos Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Luscan Lumish Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Luscan Lumish Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Macrocephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Macrocephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Macrocephaly, Macrosomia, Facial Dysmorphism Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Macrocephaly, Macrosomia, Facial Dysmorphism Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Marshall Smithsyndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Marshall Smithsyndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Megalencephalic Leukoencephalopathy With Subcortical Cysts",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Megalencephalic Leukoencephalopathy With Subcortical Cysts"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Megalencephalic Leukoencephalopathy With Subcortical Cysts, Remitting",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Megalencephalic Leukoencephalopathy With Subcortical Cysts, Remitting"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Megalencephaly Polymicrogyria Polydactyly Hydrocephalus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Megalencephaly Polymicrogyria Polydactyly Hydrocephalus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Megalencephaly Polymicrogyria Polydactyly Hydrocephalus Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Megalencephaly Polymicrogyria Polydactyly Hydrocephalus Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 41",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Mental Retardation, Autosomal Recessive 41"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Congenital Anomalies Hypotonia Seizures Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Multiple Congenital Anomalies Hypotonia Seizures Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neurodevelopmental Disorder With Or Without Anomalies Of The Brain, Eye, Or Heart (Nedbeh)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Neurodevelopmental Disorder With Or Without Anomalies Of The Brain, Eye, Or Heart (Nedbeh)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ovarioleukodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Ovarioleukodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pallister Hall Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Pallister Hall Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Perlman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Perlman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Postaxial Polydactyly Type A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Postaxial Polydactyly Type A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Preaxial Polydactyly Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Preaxial Polydactyly Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Preaxial Polydactyly Type 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Preaxial Polydactyly Type 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Primrose Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Primrose Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Proteus Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Proteus Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Shashi Pena Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Shashi Pena Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sotos Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Sotos Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sotos Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Sotos Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Tatton Brown Rahman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Tatton Brown Rahman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Turner",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Turner"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Waisman Parkinsonism Mental Retardation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Waisman Parkinsonism Mental Retardation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Weaver Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Macrocephaly Overgrowth Syndrome",
        "markers": [
          "Weaver Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aniridia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Aniridia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aniridia, Cerebellar Ataxia, And Intellectual Disability (Gillespie Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Aniridia, Cerebellar Ataxia, And Intellectual Disability (Gillespie Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia, Early Onset, With Oculomotor Apraxia And Hypoalbuminemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Ataxia, Early Onset, With Oculomotor Apraxia And Hypoalbuminemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cataract With Late Onset Corneal Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Cataract With Late Onset Corneal Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Dysplasia, Complex, With Other Brain Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Cortical Dysplasia, Complex, With Other Brain Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Duane Retraction Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Duane Retraction Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia, Childhood Onset, With Optic Atrophy And Basal Ganglia Abnormalities (Dytoabg)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Dystonia, Childhood Onset, With Optic Atrophy And Basal Ganglia Abnormalities (Dytoabg)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Encephalopathy Due To Defective Mitochondrial And Peroxisomal Fission 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Encephalopathy Due To Defective Mitochondrial And Peroxisomal Fission 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fibrosis Of Extraocular Muscles, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Fibrosis Of Extraocular Muscles, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fibrosis Of Extraocular Muscles, Congenital 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Fibrosis Of Extraocular Muscles, Congenital 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fibrosis Of Extraocular Muscles, Congenital, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Fibrosis Of Extraocular Muscles, Congenital, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Foveal Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Foveal Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gaze Palsy, Horizontal, With Progressive Scoliosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Gaze Palsy, Horizontal, With Progressive Scoliosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Growth Retardation, Alopecia, Pseudoanodontia, And Optic Atrophy (Gapo Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Growth Retardation, Alopecia, Pseudoanodontia, And Optic Atrophy (Gapo Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hemangioma, Capillary Infantile, Susceptibility To",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Hemangioma, Capillary Infantile, Susceptibility To"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Infantile Cerebellar Retinal Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Infantile Cerebellar Retinal Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Isolated Growth Hormone Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Isolated Growth Hormone Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Keratitis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Keratitis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Dna Depletion Syndrome 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Mitochondrial Dna Depletion Syndrome 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Morning Glory Disc Anomaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Morning Glory Disc Anomaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Mitochondrial Dysfunctions Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Multiple Mitochondrial Dysfunctions Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Hereditary Motor And Sensory, Type Vib",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Neuropathy, Hereditary Motor And Sensory, Type Vib"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nystagmus, Infantile Periodic Alternating",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Nystagmus, Infantile Periodic Alternating"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Atrophy 10 With Or Without Ataxia, Mental Retardation, And Seizures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Optic Atrophy 10 With Or Without Ataxia, Mental Retardation, And Seizures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Atrophy 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Optic Atrophy 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Optic Nerve Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Optic Nerve Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Peho Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Peho Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease 5, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Parkinson Disease 5, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Retinal Dystrophy, Early Onset, And Pituitary Dysfunction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Retinal Dystrophy, Early Onset, And Pituitary Dysfunction"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Septooptic Dysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Septooptic Dysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 79, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Spastic Paraplegia 79, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Thiamine Metabolism Dysfunction Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuro Ophthalmology",
        "markers": [
          "Thiamine Metabolism Dysfunction Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aicardi Gouti\u00e8res Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Aicardi Gouti\u00e8res Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Anterior Segment Dysgenesis With Cerebral Involvement",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Anterior Segment Dysgenesis With Cerebral Involvement"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Brain Small Vessel Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Brain Small Vessel Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebellar Ataxia And Hypogonadotropic Hypogonadism (Gordon Holmes Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Cerebellar Ataxia And Hypogonadotropic Hypogonadism (Gordon Holmes Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy (Cadasil)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy (Cadasil)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy Type 2 (Cadasil2)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Cerebral Arteriopathy With Subcortical Infarcts And Leukoencephalopathy Type 2 (Cadasil2)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Autosomal Recessive Arteriopathy With Subcortical Infarcts And Leukoencephalopathy (Carasil)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Cerebral Autosomal Recessive Arteriopathy With Subcortical Infarcts And Leukoencephalopathy (Carasil)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Folate Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Cerebral Folate Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Chilblain Lupus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Chilblain Lupus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Chilblain Lupus 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Chilblain Lupus 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 16",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 16"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Saposin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Combined Saposin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dyschromatosis Symmetrica Hereditaria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Dyschromatosis Symmetrica Hereditaria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gaucher Disease, Atypical, Due To Saposin C Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Gaucher Disease, Atypical, Due To Saposin C Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Krabbe Disease, Atypical",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Krabbe Disease, Atypical"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lateral Meningocele Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Lateral Meningocele Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukodystrophy, Demyelinating, Adult Onset, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukodystrophy, Demyelinating, Adult Onset, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukodystrophy, Hypomyelinating 10",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukodystrophy, Hypomyelinating 10"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukoencephalopathy With Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukoencephalopathy With Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukoencephalopathy With Brain Stem And Spinal Cord Involvement And Lactate Elevation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukoencephalopathy With Brain Stem And Spinal Cord Involvement And Lactate Elevation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukoencephalopathy, Brain Calcifications, And Cysts (Labrune Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukoencephalopathy, Brain Calcifications, And Cysts (Labrune Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukoencephalopathy, Cystic, Without Megalencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukoencephalopathy, Cystic, Without Megalencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Leukoencephalopathy, Diffuse Hereditary, With Spheroids",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Leukoencephalopathy, Diffuse Hereditary, With Spheroids"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Metachromatic Leukodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Metachromatic Leukodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Metachromatic Leukodystrophy Due To Saposin B Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Metachromatic Leukodystrophy Due To Saposin B Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Complex Ii Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Mitochondrial Complex Ii Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Complex Iii Deficiency, Nuclear Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Mitochondrial Complex Iii Deficiency, Nuclear Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Complex Iii Deficiency, Nuclear Type 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Mitochondrial Complex Iii Deficiency, Nuclear Type 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Mitochondrial Dysfunctions Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Multiple Mitochondrial Dysfunctions Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Sulfatase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Multiple Sulfatase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Porencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Retinal Artery Tortuosity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Retinal Artery Tortuosity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Schizencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Schizencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sjogren Larsson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Sjogren Larsson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Vasculopathy, Retinal, With Cerebral Leukodystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Leukodystrophy And Leukoencephalopathy",
        "markers": [
          "Vasculopathy, Retinal, With Cerebral Leukodystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "17 Beta Hydroxysteroid Dehydrogenase X Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "17 Beta Hydroxysteroid Dehydrogenase X Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "5 Fluorouracil Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "5 Fluorouracil Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Acromelic Frontonasal Dysostosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Acromelic Frontonasal Dysostosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Adenylosuccinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Adenylosuccinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aicardi Goutieres Syndrome 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Aicardi Goutieres Syndrome 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alpha Methylacyl Coa Racemase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Alpha Methylacyl Coa Racemase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alpha Thalassemia/Mental Retardation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Alpha Thalassemia/Mental Retardation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alternating Hemiplegia Of Childhood",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Alternating Hemiplegia Of Childhood"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aminoacylase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Aminoacylase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Angelman Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Angelman Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Angelman Like Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Angelman Like Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aromatic L Amino Acid Decarboxylase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Aromatic L Amino Acid Decarboxylase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Asparagine Synthetase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Asparagine Synthetase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aspartylglucosaminuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Aspartylglucosaminuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia Oculomotor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ataxia Oculomotor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Bainbridge Ropers Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Bainbridge Ropers Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Band Heterotopia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Band Heterotopia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Beck Fahrner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Beck Fahrner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Benign Familial Neonatal Seizures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Benign Familial Neonatal Seizures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Branched Chain Ketoacid Dehydrogenase Kinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Branched Chain Ketoacid Dehydrogenase Kinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ck Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ck Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Carpenter Waziri Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Carpenter Waziri Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebellar Atrophy, Developmental Delay, And Seizures (Cadeds)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cerebellar Atrophy, Developmental Delay, And Seizures (Cadeds)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ceroid Lipofuscinosis, Neuronal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ceroid Lipofuscinosis, Neuronal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ceroid Lipofuscinosis, Neuronal 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ceroid Lipofuscinosis, Neuronal 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Childhood Absence Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Childhood Absence Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Christianson",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Christianson"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Coenzyme Q10 Deficiency 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Coenzyme Q10 Deficiency 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Coffin Siris Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Coffin Siris Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cognitive Impairment",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cognitive Impairment"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 27",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 27"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 35",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 35"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Disorder Of Glycosylation, Type 1Aa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Congenital Disorder Of Glycosylation, Type 1Aa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Disorder Of Glycosylation, Type Iin",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Congenital Disorder Of Glycosylation, Type Iin"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Hemidysplasia With Ichthyosiform Erythroderma And Limb Defects (Child Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Congenital Hemidysplasia With Ichthyosiform Erythroderma And Limb Defects (Child Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Convulsions, Familial Infantile, With Paroxysmal Choreoathetosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Convulsions, Familial Infantile, With Paroxysmal Choreoathetosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cornelia De Lange Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cornelia De Lange Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Corpus Callosum Hypoplasia, Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Corpus Callosum Hypoplasia, Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Corpus Callosum, Agenesis Of, With Abnormal Genitalia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Corpus Callosum, Agenesis Of, With Abnormal Genitalia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Dysplasia, Complex, With Other Brain Malformations 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cortical Dysplasia, Complex, With Other Brain Malformations 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Dysplasia, Complex, With Other Brain Malformations 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cortical Dysplasia, Complex, With Other Brain Malformations 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Dysplasia Focal Epilepsy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cortical Dysplasia Focal Epilepsy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Creatine Deficiency Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Creatine Deficiency Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cutis Laxa, Autosomal Recessive, Type Iid",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Cutis Laxa, Autosomal Recessive, Type Iid"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Developmental Delay And Seizures With Or Without Movement Abnormalities (Dedsm)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Developmental Delay And Seizures With Or Without Movement Abnormalities (Dedsm)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dihydropyriminidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Dihydropyriminidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dravet Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Dravet Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dyskinesia, Seizures, And Intellectual Development Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Dyskinesia, Seizures, And Intellectual Development Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Dystonia 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 23",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Dystonia 23"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 3, Torsion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Dystonia 3, Torsion"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Early Infantile Epileptic Encephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Early Infantile Epileptic Encephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Early Infantile Epileptic Encephalopathy 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Early Infantile Epileptic Encephalopathy 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Early Onset Progressive Encephalopathy With Brain Atrophy And Thin Corpus Callosum (Pebat)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Early Onset Progressive Encephalopathy With Brain Atrophy And Thin Corpus Callosum (Pebat)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Encephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Encephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Encephalopathy, Familial, With Neuroserpin Inclusion Bodies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Encephalopathy, Familial, With Neuroserpin Inclusion Bodies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Endocrine Cerebroosteodysplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Endocrine Cerebroosteodysplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepitic Encephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepitic Encephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy And X Linked Mental Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy And X Linked Mental Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Childhood Absence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Childhood Absence"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Familial Focal, With Variable Foci",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Familial Focal, With Variable Foci"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Familial Focal, With Variable Foci 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Familial Focal, With Variable Foci 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Familial Focal, With Variable Foci 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Familial Focal, With Variable Foci 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Familial Temporal Lobe",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Familial Temporal Lobe"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Focal, With Speech Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Focal, With Speech Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Generalized, With Febrile Seizures Plus, Type 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Generalized, With Febrile Seizures Plus, Type 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Idiopathic Generalized",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Idiopathic Generalized"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Idiopathic Generalized, Susceptibility To, 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Idiopathic Generalized, Susceptibility To, 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Juvenile Absence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Juvenile Absence"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Juvenile Myoclonic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Juvenile Myoclonic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Myoclonic Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Myoclonic Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Nocturnal Frontal Lobe",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Nocturnal Frontal Lobe"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Progessive Myoclonic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Progessive Myoclonic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Progressive Myoclonic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Progressive Myoclonic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Progressive Myoclonic, 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Progressive Myoclonic, 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Pyridoxine Dependent",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Pyridoxine Dependent"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epilepsy, Severe Intractable",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epilepsy, Severe Intractable"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Childhood Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Childhood Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile 40",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile 40"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 17",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 17"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 35",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 35"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 37",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 37"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 38",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 38"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 41",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 41"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 42",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 42"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 44",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 44"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 45",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 45"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 47",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 47"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 48",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 48"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 49",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 49"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 50 (Congenital Disorder Of Glycosylation, Type Iz)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 50 (Congenital Disorder Of Glycosylation, Type Iz)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 51",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 51"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 52",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 52"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 53",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 53"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 55",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 55"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Epileptic Encephalopathy, Early Infantile, 56",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Epileptic Encephalopathy, Early Infantile, 56"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Episodic Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Episodic Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Episodic Ataxia/Myokymia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Episodic Ataxia/Myokymia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Episodic Kinesigenic Dyskinesia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Episodic Kinesigenic Dyskinesia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Erythermalgia, Primary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Erythermalgia, Primary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ethylmalonic Encephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ethylmalonic Encephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Familial Hypocalciuric Hypercalcemia With Transient Neonatal Hyperparathyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Familial Hypocalciuric Hypercalcemia With Transient Neonatal Hyperparathyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Familial Febrile Seizures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Familial Febrile Seizures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Febrile Seizures, Familial 3A",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Febrile Seizures, Familial 3A"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Folate Malabsorption",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Folate Malabsorption"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "French Canadian Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "French Canadian Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Frontotemporal Lobar Degeneration With Tdp43 Inclusions",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Frontotemporal Lobar Degeneration With Tdp43 Inclusions"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fuchs Endothelial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Fuchs Endothelial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fumarase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Fumarase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gaba Transaminase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Gaba Transaminase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Glut1 Deficiency Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Glut1 Deficiency Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Grn Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Grn Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gabriele De Vries Syndrome (Gadevs)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Gabriele De Vries Syndrome (Gadevs)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ganglioside Gm3 Synthase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Ganglioside Gm3 Synthase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Generalized Epilepsy With Febrile Seizures Plus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Generalized Epilepsy With Febrile Seizures Plus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Generalized Epilepsy With Febrile Seizures Plus, Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Generalized Epilepsy With Febrile Seizures Plus, Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Generalized Epilepsy With Febrile Seizures Plus, Type 7",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Generalized Epilepsy With Febrile Seizures Plus, Type 7"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Glycine Encephalopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Glycine Encephalopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Growth Retardation, Developmental Delay, And Facial Dysmorphism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Growth Retardation, Developmental Delay, And Facial Dysmorphism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Guanidinoacetate Methyltransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Guanidinoacetate Methyltransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Helsmoortel Van Der Aa Syndrome (Mental Retardation, Autosomal Dominant 28)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Helsmoortel Van Der Aa Syndrome (Mental Retardation, Autosomal Dominant 28)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hemorrhage, Intracerebral",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hemorrhage, Intracerebral"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hereditary Leiomyomatosis And Renal Cell Cancer",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hereditary Leiomyomatosis And Renal Cell Cancer"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "High Voltage Gated Calcium Channelopathy Related, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "High Voltage Gated Calcium Channelopathy Related, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Holmes Gang Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Holmes Gang Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Huntington Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Huntington Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hydranencephaly With Abnormal Genitalia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hydranencephaly With Abnormal Genitalia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperekplexia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperekplexia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperekplexia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperekplexia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperphenylalaninemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperphenylalaninemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperphosphatasia With Mental Retardation Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperphosphatasia With Mental Retardation Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperphosphatasia With Mental Retardation Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperphosphatasia With Mental Retardation Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperphosphatasia With Mental Retardation Syndrome 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperphosphatasia With Mental Retardation Syndrome 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperprolinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hyperprolinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypocalcemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hypocalcemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Insensitivity To Pain, Congenital, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Insensitivity To Pain, Congenital, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Intellectual Developmental Disorder And Microcephaly With Pontine And Cerebellar Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Intellectual Developmental Disorder And Microcephaly With Pontine And Cerebellar Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Intellectual Disability And Seizures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Intellectual Disability And Seizures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Juberg Marsidi Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Juberg Marsidi Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Kbg Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Kbg Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Kohlschutter Tonz Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Kohlschutter Tonz Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Kufs Disease,",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Kufs Disease,"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Liopdystrophy, Partial, Acquired",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Liopdystrophy, Partial, Acquired"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lipoid Proteinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Lipoid Proteinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lissencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Lissencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lopes Maciel Rodan Syndrome (Lomars)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Lopes Maciel Rodan Syndrome (Lomars)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Megaloblastic Anemia Due To Dihydrofolate Reductase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Megaloblastic Anemia Due To Dihydrofolate Reductase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 17 (Schuss Hoeijmakers Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 17 (Schuss Hoeijmakers Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 24",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 24"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 29",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 29"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 34",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 34"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 41",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 41"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 42",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 42"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Dominant 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Recessive 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 46",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Recessive 46"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 53",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Recessive 53"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 57",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Recessive 57"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, Autosomal Recessive 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, With Cerebellar Hypoplasia And Distinctive Facial Appearance",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation, With Cerebellar Hypoplasia And Distinctive Facial Appearance"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation Hypotonic Facies Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mental Retardation Hypotonic Facies Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Epilepsy, And Diabetes Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Microcephaly, Epilepsy, And Diabetes Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Postnatal Progressive, With Seizures And Brain Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Microcephaly, Postnatal Progressive, With Seizures And Brain Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Progressive, Seizures, And Cerebral And Cerebellar Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Microcephaly, Progressive, Seizures, And Cerebral And Cerebellar Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Seizures, And Developmental Delay",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Microcephaly, Seizures, And Developmental Delay"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Migraine, Familial Basilar",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Migraine, Familial Basilar"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Migraine, Familial Hemiplegic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Migraine, Familial Hemiplegic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Migraine, Familial Hemiplegic, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Migraine, Familial Hemiplegic, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mitochondrial Short Chain Enoyl Coa Hydratase 1 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mitochondrial Short Chain Enoyl Coa Hydratase 1 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Molybdenum Cofactor Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Molybdenum Cofactor Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mowat Wilson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mowat Wilson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mucopolysaccharidosis (Sanfilippo Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Mucopolysaccharidosis (Sanfilippo Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Congenital Anomalies Hypotonia Seizures Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Multiple Congenital Anomalies Hypotonia Seizures Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Congenital Anomalies Hypotonia Seizures Syndrome 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Multiple Congenital Anomalies Hypotonia Seizures Syndrome 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myoclonic Astastic Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Myoclonic Astastic Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myokymia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Myokymia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Congenital, With Neuropathy And Deafness",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Myopathy, Congenital, With Neuropathy And Deafness"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nascimento",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Nascimento"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neonatal Hyperparathyroidism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neonatal Hyperparathyroidism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nephrotic Syndrome 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Nephrotic Syndrome 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neu Laxova Syndrome 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neu Laxova Syndrome 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neurodegeneration, Childhood Onset, With Brain Atrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neurodegeneration, Childhood Onset, With Brain Atrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronal Ceroid Lipofuscinosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neuronal Ceroid Lipofuscinosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronal Ceroid Lipofuscinosis Type 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neuronal Ceroid Lipofuscinosis Type 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronal Ceroid Lipofuscinosis, Type 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neuronal Ceroid Lipofuscinosis, Type 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronal Ceroid Lipofuscinosis, Type 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neuronal Ceroid Lipofuscinosis, Type 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronal Ceroid Lipofuscinosis, Type 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neuronal Ceroid Lipofuscinosis, Type 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuronal Ceroid Lipofuscinosis, Type 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Neuronal Ceroid Lipofuscinosis, Type 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nicolaides Baraitser Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Nicolaides Baraitser Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nonaka Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Nonaka Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease (Kufor Rakeb Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Parkinson Disease (Kufor Rakeb Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease 20, Early Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Parkinson Disease 20, Early Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Paroxysmal Extreme Pain Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Paroxysmal Extreme Pain Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Paroxysmal Nonkinesigenic Dyskinesia 3 With Or Without Generalized Epilepsy (Pnkd3)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Paroxysmal Nonkinesigenic Dyskinesia 3 With Or Without Generalized Epilepsy (Pnkd3)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parry",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Parry"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Partington Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Partington Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Peroxisomal Fatty Acyl Coa Reductase 1 Disorder",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Peroxisomal Fatty Acyl Coa Reductase 1 Disorder"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Peroxisome Biogenesis Disorder, 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Peroxisome Biogenesis Disorder, 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pierpont Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Pierpont Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pitt Hopkins Like Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Pitt Hopkins Like Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pitt Hopkins Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Pitt Hopkins Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polymicrogyria, Asymmetric",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Polymicrogyria, Asymmetric"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Proud Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Proud Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Proximal Myopathy And Ophthalmoplegia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Proximal Myopathy And Ophthalmoplegia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pseudo Torch Syndrome 1 (Band Like Calcification With Simplified Gyration And Polymicrogyria)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Pseudo Torch Syndrome 1 (Band Like Calcification With Simplified Gyration And Polymicrogyria)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pyridoxamine 5' Phosphate Oxidase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Pyridoxamine 5' Phosphate Oxidase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pyruvate Dehydrogensae Lipoic Acid Synthetase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Pyruvate Dehydrogensae Lipoic Acid Synthetase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Rett Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Rett Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Rett Syndrome, Atypical",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Rett Syndrome, Atypical"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Rett Syndrome, Congenital Variant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Rett Syndrome, Congenital Variant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Rigidity And Multifocal Seizure Syndrome, Lethal Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Rigidity And Multifocal Seizure Syndrome, Lethal Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Schinzel Giedion Midface Retraction Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Schinzel Giedion Midface Retraction Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Seizures, Benign Familial Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Seizures, Benign Familial Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Seizures, Benign Familial Infantile, 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Seizures, Benign Familial Infantile, 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Seizures, Benign Neonatal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Seizures, Benign Neonatal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sialidosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Sialidosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sialuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Sialuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Singleton Merten Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Singleton Merten Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Skraban Deardorff Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Skraban Deardorff Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Small Fiber Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Small Fiber Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Smith Fineman Myers Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Smith Fineman Myers Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Smith Kingsmore Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Smith Kingsmore Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Snyder Robinson",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Snyder Robinson"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Spinocerebellar Ataxia 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive 24",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive 24"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Stomatin Deficient Cryohydrocytosis With Neurologic Defects",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Stomatin Deficient Cryohydrocytosis With Neurologic Defects"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Subcortical Laminal Heterotopia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Subcortical Laminal Heterotopia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Subcortical Laminar Heterotopia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Subcortical Laminar Heterotopia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Succinic Semialdehyde Dehydrogenase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Succinic Semialdehyde Dehydrogenase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Sulfocysteinuria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Sulfocysteinuria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Temple Baraitser Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Temple Baraitser Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Temtamy Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Temtamy Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Thiamine Metabolism Dysfunction Syndrome 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Thiamine Metabolism Dysfunction Syndrome 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Warburg Micro Syndrome 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Warburg Micro Syndrome 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Zimmermann Laband Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Epilepsy",
        "markers": [
          "Zimmermann Laband Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Myasthenic Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Congenital Myasthenic Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Escobar Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Escobar Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fetal Akinesia Deformation Sequence",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Fetal Akinesia Deformation Sequence"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Multiple Pterygium Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Multiple Pterygium Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myasthenic Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Myasthenic Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myasthenic Syndrome, Congenital 22",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Myasthenic Syndrome, Congenital 22"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nephrotic Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Nephrotic Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pierson Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Congenital Myasthenic Syndromes",
        "markers": [
          "Pierson Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Basal Ganglia Calcification, Idiopathic, 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Basal Ganglia Calcification, Idiopathic, 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Basal Ganglia Calcification, Idiopathic, 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Basal Ganglia Calcification, Idiopathic, 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Deafness, Dystonia, And Cerebral Hypomyelination",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Deafness, Dystonia, And Cerebral Hypomyelination"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dyskinesia, Familial, With Facial Myokymia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dyskinesia, Familial, With Facial Myokymia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 1, Torsion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dystonia 1, Torsion"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 11, Myoclonic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dystonia 11, Myoclonic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 16",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dystonia 16"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 24",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dystonia 24"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 28, Childhood Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dystonia 28, Childhood Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dystonia 6, Torsion",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Dystonia 6, Torsion"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypermanganesemia With Dystonia 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Hypermanganesemia With Dystonia 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperphenylalaninemia, Mild, Non Bh4 Deficient",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Hyperphenylalaninemia, Mild, Non Bh4 Deficient"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Infantile Onset Dyskinesia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Infantile Onset Dyskinesia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Kosaki Overgrowth Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Kosaki Overgrowth Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Other Hyperphenylalaninemias",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Other Hyperphenylalaninemias"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Paroxysmal Non Kinesigenic Dyskinesia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Paroxysmal Non Kinesigenic Dyskinesia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Penttinen Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Penttinen Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Premature Aging Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Premature Aging Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Primary Torsion Dystonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Primary Torsion Dystonia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Striatal Degeneration, Autosomal Dominant 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Striatal Degeneration, Autosomal Dominant 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Striatonigral Degeneration, Childhood Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dystonia",
        "markers": [
          "Striatonigral Degeneration, Childhood Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Coenzyme Q10 Deficiency, Primary 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Coenzyme Q10 Deficiency",
        "markers": [
          "Coenzyme Q10 Deficiency, Primary 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Combined Oxidative Phosphorylation Deficiency 28",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Coenzyme Q10 Deficiency",
        "markers": [
          "Combined Oxidative Phosphorylation Deficiency 28"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophy, Hereditary Neuralgic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Amyotrophy, Hereditary Neuralgic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease, Axonal, Type 2T",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Charcot Marie Tooth Disease, Axonal, Type 2T"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Compton North",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Compton North"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dowling Degos Disease 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Dowling Degos Disease 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Congenital, Due To Integrin Alpha 7 Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Muscular Dystrophy, Congenital, Due To Integrin Alpha 7 Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Congenital, With Cataracts And Intellectual Disability (Mdccaid)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Muscular Dystrophy, Congenital, With Cataracts And Intellectual Disability (Mdccaid)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Limb Girdle, Type 1G",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Muscular Dystrophy, Limb Girdle, Type 1G"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Muscular Dystrophy, Limb Girdle, Type 2Z",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Muscular Dystrophy, Limb Girdle, Type 2Z"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy With Extrapyramidal Signs",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Myopathy With Extrapyramidal Signs"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Congenital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Myopathy, Congenital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Early Onset, Areflexia, Respiratory Distress, And Dysphagia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Myopathy, Early Onset, Areflexia, Respiratory Distress, And Dysphagia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Mitochondrial, And Ataxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Myopathy, Mitochondrial, And Ataxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Myofibrillar 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Myopathy, Myofibrillar 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Oculopharyngeal Muscular Dystrophy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Oculopharyngeal Muscular Dystrophy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Severe Congenital Nemaline Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Severe Congenital Nemaline Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia 43",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Spinocerebellar Ataxia 43"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Typical Nemaline Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Typical Nemaline Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Welander Distal Myopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Comprehensive Muscular Dystrophy Myopathy",
        "markers": [
          "Welander Distal Myopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypokalemic Periodic Paralysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Periodic Paralysis",
        "markers": [
          "Hypokalemic Periodic Paralysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myotonia Congenita",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Periodic Paralysis",
        "markers": [
          "Myotonia Congenita"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myotonia Levior",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Periodic Paralysis",
        "markers": [
          "Myotonia Levior"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Thyrotoxic Periodic Paralysis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Periodic Paralysis",
        "markers": [
          "Thyrotoxic Periodic Paralysis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Abetalipoproteinemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Abetalipoproteinemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Aceruloplasminemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Aceruloplasminemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia With Isolated Vitamin E Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Ataxia With Isolated Vitamin E Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia, Cerebellar",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Ataxia, Cerebellar"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Ataxia, Posterior Column, With Retinitis Pigmentosa",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Ataxia, Posterior Column, With Retinitis Pigmentosa"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Basal Ganglia Calcification, Idiopathic, 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Basal Ganglia Calcification, Idiopathic, 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cayman",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Cayman"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebellar Ataxia, Nonprogressive, With Mental Retardation",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Cerebellar Ataxia, Nonprogressive, With Mental Retardation"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Amyloid Angiopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Cerebral Amyloid Angiopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Chorea, Hereditary Benign",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Chorea, Hereditary Benign"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dementia, Familial Danish",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Dementia, Familial Danish"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dysequilibrium Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Dysequilibrium Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypoceruloplasminemia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Hypoceruloplasminemia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypotonia, Ataxia, And Delayed Development Syndrome (Hadds)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Hypotonia, Ataxia, And Delayed Development Syndrome (Hadds)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myoclonus, Familial Cortical",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Myoclonus, Familial Cortical"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Myopathy, Distal, With Rimmed Vacuoles",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Myopathy, Distal, With Rimmed Vacuoles"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neurodegeneration With Ataxia, Dystonia, And Gaze Palsy, Childhood Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Neurodegeneration With Ataxia, Dystonia, And Gaze Palsy, Childhood Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Poretti Boltshauser Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Poretti Boltshauser Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Retinal Dystrophy With Inner Retinal Dysfunction And Ganglion Cell Abnormalities",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Retinal Dystrophy With Inner Retinal Dysfunction And Ganglion Cell Abnormalities"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia 19",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia 19"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia 22",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia 22"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive 19 (Lichtenstein Knorr Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive 19 (Lichtenstein Knorr Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive 22",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive 22"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive 23",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive 23"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, Autosomal Recessive, 26",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia, Autosomal Recessive, 26"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spinocerebellar Ataxia, With Axonal Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Spinocerebellar Ataxia, With Axonal Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Thyroid Cancer, Nonmedullary",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Ataxia",
        "markers": [
          "Thyroid Cancer, Nonmedullary"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophic Lateral Sclerosis 12",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Amyotrophic Lateral Sclerosis 12"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophic Lateral Sclerosis 18",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Amyotrophic Lateral Sclerosis 18"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophic Lateral Sclerosis 21",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Amyotrophic Lateral Sclerosis 21"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Amyotrophic Lateral Sclerosis 22",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Amyotrophic Lateral Sclerosis 22"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Chmp2B Related",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Chmp2B Related"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Essential Tremor",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Essential Tremor"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Frontotemporal Dementia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Frontotemporal Dementia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Glaucoma, Normal Tension",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Glaucoma, Normal Tension"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Glaucoma, Open Angle",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Glaucoma, Open Angle"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Keratoconus",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Amyotrophic Lateral Sclerosis",
        "markers": [
          "Keratoconus"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Culler Jones Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Holoprosencephaly",
        "markers": [
          "Culler Jones Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microphthalmia With Coloboma",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Holoprosencephaly",
        "markers": [
          "Microphthalmia With Coloboma"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Blepharophimosis Ptosis Intellectual Disability Syndrome (Kaufman Oculocerebrofacial Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Blepharophimosis Ptosis Intellectual Disability Syndrome (Kaufman Oculocerebrofacial Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Bohring Opitz Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Bohring Opitz Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Congenital Symmetric Circumferential Skin Creases 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Congenital Symmetric Circumferential Skin Creases 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Dysplasia, Complex, With Other Brain Malformations 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Cortical Dysplasia, Complex, With Other Brain Malformations 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Galloway Mowat Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Galloway Mowat Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Global Developmental Delay, Absent Or Hypoplastic Corpus Callosum, And Dysmorphic Facies (Gdaccf)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Global Developmental Delay, Absent Or Hypoplastic Corpus Callosum, And Dysmorphic Facies (Gdaccf)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Intellectual Developmental Disorder With Microcephaly And With Or Without Ocular Malformations Or Hypogonadotropic Hypogonadism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Intellectual Developmental Disorder With Microcephaly And With Or Without Ocular Malformations Or Hypogonadotropic Hypogonadism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Koolen De Vries Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Koolen De Vries Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lissencephaly 6, With Microcephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Lissencephaly 6, With Microcephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lissencephaly 8",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Lissencephaly 8"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Malformations",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Malformations"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly 10, Primary, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly 10, Primary, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly 15, Primary, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly 15, Primary, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly And Chorioretinopathy, Autosomal Recessive 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly And Chorioretinopathy, Autosomal Recessive 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly And Chorioretinopathy, Autosomal Recessive 2",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly And Chorioretinopathy, Autosomal Recessive 2"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly And Chorioretinopathy, Autosomal Recessive 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly And Chorioretinopathy, Autosomal Recessive 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly With Or Without Chorioretinopathy, Lymphedema, Or Intellectual Disability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly With Or Without Chorioretinopathy, Lymphedema, Or Intellectual Disability"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Short Stature, And Impaired Glucose Metabolism 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly, Short Stature, And Impaired Glucose Metabolism 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Short Stature, And Limb Abnormalities (Missla)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly, Short Stature, And Limb Abnormalities (Missla)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly, Short Stature, And Polymicrogyria With Or Without Seizures",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly, Short Stature, And Polymicrogyria With Or Without Seizures"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly Micromelia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microcephaly Micromelia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microhydranencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Microhydranencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neu Laxova Syndrome 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Neu Laxova Syndrome 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pontocerebellar Hypoplasia Type 9",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Pontocerebellar Hypoplasia Type 9"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pontocerebellar Hypoplasia, Type 11",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Pontocerebellar Hypoplasia, Type 11"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pontocerebellar Hypoplasia, Type 2D",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Pontocerebellar Hypoplasia, Type 2D"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Renpenning Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Renpenning Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Short Stature, Microcephaly, And Endocrine Dysfunction",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Short Stature, Microcephaly, And Endocrine Dysfunction"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spastic Paraplegia 63",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Microcephaly And Pontocerebellar Hypoplasia",
        "markers": [
          "Spastic Paraplegia 63"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Arginine:Glycine Amidinotransferase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Creatine Metabolism Deficiency",
        "markers": [
          "Arginine:Glycine Amidinotransferase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "?Rolandic Epilepsy, Impaired Intellectual Development, And Speech Dyspraxia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "?Rolandic Epilepsy, Impaired Intellectual Development, And Speech Dyspraxia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Asperger Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Asperger Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Autism Susceptibility",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Autism Susceptibility"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Brunner Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Brunner Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Corpus Callosum, Agenesis Of, With Mental Retardation, Ocular Coloboma And Micrognathia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Corpus Callosum, Agenesis Of, With Mental Retardation, Ocular Coloboma And Micrognathia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dent Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Dent Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fraxe Type",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Fraxe Type"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Familial Heart Block And Focal Segmental Glomerulosclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Familial Heart Block And Focal Segmental Glomerulosclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Focal Dermal Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Focal Dermal Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Fried (Pettigrew Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Fried (Pettigrew Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Glycerol Kinase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Glycerol Kinase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hedera",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Hedera"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Intellectual Disability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Intellectual Disability"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Linear Skin Defects With Multiple Congenital Anomalies 1 (Midas Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Linear Skin Defects With Multiple Congenital Anomalies 1 (Midas Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lowe Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Lowe Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Mental Retardation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Nance Horan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Nance Horan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Panhypopituitarism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Panhypopituitarism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinsonism With Spasticity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Parkinsonism With Spasticity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Siderius",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Siderius"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Stocco Dos Santos Mental Retardation Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "X Linked Intellectual Disability With Fmr1 Repeat Expansion",
        "markers": [
          "Stocco Dos Santos Mental Retardation Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Dysplasia, Complex, With Other Brain Malformations 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Cortical Dysplasia, Complex, With Other Brain Malformations 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Distal 17P13.3 Microdeletion Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Distal 17P13.3 Microdeletion Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Endometrial Stromal Sarcoma, 17P13.3 Microduplication Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Endometrial Stromal Sarcoma, 17P13.3 Microduplication Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lissencephaly 5",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Lissencephaly 5"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Recessive 34, With Variant Lissencephaly",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Mental Retardation, Autosomal Recessive 34, With Variant Lissencephaly"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Microcephaly 17, Primary, Autosomal Recessive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Microcephaly 17, Primary, Autosomal Recessive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Miller Dieker Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Lissencephaly",
        "markers": [
          "Miller Dieker Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Coproporphyria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Coproporphyria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Harderoporphyria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Harderoporphyria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hydroxymethylbilane Synthase Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Hydroxymethylbilane Synthase Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porphyria Cutanea Tarda",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Porphyria Cutanea Tarda"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porphyria Variegata",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Porphyria Variegata"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porphyria, Acute Hepatic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Porphyria, Acute Hepatic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porphyria, Acute Intermittent",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Porphyria, Acute Intermittent"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porphyria, Congenital Erythropoietic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Porphyria, Congenital Erythropoietic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Porphyria, Hepatoerythropoietic",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Porphyria",
        "markers": [
          "Porphyria, Hepatoerythropoietic"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Migraine, With Or Without Aura",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Migraine",
        "markers": [
          "Migraine, With Or Without Aura"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Acne Inversa, Familial, 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Acne Inversa, Familial, 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alzheimer Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Alzheimer Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Basal Ganglia Calcification, Idiopathic, 6",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Basal Ganglia Calcification, Idiopathic, 6"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dementia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Dementia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dementia With Lewy Bodies",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Dementia With Lewy Bodies"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dementia, Frontotemporal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Dementia, Frontotemporal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hyperferritinemia Cataract Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Hyperferritinemia Cataract Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hypermanganesemia With Dystonia, Polycythemia, And Cirrhosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Hypermanganesemia With Dystonia, Polycythemia, And Cirrhosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Juvenile Parkinsonism",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Juvenile Parkinsonism"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "L Ferritin Deficiency",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "L Ferritin Deficiency"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lewy Body",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Lewy Body"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinson Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease 22, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinson Disease 22, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease 23, Autosomal Recessive, Early Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinson Disease 23, Autosomal Recessive, Early Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease, Early Onset",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinson Disease, Early Onset"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Disease, Juvenile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinson Disease, Juvenile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinson Dementia Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinson Dementia Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Parkinsonism Dystonia, Infantile",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Parkinsonism Dystonia, Infantile"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Pick Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Pick Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Striatal Degeneration, Autosomal Dominant 1",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Striatal Degeneration, Autosomal Dominant 1"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Supranuclear Palsy, Progressive",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Parkinson Disease",
        "markers": [
          "Supranuclear Palsy, Progressive"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cortical Malformations, Occipital",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuronal Migration Disorder",
        "markers": [
          "Cortical Malformations, Occipital"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Heterotopia, Periventricular",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuronal Migration Disorder",
        "markers": [
          "Heterotopia, Periventricular"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polymicrogyria With Optic Nerve Hypoplasia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuronal Migration Disorder",
        "markers": [
          "Polymicrogyria With Optic Nerve Hypoplasia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polymicrogyria, Bilateral Frontoparietal",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuronal Migration Disorder",
        "markers": [
          "Polymicrogyria, Bilateral Frontoparietal"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Polymicrogyris, Bilateral Perisylvian",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuronal Migration Disorder",
        "markers": [
          "Polymicrogyris, Bilateral Perisylvian"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Alzheimer Disease, 4",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Alzheimer Disease, 4"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Creutzfeldt Jakob Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Creutzfeldt Jakob Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Early Onset Alzheimer Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Early Onset Alzheimer Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Frontotemporal Lobar Degeneration Motor Neuron Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Frontotemporal Lobar Degeneration Motor Neuron Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Gerstmann Straussler Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Gerstmann Straussler Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Huntington Disease Like",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Huntington Disease Like"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Insomnia, Fatal Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Insomnia, Fatal Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Peripartum/Pregnancy Associated Cardiomyopathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Peripartum/Pregnancy Associated Cardiomyopathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Spongiform Encephalopathy With Neuropsychiatric Features",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Dementia",
        "markers": [
          "Spongiform Encephalopathy With Neuropsychiatric Features"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "2 Aminoadipic And 2 Oxoadipic Aciduria",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "2 Aminoadipic And 2 Oxoadipic Aciduria"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Agenesis Of The Corpus Callosum With Peripheral Neuropathy (Andermann Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Agenesis Of The Corpus Callosum With Peripheral Neuropathy (Andermann Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Axonal Neuropathy With Neuromyotonia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Axonal Neuropathy With Neuromyotonia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Basel Vanagait Smirin Yosef Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Basel Vanagait Smirin Yosef Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease Type, Axonal, Type 2Z",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Charcot Marie Tooth Disease Type, Axonal, Type 2Z"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease, Axonal, Type 2Cc",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Charcot Marie Tooth Disease, Axonal, Type 2Cc"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Disease, Axonal, Type 2U",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Charcot Marie Tooth Disease, Axonal, Type 2U"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Charcot Marie Tooth Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Charcot Marie Tooth Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dysautonomia, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Dysautonomia, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Episodic Pain Syndrome, Familial, 3",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Episodic Pain Syndrome, Familial, 3"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Giant Axonal Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Giant Axonal Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Giant Axonal Neuropathy 2, Autosomal Dominant",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Giant Axonal Neuropathy 2, Autosomal Dominant"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Glomerulosclerosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Glomerulosclerosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Hereditary Sensory And Autonomic Neuropathy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Hereditary Sensory And Autonomic Neuropathy"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Insensitivity To Pain, Congenital, With Anhidrosis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Insensitivity To Pain, Congenital, With Anhidrosis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Interstitial Lung And Liver Disease",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Interstitial Lung And Liver Disease"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Lethal Akinesia And Musculoskeletal Abnormalities, With Brain And Retinal Hemorrhages",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Lethal Akinesia And Musculoskeletal Abnormalities, With Brain And Retinal Hemorrhages"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Medullary Thyroid Carcinoma, Familial",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Medullary Thyroid Carcinoma, Familial"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Hereditary Sensory And Autonomic, Type Vii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Neuropathy, Hereditary Sensory And Autonomic, Type Vii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Hereditary Sensory And Autonomic, Type Viii",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Neuropathy, Hereditary Sensory And Autonomic, Type Viii"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Neuropathy, Hereditary Sensory, With Spastic Paraplegia",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Neuropathy, Hereditary Sensory, With Spastic Paraplegia"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Slowed Nerve Conduction Velocity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Charcot Marie Tooth Neuropathy",
        "markers": [
          "Slowed Nerve Conduction Velocity"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Cerebral Dysgenesis, Neuropathy, Ichthyosis, And Palmoplantar Keratoderma Syndrome (Cednik Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polymicrogyria",
        "markers": [
          "Cerebral Dysgenesis, Neuropathy, Ichthyosis, And Palmoplantar Keratoderma Syndrome (Cednik Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Perisylvian Polymicrogyria, Cerebellar Hypoplasia, And Arthrogryposis",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Polymicrogyria",
        "markers": [
          "Perisylvian Polymicrogyria, Cerebellar Hypoplasia, And Arthrogryposis"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Autism Spectrum Disorder, Overgrowth Syndrome With Intellectual Disability",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Autism Spectrum Disorders",
        "markers": [
          "Autism Spectrum Disorder, Overgrowth Syndrome With Intellectual Disability"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Dias Logan Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Autism Spectrum Disorders",
        "markers": [
          "Dias Logan Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Mental Retardation, Autosomal Dominant 37 (White Sutton Syndrome)",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Autism Spectrum Disorders",
        "markers": [
          "Mental Retardation, Autosomal Dominant 37 (White Sutton Syndrome)"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Phelan Mcdermid Syndrome",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Autism Spectrum Disorders",
        "markers": [
          "Phelan Mcdermid Syndrome"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      },
      {
        "name": "Schizophrenia 15",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: Neurology.",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_exome",
        "insight_type": "biomarker_assessment",
        "subcategory": "Autism Spectrum Disorders",
        "markers": [
          "Schizophrenia 15"
        ],
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        },
        "verticals": [
          "mental_health",
          "precision_medicine",
          "longevity"
        ]
      }
    ],
    "_marker_count": 1090,
    "marker_count": 1090,
    "insight_count": 929
  },
  {
    "id": "precision_medicine",
    "name": "Precision Medicine",
    "sub": "Disease Risk \u00b7 Pharmacogenomics \u00b7 Chronic Disease \u00b7 Exome Diagnostics",
    "color": "#0f4c8a",
    "lt": "#e8f0fb",
    "img": "https://images.unsplash.com/photo-1576671081837-49000212a370?w=320&q=75",
    "desc": "The most comprehensive genomic medicine vertical on the platform. Integrates polygenic disease risk across 17 clinical organ systems, full pharmacogenomics (192 drug-gene interactions), chronic disease management, and exome-level rare variant diagnostics \u2014 enabling truly individualized prevention, treatment selection, and drug dosing.",
    "tags": [
      "Disease Risk Scoring",
      "Pharmacogenomics",
      "Chronic Disease Management",
      "Cancer Genetics",
      "Cardiovascular Genomics",
      "Neurogenomics",
      "Rare Disease Exome",
      "Drug Efficacy & Toxicity",
      "Metabolic Disease",
      "Women's Health Genomics",
      "Autoimmune",
      "Musculoskeletal",
      "Respiratory",
      "Mental Health Genomics",
      "Exome+ Clinical Panels"
    ],
    "insights": [
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Cardiovascular Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores across 24 circulatory conditions including coronary atherosclerosis, heart attack, atrial fibrillation, hypertension, heart failure, stroke, deep vein thrombosis, and peripheral artery disease. Integrates ApoE, 9p21, LPA, and 300+ cardiovascular GWAS loci for lifetime risk stratification.",
        "markers": [
          "Acute Ischeamic Heart Disease",
          "Angina",
          "Atrial Fibrillation",
          "Cardiomyopathy",
          "Coronary Atherosclerosis",
          "Deep Vein Thrombosis",
          "Gestational Hypertension",
          "Heart Attack Myocardial Infarction",
          "Heart Beat Abnormalities",
          "Heart Cardiac Problem",
          "Heart Failure Pulmonary Odema",
          "Heart Valve Problem Heart Murmur",
          "Hemorrhoids",
          "Hypertension",
          "Leg Claudication",
          "Peripheral Artery Disease",
          "Preeclampsia",
          "Raynauds Disease",
          "Rheumatic Fever",
          "Stroke",
          "Subarachnoid Hemorrhage",
          "Supraventricular Tachycardia",
          "Varicose Veins",
          "Vasculitis"
        ],
        "unit": "PRS percentile (0\u2013100th)",
        "range": "Low: <20th | Average: 20\u201380th | High: >80th | Very High: >95th",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Metabolic & Endocrine Disease Risk Score",
        "desc": "Polygenic risk scores for 16 metabolic conditions: Type 1 & 2 diabetes, hypothyroidism, hyperthyroidism, thyroiditis, thyroid goiter, gestational diabetes, high cholesterol, hepatitis, adrenal insufficiency, diabetic neuropathy, and diabetic retinopathy. TCF7L2, KCNJ11, PPARG and 400+ T2DM loci.",
        "markers": [
          "Adrenal Insufficiency",
          "Diabetic Neuropathy",
          "Diabetic Retinopathy",
          "Gestational Diabetes",
          "Gestational Diabetes Only During Pregnancy",
          "Hepatitis",
          "Hepatitis A",
          "High Cholesterol",
          "Hyperthyroidism",
          "Hypopituitarism",
          "Hypothyroidism",
          "Pituitary Tumor",
          "Thyroid Goiter",
          "Thyroiditis",
          "Type 1 Diabetes",
          "Type 2 Diabetes"
        ],
        "unit": "PRS percentile per condition",
        "range": "Type 2 diabetes PRS: <30th protective | >80th elevated | >95th high",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Musculoskeletal & Connective Tissue Disease Risk",
        "desc": "Polygenic risk scores for 20 MSK conditions: rheumatoid arthritis, osteoporosis, gout, ankylosing spondylitis, osteoarthritis, psoriatic arthritis, scoliosis, back pain, herniated disk, and connective tissue disorders. HLA-DRB1, PTPN22, TNFAIP3, and 200+ loci.",
        "markers": [
          "Ankylosing Spondylitis",
          "Arthritis",
          "Back Pain",
          "Bursitis",
          "Carpal Tunnel Syndrome",
          "Cervical Spondylosis",
          "Gout",
          "Herniated Disk",
          "Hip Fracture",
          "Mixed Connective Tissue Disease",
          "Osteoarthritis",
          "Osteomyelitis",
          "Osteoporosis",
          "Plantar Fasciitis",
          "Polymyalgia Rheumatica",
          "Rheumatoid Arthritis",
          "Sciatica",
          "Scoliosis",
          "Spinal Stenosis",
          "Tendinitis"
        ],
        "unit": "PRS percentile per condition",
        "range": "RA: >80th elevated | Osteoporosis: FRAX integration",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "dna_array",
        "name": "Chronic Disease Multimorbidity Index",
        "desc": "Composite genomic risk index quantifying probability of developing \u22652 chronic conditions simultaneously (multimorbidity). Combines PRS from cardiovascular, metabolic, musculoskeletal, respiratory, and neurological domains. High multimorbidity index triggers precision lifestyle and pharmacological prevention protocols.",
        "markers": [
          "Cardiovascular PRS",
          "Metabolic PRS",
          "Musculoskeletal PRS",
          "Respiratory PRS",
          "Neurological PRS",
          "Inflammatory load index",
          "HLA haplotype risk",
          "Clonal hematopoiesis variants"
        ],
        "unit": "Multimorbidity Score 0\u2013100",
        "range": "Low: <30 | Moderate: 30\u201360 | High: >60 | Extreme: >80",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "blood",
        "name": "Chronic Disease Biomarker Surveillance Panel",
        "desc": "Longitudinal blood monitoring panel for established chronic disease patients: glycemic control, lipid management, inflammatory burden, renal function, hepatic status, and thyroid tracking. Pairs with PRS for genotype-informed target ranges and medication adjustment triggers.",
        "markers": [
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "ApoB",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "creatinine",
          "eGFR",
          "cystatin-C",
          "uric acid",
          "ALT",
          "AST",
          "GGT",
          "TSH",
          "Free T4",
          "NT-proBNP",
          "fibrinogen"
        ],
        "unit": "Multi-organ composite",
        "range": "HbA1c: <5.7% optimal | ApoB: <80 mg/dL | hs-CRP: <1.0 mg/L",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Chronic Disease Management & Prevention",
        "src": "lifestyle",
        "name": "Gene-Environment Interaction Risk Assessment",
        "desc": "Integrates validated lifestyle factors (diet quality score, physical activity, smoking, alcohol, sleep quality, BMI, stress) with polygenic disease risk to compute modifiable vs. non-modifiable risk fractions. Identifies highest-leverage behavioral interventions per individual genetic profile.",
        "markers": [
          "Diet quality score (HEI/MeDi)",
          "Physical activity (MET-hours/week)",
          "Smoking status & pack-years",
          "Alcohol units/week",
          "Sleep duration & quality",
          "BMI & waist circumference",
          "Psychosocial stress score",
          "Environmental exposures"
        ],
        "unit": "Modifiable risk fraction %",
        "range": "High modifiable: >60% | Primarily genetic: <30%",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Cancer Genetics & Risk",
        "src": "dna_array",
        "name": "Multi-Cancer Polygenic Risk Score Panel",
        "desc": "Polygenic risk scores for 27 cancer types: breast, prostate, colorectal, lung, melanoma, ovarian, thyroid, endometrial, kidney, stomach, testicular, cervical, bladder, and hematologic malignancies. Integrates BRCA1/2-adjacent polygenic background, HER2 loci, and tissue-specific GWAS signals.",
        "markers": [
          "Basal Cell Carcinoma",
          "Bladder Cancer",
          "Bone Cancer",
          "Breast Cancer",
          "Cervical Cancer",
          "Chronic Lymphocytic Leukemia",
          "Colon Cancer",
          "Endometrial Cancer",
          "Esophageal Cancer",
          "Hodgkins Lymphoma",
          "Kidney Cancer",
          "Leukemia",
          "Lung Cancer",
          "Melanoma",
          "Multiple Myeloma",
          "Non Hodgkins Lymphoma",
          "Nonmelanoma Skin Cancer",
          "Ovarian Cancer",
          "Prostate Cancer",
          "Rectal Cancer",
          "Sarcoma",
          "Skin Cancer",
          "Squamous Cell Carcinoma",
          "Stomach Cancer",
          "Testicular Cancer",
          "Throat Cancer",
          "Thyroid Cancer"
        ],
        "unit": "PRS percentile per cancer type",
        "range": "High risk: >90th percentile | Very high: >95th | Actionable: BRCA-equivalent risk",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Cancer Genetics & Risk",
        "src": "dna_exome",
        "name": "Hereditary Cancer Syndrome Exome Panel",
        "desc": "Clinical-grade exome analysis of 0+ pathogenic variants across BRCA1, BRCA2, PALB2, CHEK2, ATM, MLH1, MSH2, MSH6, PMS2 (Lynch syndrome), APC, PTEN, TP53, RET, VHL, MEN1, CDKN2A, and 70+ hereditary cancer genes. ACMG Tier I reportable.",
        "markers": [
          "BRCA1 pathogenic variants",
          "BRCA2 pathogenic variants",
          "PALB2",
          "CHEK2 c.1100delC",
          "ATM",
          "MLH1 (Lynch)",
          "MSH2 (Lynch)",
          "MSH6 (Lynch)",
          "PMS2 (Lynch)",
          "APC (FAP)",
          "PTEN (Cowden)",
          "TP53 (Li-Fraumeni)",
          "RET (MEN2)",
          "VHL",
          "MEN1",
          "CDKN2A",
          "STK11",
          "SMAD4"
        ],
        "unit": "Pathogenic/Likely Pathogenic variant call",
        "range": "Pathogenic (P) | Likely Pathogenic (LP) | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Cancer Genetics & Risk",
        "src": "blood",
        "name": "Cancer Risk & Early Detection Biomarker Panel",
        "desc": "Blood-based cancer risk and surveillance markers: PSA for prostate, CA-125 for ovarian, CEA for colorectal, AFP for liver, CA 19-9 for pancreatic, and ctDNA methylation markers for multi-cancer early detection (MCED). Complements genomic risk scoring with phenotypic surveillance.",
        "markers": [
          "PSA (prostate-specific antigen)",
          "CEA (carcinoembryonic antigen)",
          "CA-125",
          "AFP (alpha-fetoprotein)",
          "CA 19-9",
          "LDH",
          "beta-hCG",
          "CA 15-3",
          "calcitonin",
          "ctDNA methylation (MCED)",
          "NfL (neuroblastoma proxy)"
        ],
        "unit": "ng/mL per marker",
        "range": "PSA: <4.0 ng/mL | CEA: <2.5 ng/mL | CA-125: <35 U/mL",
        "tier": "comprehensive",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Cardiovascular Drugs",
        "desc": "Pharmacogenomic guidance for 34 drug interactions in cardiovascular drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Candesartan, Atenolol, Rosuvastatin, Irbesartan, Chlorthalidone, Hydrochlorothiazide. Genes: CYP2C9, VKORC1, CYP2C19, SLCO1B1, ABCB1 and more.",
        "markers": [
          "CYP2C9",
          "VKORC1",
          "CYP2C19",
          "SLCO1B1",
          "ABCB1",
          "ACE I/D",
          "AGT M235T",
          "ADD1 460W",
          "CYP3A5",
          "Ace Inhibitors Efficacy",
          "Ace Inhibitors Toxicity",
          "Amiodarone Toxicity",
          "Amlodipine Efficacy",
          "Aspirin Efficacy",
          "Aspirin Toxicity"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Oncology Drugs",
        "desc": "Pharmacogenomic guidance for 47 drug interactions in oncology drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Gemcitabine, Cetuximab, Carboplatin, Doxorubicin, Sorafenib, Cytarabine. Genes: DPYD (fluorouracil), UGT1A1 (irinotecan), CYP2D6 (tamoxifen), ERCC1, GSTP1 and more.",
        "markers": [
          "DPYD (fluorouracil)",
          "UGT1A1 (irinotecan)",
          "CYP2D6 (tamoxifen)",
          "ERCC1",
          "GSTP1",
          "TP53",
          "KRAS",
          "BRAF V600E",
          "HER2/ERBB2",
          "MLH1 (capecitabine)",
          "TPMT (mercaptopurine)",
          "Anastrozole Toxicity",
          "Bevacizumab Efficacy",
          "Bevacizumab Toxicity",
          "Bleomycin Toxicity",
          "Capecitabine Efficacy",
          "Capecitabine Toxicity"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Psychiatric & Neuro Drugs",
        "desc": "Pharmacogenomic guidance for 36 drug interactions in psychiatric & neuro drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Aripiprazole, Clozapine, Venlafaxine, Haloperidol, Amitriptyline, Phenytoin. Genes: CYP2D6, CYP2C19, CYP3A4, SLC6A4 (SSRI response), HTR2A and more.",
        "markers": [
          "CYP2D6",
          "CYP2C19",
          "CYP3A4",
          "SLC6A4 (SSRI response)",
          "HTR2A",
          "COMT Val158Met",
          "ABCB1",
          "HLA-A*31:01 (carbamazepine)",
          "HLA-B*15:02",
          "Amitriptyline Efficacy",
          "Aripiprazole Efficacy",
          "Aripiprazole Toxicity",
          "Bupropion Efficacy",
          "Bupropion Toxicity",
          "Carbamazepine Dosage"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Pain & Opioids",
        "desc": "Pharmacogenomic guidance for 16 drug interactions in pain & opioids. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Oxycodone, Acetaminophen, Buprenorphine, Tramadol, Morphine, Methadone. Genes: CYP2D6 (codeine/tramadol), OPRM1 A118G, COMT Val158Met, CYP3A4, UGT2B7 and more.",
        "markers": [
          "CYP2D6 (codeine/tramadol)",
          "OPRM1 A118G",
          "COMT Val158Met",
          "CYP3A4",
          "UGT2B7",
          "ABCB1",
          "Acetaminophen Efficacy",
          "Acetaminophen Toxicity",
          "Buprenorphine Efficacy",
          "Buprenorphine Toxicity",
          "Fentanyl Dosage",
          "Fentanyl Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Immunosuppressants",
        "desc": "Pharmacogenomic guidance for 15 drug interactions in immunosuppressants. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Corticosteroids, Rituximab, Tocilizumab, Tumor Necrosis Factor Alpha Inhibitors, Tacrolimus, Dexamethasone. Genes: CYP3A5 *1/*3, ABCB1, TPMT, NUDT15, UGT1A9 and more.",
        "markers": [
          "CYP3A5 *1/*3",
          "ABCB1",
          "TPMT",
          "NUDT15",
          "UGT1A9",
          "HLA-DRB1",
          "Adalimumab Efficacy",
          "Corticosteroids Efficacy",
          "Cyclosporine Dosage",
          "Cyclosporine Efficacy",
          "Cyclosporine Toxicity",
          "Dexamethasone Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Diabetes Drugs",
        "desc": "Pharmacogenomic guidance for 2 drug interactions in diabetes drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Metformin, Repaglinide. Genes: SLC22A1 (metformin), KCNJ11, TCF7L2, PPARG and more.",
        "markers": [
          "SLC22A1 (metformin)",
          "KCNJ11",
          "TCF7L2",
          "PPARG",
          "Metformin Efficacy",
          "Repaglinide Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Antiviral & Antibiotic",
        "desc": "Pharmacogenomic guidance for 8 drug interactions in antiviral & antibiotic. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Ribavirin. Genes: HLA-B*57:01 (abacavir), CYP2B6 (efavirenz), UGT1A1 (atazanavir), NAT2 (rifampin), HLA-B*35:01 and more.",
        "markers": [
          "HLA-B*57:01 (abacavir)",
          "CYP2B6 (efavirenz)",
          "UGT1A1 (atazanavir)",
          "NAT2 (rifampin)",
          "HLA-B*35:01",
          "Atazanavir Toxicity",
          "Efavirenz Toxicity",
          "Ethambutol Toxicity",
          "Nevirapine Toxicity",
          "Ribavirin Efficacy",
          "Ribavirin Toxicity"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Hair & Dermatology Drugs",
        "desc": "Pharmacogenomic guidance for 13 drug interactions in hair & dermatology drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: . Genes: SRD5A2 (finasteride), CYP3A4, PTGDR2, IGF1R, FGF5 and more.",
        "markers": [
          "SRD5A2 (finasteride)",
          "CYP3A4",
          "PTGDR2",
          "IGF1R",
          "FGF5",
          "Biotin Deficiency",
          "Collagen Stability",
          "Dutasteride Effectiveness",
          "Dutasteride Metabolism",
          "Estradiol Effectiveness",
          "Finasteride Effectiveness"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Respiratory Drugs",
        "desc": "Pharmacogenomic guidance for 3 drug interactions in respiratory drugs. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Montelukast, Salbutamol. Genes: ADRB2 (salbutamol), CYP2C8 (montelukast), LTC4S and more.",
        "markers": [
          "ADRB2 (salbutamol)",
          "CYP2C8 (montelukast)",
          "LTC4S",
          "Montelukast Efficacy",
          "Salbutamol Efficacy",
          "Cetirizine Effectiveness"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "PGx: Anticoagulants",
        "desc": "Pharmacogenomic guidance for 7 drug interactions in anticoagulants. Reports predicted efficacy, toxicity risk, and optimal dosing based on metabolizer phenotype (poor/intermediate/normal/ultra-rapid). Covers: Prasugrel, Clopidogrel, Warfarin, Acenocoumarol. Genes: CYP2C9 *2/*3, VKORC1 -1639G>A, CYP4F2 V433M, GGCX and more.",
        "markers": [
          "CYP2C9 *2/*3",
          "VKORC1 -1639G>A",
          "CYP4F2 V433M",
          "GGCX",
          "Acenocoumarol Dosage",
          "Clopidogrel Efficacy",
          "Clopidogrel Toxicity",
          "Prasugrel Efficacy",
          "Warfarin Dosage",
          "Warfarin Efficacy"
        ],
        "unit": "Metabolizer phenotype + drug guidance",
        "range": "Poor Metabolizer (PM) | IM | NM | Rapid (RM) | Ultra-Rapid (UM)",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Pharmacogenomics",
        "src": "dna_array",
        "name": "Pharmacogenomics Master Profile (192 Drugs)",
        "desc": "Complete pharmacogenomics report covering all 192 drug-gene interactions in the Lifenome database across 10 drug classes. Generates a prescribing guidance table for clinicians showing predicted metabolizer phenotype, recommended dose adjustments, contraindications, and alternative drug suggestions. Powered by CPIC, PharmGKB, and FDA PGx guidelines.",
        "markers": [
          "CYP2D6 genotype & phenotype",
          "CYP2C9 *1\u2013*8",
          "CYP2C19 *1\u2013*17",
          "CYP3A4/3A5",
          "VKORC1 -1639G>A",
          "DPYD *2A/*13",
          "TPMT *2/*3C",
          "UGT1A1 *28/*6",
          "SLCO1B1 *5",
          "HLA-B*57:01",
          "HLA-B*15:02",
          "HLA-A*31:01",
          "OPRM1 A118G",
          "SLC22A1",
          "ABCB1 C3435T"
        ],
        "unit": "Clinical action score (CPIC) + phenotype",
        "range": "No action | Prescribing alert | Contraindicated | Dose adjust required",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Neurological & Psychiatric Disease Risk",
        "src": "dna_array",
        "name": "Neurological Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores for 15 neurological conditions: Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, migraine, essential tremor, myasthenia gravis, peripheral neuropathy, brain aneurysm, and Guillain-Barr\u00e9 syndrome. APOE \u03b54, LRRK2, SNCA, C9orf72, and 500+ GWAS loci.",
        "markers": [
          "Alzheimers Disease",
          "Bells Palsy",
          "Benign Peripheral Nerve Tumor",
          "Brain Aneurysm",
          "Cerebral Palsy",
          "Encephalitis",
          "Epilepsy",
          "Essential Tremor Benign",
          "Guillain Barre Syndrome",
          "Intracranial Hematoma",
          "Migraine",
          "Multiple Sclerosis",
          "Myasthenia Gravis",
          "Parkinsons Disease",
          "Peripheral Neuropathy"
        ],
        "unit": "PRS percentile per condition",
        "range": "Alzheimer's APOE \u03b54/\u03b54: 8\u201312\u00d7 risk | Parkinson's LRRK2 G2019S carrier",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Neurological & Psychiatric Disease Risk",
        "src": "dna_array",
        "name": "Psychiatric Disease Genomic Risk Panel",
        "desc": "Polygenic risk scores for 11 psychiatric and behavioral conditions: depression, bipolar disorder, schizophrenia, PTSD, panic disorder, postpartum depression, eating disorders, fibromyalgia, chronic fatigue, insomnia, and sleep apnea. SCN1A, CACNA1C, TCF4, DISC1, and 200+ psychiatric GWAS loci.",
        "markers": [
          "Bipolar Disorder",
          "Chronic Fatigue Syndrome",
          "Depression",
          "Eating Disorders",
          "Fibromyalgia",
          "Insomnia",
          "Panic Attacks Disorder",
          "Post Traumatic Stress Disorder",
          "Postpartum Depression",
          "Schizophrenia",
          "Sleep Apnea"
        ],
        "unit": "PRS percentile per condition",
        "range": "Schizophrenia PRS >90th: 3\u00d7 population risk | Bipolar >85th: elevated",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Neurological & Psychiatric Disease Risk",
        "src": "dna_wgs",
        "name": "Neurological Exome \u2014 Rare Variant Diagnostics",
        "desc": "Clinical exome analysis of 48+ rare pathogenic variants across 27 neurological panels: spinal muscular atrophy, ALS, Charcot-Marie-Tooth, epileptic encephalopathy, neuromuscular disorders, hereditary spastic paraplegia, mitochondrial disease, and 27 rare neurological panel categories.",
        "markers": [
          "SMN1/SMN2 (SMA)",
          "SOD1/TDP-43/FUS (ALS)",
          "C9orf72 repeat expansion",
          "LRRK2/SNCA (Parkinson's)",
          "SCN1A (Dravet syndrome)",
          "KCNQ2/3 (epilepsy)",
          "PMP22/MPZ (CMT)",
          "MAPT/GRN (FTD)",
          "HTT CAG repeat (Huntington)",
          "PSEN1/PSEN2/APP (early AD)",
          "MECP2 (Rett syndrome)",
          "FMR1 (Fragile X)",
          "DMPK (myotonic dystrophy)"
        ],
        "unit": "Pathogenic variant call (ACMG 5-tier)",
        "range": "Pathogenic (P) | Likely Pathogenic (LP) | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Women's Health Genomics",
        "src": "dna_array",
        "name": "Female Reproductive & Breast Health Genetic Risk",
        "desc": "Polygenic risk scores for 19 female health conditions: endometriosis, polycystic ovary syndrome (PCOS), premature/early menopause, female infertility, uterine fibroids, breast conditions, ovarian dysfunction, miscarriage risk, gestational hypertension, and preeclampsia. BRCA-context PRS, FSHR, ESR1, and WNT4 loci.",
        "markers": [
          "Breast Cysts",
          "Breast Fibroadenoma",
          "Breast Lumps",
          "Cervical Polyps",
          "Dysmenorrhea",
          "Early Menopause",
          "Ectopic Pregnancy",
          "Endometriosis",
          "Female Infertility",
          "Fibrocystic Breasts",
          "Menorrhagia",
          "Miscarriage",
          "Ovarian Dysfunction",
          "Polycystic Ovary Syndrome",
          "Postmenopausal Osteoporosis",
          "Premature Menopause",
          "Uterine Fibroids",
          "Uterine Polyps",
          "Uterine Prolapse"
        ],
        "unit": "PRS percentile per condition",
        "range": "PCOS: >80th elevated | Endometriosis: >85th elevated | Early menopause: FOXL2",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Women's Health Genomics",
        "src": "dna_array",
        "name": "Menstrual & Hormonal Cycle Genomic Profile",
        "desc": "Genetic determinants of menstrual cycle regulation, hormone sensitivity, and cycle-related symptoms. SHBG, ESR1, PGR, and FSHR variants predicting estrogen dominance, progesterone resistance, premenstrual dysphoria (PMDD), pain sensitivity (COMT), and response to hormonal therapy.",
        "markers": [
          "SHBG (rs727428)",
          "ESR1 (rs2234693)",
          "PGR PROGINS allele",
          "FSHR (rs6166)",
          "COMT Val158Met (pain)",
          "OPRM1 A118G",
          "CYP19A1 (aromatase)",
          "MAOA uVNTR",
          "FKBP5 rs1360780"
        ],
        "unit": "Risk tier per phenotype",
        "range": "Estrogen dominance risk | PMDD risk | Hormone therapy benefit score",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Women's Health Genomics",
        "src": "blood",
        "name": "Hormonal & Reproductive Biomarker Panel",
        "desc": "Comprehensive hormonal blood panel for reproductive health monitoring: fertility hormones, thyroid function, adrenal status, and metabolic markers that modulate female hormone balance. Designed to pair with PRS for personalized reproductive health planning.",
        "markers": [
          "FSH",
          "LH",
          "AMH (anti-M\u00fcllerian hormone)",
          "estradiol (E2)",
          "progesterone",
          "total testosterone",
          "free testosterone",
          "SHBG",
          "prolactin",
          "TSH",
          "Free T4",
          "DHEA-S",
          "cortisol AM",
          "fasting insulin",
          "25-OH Vitamin D",
          "hs-CRP"
        ],
        "unit": "Hormone panel (mIU/mL, pg/mL, ng/mL)",
        "range": "AMH: >1.0 ng/mL good reserve | FSH day 3: <10 mIU/mL | E2: 25\u201375 pg/mL",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Digestive & Gastrointestinal Genomics",
        "src": "dna_array",
        "name": "Gastrointestinal Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores for 22 GI conditions: Crohn's disease, ulcerative colitis, celiac disease, IBS, GERD, pancreatitis, H. pylori susceptibility, peptic ulcer, diverticulosis, and hepatic diseases. NOD2, IL23R, HLA-DQ2/DQ8, ATG16L1, and 300+ IBD GWAS loci.",
        "markers": [
          "Acute Liver Failure",
          "Anal Fissure",
          "Appendicitis",
          "Celiac Disease",
          "Cholecystitis",
          "Constipation",
          "Crohns Disease",
          "Functional Dyspepsia",
          "Gastritis",
          "Gastroesophageal Reflux Disease",
          "Gastrointestinal Bleeding",
          "Helicobacter Pylori Infection",
          "Hiatal Hernia",
          "Inguinal Hernia",
          "Intestinal Obstruction",
          "Irritable Bowel Syndrome",
          "Pancreatitis",
          "Peptic Ulcer",
          "Peritonitis",
          "Rectal Prolapse",
          "Ulcerative Colitis",
          "Umbilical Hernia"
        ],
        "unit": "PRS percentile per condition",
        "range": "IBD (Crohn's/UC): >85th elevated | Celiac: HLA-DQ2/DQ8 required",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Digestive & Gastrointestinal Genomics",
        "src": "micro_16s",
        "name": "Gut Microbiome Disease Association Panel",
        "desc": "16S microbiome analysis linking dysbiosis patterns to GI disease risk: reduced Faecalibacterium prausnitzii in IBD, Helicobacter pylori detection, SIBO-associated taxa, and reduced diversity markers in IBS and colorectal cancer risk. Generates targeted probiotic and dietary intervention plan.",
        "markers": [
          "Faecalibacterium prausnitzii %",
          "Helicobacter pylori detection",
          "Fusobacterium nucleatum (CRC marker)",
          "Ruminococcus gnavus (IBD)",
          "Bacteroides fragilis",
          "Prevotella copri (RA association)",
          "Shannon diversity index",
          "Butyrate producer abundance",
          "Firmicutes:Bacteroidetes ratio"
        ],
        "unit": "Relative abundance % + diversity score",
        "range": "F. prausnitzii: optimal >5% | H. pylori: negative | Shannon: >3.5",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "bacteria": "2,000+"
        }
      },
      {
        "subcategory": "Digestive & Gastrointestinal Genomics",
        "src": "blood",
        "name": "Gut Inflammation & Permeability Biomarkers",
        "desc": "Blood markers of intestinal inflammation, permeability, and hepatic stress: calprotectin pathway proteins, zonulin, LPS/endotoxemia markers, liver enzymes, and celiac antibodies. Enables monitoring of IBD activity, leaky gut, and NAFLD progression.",
        "markers": [
          "calprotectin (fecal proxy \u2014 serum IL-6)",
          "zonulin",
          "LPS-binding protein (LBP)",
          "anti-tissue transglutaminase IgA (tTG-IgA)",
          "anti-endomysial antibody",
          "hs-CRP",
          "ALT",
          "AST",
          "GGT",
          "total bilirubin",
          "albumin",
          "alkaline phosphatase",
          "fecal lactoferrin (proxy \u2014 fecal test add-on)"
        ],
        "unit": "IU/mL, mg/L",
        "range": "tTG-IgA: <4 U/mL normal | Zonulin: <22 ng/mL | LBP: <5 \u03bcg/mL",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Immune, Autoimmune & Allergy Genomics",
        "src": "dna_array",
        "name": "Autoimmune & Allergy Polygenic Risk Panel",
        "desc": "Polygenic risk scores for 12 immune conditions: lupus, Sj\u00f6gren's syndrome, anaphylaxis, hay fever/allergic rhinitis, house dust mite allergy, sarcoidosis, thrombocytopenia, iron deficiency anemia, and pernicious anemia. Plus 23 sensitivity traits: food allergies (nuts, dairy, shellfish), indoor/outdoor allergies, physiological sensitivities, and chemical sensitivities. HLA-DRB1, PTPN22, STAT4, IRF5 loci.",
        "markers": [
          "Allergy Anaphylactic Reaction Drug",
          "Allergy Anaphylactic Reaction Food",
          "Allergy House Dust Mite",
          "Allergy Hypersensitivity Anaphylaxis",
          "Hayfever Allergic Rhinitis",
          "Lupus",
          "Sjogrens Sicca Syndrome",
          "Anemia",
          "Iron Deficiency Anemia",
          "Pernicious Anemia",
          "Sarcoidosis",
          "Thrombocytopenia",
          "Allergy Eggs",
          "Allergy Milk",
          "Allergy Peanuts",
          "General Food Sensitivities",
          "Gluten Sensitivity",
          "Lactose Intolerance",
          "Allergy Cockroaches",
          "Allergy Dust Mites"
        ],
        "unit": "PRS percentile + allergy risk tier",
        "range": "Lupus: >85th elevated | Anaphylaxis risk: actionable at >90th",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Immune, Autoimmune & Allergy Genomics",
        "src": "blood",
        "name": "Comprehensive Autoimmune & Immune Panel",
        "desc": "Full blood panel for autoimmune surveillance and immune function: ANA screen, specific autoantibodies, immunoglobulin levels, complement proteins, and complete blood count with differential. Function Health data shows 23% of individuals have elevated autoimmune antibodies with no symptoms.",
        "markers": [
          "ANA screen (IIF)",
          "ANA pattern",
          "anti-dsDNA (lupus)",
          "anti-Sm",
          "anti-SSA/SSB (Sj\u00f6gren's)",
          "anti-CCP (RA)",
          "RF (rheumatoid factor)",
          "anti-TPO",
          "anti-TgAb",
          "C3 complement",
          "C4 complement",
          "IgA",
          "IgG",
          "IgM",
          "IgE (total)",
          "CBC with differential",
          "eosinophil count",
          "basophil count"
        ],
        "unit": "Titer / IU/mL per antibody",
        "range": "ANA: negative | anti-dsDNA: <30 IU/mL | IgE total: <100 IU/mL",
        "tier": "comprehensive",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Immune, Autoimmune & Allergy Genomics",
        "src": "dna_wgs",
        "name": "Immunological Rare Variant Panel (Exome+)",
        "desc": "Clinical exome analysis across immunological conditions: severe-combined-immunodeficiency, primary-immunodeficiency-(pid)-and-primary-ciliary-dyskinesia-(pcd), complement-system-disorder panels covering 218 rare immune conditions including primary immunodeficiencies, autoinflammatory syndromes, and complement deficiencies.",
        "markers": [
          "RAG1/RAG2 (SCID)",
          "MEFV (familial Mediterranean fever)",
          "NLRP3 (CAPS)",
          "ADA (adenosine deaminase)",
          "BTK (X-linked agammaglobulinemia)",
          "AIRE (APECED)",
          "DOCK8",
          "PIK3CD/PIK3R1",
          "LRBA",
          "CTLA4"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | Likely Pathogenic (LP) | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Respiratory & Pulmonary Genomics",
        "src": "dna_array",
        "name": "Respiratory Disease Polygenic Risk Profile",
        "desc": "Polygenic risk scores for 12 respiratory conditions: asthma, COPD, emphysema, interstitial lung disease, pulmonary embolism, bronchitis, sinusitis, nasal polyps, and pleurisy. ORMDL3, IL13, GSDMB (asthma), SERPINA1 (COPD/alpha-1-antitrypsin), and 150+ respiratory GWAS loci.",
        "markers": [
          "Asthma",
          "Bronchitis",
          "Chronic Obstructive Pulmonary Disease",
          "Chronic Sinusitis",
          "Emphysema",
          "Interstitial Lung Disease",
          "Nasal Polyps",
          "Pleurisy",
          "Pneumonia",
          "Pulmonary Embolism",
          "Respiratory Infection Unspecified Acute Lower",
          "Whooping Cough"
        ],
        "unit": "PRS percentile per condition",
        "range": "Asthma: >80th elevated | COPD: SERPINA1 ZZ-genotype critical",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Respiratory & Pulmonary Genomics",
        "src": "dna_wgs",
        "name": "Pulmonary Rare Disease Exome Panel",
        "desc": "Clinical exome analysis across 3 pulmonary panels covering 12 rare lung conditions. Includes cystic fibrosis (CFTR), primary ciliary dyskinesia, alpha-1 antitrypsin deficiency, surfactant protein deficiencies, and hereditary pulmonary arterial hypertension (BMPR2).",
        "markers": [
          "CFTR (all 2,000+ variants)",
          "SERPINA1 *S/*Z alleles",
          "BMPR2/ACVRL1/ENG (PAH)",
          "SFTPB/SFTPC (surfactant)",
          "DNAI1/DNAI2/DNAH5 (PCD)",
          "SLC34A2 (pulmonary alveolar microlithiasis)"
        ],
        "unit": "Pathogenic variant call",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Respiratory & Pulmonary Genomics",
        "src": "wearable",
        "name": "Respiratory & Cardiopulmonary Function Monitoring",
        "desc": "Continuous wearable monitoring for respiratory health: SpO2 (blood oxygen saturation), respiratory rate variability, nocturnal breathing patterns, apnea-hypopnea events (sleep apnea screening), and VO2max as cardiopulmonary capacity marker.",
        "markers": [
          "SpO2 (% oxygen saturation)",
          "respiratory rate (breaths/min)",
          "respiratory rate variability",
          "apnea events/night (AHI proxy)",
          "VO2max estimate",
          "nocturnal SpO2 nadir",
          "exertional SpO2 drop"
        ],
        "unit": "SpO2 % + respiratory rate",
        "range": "SpO2 optimal: \u226597% | AHI proxy: <5/hr normal | VO2max: age/sex normalized",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Cardiogenomics & Structural Heart Disease",
        "src": "dna_exome",
        "name": "Hereditary Cardiovascular Exome Panel",
        "desc": "Clinical exome analysis across 11 cardiology panels: marfan-syndrome, cardiomyopathy, hyperlipidemia-core, congenital-structural-heart-disease, short-qt-syndrome-(sqts), and more. Covers 307 rare pathogenic variants for inherited cardiomyopathies, channelopathies, aortopathies, arrhythmias, and lipid disorders. ACMG Tier I reportable variants.",
        "markers": [
          "MYBPC3 (HCM)",
          "MYH7 (HCM/DCM)",
          "LDLR/APOB/PCSK9 (FH)",
          "SCN5A (Brugada/LQTS)",
          "KCNQ1/KCNH2 (LQTS)",
          "PKP2 (ARVC)",
          "FBN1/FBN2 (Marfan/aortopathy)",
          "TNNT2/TPM1 (cardiomyopathy)",
          "RYR2 (CPVT)",
          "LMNA (dilated CM)",
          "TTR (transthyretin amyloid)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Cardiogenomics & Structural Heart Disease",
        "src": "blood",
        "name": "Advanced Cardiometabolic Risk Biomarker Suite",
        "desc": "Extended cardiovascular risk assessment beyond standard lipids: Lp(a) for familial hypercholesterolemia context, NT-proBNP for subclinical heart failure, troponin for myocardial stress, ApoB/ApoA1 ratio, and homocysteine. Pairs with hereditary exome panel for genotype-informed risk thresholds.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "ApoA1",
          "ApoB:ApoA1 ratio",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "homocysteine",
          "hs-CRP",
          "fibrinogen",
          "D-dimer",
          "lipoprotein(a) particle number",
          "LDL-C",
          "HDL-C",
          "small dense LDL",
          "oxidized LDL"
        ],
        "unit": "ng/mL, mg/dL, pmol/L",
        "range": "Lp(a): <30 mg/dL low | >50 high risk | NT-proBNP: <125 pg/mL normal",
        "tier": "advanced",
        "insight_type": "health_dashboard"
      },
      {
        "subcategory": "Metabolic & Endocrine Rare Disease",
        "src": "dna_exome",
        "name": "Hereditary Metabolic Disorders Exome Panel",
        "desc": "Clinical exome analysis across 16 metabolic panels covering 206 rare conditions: organic-acidemia-aciduria-&-cobalamin-deficiency, hyperammonemia-and-urea-cycle-disorder, monogenic-obesity, congenital-mono--and-disaccharide-disorders, hypomagnesemia, peroxisomal-disorders, and more. Amino acid, fatty acid oxidation, lysosomal storage, glycogen storage, and peroxisomal disorders.",
        "markers": [
          "PAH (PKU)",
          "GALT (galactosemia)",
          "FAH (tyrosinemia)",
          "GAA (Pompe disease)",
          "HEXA/HEXB (Tay-Sachs/Sandhoff)",
          "GBA (Gaucher)",
          "IDUA/IDS (MPS I/II)",
          "ABCD1 (adrenoleukodystrophy)",
          "ACADM (MCAD)",
          "HADHA (LCHAD)",
          "NPC1/NPC2",
          "PCCA/PCCB (propionic acidemia)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Metabolic & Endocrine Rare Disease",
        "src": "dna_exome",
        "name": "Hereditary Endocrine Disorders Exome Panel",
        "desc": "Clinical exome analysis across 8 endocrinology panels: glucocorticoid-deficiency, premature-ovarian-failure-with-fmr1-repeat-expansion, abnormal-genitalia--disorders-of-sex-development, hyperparathyroidism, hypothyroidism-and-resistance-to-thyroid-hormone, and more. Covers 106 rare endocrine conditions including hereditary thyroid disorders, adrenal syndromes, pituitary tumors, MEN syndromes, and growth hormone pathway variants.",
        "markers": [
          "MENIN/MEN1 (MEN1)",
          "RET (MEN2/MTC)",
          "VHL (pheochromocytoma)",
          "SDHB/SDHD (paraganglioma)",
          "CYP21A2 (CAH)",
          "TSHR (TSH resistance)",
          "PRKAR1A (Carney complex)",
          "GH1/GHR (growth hormone)",
          "PROP1/POU1F1 (panhypopituitarism)"
        ],
        "unit": "Pathogenic variant call",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Renal, Ophthalmology & ENT Genomics",
        "src": "dna_array",
        "name": "Renal & Urological Disease Genetic Risk",
        "desc": "Polygenic risk scores for 9 renal/urological conditions: polycystic kidney disease, end-stage renal disease, kidney stones, UTI susceptibility, erectile dysfunction, and urinary incontinence. PKD1/PKD2, UMOD, and GWAS loci for kidney function.",
        "markers": [
          "Cystitis",
          "End Stage Renal Disease",
          "Erectile Dysfunction",
          "Hydronephrosis",
          "Kidney Ureter Bladder Stone",
          "Polycystic Kidney Disease",
          "Undescended Testicle",
          "Urinary Incontinence",
          "Urinary Tract Infection"
        ],
        "unit": "PRS percentile per condition",
        "range": "ADPKD: PKD1/PKD2 variant carrier | ESRD: APOL1 G1/G2 alleles",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Renal, Ophthalmology & ENT Genomics",
        "src": "dna_array",
        "name": "Ophthalmological Disease Genetic Risk",
        "desc": "Polygenic risk scores for 6 eye conditions: glaucoma, macular degeneration, dry eyes, iritis, retinal detachment, and blepharitis. MYOC/OPTN (glaucoma), CFH/ARMS2 (AMD), and 150+ ophthalmic GWAS loci. Exome panels cover 199 rare ophthalmic conditions.",
        "markers": [
          "Blepharitis",
          "Dry Eyes",
          "Glaucoma",
          "Iritis",
          "Macular Degeneration",
          "Retinal Detachment",
          "MYOC/OPTN/TBK1 (glaucoma)",
          "CFH/ARMS2/HTRA1 (AMD)",
          "PRPF31/RHO (RP)",
          "RS1 (retinoschisis)",
          "ABCA4 (Stargardt)",
          "CRX/RPGR"
        ],
        "unit": "PRS percentile + variant call",
        "range": "AMD: >90th elevated | Glaucoma: MYOC pathogenic = monogenic",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Renal, Ophthalmology & ENT Genomics",
        "src": "dna_wgs",
        "name": "ENT & Hearing Loss Exome Panel",
        "desc": "Clinical exome analysis for 274 ENT and hearing conditions including non-syndromic hearing loss (GJB2/GJB6, most common monogenic condition worldwide), Meni\u00e8re's disease, tinnitus susceptibility, benign positional vertigo, and otosclerosis. Largest ENT rare disease panel on the platform.",
        "markers": [
          "GJB2 (Cx26 \u2014 non-syndromic HL)",
          "GJB6 (Cx30 \u2014 DFNB1)",
          "TMPRSS3",
          "SLC26A4 (Pendred)",
          "CDH23/PCDH15 (Usher)",
          "MYO7A/MYO15A",
          "TECTA",
          "COCH (DFNA9)",
          "WFS1 (Wolfram)",
          "KCNQ4 (DFNA2)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Nutrition Genomics & Precision Supplementation",
        "src": "dna_array",
        "name": "Diet Response & Metabolic Type Profile",
        "desc": "Genetic predispositions for 35 diet and metabolic traits: carbohydrate/fat/protein overconsumption tendencies, satiety impairment, low resting metabolic rate, sweet preference, starch metabolism, bitter taste sensitivity, and response to low-carb, low-fat, Mediterranean, and high-protein diets. Informs macronutrient ratios and meal timing strategy.",
        "markers": [
          "Bitter Taste Sensitivity",
          "Caffeine Metabolism Impairment",
          "Carb Overconsumption",
          "Difficulty Losing Weight",
          "Fat Overconsumption",
          "Fat Taste Perception",
          "Low Carb Diet Effectiveness",
          "Low Fat Diet Effectiveness",
          "Low Protein Intake Risk",
          "Low Resting Metabolic Rate",
          "Low Vegetable Intake",
          "Mediterranean Diet Effectiveness",
          "Monounsaturated Fats Increased Benefits",
          "Overweight Potential",
          "Polyunsaturated Fats Increased Benefits",
          "Risk Saturated Fats",
          "Satiety Impairment",
          "Snacking",
          "Starch Metabolism",
          "Sweet Snack Preference",
          "Sweet Tooth",
          "Trans Fats Sensitivity",
          "Calcium Deficiency",
          "Choline Deficiency",
          "Coenzymeq10 Deficiency",
          "Copper Deficiency",
          "Glutathione Deficiency",
          "Iron Deficiency",
          "Iron Overload",
          "Magnesium Deficiency",
          "Phosphorus Deficiency",
          "Phytosterols Imbalance",
          "Selenium Deficiency",
          "Sensitivity Salt",
          "Zinc Deficiency"
        ],
        "unit": "Risk tier per dietary trait",
        "range": "Low-carb responder | Fat-sensitive | Mediterranean optimal | Standard",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Nutrition Genomics & Precision Supplementation",
        "src": "dna_array",
        "name": "Vitamin & Micronutrient Genetic Deficiency Risk",
        "desc": "Genetic variants predisposing to deficiency of 16 vitamins and 13 minerals: all B vitamins (B1, B2, B3, B5, B6, B7, B9/folate, B12), Vitamins A, C, D, E, K, plus carotenoids (lutein/zeaxanthin, lycopene), calcium, iron, magnesium, zinc, copper, selenium, CoQ10, glutathione, and choline. Enables truly personalized supplement protocol.",
        "markers": [
          "Lutein Zeaxanthin Deficiency",
          "Lycopene Deficiency",
          "Vitamina Carotene Deficiency",
          "Vitamina Retinol Deficiency",
          "Vitaminb1 Deficiency",
          "Vitaminb12 Deficiency",
          "Vitaminb2 Deficiency",
          "Vitaminb3 Deficiency",
          "Vitaminb5 Deficiency",
          "Vitaminb6 Deficiency",
          "Vitaminb7 Deficiency",
          "Vitaminb9 Deficiency",
          "Vitaminc Deficiency",
          "Vitamind Deficiency",
          "Vitamine Deficiency",
          "Vitamink Deficiency",
          "Calcium Deficiency",
          "Choline Deficiency",
          "Coenzymeq10 Deficiency",
          "Copper Deficiency",
          "Glutathione Deficiency",
          "Iron Deficiency",
          "Iron Overload",
          "Magnesium Deficiency",
          "Phosphorus Deficiency",
          "Phytosterols Imbalance",
          "Selenium Deficiency",
          "Sensitivity Salt",
          "Zinc Deficiency"
        ],
        "unit": "Deficiency risk tier per nutrient",
        "range": "High risk = 2\u20134\u00d7 population prevalence | Low risk = below average",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Nutrition Genomics & Precision Supplementation",
        "src": "blood",
        "name": "Precision Micronutrient Status Blood Panel",
        "desc": "Confirmatory blood testing of genetically predicted nutrient deficiencies. Pairs genomic risk scores with measured levels for the highest-evidence actionable nutrients. Differentiates genetic vs. dietary/absorption etiology for targeted supplementation.",
        "markers": [
          "25-OH Vitamin D",
          "Vitamin B12",
          "methylmalonic acid (functional B12)",
          "folate (RBC)",
          "homocysteine (B9/B12 proxy)",
          "ferritin",
          "serum iron",
          "transferrin saturation",
          "magnesium RBC",
          "zinc",
          "selenium",
          "CoQ10",
          "glutathione",
          "Omega-3 index",
          "retinol (Vitamin A)",
          "tocopherol (Vitamin E)",
          "Vitamin K2 (MK-7)"
        ],
        "unit": "Per-nutrient units (ng/mL, nmol/L, mg/L)",
        "range": "Vitamin D: 40\u201380 ng/mL | B12: >400 pg/mL | Folate: >15 ng/mL",
        "tier": "advanced",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Addiction & Behavioral Genomics",
        "src": "dna_array",
        "name": "Substance Use & Addiction Risk Genomic Profile",
        "desc": "Polygenic risk scores for 21 addiction and substance use traits: alcohol dependence (age-at-onset, co-dependence, weekly consumption), nicotine dependence (initiation, cessation, quantity), cannabis use and dependence, cocaine sensitivity, opioid sensitivity, and gambling disorder. Neurotransmitter gene variants (GABRA2, ADH1B, CYP2A6, OPRM1, DRD2/DRD4, COMT).",
        "markers": [
          "Alcohol And Nicotine Co Dependence",
          "Alcohol Consumption Drinks Per Week Mtag",
          "Alcohol Dependence",
          "Alcohol Dependence Age At Onset",
          "Alcoholic Chronic Pancreatitis",
          "Caffeine Consumption",
          "Coffee Consumption",
          "Coffee Consumption Cups Per Day",
          "Gambling",
          "Cannabis Dependence",
          "Cannabis Use Initiation",
          "Cocaine Dependence",
          "Methadone Dose In Opioid Dependence",
          "Opioid Sensitivity",
          "Nicotine Glucouronidation",
          "Nicotine Use",
          "Smoking Cessation In Chronic Obstructive Pulmonary Disease",
          "Smoking Cessation Mtag",
          "Smoking Initiation Age Mtag",
          "Smoking Initiation Ever Regular Vs Never Regular Mtag",
          "Smoking Quantity Cigarettes Per Day Mtag"
        ],
        "unit": "PRS percentile per substance",
        "range": "Alcohol: >80th elevated risk | Nicotine cessation: CYP2A6 slow metabolizer",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Addiction & Behavioral Genomics",
        "src": "dna_array",
        "name": "Personality & Behavioral Trait Genomic Profile",
        "desc": "Genetic contributions to 21 personality and behavioral traits: agreeableness, extraversion, empathy, impulsivity, anger response, optimism, exploratory behavior, warrior/worrier personality (COMT), leadership potential, pleasure response, and morning chronotype. Enables personalized behavioral health coaching.",
        "markers": [
          "Agreeableness",
          "Empathy",
          "Extraversion",
          "Leadership Potential",
          "Sociability",
          "Creativity",
          "Experiential Learning Impairment",
          "Mathematical Aptitude",
          "Memory Performance",
          "Music Performance Aptitude",
          "Musical Creativity",
          "Reading Aptitude",
          "Addictive Personality",
          "Anger Response",
          "Exploratory Behavior",
          "Impulsivity",
          "Morning Person",
          "Optimism",
          "Pleasure Response Impairment",
          "Warrior Personality",
          "Worrier Personality"
        ],
        "unit": "PRS score per trait",
        "range": "Quantitative trait \u2014 population distribution",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Addiction & Behavioral Genomics",
        "src": "blood",
        "name": "Addiction & Reward Pathway Biomarker Panel",
        "desc": "Blood markers reflecting reward pathway biology and addiction vulnerability: dopamine precursors, cortisol stress burden, liver enzyme markers of alcohol use, and inflammatory markers. Pairs with PGx data for medication-assisted treatment optimization (buprenorphine, methadone, naltrexone dosing).",
        "markers": [
          "GGT (alcohol use marker)",
          "MCV (alcohol-related macrocytosis)",
          "CDT (carbohydrate-deficient transferrin)",
          "tyrosine (dopamine precursor)",
          "cortisol AM",
          "DHEA-S",
          "hs-CRP",
          "ALT/AST ratio",
          "bilirubin",
          "platelet count"
        ],
        "unit": "U/L, mg/dL per marker",
        "range": "GGT: <25 U/L normal | CDT: <1.7% normal | MCV: 80\u2013100 fL",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Dermatology & Skin Disease Genomics",
        "src": "dna_array",
        "name": "Inflammatory Skin Disease Polygenic Risk",
        "desc": "Polygenic risk scores for 10 skin conditions: psoriasis, atopic dermatitis/eczema, rosacea, vitiligo, chronic urticaria, acne vulgaris, scleroderma, lichen planus, cellulitis, and Dupuytren's contracture. HLA-Cw*06 (psoriasis), FLG (atopic dermatitis), IRF4, and 100+ dermatological GWAS loci. Exome+ covers 131 rare skin conditions.",
        "markers": [
          "Acne Vulgaris",
          "Atopic Dermatitis",
          "Cellulitis",
          "Chronic Hives Urticaria",
          "Dupuytrens Contracture",
          "Lichen Planus",
          "Psoriasis",
          "Rosacea",
          "Scleroderma",
          "Vitiligo"
        ],
        "unit": "PRS percentile per condition",
        "range": "Psoriasis: HLA-Cw*06 = 10\u00d7 risk | Atopic dermatitis: FLG null = 3\u00d7 risk",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Dermatology & Skin Disease Genomics",
        "src": "dna_wgs",
        "name": "Dermatology Rare Disease Exome Panel",
        "desc": "Clinical exome analysis across 7 dermatology panels covering 131 rare conditions: epidermolysis bullosa, ichthyosis, ectodermal dysplasia, palmoplantar keratoderma, Darier disease, and hereditary skin tumor syndromes.",
        "markers": [
          "COL7A1/COL17A1 (EB)",
          "KRT1/KRT10 (bullous ichthyosiform)",
          "GJB2 (KID syndrome)",
          "ATP2A2 (Darier)",
          "PTCH1 (basal cell nevus)",
          "TP53 (Li-Fraumeni skin)",
          "CDKN2A (familial melanoma)",
          "BAP1",
          "SH3BP2 (cherubism)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Hematology & Blood Disorders",
        "src": "dna_exome",
        "name": "Hereditary Blood Disorder Exome Panel",
        "desc": "Clinical exome analysis across 4 hematology panels: bone-marrow-failure-syndrome, bleeding-disorder-coagulopathy, anemia, comprehensive-immune-and-cytopenia, and more. Covers 281 rare conditions including hereditary hemochromatosis, hemophilia A & B, von Willebrand disease, sickle cell disease, thalassemias, platelet disorders, and rare anemias.",
        "markers": [
          "HFE C282Y/H63D (hemochromatosis)",
          "F8/F9 (hemophilia A/B)",
          "VWF (von Willebrand)",
          "HBB (sickle cell / \u03b2-thal)",
          "HBA1/HBA2 (\u03b1-thalassemia)",
          "RUNX1 (platelet disorder)",
          "CALR/JAK2/MPL (MPN)",
          "TP53/SF3B1 (MDS)",
          "G6PD",
          "PIGA (PNH)"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Carrier status | Affected | Pathogenic variant detected",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Hematology & Blood Disorders",
        "src": "blood",
        "name": "Comprehensive Hematology & Iron Panel",
        "desc": "Full blood count with differential, iron studies, coagulation screen, and hemoglobin electrophoresis for blood disorder monitoring. Enables detection of anemia subtypes, iron overload (hemochromatosis monitoring), polycythemia, thrombocytopenia, and early hematological malignancy signs.",
        "markers": [
          "CBC with 5-part differential",
          "reticulocyte count",
          "serum iron",
          "ferritin",
          "TIBC",
          "transferrin saturation",
          "haptoglobin",
          "LDH",
          "PT/INR",
          "aPTT",
          "fibrinogen",
          "D-dimer",
          "homocysteine",
          "folate",
          "vitamin B12",
          "peripheral blood smear"
        ],
        "unit": "Multi-marker panel",
        "range": "Ferritin: 30\u2013300 ng/mL | Transferrin sat: 20\u201350% | LDH: <250 U/L",
        "tier": "standard",
        "insight_type": "biomarker_assessment"
      },
      {
        "subcategory": "Developmental & Congenital Disorders",
        "src": "dna_exome",
        "name": "Congenital Malformation Exome Panel (21 Panels)",
        "desc": "The most comprehensive rare disease panel on the platform: 21 malformation categories covering 391 pathogenic variants. Includes: osteopetrosis-and-dense-bone-dysplasia, brachydactyly---syndactyly, gastrointestinal-atresia, vascular-malformations, seckel-syndrome, meier-gorlin-syndrome, arthrogryposes, micromelic-dysplasia, and more. Critical for preconception, prenatal, and pediatric precision medicine.",
        "markers": [
          "Panel: osteopetrosis-and-dense-bone-dysplasia",
          "Panel: brachydactyly---syndactyly",
          "Panel: gastrointestinal-atresia",
          "Panel: vascular-malformations",
          "Panel: seckel-syndrome",
          "Panel: meier-gorlin-syndrome",
          "Panel: arthrogryposes",
          "Panel: micromelic-dysplasia",
          "Panel: cornelia-de-lange-syndrome",
          "Panel: spondylometaphyseal---spondyloepi-(meta)-physeal-dysplasia",
          "Panel: metaphyseal-dysplasia",
          "Panel: 3-m-syndrome---primordial-dwarfism"
        ],
        "unit": "Pathogenic variant call (ACMG)",
        "range": "Pathogenic (P) | LP | VUS | Benign",
        "insight_type": "biomarker_assessment",
        "genomic_scope": {
          "snps": "4,000,000",
          "indels": "800,000",
          "genes": "20,500"
        }
      },
      {
        "subcategory": "Oral Health Genomics",
        "src": "dna_array",
        "name": "Oral Health Genetic Risk Profile",
        "desc": "Polygenic risk for 5 oral conditions: periodontal disease (bleeding gums, loose teeth, painful gums), mouth ulcers, and dental hypersensitivity. Integrates IL-1\u03b2, TNF-\u03b1, and vitamin D receptor variants linked to periodontitis risk \u2014 the strongest genetic predictor of tooth loss.",
        "markers": [
          "Bleeding Gums",
          "Loose Teeth",
          "Mouth Ulcers",
          "Painful Gums",
          "Toothache",
          "IL-1\u03b2 rs1143634",
          "IL-1\u03b1 rs1800587",
          "TNF-\u03b1 rs1799964",
          "VDR BsmI/FokI",
          "MMP-3 rs3025058",
          "IL-6 rs1800795",
          "TLR4 rs4986790"
        ],
        "unit": "PRS percentile",
        "range": "High risk: >80th | Very high (IL-1 composite positive): 3\u00d7 tooth loss risk",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "snps": "700,000",
          "indels": "100,000",
          "genes": "20,000"
        }
      },
      {
        "subcategory": "Epigenetic Disease Risk",
        "src": "epigenetics",
        "name": "Multi-Disease Epigenetic Age & Risk Methylation",
        "desc": "DNA methylation-based biomarkers of disease risk beyond genetic sequence: GrimAge acceleration predicts all-cause mortality better than any single blood marker; tissue-specific methylation signatures identify pre-cancer epigenetic states; inflammatory methylation indices link lifestyle to chronic disease trajectory.",
        "markers": [
          "GrimAge (mortality clock)",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking exposure)",
          "EpiTOC2 (cancer stem cell index)",
          "DNAm CRP (inflammatory methylation)",
          "MiAge (mitotic age/cancer risk)",
          "HypoClock (loss of methylation)",
          "TicTimeClock (immune aging)"
        ],
        "unit": "Methylation-based age/risk score",
        "range": "GrimAge accel >3 yr: actionable | EpiTOC2: high = cancer field effect",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "subcategory": "Epigenetic Disease Risk",
        "src": "epigenetics",
        "name": "Pharmacoepigenomics & Treatment Response",
        "desc": "Epigenetic markers predicting response to precision treatments: methylation status of gene promoters that predict statin response (HMGCR), metformin response (OCT1 epigenetics), immunotherapy response (PD-L1 methylation), and DNA methylation patterns linked to antidepressant treatment outcomes.",
        "markers": [
          "HMGCR promoter methylation (statin)",
          "SLC22A1 methylation (metformin)",
          "PD-L1/CD274 methylation (immunotherapy)",
          "SLC6A4 methylation (SSRI)",
          "MGMT methylation (chemotherapy)",
          "BRCA1 promoter methylation (PARP inhibitor)",
          "MLH1 methylation (mismatch repair)"
        ],
        "unit": "Methylation % + treatment response score",
        "range": "Hypermethylation = gene silencing | Hypomethylation = active expression",
        "insight_type": "health_dashboard",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Blood-Based Biological Age",
        "desc": "Biological age calculated from 18 key blood biomarkers using ML algorithms trained on 42,000+ samples (methodology: InsideTracker InnerAge 2.0 + PhenoAge). Biomarkers weighted by their correlation with chronological aging: glucose, LDL, albumin, hematocrit, lymphocytes, GGT, HbA1c, triglycerides, cortisol, DHEA-S, ferritin, vitamin D, hs-CRP, insulin, MCHC, creatinine, uric acid, WBC.",
        "markers": [
          "fasting glucose",
          "LDL cholesterol",
          "albumin",
          "hematocrit",
          "lymphocyte %",
          "GGT",
          "HbA1c",
          "triglycerides",
          "cortisol AM",
          "DHEA-S",
          "ferritin",
          "25-OH Vitamin D",
          "hs-CRP",
          "fasting insulin",
          "MCHC",
          "creatinine",
          "uric acid",
          "WBC"
        ],
        "unit": "Biological age (years)",
        "range": "Optimal: \u22653 years younger than chronological | Concern: >3 years older",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "epigenetics",
        "insight_type": "health_dashboard",
        "name": "Epigenetic Biological Age (Methylation)",
        "desc": "DNA methylation-based biological age using 4 validated epigenetic clocks: Horvath clock (pan-tissue), GrimAge (strongest all-cause mortality predictor), PhenoAge (phenotypic health proxy), and DunedinPACE (real-time aging speed). GrimAge acceleration >3 years is a major actionable threshold. Covers 850,000 CpG sites.",
        "markers": [
          "Horvath clock age (353 CpGs)",
          "GrimAge acceleration",
          "PhenoAge acceleration",
          "DunedinPACE (aging rate)",
          "EpiSmokEr (smoking epigenetic score)",
          "DNAmTL (telomere length proxy)",
          "DNAm CRP",
          "EpiTOC2 (cancer stem cell index)"
        ],
        "unit": "Biological age (years) per clock",
        "range": "Ideal: clock age \u2264 chronological | Alert: GrimAge >3 yr acceleration",
        "subcategory": "Chronic Disease Management & Prevention",
        "genomic_scope": {
          "genes": "20,000",
          "cpg": "850,000"
        }
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Actuarial Age (Lifestyle & Demographic)",
        "desc": "Validated actuarial biological age calculation from lifestyle and demographic inputs, based on RealAge and Levine mortality risk models. Factors: smoking history, alcohol intake, BMI, physical activity level, diet quality score, sleep duration, psychosocial stress, social connectedness, education, income proxy, environmental exposures, and medical history. Each factor is weighted by its effect size on all-cause mortality.",
        "markers": [
          "smoking history (pack-years)",
          "alcohol units/week",
          "BMI",
          "physical activity (MET-hours/week)",
          "diet quality (HEI score)",
          "sleep duration (hours/night)",
          "sleep quality (PSQI)",
          "psychosocial stress (PSS-10)",
          "social connection score",
          "SES proxy",
          "environmental exposure index",
          "medical conditions count"
        ],
        "unit": "Actuarial age (years)",
        "range": "Optimal: \u22655 years younger | Danger zone: >5 years older",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "wearable",
        "insight_type": "health_dashboard",
        "name": "Physiological Age (HRV \u00b7 VO\u2082Max \u00b7 HR \u00b7 BP)",
        "desc": "Composite physiological age score derived from four objective performance biomarkers: resting heart rate variability (RMSSD \u2014 validated vs. chronological age normative curves), VO\u2082max (cardiorespiratory fitness age from submaximal exercise), resting heart rate trend, and blood pressure index. Each metric is z-scored against age/sex-matched population norms and combined into a single physiological age.",
        "markers": [
          "RMSSD (ms) \u2014 HRV physiological age",
          "VO\u2082max (mL/kg/min) \u2014 cardiorespiratory age",
          "resting heart rate \u2014 cardiovascular age",
          "systolic BP \u2014 vascular age",
          "diastolic BP",
          "HRV trend (30-day)",
          "RHR trend (30-day)",
          "SpO\u2082 resting"
        ],
        "unit": "Physiological age (years)",
        "range": "Optimal: \u22655 years younger | HRV age: RMSSD age-matched percentile >60th",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Cardiovascular System Age",
        "desc": "Dedicated biological age for the cardiovascular system integrating vascular stiffness proxies, lipid particle quality, inflammatory burden, and hemodynamic markers. Based on the Framingham Heart Age model extended with ApoB, Lp(a), NT-proBNP, and hs-CRP weighting. Expresses how much older or younger your cardiovascular system is than your chronological age.",
        "markers": [
          "ApoB",
          "Lp(a)",
          "LDL-C",
          "HDL-C",
          "triglycerides",
          "hs-CRP",
          "homocysteine",
          "NT-proBNP",
          "high-sensitivity troponin I",
          "resting HR",
          "systolic BP",
          "HbA1c",
          "eGFR"
        ],
        "unit": "Cardiovascular age (years)",
        "range": "Optimal: \u22655 yr younger | Alert: >5 yr older | Critical: >10 yr older",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic System Age",
        "desc": "Biological age of the metabolic system derived from glucose regulation, insulin sensitivity, lipid metabolism, liver function, and body composition markers. The MetaboAge algorithm weights HOMA-IR, HbA1c, fasting insulin, triglycerides, ALT, GGT, uric acid, and adipokines against age-matched population norms.",
        "markers": [
          "HOMA-IR (insulin resistance)",
          "HbA1c",
          "fasting glucose",
          "fasting insulin",
          "triglycerides",
          "ALT",
          "GGT",
          "uric acid",
          "ApoB",
          "ferritin",
          "adiponectin",
          "leptin proxy (BMI + TG/HDL)"
        ],
        "unit": "Metabolic age (years)",
        "range": "Optimal: \u22653 yr younger | Metabolic syndrome threshold: >8 yr older",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Immune System Age (Immunological Age)",
        "desc": "Immunological age derived from the composition of white blood cell subpopulations, inflammatory cytokines, and autoimmune markers. Based on the iAge (inflammatory age) framework from Stanford and the immunosenescence scoring of Lehallier et al. (2019). Captures both inflammaging (chronic low-grade inflammation) and immunosenescence (loss of adaptive immune capacity).",
        "markers": [
          "neutrophil:lymphocyte ratio",
          "lymphocyte %",
          "CD4:CD8 T-cell ratio (if available)",
          "hs-CRP",
          "IL-6",
          "TNF-\u03b1",
          "CXCL9 (iAge cytokine)",
          "WBC differential",
          "eosinophil count",
          "IgG",
          "IgA",
          "IgM",
          "anti-CMV IgG proxy"
        ],
        "unit": "Immune age (years)",
        "range": "iAge optimal: <30 | Alert: >chronological | Immunosenescence: NLR >3.0",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Respiratory System Age",
        "desc": "Biological age of respiratory function integrating blood-based markers of pulmonary capacity and oxygenation with wearable SpO\u2082 and resting respiratory rate. Proxy for FEV1/FVC ratio decline using SERPINA1, CRP, and RBC indices. Validated against NHANES spirometry normative age curves.",
        "markers": [
          "SpO\u2082 resting %",
          "SpO\u2082 exertional",
          "respiratory rate (resting)",
          "hs-CRP (lung inflammation)",
          "WBC (respiratory infection burden)",
          "hemoglobin (O\u2082 carrying capacity)",
          "hematocrit",
          "neutrophil %",
          "eosinophil % (asthma proxy)",
          "SERPINA1 genotype risk"
        ],
        "unit": "Respiratory age (years)",
        "range": "Optimal: \u22653 yr younger | SpO\u2082 <95% resting = significant aging signal",
        "tier": "standard",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Musculoskeletal System Age",
        "desc": "Biological age of the musculoskeletal system derived from bone turnover markers, inflammatory burden on joints, muscle catabolism indicators, and hormonal support for lean mass. Integrates vitamin D, testosterone/DHEA-S, IGF-1, and bone resorption/formation markers into a composite MSK age score.",
        "markers": [
          "vitamin D 25-OH",
          "testosterone total",
          "DHEA-S",
          "IGF-1",
          "osteocalcin (bone formation)",
          "CTX-I (bone resorption)",
          "P1NP (bone synthesis)",
          "hs-CRP (joint inflammation)",
          "uric acid (gout risk)",
          "albumin (muscle catabolism proxy)",
          "magnesium RBC",
          "creatine kinase"
        ],
        "unit": "Musculoskeletal age (years)",
        "range": "Optimal: \u22653 yr younger | Osteoporosis risk: CTX-I high + low osteocalcin",
        "tier": "advanced",
        "subcategory": "Chronic Disease Management & Prevention"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Cardiovascular Drug Optimization (PGx)",
        "desc": "Pharmacogenomics-guided cardiovascular drug selection from prescribing formulary: warfarin vs DOAC selection by CYP2C9/VKORC1, statin selection by SLCO1B1 (myopathy risk), clopidogrel vs alternatives by CYP2C19, ACE inhibitor response by ACE I/D polymorphism, and antihypertensive class selection by ADD1/AGT genotype.",
        "markers": [
          "CYP2C9 *1\u2013*8",
          "VKORC1 -1639G>A",
          "SLCO1B1 *5",
          "CYP2C19 *2/*17",
          "ACE I/D",
          "AGT M235T",
          "CYP4F2 V433M"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Oncology Treatment Personalization (PGx)",
        "desc": "Pharmacogenomics guidance for oncology drug selection: DPYD screening before fluorouracil/capecitabine, UGT1A1 before irinotecan, TPMT/NUDT15 before mercaptopurine/thiopurines, HER2/KRAS/BRAF tumor marker integration, tamoxifen vs aromatase inhibitor selection by CYP2D6.",
        "markers": [
          "DPYD *2A/*13",
          "UGT1A1 *28/*6",
          "TPMT *2/*3C",
          "NUDT15 *3",
          "CYP2D6 (tamoxifen)",
          "KRAS/BRAF",
          "HER2 amplification proxy"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Psychiatric Drug Selection & Dosing (PGx)",
        "desc": "Personalized psychiatric medication guidance: SSRI/SNRI selection by CYP2C19/2D6 metabolizer phenotype (antidepressant efficacy), antipsychotic dosing by CYP2D6 (risperidone, aripiprazole, haloperidol), mood stabilizer optimization (lithium, carbamazepine \u2014 HLA-A*31:01 SJS risk screening), and ADHD stimulant selection.",
        "markers": [
          "CYP2C19 *1\u2013*17",
          "CYP2D6 *1\u2013*10",
          "SLC6A4 methylation",
          "HLA-A*31:01",
          "HLA-B*15:02",
          "HTR2A",
          "COMT Val158Met",
          "ABCB1"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Pain & Opioid Pharmacogenomics (PGx)",
        "desc": "Personalized pain management: opioid selection by CYP2D6 metabolizer status (codeine/tramadol toxicity in UMs, inefficacy in PMs), fentanyl/morphine dosing by OPRM1 A118G, NSAIDs vs opioid decision by COMT pain sensitivity, and methadone safety by CYP2B6.",
        "markers": [
          "CYP2D6 metabolizer phenotype",
          "OPRM1 A118G",
          "COMT Val158Met",
          "CYP2B6 *6",
          "UGT2B7",
          "ABCB1 C3435T"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Diabetes Medication Optimization (PGx)",
        "desc": "Metformin response and tolerability by SLC22A1 (OCT1) genotype, sulfonylurea selection by CYP2C9, GLP-1 agonist response prediction by GLP1R/TCF7L2, and SGLT2i consideration by eGFR + genetic kidney risk.",
        "markers": [
          "SLC22A1 (OCT1)",
          "CYP2C9 *2/*3",
          "TCF7L2",
          "GLP1R variants",
          "eGFR",
          "KCNJ11",
          "PPARG"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Immunosuppressant Dosing Protocol (PGx)",
        "desc": "Transplant and autoimmune immunosuppressant personalization: tacrolimus dose by CYP3A5 *1/*3 genotype (50% dose difference), azathioprine/mercaptopurine safety by TPMT/NUDT15, mycophenolate by UGT1A9, and TNF-\u03b1 inhibitor response prediction by HLA-DRB1.",
        "markers": [
          "CYP3A5 *1/*3",
          "TPMT *2/*3C",
          "NUDT15 *3",
          "UGT1A9 *3",
          "HLA-DRB1 SE alleles",
          "ABCB1",
          "CYP3A4/3A5"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Chronic Disease Lifestyle Intervention Plan",
        "desc": "Comprehensive lifestyle modification program for chronic disease management: Mediterranean diet prescription (strongest evidence across CVD, T2DM, inflammation), exercise prescription by cardiovascular system age, stress management by HPA-axis resilience index, and sleep optimization by circadian profiling.",
        "markers": [
          "cardiovascular system age",
          "metabolic system age",
          "immune system age",
          "HOMA-IR",
          "hs-CRP",
          "cortisol AM",
          "sleep architecture",
          "HRV"
        ],
        "unit": "Personalized program plan",
        "range": "Personalized based on biomarker profile"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "product",
        "name": "Preventive Supplementation Protocol",
        "desc": "Evidence-based preventive supplementation from client catalog for chronic disease risk reduction: omega-3 (CVD prevention if ApoB elevated), vitamin D (all-cause mortality reduction), magnesium (T2DM and CVD risk), CoQ10 (statin users), and folate/B12 (homocysteine reduction).",
        "markers": [
          "ApoB",
          "25-OH Vit D",
          "magnesium RBC",
          "homocysteine",
          "omega-3 index",
          "CoQ10",
          "MTHFR genotype",
          "statin PGx"
        ],
        "unit": "Matched product catalog items",
        "range": "Personalized based on biomarker profile"
      },
      {
        "name": "VO\u2082 Max Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Cardiovascular Fitness",
        "desc": "Maximal oxygen uptake measured via graded exercise test (GXT) or field protocol. Gold-standard predictor of cardiovascular fitness and longevity.",
        "unit": "mL/kg/min",
        "range": "Elite \u226555 (M) / \u226550 (F) | Avg 35\u201345 | Poor <30",
        "markers": [
          "VO\u2082max mL/kg/min",
          "heart rate reserve",
          "ventilatory threshold",
          "RER",
          "exercise duration"
        ]
      },
      {
        "name": "Body Composition Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Body Composition",
        "desc": "Multi-compartment body composition: fat mass, lean mass, visceral fat, and bone mineral content via DXA or bioelectrical impedance.",
        "unit": "% body fat / kg lean mass",
        "range": "Optimal BF%: 10\u201320% (M) / 18\u201328% (F) | Visceral fat <100 cm\u00b2",
        "markers": [
          "body fat %",
          "lean mass kg",
          "visceral fat area cm\u00b2",
          "BMI",
          "waist circumference"
        ]
      },
      {
        "name": "Grip Strength Assessment",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Musculoskeletal Function",
        "desc": "Handgrip dynamometry \u2014 validated proxy for overall muscle strength, functional capacity, and all-cause mortality risk.",
        "unit": "kg (dominant hand)",
        "range": "Optimal >45 kg (M) / >30 kg (F) | Low <30 kg (M) / <20 kg (F)",
        "markers": [
          "grip strength kg",
          "grip strength percentile",
          "dominant hand",
          "bilateral asymmetry"
        ]
      },
      {
        "name": "Overhead Squat Assessment (FMS)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Functional Movement Screen overhead squat test evaluating mobility, stability, and movement compensation patterns across the kinetic chain.",
        "unit": "FMS score 0\u20133",
        "range": "3 = Full depth bilateral symmetry | 2 = Compensated | 1 = Pain or failure",
        "markers": [
          "FMS overhead squat score",
          "ankle dorsiflexion",
          "hip mobility",
          "thoracic extension",
          "shoulder mobility"
        ]
      },
      {
        "name": "Full FMS Screen (7 Tests)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Movement Quality",
        "desc": "Complete 7-test Functional Movement Screen: deep squat, hurdle step, inline lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, rotary stability.",
        "unit": "FMS composite score /21",
        "range": "\u226514 = Low injury risk | 11\u201313 = Moderate | \u226410 = High injury risk | Any asymmetry = elevated risk",
        "markers": [
          "FMS total score /21",
          "deep squat",
          "hurdle step",
          "inline lunge",
          "shoulder mobility",
          "ASLR",
          "trunk stability",
          "rotary stability"
        ]
      },
      {
        "name": "Resting Metabolic Rate (RMR)",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Metabolic Function",
        "desc": "Indirect calorimetry measurement of oxygen consumption at rest. Calibrates caloric targets and detects metabolic adaptation.",
        "unit": "kcal/day",
        "range": "Within \u00b110% of predicted = normal | >10% below predicted = metabolic adaptation",
        "markers": [
          "RMR kcal/day",
          "respiratory quotient",
          "carbohydrate oxidation rate",
          "fat oxidation rate"
        ]
      },
      {
        "name": "Vertical Jump Power",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neuromuscular Power",
        "desc": "Countermovement jump (CMJ) height and estimated peak power. Indicates fast-twitch fiber recruitment and neuromuscular readiness.",
        "unit": "cm / W/kg",
        "range": "Elite >60 cm (M) / >45 cm (F) | Average 40\u201355 cm (M) / 28\u201338 cm (F)",
        "markers": [
          "CMJ height cm",
          "estimated peak power W/kg",
          "flight time ms",
          "reactive strength index"
        ]
      },
      {
        "name": "Gait & Balance Analysis",
        "src": "functional",
        "insight_type": "biomarker_assessment",
        "subcategory": "Neurological Function",
        "desc": "Timed Up and Go (TUG) test, single-leg stance duration, and gait velocity \u2014 validated fall risk and neurological health markers.",
        "unit": "seconds (TUG) / gait velocity m/s",
        "range": "TUG <10s = normal | Single-leg stance >30s = good balance | Gait velocity >1.0 m/s = healthy aging",
        "markers": [
          "TUG time s",
          "single-leg stance s",
          "gait velocity m/s",
          "step width cm",
          "cadence steps/min"
        ]
      },
      {
        "name": "Functional Age Index",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Functional Aging",
        "desc": "Composite functional age from VO\u2082max, grip strength, body composition, and movement quality relative to age/sex norms.",
        "unit": "Functional age (years)",
        "range": "Optimal \u22655 yr younger | Alert: >3 yr older",
        "markers": [
          "VO\u2082max",
          "grip strength",
          "body fat %",
          "FMS score",
          "gait velocity",
          "CMJ height"
        ]
      },
      {
        "name": "Injury Risk Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Movement Quality",
        "desc": "Aggregate injury risk based on FMS asymmetry, movement compensation patterns, flexibility deficits, and neuromuscular power imbalances.",
        "unit": "Risk score 0\u2013100",
        "range": "<25 = Low | 25\u201350 = Moderate | >50 = Elevated \u2014 recommend corrective protocol",
        "markers": [
          "FMS total score",
          "bilateral grip asymmetry",
          "CMJ asymmetry",
          "single-leg balance",
          "ankle mobility deficit"
        ]
      },
      {
        "name": "Metabolic Flexibility Score",
        "src": "functional",
        "insight_type": "health_dashboard",
        "subcategory": "Metabolic Function",
        "desc": "Ability to switch between carbohydrate and fat oxidation at rest and during exercise, derived from RMR respiratory quotient.",
        "unit": "Composite score 0\u2013100",
        "range": "Optimal RQ at rest 0.7\u20130.85 | Poor fat oxidation: RQ >0.9 at rest",
        "markers": [
          "RQ at rest",
          "fat oxidation rate",
          "carbohydrate oxidation rate",
          "VO\u2082max",
          "metabolic adaptation index"
        ]
      },
      {
        "name": "Ace Inhibitors Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Ace Inhibitors Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Ace Inhibitors Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Ace Inhibitors Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Acenocoumarol Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Acenocoumarol Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Acetaminophen Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Acetaminophen Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Acetaminophen Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Acetaminophen Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Adalimumab Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Adalimumab Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Allopurinol Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Allopurinol Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Allopurinol Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Allopurinol Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Allopurinol Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Allopurinol Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Amiodarone Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Amiodarone Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Amitriptyline Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Amitriptyline Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Amlodipine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Amlodipine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Anastrozole Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Anastrozole Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Aripiprazole Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Aripiprazole Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Aripiprazole Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Aripiprazole Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Aspirin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Aspirin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Aspirin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Aspirin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Atazanavir Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Atazanavir Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Atenolol Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Atenolol Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Atenolol Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Atenolol Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Atorvastatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Atorvastatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Atorvastatin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Atorvastatin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Benazepril Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Benazepril Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bevacizumab Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bevacizumab Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bevacizumab Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bevacizumab Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bisphosphonates Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bisphosphonates Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bisphosphonates Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bisphosphonates Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bleomycin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bleomycin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bumetanide Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bumetanide Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Buprenorphine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Buprenorphine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Buprenorphine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Buprenorphine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bupropion Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bupropion Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Bupropion Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Bupropion Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Calcium Channel Blockers Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Calcium Channel Blockers Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Candesartan Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Candesartan Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Capecitabine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Capecitabine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Capecitabine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Capecitabine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Captopril Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Captopril Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Carbamazepine Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Carbamazepine Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Carbamazepine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Carbamazepine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Carbamazepine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Carbamazepine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Carboplatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Carboplatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Carboplatin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Carboplatin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Celecoxib Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Celecoxib Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cetuximab Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cetuximab Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Chlorthalidone Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Chlorthalidone Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cisplatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cisplatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cisplatin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cisplatin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Citalopram Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Citalopram Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Citalopram Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Citalopram Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cladribine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cladribine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Clopidogrel Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Clopidogrel Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Clopidogrel Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Clopidogrel Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Clozapine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Clozapine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Clozapine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Clozapine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Corticosteroids Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Corticosteroids Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cyclophosphamide Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cyclophosphamide Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cyclophosphamide Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cyclophosphamide Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cyclosporine Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cyclosporine Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cyclosporine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cyclosporine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cyclosporine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cyclosporine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cytarabine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cytarabine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Cytarabine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Cytarabine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Dapsone Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Dapsone Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Daunorubicin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Daunorubicin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Daunorubicin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Daunorubicin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Deferasirox Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Deferasirox Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Dexamethasone Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Dexamethasone Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Dexamethasone Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Dexamethasone Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Docetaxel Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Docetaxel Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Docetaxel Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Docetaxel Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Docetaxel Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Docetaxel Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Doxorubicin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Doxorubicin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Doxorubicin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Doxorubicin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Duloxetine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Duloxetine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Efavirenz Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Efavirenz Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Enalapril Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Enalapril Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Epirubicin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Epirubicin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Epirubicin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Epirubicin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Escitalopram Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Escitalopram Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Escitalopram Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Escitalopram Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Ethambutol Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Ethambutol Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Everolimus Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Everolimus Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Exemestane Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Exemestane Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fenofibrate Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fenofibrate Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fentanyl Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fentanyl Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fentanyl Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fentanyl Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fentanyl Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fentanyl Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fluorouracil Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fluorouracil Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fluorouracil Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fluorouracil Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fluoxetine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fluoxetine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fluvastatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fluvastatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Fluvoxamine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Fluvoxamine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Gefitinib Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Gefitinib Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Gefitinib Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Gefitinib Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Gemcitabine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Gemcitabine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Gemcitabine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Gemcitabine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Haloperidol Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Haloperidol Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Haloperidol Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Haloperidol Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Hormonal Contraceptives Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Hormonal Contraceptives Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Hydrochlorothiazide Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Hydrochlorothiazide Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Hydrochlorothiazide Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Hydrochlorothiazide Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Imatinib Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Imatinib Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Imatinib Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Imatinib Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Irbesartan Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Irbesartan Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Irinotecan Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Irinotecan Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Irinotecan Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Irinotecan Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Ivacaftor Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Ivacaftor Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Lamotrigine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Lamotrigine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Letrozole Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Letrozole Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Levodopa Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Levodopa Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Lithium Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Lithium Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Losartan Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Losartan Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Mercaptopurine Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Mercaptopurine Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Mercaptopurine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Mercaptopurine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Metformin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Metformin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Methadone Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Methadone Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Methadone Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Methadone Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Methadone Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Methadone Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Methotrexate Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Methotrexate Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Methotrexate Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Methotrexate Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Methylphenidate Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Methylphenidate Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Metoprolol Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Metoprolol Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Montelukast Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Montelukast Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Morphine Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Morphine Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Morphine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Morphine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Morphine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Morphine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Mycophenolate Mofetil Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Mycophenolate Mofetil Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Mycophenolate Mofetil Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Mycophenolate Mofetil Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Nevirapine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Nevirapine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Olanzapine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Olanzapine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Olanzapine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Olanzapine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Oxycodone Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Oxycodone Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Paclitaxel Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Paclitaxel Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Paclitaxel Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Paclitaxel Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Paroxetine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Paroxetine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Paroxetine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Paroxetine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Phenytoin Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Phenytoin Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Phenytoin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Phenytoin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Phenytoin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Phenytoin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Prasugrel Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Prasugrel Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Pravastatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Pravastatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Quetiapine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Quetiapine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Quetiapine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Quetiapine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Repaglinide Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Repaglinide Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Ribavirin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Ribavirin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Ribavirin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Ribavirin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Rifampin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Rifampin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Risperidone Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Risperidone Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Risperidone Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Risperidone Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Rituximab Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Rituximab Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Rosuvastatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Rosuvastatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Salbutamol Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Salbutamol Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Selective Serotonin Reuptake Inhibitors Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Selective Serotonin Reuptake Inhibitors Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Simvastatin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Simvastatin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Simvastatin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Simvastatin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Sorafenib Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Sorafenib Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Sorafenib Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Sorafenib Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Sunitinib Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Sunitinib Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Sunitinib Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Sunitinib Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tacrolimus Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tacrolimus Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tacrolimus Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tacrolimus Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tacrolimus Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tacrolimus Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tamoxifen Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tamoxifen Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tamoxifen Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tamoxifen Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tenofovir Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tenofovir Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tocilizumab Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tocilizumab Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tramadol Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tramadol Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tramadol Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tramadol Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Tumor Necrosis Factor Alpha Inhibitors Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Tumor Necrosis Factor Alpha Inhibitors Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Venlafaxine Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Venlafaxine Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Venlafaxine Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Venlafaxine Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Verapamil Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Verapamil Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Verapamil Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Verapamil Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Warfarin Dosage",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Warfarin Dosage"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Warfarin Efficacy",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Warfarin Efficacy"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      },
      {
        "name": "Warfarin Toxicity",
        "desc": "DNA trait assessment. Risk level categorized as Low / Moderate / High based on polygenic or monogenic analysis. Category: .",
        "unit": "Low / Moderate / High",
        "range": "Low = favorable | Moderate = elevated risk | High = significant risk",
        "src": "dna_wgs",
        "insight_type": "biomarker_assessment",
        "subcategory": "Pharmacogenomics",
        "markers": [
          "Warfarin Toxicity"
        ],
        "genomic_scope": {
          "snps": "4,500,000",
          "indels": "900,000",
          "genes": "20,500"
        },
        "verticals": [
          "precision_medicine"
        ]
      }
    ],
    "_marker_count": 992,
    "marker_count": 992,
    "insight_count": 261
  },
  {
    "id": "meal_delivery",
    "name": "Meal Delivery Personalization",
    "sub": "Food & Nutrition Tech",
    "color": "#f59e0b",
    "lt": "#fef3c7",
    "img": "https://images.unsplash.com/photo-1512621776951-a57141f2eefd?w=400&q=75",
    "desc": "Precision nutrition API for meal delivery platforms. Personalizes meal plans, macronutrient ratios, ingredient choices, and portion sizes based on individual biomarkers, genetics, gut microbiome, and health goals.",
    "tags": [
      "Meal Personalization",
      "Nutrigenomics",
      "Glycemic Optimization",
      "Microbiome Nutrition",
      "Weight Management"
    ],
    "insights": [
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Personalized Meal Delivery Program",
        "desc": "AI-driven weekly meal plan curation based on macronutrient needs, food sensitivities, metabolic rate, glycemic response patterns, and micronutrient gaps. Recipes and portion sizes dynamically adjusted to health goals (weight loss, muscle gain, energy optimization).",
        "markers": [
          "fasting glucose",
          "insulin response",
          "LDL particle size",
          "ApoB",
          "hsCRP",
          "ferritin",
          "vitamin D",
          "omega-3 index",
          "food sensitivity IgG panel",
          "MTHFR genotype",
          "metabolic rate estimate"
        ],
        "unit": "Personalized meal plan",
        "range": "Personalized based on biomarker + genomic profile",
        "subcategory": "Meal Personalization"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Glycemic Response Meal Optimization",
        "desc": "Meal timing, composition, and sequencing protocol to minimize post-prandial glucose spikes. Carbohydrate type and quantity recommendations calibrated to continuous glucose monitor data and insulin sensitivity index.",
        "markers": [
          "fasting glucose",
          "HbA1c",
          "insulin",
          "HOMA-IR",
          "CGM AUC",
          "cortisol",
          "adiponectin"
        ],
        "unit": "Personalized meal plan",
        "range": "Personalized based on metabolic profile",
        "subcategory": "Glycemic Optimization"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Gut Microbiome Meal Program",
        "desc": "Prebiotic and probiotic-rich meal recommendations informed by microbiome diversity, keystone species abundance, and short-chain fatty acid production capacity. Fermented food integration and fiber type matching to promote microbial balance.",
        "markers": [
          "microbiome diversity index",
          "Akkermansia abundance",
          "Bifidobacterium count",
          "Faecalibacterium prausnitzii",
          "butyrate producers",
          "zonulin",
          "calprotectin"
        ],
        "unit": "Personalized meal plan",
        "range": "Personalized based on microbiome profile",
        "subcategory": "Microbiome Nutrition"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Nutrigenomics Meal Customization",
        "desc": "Meal plans incorporating genetic variants affecting nutrient metabolism: MTHFR (folate), APOE (fat type), FTO (satiety), lactase persistence, gluten sensitivity genes, and caffeine metabolism (CYP1A2). Portions and food types calibrated to genetic predispositions.",
        "markers": [
          "MTHFR genotype",
          "APOE genotype",
          "FTO genotype",
          "LCT genotype",
          "HLA-DQ2/DQ8",
          "CYP1A2 genotype",
          "BCMO1 genotype",
          "FADS1 genotype"
        ],
        "unit": "Personalized meal plan",
        "range": "Personalized based on genomic profile",
        "subcategory": "Nutrigenomics"
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Nutritional Gap Score",
        "desc": "Composite index of micronutrient deficiency risk across 12 key vitamins and minerals based on dietary intake patterns, blood biomarkers, and genetic metabolism variants.",
        "markers": [
          "vitamin D",
          "vitamin B12",
          "ferritin",
          "zinc",
          "magnesium",
          "omega-3 index",
          "folate",
          "iodine",
          "selenium",
          "CoQ10",
          "vitamin K2",
          "choline"
        ],
        "unit": "Score 0\u2013100",
        "range": "Optimal: >75 | At-risk: <50",
        "subcategory": "Nutritional Assessment"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Metabolic Flexibility Index",
        "desc": "Measures the body's ability to switch between carbohydrate and fat fuel sources based on fasting insulin, triglycerides, glucose variability, and ketone capacity.",
        "markers": [
          "fasting insulin",
          "fasting glucose",
          "triglycerides",
          "beta-hydroxybutyrate",
          "HOMA-IR",
          "free fatty acids"
        ],
        "unit": "Score 0\u2013100",
        "range": "Flexible: >70 | Inflexible: <40",
        "subcategory": "Metabolic Health"
      }
    ],
    "_marker_count": 30,
    "marker_count": 30,
    "insight_count": 6
  },
  {
    "id": "food_beverage",
    "name": "Food Product Personalization",
    "sub": "Consumer Food & Beverage",
    "color": "#10b981",
    "lt": "#d1fae5",
    "img": "https://images.unsplash.com/photo-1542838132-92c53300491e?w=400&q=75",
    "desc": "Precision nutrition API for food & beverage brands. Enables product personalization, consumer segmentation, functional ingredient matching, and evidence-based product claims tied to individual biomarker profiles.",
    "tags": [
      "Product Personalization",
      "Consumer Segmentation",
      "Functional Ingredients",
      "Nutrigenomics",
      "Brand Science"
    ],
    "insights": [
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Personalized Food Product Program",
        "desc": "Precision nutrition product matching: recommends specific food products, formulations, and functional ingredients based on individual biomarker status, genetic predispositions, gut microbiome composition, and lifestyle goals. Enables mass-personalization of product portfolios.",
        "markers": [
          "vitamin D status",
          "omega-3 index",
          "MTHFR genotype",
          "APOE genotype",
          "gut microbiome profile",
          "hsCRP",
          "lipid panel",
          "fasting glucose",
          "food sensitivity IgG",
          "antioxidant capacity"
        ],
        "unit": "Personalized product recommendation",
        "range": "Personalized based on biomarker + genomic profile",
        "subcategory": "Product Personalization"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Functional Ingredient Matching Program",
        "desc": "Maps functional ingredient efficacy to individual biomarker profiles: polyphenol types matched to oxidative stress markers, probiotic strains matched to microbiome gaps, adaptogens matched to cortisol/HRV patterns, and omega-3 forms matched to APOE genotype.",
        "markers": [
          "8-OHdG",
          "oxidized LDL",
          "hsCRP",
          "cortisol AM",
          "HRV (RMSSD)",
          "APOE genotype",
          "microbiome diversity",
          "Lactobacillus species",
          "EPA+DHA blood levels",
          "FADS1 genotype"
        ],
        "unit": "Ingredient efficacy match",
        "range": "Personalized based on biomarker profile",
        "subcategory": "Functional Ingredients"
      },
      {
        "src": "recommendation",
        "insight_type": "recommendation",
        "rec_type": "program",
        "name": "Consumer Health Segmentation Program",
        "desc": "Clusters consumers into precision health segments using multi-omic profiles: metabolic syndrome risk, longevity optimization, athletic performance, cognitive health, and gut health archetypes. Enables targeted product development and marketing.",
        "markers": [
          "metabolic syndrome score",
          "biological age gap",
          "VO2max estimate",
          "cognitive resilience score",
          "microbiome enterotype",
          "inflammatory index",
          "hormonal balance index"
        ],
        "unit": "Consumer segment classification",
        "range": "Based on multi-biomarker clustering",
        "subcategory": "Consumer Segmentation"
      },
      {
        "src": "lifestyle",
        "insight_type": "health_dashboard",
        "name": "Food Product Personalization Score",
        "desc": "Quantifies how well a specific product formulation matches an individual's nutritional needs, genetic predispositions, and health goals. Used by brands to demonstrate product-consumer fit.",
        "markers": [
          "nutritional gap score",
          "genetic compatibility",
          "microbiome fit",
          "metabolic suitability",
          "allergen risk",
          "sensory preference profile"
        ],
        "unit": "Match score 0\u2013100",
        "range": "High match: >80 | Low match: <50",
        "subcategory": "Product Matching"
      },
      {
        "src": "blood",
        "insight_type": "health_dashboard",
        "name": "Antioxidant & Phytonutrient Status",
        "desc": "Comprehensive assessment of antioxidant capacity and phytonutrient sufficiency including carotenoids, polyphenols, vitamin C, E, and glutathione levels \u2014 key targets for functional food and beverage formulations.",
        "markers": [
          "ORAC capacity",
          "carotenoids",
          "lycopene",
          "lutein/zeaxanthin",
          "vitamin C",
          "vitamin E",
          "glutathione",
          "CoQ10",
          "resveratrol metabolites",
          "quercetin"
        ],
        "unit": "Composite score",
        "range": "Optimal: >70 | Insufficient: <45",
        "subcategory": "Phytonutrient Assessment"
      }
    ],
    "_marker_count": 25,
    "marker_count": 25,
    "insight_count": 5
  }
];
initOnboarding();









</script>
</body>
</html>
